{
  "AAAP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.63,
    "ebitda": 1580000.0,
    "eps_estimate_current_year": -0.3,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 27.35,
    "fifty_two_week_high": 32.71,
    "fifty_two_week_low": 24.06,
    "percent_change_from_200_day_moving_average": 0.16870000000000002,
    "percent_change_from_50_day_moving_average": 0.16870000000000002,
    "shares_owned": "N/A",
    "short_ratio": 0.03,
    "two_hundred_day_moving_average": 27.35,
    "volume": 95548.0,
    "market_cap": 1080000000.0,
    "price_to_sales_ttm": 10.73,
    "price_to_book_mrq": 9.07,
    "roa_ttm": -0.0291,
    "roe_ttm": -0.1848,
    "shares_outstanding": 33890000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -6400000.0,
    "levered_cash_flow_ttm": -6140000.0,
    "book_value_per_share_mrq": 3.25,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Advanced Accelerator Applications S.A."
  },
  "AAC": {
    "p_e_ratio": 36.46,
    "peg_ratio": 1.21,
    "earnings_per_share": 0.61,
    "ebitda": 32420000.0,
    "eps_estimate_current_year": 0.91,
    "eps_estimate_next_quarter": 0.22,
    "fifty_day_moving_average": 23.11,
    "fifty_two_week_high": 46.6,
    "fifty_two_week_low": 15.09,
    "percent_change_from_200_day_moving_average": -0.245,
    "percent_change_from_50_day_moving_average": -0.0455,
    "shares_owned": "N/A",
    "short_ratio": 31.94,
    "two_hundred_day_moving_average": 29.22,
    "volume": 208764.0,
    "market_cap": 494310000.0,
    "price_to_sales_ttm": 2.9,
    "price_to_book_mrq": 3.64,
    "roa_ttm": 0.08349999999999999,
    "roe_ttm": 0.1423,
    "shares_outstanding": 22410000.0,
    "pcnt_held_by_insiders": 0.6576000000000001,
    "pcnt_held_by_institutions": 0.41600000000000004,
    "pcnt_short_of_float": 0.7112,
    "operating_cash_flow_ttm": 8070000.0,
    "levered_cash_flow_ttm": -44500000.0,
    "book_value_per_share_mrq": 6.24,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "AAC Holdings, Inc."
  },
  "AAVL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.77,
    "ebitda": -43460000.0,
    "eps_estimate_current_year": -1.72,
    "eps_estimate_next_quarter": -0.39,
    "fifty_day_moving_average": 8.97,
    "fifty_two_week_high": 62.48,
    "fifty_two_week_low": 7.4,
    "percent_change_from_200_day_moving_average": -0.305,
    "percent_change_from_50_day_moving_average": 0.0291,
    "shares_owned": "N/A",
    "short_ratio": 5.53,
    "two_hundred_day_moving_average": 13.28,
    "volume": 392232.0,
    "market_cap": 237760000.0,
    "price_to_sales_ttm": 121.71,
    "price_to_book_mrq": 0.87,
    "roa_ttm": -0.12480000000000001,
    "roe_ttm": -0.20929999999999999,
    "shares_outstanding": 25760000.0,
    "pcnt_held_by_insiders": 0.38060000000000005,
    "pcnt_held_by_institutions": 0.5770000000000001,
    "pcnt_short_of_float": 0.1151,
    "operating_cash_flow_ttm": -31270000.0,
    "levered_cash_flow_ttm": -17340000.0,
    "book_value_per_share_mrq": 10.19,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Avalanche Biotechnologies, Inc."
  },
  "ABAX": {
    "p_e_ratio": 36.71,
    "peg_ratio": 2.69,
    "earnings_per_share": 1.39,
    "ebitda": 46270000.0,
    "eps_estimate_current_year": 1.31,
    "eps_estimate_next_quarter": 0.34,
    "fifty_day_moving_average": 52.69,
    "fifty_two_week_high": 66.89,
    "fifty_two_week_low": 41.53,
    "percent_change_from_200_day_moving_average": 0.0259,
    "percent_change_from_50_day_moving_average": -0.0288,
    "shares_owned": "N/A",
    "short_ratio": 19.98,
    "two_hundred_day_moving_average": 49.88,
    "volume": 371249.0,
    "market_cap": 1160000000.0,
    "price_to_sales_ttm": 5.54,
    "price_to_book_mrq": 5.17,
    "roa_ttm": 0.0984,
    "roe_ttm": 0.1143,
    "shares_outstanding": 22720000.0,
    "pcnt_held_by_insiders": 0.0429,
    "pcnt_held_by_institutions": 1.062,
    "pcnt_short_of_float": 0.1873,
    "operating_cash_flow_ttm": 29310000.0,
    "levered_cash_flow_ttm": 36790000.0,
    "book_value_per_share_mrq": 10.24,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Abaxis, Inc."
  },
  "ABEO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -15.26,
    "ebitda": -12350000.0,
    "eps_estimate_current_year": -0.5,
    "eps_estimate_next_quarter": -0.13,
    "fifty_day_moving_average": 4.08,
    "fifty_two_week_high": 11.15,
    "fifty_two_week_low": 2.75,
    "percent_change_from_200_day_moving_average": -0.3012,
    "percent_change_from_50_day_moving_average": -0.13470000000000001,
    "shares_owned": "N/A",
    "short_ratio": 13.49,
    "two_hundred_day_moving_average": 5.05,
    "volume": 72677.0,
    "market_cap": 115550000.0,
    "price_to_sales_ttm": 110.96,
    "price_to_book_mrq": 1.61,
    "roa_ttm": -0.1776,
    "roe_ttm": -0.8661,
    "shares_outstanding": 32729999.999999996,
    "pcnt_held_by_insiders": 0.47700000000000004,
    "pcnt_held_by_institutions": 0.131,
    "pcnt_short_of_float": 0.2992,
    "operating_cash_flow_ttm": -8650000.0,
    "levered_cash_flow_ttm": -12500000.0,
    "book_value_per_share_mrq": 2.23,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Abeona Therapeutics Inc."
  },
  "ABIO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.28,
    "ebitda": -10870000.0,
    "eps_estimate_current_year": -1.75,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 5.35,
    "fifty_two_week_high": 10.85,
    "fifty_two_week_low": 4.55,
    "percent_change_from_200_day_moving_average": -0.2181,
    "percent_change_from_50_day_moving_average": -0.0857,
    "shares_owned": "N/A",
    "short_ratio": 1.63,
    "two_hundred_day_moving_average": 6.25,
    "volume": 16359.0,
    "market_cap": 44260000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.07,
    "roa_ttm": -0.2253,
    "roe_ttm": -0.3736,
    "shares_outstanding": 9050000.0,
    "pcnt_held_by_insiders": 0.0274,
    "pcnt_held_by_institutions": 0.588,
    "pcnt_short_of_float": 0.0775,
    "operating_cash_flow_ttm": -9790000.0,
    "levered_cash_flow_ttm": -5560000.0,
    "book_value_per_share_mrq": 4.54,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ARCA biopharma, Inc."
  },
  "ABMD": {
    "p_e_ratio": 30.25,
    "peg_ratio": 7.36,
    "earnings_per_share": 2.9,
    "ebitda": 58500000.0,
    "eps_estimate_current_year": 0.7,
    "eps_estimate_next_quarter": 0.17,
    "fifty_day_moving_average": 81.42,
    "fifty_two_week_high": 110.68,
    "fifty_two_week_low": 35.75,
    "percent_change_from_200_day_moving_average": 0.0545,
    "percent_change_from_50_day_moving_average": 0.0759,
    "shares_owned": "N/A",
    "short_ratio": 2.88,
    "two_hundred_day_moving_average": 83.07,
    "volume": 638730.0,
    "market_cap": 3720000000.0,
    "price_to_sales_ttm": 12.95,
    "price_to_book_mrq": 10.93,
    "roa_ttm": 0.11800000000000001,
    "roe_ttm": 0.5059,
    "shares_outstanding": 42420000.0,
    "pcnt_held_by_insiders": 0.0215,
    "pcnt_held_by_institutions": 0.985,
    "pcnt_short_of_float": 0.0501,
    "operating_cash_flow_ttm": 62240000.0,
    "levered_cash_flow_ttm": 11590000.0,
    "book_value_per_share_mrq": 7.84,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "ABIOMED, Inc."
  },
  "ABUS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.62,
    "ebitda": 0.0,
    "eps_estimate_current_year": -0.41,
    "eps_estimate_next_quarter": -0.38,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 4.94,
    "fifty_two_week_low": 4.64,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 9.8,
    "two_hundred_day_moving_average": 0.0,
    "volume": 301871.0,
    "market_cap": 259209999.99999997,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.19,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 54570000.0,
    "pcnt_held_by_insiders": 0.0816,
    "pcnt_held_by_institutions": 0.67,
    "pcnt_short_of_float": 0.0857,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 3.92,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Arbutus Biopharma Corporation"
  },
  "ACAD": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.13,
    "earnings_per_share": -1.48,
    "ebitda": -138020000.0,
    "eps_estimate_current_year": -1.52,
    "eps_estimate_next_quarter": -0.42,
    "fifty_day_moving_average": 36.35,
    "fifty_two_week_high": 51.99,
    "fifty_two_week_low": 29.41,
    "percent_change_from_200_day_moving_average": -0.1359,
    "percent_change_from_50_day_moving_average": -0.0729,
    "shares_owned": "N/A",
    "short_ratio": 9.23,
    "two_hundred_day_moving_average": 39.0,
    "volume": 2204885.0,
    "market_cap": 3400000000.0,
    "price_to_sales_ttm": 37819.69,
    "price_to_book_mrq": 15.3,
    "roa_ttm": -0.29510000000000003,
    "roe_ttm": -0.5271,
    "shares_outstanding": 100910000.0,
    "pcnt_held_by_insiders": 0.0031,
    "pcnt_held_by_institutions": 0.992,
    "pcnt_short_of_float": 0.20829999999999999,
    "operating_cash_flow_ttm": -104870000.0,
    "levered_cash_flow_ttm": -44460000.0,
    "book_value_per_share_mrq": 2.25,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ACADIA Pharmaceuticals Inc."
  },
  "ACHC": {
    "p_e_ratio": 40.16,
    "peg_ratio": 1.03,
    "earnings_per_share": 1.52,
    "ebitda": 341750000.0,
    "eps_estimate_current_year": 2.22,
    "eps_estimate_next_quarter": 0.6,
    "fifty_day_moving_average": 67.09,
    "fifty_two_week_high": 85.62,
    "fifty_two_week_low": 54.41,
    "percent_change_from_200_day_moving_average": -0.152,
    "percent_change_from_50_day_moving_average": -0.0901,
    "shares_owned": "N/A",
    "short_ratio": 5.5,
    "two_hundred_day_moving_average": 71.99,
    "volume": 672863.0,
    "market_cap": 4380000000.0,
    "price_to_sales_ttm": 2.77,
    "price_to_book_mrq": 2.6,
    "roa_ttm": 0.056900000000000006,
    "roe_ttm": 0.07780000000000001,
    "shares_outstanding": 71690000.0,
    "pcnt_held_by_insiders": 0.2341,
    "pcnt_held_by_institutions": 0.8,
    "pcnt_short_of_float": 0.0782,
    "operating_cash_flow_ttm": 188320000.0,
    "levered_cash_flow_ttm": -89720000.0,
    "book_value_per_share_mrq": 23.62,
    "next_earnings_announcement_date": [
      "2016-02-09",
      "2016-02-15"
    ],
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "Acadia Healthcare Company, Inc."
  },
  "ACHN": {
    "p_e_ratio": "N/A",
    "peg_ratio": -4.58,
    "earnings_per_share": -0.37,
    "ebitda": -52630000.0,
    "eps_estimate_current_year": -0.12,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 9.7,
    "fifty_two_week_high": 16.87,
    "fifty_two_week_low": 6.41,
    "percent_change_from_200_day_moving_average": 0.1457,
    "percent_change_from_50_day_moving_average": 0.0115,
    "shares_owned": "N/A",
    "short_ratio": 9.2,
    "two_hundred_day_moving_average": 8.56,
    "volume": 4201444.0,
    "market_cap": 1340000000.0,
    "price_to_sales_ttm": 38.2,
    "price_to_book_mrq": 3.07,
    "roa_ttm": -0.1091,
    "roe_ttm": -0.15869999999999998,
    "shares_outstanding": 136540000.0,
    "pcnt_held_by_insiders": 0.1578,
    "pcnt_held_by_institutions": 0.802,
    "pcnt_short_of_float": 0.1877,
    "operating_cash_flow_ttm": 5010000.0,
    "levered_cash_flow_ttm": 13990000.0,
    "book_value_per_share_mrq": 3.15,
    "next_earnings_announcement_date": [
      "2016-03-03",
      "2016-03-07"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Achillion Pharmaceuticals, Inc."
  },
  "ACOR": {
    "p_e_ratio": 783.08,
    "peg_ratio": 1.45,
    "earnings_per_share": 0.05,
    "ebitda": 69630000.0,
    "eps_estimate_current_year": 0.96,
    "eps_estimate_next_quarter": 0.15,
    "fifty_day_moving_average": 37.67,
    "fifty_two_week_high": 45.45,
    "fifty_two_week_low": 25.5,
    "percent_change_from_200_day_moving_average": 0.2114,
    "percent_change_from_50_day_moving_average": 0.0809,
    "shares_owned": "N/A",
    "short_ratio": 13.66,
    "two_hundred_day_moving_average": 33.62,
    "volume": 1547649.0,
    "market_cap": 1760000000.0,
    "price_to_sales_ttm": 3.61,
    "price_to_book_mrq": 3.01,
    "roa_ttm": 0.0334,
    "roe_ttm": 0.004,
    "shares_outstanding": 43160000.0,
    "pcnt_held_by_insiders": 0.0187,
    "pcnt_held_by_institutions": 1.0759999999999998,
    "pcnt_short_of_float": 0.22649999999999998,
    "operating_cash_flow_ttm": 29740000.0,
    "levered_cash_flow_ttm": 34630000.0,
    "book_value_per_share_mrq": 13.41,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Acorda Therapeutics, Inc."
  },
  "ACRS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -10.32,
    "ebitda": -18410000.0,
    "eps_estimate_current_year": -3.11,
    "eps_estimate_next_quarter": -0.64,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 29.75,
    "fifty_two_week_low": 27.5,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 1.34,
    "two_hundred_day_moving_average": 0.0,
    "volume": 873350.0,
    "market_cap": 578120000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 20160000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0095,
    "operating_cash_flow_ttm": -18990000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -13.96,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Aclaris Therapeutics, Inc."
  },
  "ACRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.65,
    "ebitda": -21540000.0,
    "eps_estimate_current_year": -0.41,
    "eps_estimate_next_quarter": -0.22,
    "fifty_day_moving_average": 4.85,
    "fifty_two_week_high": 9.32,
    "fifty_two_week_low": 2.92,
    "percent_change_from_200_day_moving_average": 0.0706,
    "percent_change_from_50_day_moving_average": -0.07519999999999999,
    "shares_owned": "N/A",
    "short_ratio": 5.75,
    "two_hundred_day_moving_average": 4.19,
    "volume": 1947465.0,
    "market_cap": 199560000.0,
    "price_to_sales_ttm": 10.46,
    "price_to_book_mrq": 4.65,
    "roa_ttm": -0.1285,
    "roe_ttm": -0.5588000000000001,
    "shares_outstanding": 44450000.0,
    "pcnt_held_by_insiders": 0.3447,
    "pcnt_held_by_institutions": 0.41,
    "pcnt_short_of_float": 0.1602,
    "operating_cash_flow_ttm": -35870000.0,
    "levered_cash_flow_ttm": -26220000.0,
    "book_value_per_share_mrq": 0.9,
    "next_earnings_announcement_date": [
      "2016-03-07",
      "2016-03-11"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "AcelRx Pharmaceuticals, Inc."
  },
  "ACST": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.1,
    "ebitda": -6020000.0,
    "eps_estimate_current_year": -1.1,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 4.07,
    "fifty_two_week_high": 65.49,
    "fifty_two_week_low": 1.57,
    "percent_change_from_200_day_moving_average": -0.1618,
    "percent_change_from_50_day_moving_average": -0.2848,
    "shares_owned": "N/A",
    "short_ratio": 0.37,
    "two_hundred_day_moving_average": 3.47,
    "volume": 124540.0,
    "market_cap": 31020000.0,
    "price_to_sales_ttm": 186.35,
    "price_to_book_mrq": 1.31,
    "roa_ttm": -0.1804,
    "roe_ttm": -0.047599999999999996,
    "shares_outstanding": 10660000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0014000000000000002,
    "operating_cash_flow_ttm": -5820000.0,
    "levered_cash_flow_ttm": -3070000.0,
    "book_value_per_share_mrq": 2.1,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Acasti Pharma Inc."
  },
  "ACUR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.66,
    "ebitda": -5320000.0,
    "eps_estimate_current_year": -0.39,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.36,
    "fifty_two_week_high": 6.75,
    "fifty_two_week_low": 1.62,
    "percent_change_from_200_day_moving_average": -0.25920000000000004,
    "percent_change_from_50_day_moving_average": -0.0007000000000000001,
    "shares_owned": "N/A",
    "short_ratio": 3.13,
    "two_hundred_day_moving_average": 3.19,
    "volume": 31210.0,
    "market_cap": 27850000.0,
    "price_to_sales_ttm": 3.67,
    "price_to_book_mrq": 2.71,
    "roa_ttm": -0.18789999999999998,
    "roe_ttm": -0.8304,
    "shares_outstanding": 11800000.0,
    "pcnt_held_by_insiders": 0.4252,
    "pcnt_held_by_institutions": 0.19899999999999998,
    "pcnt_short_of_float": 0.008100000000000001,
    "operating_cash_flow_ttm": -4990000.0,
    "levered_cash_flow_ttm": -3000000.0,
    "book_value_per_share_mrq": 0.74,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Delivery",
    "company_name": "Acura Pharmaceuticals, Inc."
  },
  "ADAP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.4,
    "earnings_per_share": -0.3,
    "ebitda": -27340000.0,
    "eps_estimate_current_year": -0.97,
    "eps_estimate_next_quarter": -0.34,
    "fifty_day_moving_average": 10.02,
    "fifty_two_week_high": 21.57,
    "fifty_two_week_low": 7.07,
    "percent_change_from_200_day_moving_average": -0.2656,
    "percent_change_from_50_day_moving_average": -0.053200000000000004,
    "shares_owned": "N/A",
    "short_ratio": 6.15,
    "two_hundred_day_moving_average": 12.92,
    "volume": 123333.0,
    "market_cap": 671750000.0,
    "price_to_sales_ttm": 49.58,
    "price_to_book_mrq": 2.54,
    "roa_ttm": "N/A",
    "roe_ttm": -0.1512,
    "shares_outstanding": 70780000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -19300000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 3.49,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Adaptimmune Therapeutics plc"
  },
  "ADHD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.12,
    "ebitda": -21510000.0,
    "eps_estimate_current_year": -1.05,
    "eps_estimate_next_quarter": -0.3,
    "fifty_day_moving_average": 6.65,
    "fifty_two_week_high": 9.5,
    "fifty_two_week_low": 3.64,
    "percent_change_from_200_day_moving_average": -0.1826,
    "percent_change_from_50_day_moving_average": -0.1258,
    "shares_owned": "N/A",
    "short_ratio": 9.61,
    "two_hundred_day_moving_average": 7.11,
    "volume": 759845.0,
    "market_cap": 158940000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.53,
    "roa_ttm": -0.3932,
    "roe_ttm": -0.7,
    "shares_outstanding": 27360000.0,
    "pcnt_held_by_insiders": 0.3,
    "pcnt_held_by_institutions": 0.643,
    "pcnt_short_of_float": 0.0613,
    "operating_cash_flow_ttm": -21610000.0,
    "levered_cash_flow_ttm": -13920000.0,
    "book_value_per_share_mrq": 1.66,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Alcobra Ltd."
  },
  "ADK": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.26,
    "ebitda": 22500000.0,
    "eps_estimate_current_year": -0.25,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.81,
    "fifty_two_week_high": 4.5,
    "fifty_two_week_low": 1.9,
    "percent_change_from_200_day_moving_average": -0.36579999999999996,
    "percent_change_from_50_day_moving_average": -0.2389,
    "shares_owned": "N/A",
    "short_ratio": 3.43,
    "two_hundred_day_moving_average": 3.37,
    "volume": 187532.0,
    "market_cap": 42590000.0,
    "price_to_sales_ttm": 0.22,
    "price_to_book_mrq": "N/A",
    "roa_ttm": 0.0461,
    "roe_ttm": 0.0638,
    "shares_outstanding": 19900000.0,
    "pcnt_held_by_insiders": 0.2966,
    "pcnt_held_by_institutions": 0.228,
    "pcnt_short_of_float": 0.006500000000000001,
    "operating_cash_flow_ttm": -13450000.0,
    "levered_cash_flow_ttm": 2460000.0,
    "book_value_per_share_mrq": -0.71,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "AdCare Health Systems, Inc."
  },
  "ADMA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.67,
    "ebitda": -14640000.0,
    "eps_estimate_current_year": -1.72,
    "eps_estimate_next_quarter": -0.35,
    "fifty_day_moving_average": 8.97,
    "fifty_two_week_high": 12.0,
    "fifty_two_week_low": 7.51,
    "percent_change_from_200_day_moving_average": -0.06570000000000001,
    "percent_change_from_50_day_moving_average": -0.053200000000000004,
    "shares_owned": "N/A",
    "short_ratio": 14.28,
    "two_hundred_day_moving_average": 9.09,
    "volume": 27437.0,
    "market_cap": 90950000.0,
    "price_to_sales_ttm": 14.73,
    "price_to_book_mrq": 18.43,
    "roa_ttm": -0.3552,
    "roe_ttm": -2.3943,
    "shares_outstanding": 10710000.0,
    "pcnt_held_by_insiders": 0.2481,
    "pcnt_held_by_institutions": 0.659,
    "pcnt_short_of_float": 0.0263,
    "operating_cash_flow_ttm": -14240000.0,
    "levered_cash_flow_ttm": -10610000.0,
    "book_value_per_share_mrq": 0.46,
    "next_earnings_announcement_date": [
      "2016-03-07",
      "2016-03-11"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ADMA Biologics, Inc."
  },
  "ADMP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.34,
    "ebitda": -14350000.0,
    "eps_estimate_current_year": -0.87,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 4.61,
    "fifty_two_week_high": 7.26,
    "fifty_two_week_low": 3.05,
    "percent_change_from_200_day_moving_average": 0.2966,
    "percent_change_from_50_day_moving_average": 0.1746,
    "shares_owned": "N/A",
    "short_ratio": 7.63,
    "two_hundred_day_moving_average": 4.17,
    "volume": 97138.0,
    "market_cap": 72670000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 5.58,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 13430000.0,
    "pcnt_held_by_insiders": 0.1722,
    "pcnt_held_by_institutions": 0.193,
    "pcnt_short_of_float": 0.022799999999999997,
    "operating_cash_flow_ttm": -10410000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.92,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Delivery",
    "company_name": "Adamis Pharmaceuticals Corporation"
  },
  "ADMS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.06,
    "earnings_per_share": -1.8,
    "ebitda": -23980000.0,
    "eps_estimate_current_year": -3.24,
    "eps_estimate_next_quarter": -0.79,
    "fifty_day_moving_average": 15.78,
    "fifty_two_week_high": 30.86,
    "fifty_two_week_low": 12.73,
    "percent_change_from_200_day_moving_average": -0.2572,
    "percent_change_from_50_day_moving_average": -0.06269999999999999,
    "shares_owned": "N/A",
    "short_ratio": 5.3,
    "two_hundred_day_moving_average": 19.91,
    "volume": 661035.0,
    "market_cap": 272460000.0,
    "price_to_sales_ttm": 8.62,
    "price_to_book_mrq": 2.2,
    "roa_ttm": -0.1101,
    "roe_ttm": -0.2445,
    "shares_outstanding": 18420000.0,
    "pcnt_held_by_insiders": 0.1887,
    "pcnt_held_by_institutions": 0.7609999999999999,
    "pcnt_short_of_float": 0.0571,
    "operating_cash_flow_ttm": -15920000.0,
    "levered_cash_flow_ttm": -3920000.0,
    "book_value_per_share_mrq": 6.73,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Adamas Pharmaceuticals, Inc."
  },
  "ADPT": {
    "p_e_ratio": 47.75,
    "peg_ratio": 0.5,
    "earnings_per_share": 1.11,
    "ebitda": 36910000.0,
    "eps_estimate_current_year": 1.27,
    "eps_estimate_next_quarter": 0.36,
    "fifty_day_moving_average": 58.0,
    "fifty_two_week_high": 123.97,
    "fifty_two_week_low": 30.12,
    "percent_change_from_200_day_moving_average": -0.3832,
    "percent_change_from_50_day_moving_average": -0.0895,
    "shares_owned": "N/A",
    "short_ratio": 9.46,
    "two_hundred_day_moving_average": 85.62,
    "volume": 471061.0,
    "market_cap": 752940000.0,
    "price_to_sales_ttm": 2.22,
    "price_to_book_mrq": 8.13,
    "roa_ttm": 0.0288,
    "roe_ttm": 0.23379999999999998,
    "shares_outstanding": 14260000.0,
    "pcnt_held_by_insiders": 0.6306,
    "pcnt_held_by_institutions": 0.452,
    "pcnt_short_of_float": 1.0009000000000001,
    "operating_cash_flow_ttm": 1260000.0,
    "levered_cash_flow_ttm": -22390000.0,
    "book_value_per_share_mrq": 6.3,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Hospitals",
    "company_name": "Adeptus Health Inc."
  },
  "ADRO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 1.3,
    "earnings_per_share": -0.81,
    "ebitda": -17060000.0,
    "eps_estimate_current_year": -1.04,
    "eps_estimate_next_quarter": -0.35,
    "fifty_day_moving_average": 29.52,
    "fifty_two_week_high": 49.25,
    "fifty_two_week_low": 16.28,
    "percent_change_from_200_day_moving_average": 0.1121,
    "percent_change_from_50_day_moving_average": 0.0015,
    "shares_owned": "N/A",
    "short_ratio": 5.87,
    "two_hundred_day_moving_average": 26.58,
    "volume": 2984540.0,
    "market_cap": 1870000000.0,
    "price_to_sales_ttm": 41.38,
    "price_to_book_mrq": 8.13,
    "roa_ttm": -0.0438,
    "roe_ttm": -0.3235,
    "shares_outstanding": 63220000.0,
    "pcnt_held_by_insiders": 0.6654000000000001,
    "pcnt_held_by_institutions": 0.244,
    "pcnt_short_of_float": 0.09949999999999999,
    "operating_cash_flow_ttm": 182880000.0,
    "levered_cash_flow_ttm": 4540000.0,
    "book_value_per_share_mrq": 3.91,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Aduro BioTech, Inc."
  },
  "ADUS": {
    "p_e_ratio": 21.92,
    "peg_ratio": 1.5,
    "earnings_per_share": 1.1,
    "ebitda": 23930000.0,
    "eps_estimate_current_year": 1.09,
    "eps_estimate_next_quarter": 0.29,
    "fifty_day_moving_average": 22.37,
    "fifty_two_week_high": 38.08,
    "fifty_two_week_low": 18.75,
    "percent_change_from_200_day_moving_average": -0.12990000000000002,
    "percent_change_from_50_day_moving_average": 0.0727,
    "shares_owned": "N/A",
    "short_ratio": 3.43,
    "two_hundred_day_moving_average": 27.58,
    "volume": 96901.0,
    "market_cap": 264700000.0,
    "price_to_sales_ttm": 0.81,
    "price_to_book_mrq": 1.96,
    "roa_ttm": 0.06509999999999999,
    "roe_ttm": 0.0916,
    "shares_outstanding": 11030000.0,
    "pcnt_held_by_insiders": 0.0781,
    "pcnt_held_by_institutions": 0.861,
    "pcnt_short_of_float": 0.0537,
    "operating_cash_flow_ttm": 8220000.000000001,
    "levered_cash_flow_ttm": 683750.0,
    "book_value_per_share_mrq": 12.51,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Home Health Care",
    "company_name": "Addus HomeCare Corporation"
  },
  "ADXS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.53,
    "ebitda": -39000000.0,
    "eps_estimate_current_year": -1.51,
    "eps_estimate_next_quarter": -0.4,
    "fifty_day_moving_average": 11.87,
    "fifty_two_week_high": 30.13,
    "fifty_two_week_low": 5.86,
    "percent_change_from_200_day_moving_average": -0.2194,
    "percent_change_from_50_day_moving_average": 0.0042,
    "shares_owned": "N/A",
    "short_ratio": 14.04,
    "two_hundred_day_moving_average": 15.27,
    "volume": 1888333.0,
    "market_cap": 397720000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.98,
    "roa_ttm": -0.38189999999999996,
    "roe_ttm": -0.6241,
    "shares_outstanding": 33369999.999999996,
    "pcnt_held_by_insiders": 0.0787,
    "pcnt_held_by_institutions": 0.611,
    "pcnt_short_of_float": 0.4572,
    "operating_cash_flow_ttm": -20030000.0,
    "levered_cash_flow_ttm": -8270000.0,
    "book_value_per_share_mrq": 3.1,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Advaxis, Inc."
  },
  "AEGR": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.86,
    "earnings_per_share": -1.57,
    "ebitda": 4240000.0,
    "eps_estimate_current_year": -2.05,
    "eps_estimate_next_quarter": -0.48,
    "fifty_day_moving_average": 10.86,
    "fifty_two_week_high": 28.97,
    "fifty_two_week_low": 8.68,
    "percent_change_from_200_day_moving_average": -0.4291,
    "percent_change_from_50_day_moving_average": -0.17059999999999997,
    "shares_owned": "N/A",
    "short_ratio": 6.61,
    "two_hundred_day_moving_average": 15.78,
    "volume": 4735181.0,
    "market_cap": 260730000.00000003,
    "price_to_sales_ttm": 1.07,
    "price_to_book_mrq": 1.79,
    "roa_ttm": -0.0184,
    "roe_ttm": -0.2926,
    "shares_outstanding": 28940000.0,
    "pcnt_held_by_insiders": 0.1705,
    "pcnt_held_by_institutions": 1.0590000000000002,
    "pcnt_short_of_float": 0.4796,
    "operating_cash_flow_ttm": 33299999.999999996,
    "levered_cash_flow_ttm": -49480000.0,
    "book_value_per_share_mrq": 5.01,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Aegerion Pharmaceuticals, Inc."
  },
  "AEMD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.7,
    "ebitda": -4400000.0,
    "eps_estimate_current_year": -0.5,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 7.24,
    "fifty_two_week_high": 20.0,
    "fifty_two_week_low": 6.0,
    "percent_change_from_200_day_moving_average": -0.053099999999999994,
    "percent_change_from_50_day_moving_average": -0.005699999999999999,
    "shares_owned": "N/A",
    "short_ratio": 4.93,
    "two_hundred_day_moving_average": 7.6,
    "volume": 14846.0,
    "market_cap": 54840000.0,
    "price_to_sales_ttm": 85.98,
    "price_to_book_mrq": 13.52,
    "roa_ttm": -0.9565,
    "roe_ttm": "-1,653.37%",
    "shares_outstanding": 7620000.0,
    "pcnt_held_by_insiders": 0.0913,
    "pcnt_held_by_institutions": 0.002,
    "pcnt_short_of_float": 0.0215,
    "operating_cash_flow_ttm": -5890000.0,
    "levered_cash_flow_ttm": -4480000.0,
    "book_value_per_share_mrq": 0.51,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Aethlon Medical, Inc."
  },
  "AERI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.79,
    "ebitda": -70980000.0,
    "eps_estimate_current_year": -2.41,
    "eps_estimate_next_quarter": -0.79,
    "fifty_day_moving_average": 24.9,
    "fifty_two_week_high": 35.89,
    "fifty_two_week_low": 8.84,
    "percent_change_from_200_day_moving_average": 0.1723,
    "percent_change_from_50_day_moving_average": -0.06559999999999999,
    "shares_owned": "N/A",
    "short_ratio": 7.88,
    "two_hundred_day_moving_average": 19.85,
    "volume": 1091992.0,
    "market_cap": 613510000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 19.2,
    "roa_ttm": -0.255,
    "roe_ttm": -1.8888,
    "shares_outstanding": 26360000.0,
    "pcnt_held_by_insiders": 0.18780000000000002,
    "pcnt_held_by_institutions": 0.915,
    "pcnt_short_of_float": 0.1802,
    "operating_cash_flow_ttm": -52850000.0,
    "levered_cash_flow_ttm": -24620000.0,
    "book_value_per_share_mrq": 1.23,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Aerie Pharmaceuticals, Inc."
  },
  "AEZS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -30.09,
    "ebitda": -34840000.0,
    "eps_estimate_current_year": -2.18,
    "eps_estimate_next_quarter": -1.09,
    "fifty_day_moving_average": 6.14,
    "fifty_two_week_high": 89.0,
    "fifty_two_week_low": 3.19,
    "percent_change_from_200_day_moving_average": -0.659,
    "percent_change_from_50_day_moving_average": -0.25370000000000004,
    "shares_owned": "N/A",
    "short_ratio": 0.11,
    "two_hundred_day_moving_average": 13.43,
    "volume": 624754.0,
    "market_cap": 28980000.0,
    "price_to_sales_ttm": 64.8,
    "price_to_book_mrq": 1.79,
    "roa_ttm": -0.4178,
    "roe_ttm": -3.5782,
    "shares_outstanding": 6330000.0,
    "pcnt_held_by_insiders": 0.0886,
    "pcnt_held_by_institutions": 0.092,
    "pcnt_short_of_float": 0.5334,
    "operating_cash_flow_ttm": -34030000.0,
    "levered_cash_flow_ttm": -4600000.0,
    "book_value_per_share_mrq": 2.6,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Aeterna Zentaris Inc."
  },
  "AFAM": {
    "p_e_ratio": 17.37,
    "peg_ratio": 1.55,
    "earnings_per_share": 2.28,
    "ebitda": 36700000.0,
    "eps_estimate_current_year": 2.11,
    "eps_estimate_next_quarter": 0.56,
    "fifty_day_moving_average": 41.05,
    "fifty_two_week_high": 50.48,
    "fifty_two_week_low": 28.1,
    "percent_change_from_200_day_moving_average": -0.0638,
    "percent_change_from_50_day_moving_average": -0.0355,
    "shares_owned": "N/A",
    "short_ratio": 4.14,
    "two_hundred_day_moving_average": 42.29,
    "volume": 331689.0,
    "market_cap": 388890000.0,
    "price_to_sales_ttm": 0.74,
    "price_to_book_mrq": 1.45,
    "roa_ttm": 0.053099999999999994,
    "roe_ttm": 0.0864,
    "shares_outstanding": 9820000.0,
    "pcnt_held_by_insiders": 0.1561,
    "pcnt_held_by_institutions": 0.728,
    "pcnt_short_of_float": 0.04019999999999999,
    "operating_cash_flow_ttm": 21140000.0,
    "levered_cash_flow_ttm": 12970000.0,
    "book_value_per_share_mrq": 27.08,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Home Health Care",
    "company_name": "Almost Family Inc."
  },
  "AFMD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.81,
    "ebitda": -23770000.0,
    "eps_estimate_current_year": -0.75,
    "eps_estimate_next_quarter": -0.24,
    "fifty_day_moving_average": 6.66,
    "fifty_two_week_high": 24.2,
    "fifty_two_week_low": 5.16,
    "percent_change_from_200_day_moving_average": -0.2365,
    "percent_change_from_50_day_moving_average": 0.15839999999999999,
    "shares_owned": "N/A",
    "short_ratio": 3.75,
    "two_hundred_day_moving_average": 10.1,
    "volume": 1355614.0,
    "market_cap": 229250000.0,
    "price_to_sales_ttm": 31.11,
    "price_to_book_mrq": 3.92,
    "roa_ttm": -0.25079999999999997,
    "roe_ttm": -0.42100000000000004,
    "shares_outstanding": 29730000.0,
    "pcnt_held_by_insiders": 0.6804000000000001,
    "pcnt_held_by_institutions": 0.349,
    "pcnt_short_of_float": 0.0922,
    "operating_cash_flow_ttm": -21650000.0,
    "levered_cash_flow_ttm": -15440000.0,
    "book_value_per_share_mrq": 1.92,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Affimed N.V."
  },
  "AGEN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.36,
    "ebitda": -60450000.0,
    "eps_estimate_current_year": -1.07,
    "eps_estimate_next_quarter": -0.18,
    "fifty_day_moving_average": 4.59,
    "fifty_two_week_high": 10.16,
    "fifty_two_week_low": 3.75,
    "percent_change_from_200_day_moving_average": -0.3165,
    "percent_change_from_50_day_moving_average": -0.02,
    "shares_owned": "N/A",
    "short_ratio": 10.0,
    "two_hundred_day_moving_average": 6.58,
    "volume": 6413438.0,
    "market_cap": 380910000.0,
    "price_to_sales_ttm": 20.47,
    "price_to_book_mrq": 5.0,
    "roa_ttm": -0.23629999999999998,
    "roe_ttm": -1.5615,
    "shares_outstanding": 84650000.0,
    "pcnt_held_by_insiders": 0.1452,
    "pcnt_held_by_institutions": 0.5,
    "pcnt_short_of_float": 0.19899999999999998,
    "operating_cash_flow_ttm": -38090000.0,
    "levered_cash_flow_ttm": -25300000.0,
    "book_value_per_share_mrq": 0.91,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Agenus Inc."
  },
  "AGIO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.82,
    "ebitda": -101970000.0,
    "eps_estimate_current_year": -2.57,
    "eps_estimate_next_quarter": -1.13,
    "fifty_day_moving_average": 62.82,
    "fifty_two_week_high": 138.85,
    "fifty_two_week_low": 48.0,
    "percent_change_from_200_day_moving_average": -0.3515,
    "percent_change_from_50_day_moving_average": -0.1014,
    "shares_owned": "N/A",
    "short_ratio": 8.29,
    "two_hundred_day_moving_average": 87.04,
    "volume": 1674702.0,
    "market_cap": 2120000000.0,
    "price_to_sales_ttm": 30.97,
    "price_to_book_mrq": 5.56,
    "roa_ttm": -0.1818,
    "roe_ttm": -0.3558,
    "shares_outstanding": 37640000.0,
    "pcnt_held_by_insiders": 0.2539,
    "pcnt_held_by_institutions": 0.821,
    "pcnt_short_of_float": 0.2218,
    "operating_cash_flow_ttm": -54190000.0,
    "levered_cash_flow_ttm": -31930000.0,
    "book_value_per_share_mrq": 9.99,
    "next_earnings_announcement_date": [
      "2016-02-15",
      "2016-02-19"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Agios Pharmaceuticals, Inc."
  },
  "AGRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.58,
    "ebitda": -30430000.0,
    "eps_estimate_current_year": -1.56,
    "eps_estimate_next_quarter": -0.42,
    "fifty_day_moving_average": 8.15,
    "fifty_two_week_high": 13.19,
    "fifty_two_week_low": 5.8,
    "percent_change_from_200_day_moving_average": -0.0902,
    "percent_change_from_50_day_moving_average": -0.0528,
    "shares_owned": "N/A",
    "short_ratio": 17.48,
    "two_hundred_day_moving_average": 8.49,
    "volume": 40938.0,
    "market_cap": 172090000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 5.18,
    "roa_ttm": -0.3283,
    "roe_ttm": -0.8861,
    "shares_outstanding": 22290000.0,
    "pcnt_held_by_insiders": 0.1389,
    "pcnt_held_by_institutions": 0.77,
    "pcnt_short_of_float": 0.055,
    "operating_cash_flow_ttm": -25920000.0,
    "levered_cash_flow_ttm": -14580000.0,
    "book_value_per_share_mrq": 1.47,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Agile Therapeutics, Inc."
  },
  "AGTC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.69,
    "ebitda": -27950000.0,
    "eps_estimate_current_year": -0.98,
    "eps_estimate_next_quarter": -0.21,
    "fifty_day_moving_average": 15.88,
    "fifty_two_week_high": 25.42,
    "fifty_two_week_low": 10.89,
    "percent_change_from_200_day_moving_average": 0.11810000000000001,
    "percent_change_from_50_day_moving_average": 0.1295,
    "shares_owned": "N/A",
    "short_ratio": 3.45,
    "two_hundred_day_moving_average": 16.05,
    "volume": 906530.0,
    "market_cap": 322990000.0,
    "price_to_sales_ttm": 25.59,
    "price_to_book_mrq": 3.34,
    "roa_ttm": -0.11230000000000001,
    "roe_ttm": -0.2816,
    "shares_outstanding": 18000000.0,
    "pcnt_held_by_insiders": 0.5115,
    "pcnt_held_by_institutions": 0.523,
    "pcnt_short_of_float": 0.030699999999999998,
    "operating_cash_flow_ttm": 79510000.0,
    "levered_cash_flow_ttm": 37830000.0,
    "book_value_per_share_mrq": 5.42,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Applied Genetic Technologies Corporation"
  },
  "AHPI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.2,
    "ebitda": -336566.0,
    "eps_estimate_current_year": "nan",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.19,
    "fifty_two_week_high": 1.9,
    "fifty_two_week_low": 0.99,
    "percent_change_from_200_day_moving_average": -0.2314,
    "percent_change_from_50_day_moving_average": -0.1168,
    "shares_owned": "N/A",
    "short_ratio": 1.76,
    "two_hundred_day_moving_average": 1.37,
    "volume": 11524.0,
    "market_cap": 8430000.0,
    "price_to_sales_ttm": 0.25,
    "price_to_book_mrq": 0.43,
    "roa_ttm": -0.04,
    "roe_ttm": -0.0764,
    "shares_outstanding": 8029999.999999999,
    "pcnt_held_by_insiders": 0.4439,
    "pcnt_held_by_institutions": 0.29600000000000004,
    "pcnt_short_of_float": 0.0031,
    "operating_cash_flow_ttm": 390940.0,
    "levered_cash_flow_ttm": 941010.0,
    "book_value_per_share_mrq": 2.5,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Allied Healthcare Products Inc."
  },
  "AHS": {
    "p_e_ratio": 20.17,
    "peg_ratio": 1.56,
    "earnings_per_share": 1.47,
    "ebitda": 134810000.0,
    "eps_estimate_current_year": 1.6,
    "eps_estimate_next_quarter": 0.39,
    "fifty_day_moving_average": 29.71,
    "fifty_two_week_high": 37.47,
    "fifty_two_week_low": 17.92,
    "percent_change_from_200_day_moving_average": -0.0436,
    "percent_change_from_50_day_moving_average": -0.0012,
    "shares_owned": "N/A",
    "short_ratio": 5.29,
    "two_hundred_day_moving_average": 31.02,
    "volume": 1105490.0,
    "market_cap": 1420000000.0,
    "price_to_sales_ttm": 1.07,
    "price_to_book_mrq": 4.41,
    "roa_ttm": 0.09630000000000001,
    "roe_ttm": 0.2516,
    "shares_outstanding": 47690000.0,
    "pcnt_held_by_insiders": 0.016399999999999998,
    "pcnt_held_by_institutions": 0.93,
    "pcnt_short_of_float": 0.1364,
    "operating_cash_flow_ttm": 60820000.0,
    "levered_cash_flow_ttm": 21330000.0,
    "book_value_per_share_mrq": 6.79,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "AMN Healthcare Services Inc."
  },
  "AIMT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.52,
    "ebitda": -23400000.0,
    "eps_estimate_current_year": -2.15,
    "eps_estimate_next_quarter": -0.59,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 19.84,
    "fifty_two_week_low": 17.9,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 8.44,
    "two_hundred_day_moving_average": 0.0,
    "volume": 369777.0,
    "market_cap": 795130000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.54,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 42250000.0,
    "pcnt_held_by_insiders": 0.2389,
    "pcnt_held_by_institutions": 0.03,
    "pcnt_short_of_float": 0.0305,
    "operating_cash_flow_ttm": -20340000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 5.18,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Aimmune Therapeutics, Inc."
  },
  "AIQ": {
    "p_e_ratio": 11.2,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.83,
    "ebitda": 115540000.0,
    "eps_estimate_current_year": -0.06,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 8.82,
    "fifty_two_week_high": 25.33,
    "fifty_two_week_low": 6.73,
    "percent_change_from_200_day_moving_average": -0.29350000000000004,
    "percent_change_from_50_day_moving_average": 0.054400000000000004,
    "shares_owned": "N/A",
    "short_ratio": 1.74,
    "two_hundred_day_moving_average": 13.16,
    "volume": 47042.0,
    "market_cap": 98190000.0,
    "price_to_sales_ttm": 0.21,
    "price_to_book_mrq": "N/A",
    "roa_ttm": 0.06860000000000001,
    "roe_ttm": "N/A",
    "shares_outstanding": 10560000.0,
    "pcnt_held_by_insiders": 0.625,
    "pcnt_held_by_institutions": 0.39399999999999996,
    "pcnt_short_of_float": 0.031400000000000004,
    "operating_cash_flow_ttm": 96330000.0,
    "levered_cash_flow_ttm": 21270000.0,
    "book_value_per_share_mrq": -15.37,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Alliance Healthcare Services, Inc."
  },
  "AKAO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.15,
    "ebitda": -20170000.0,
    "eps_estimate_current_year": -1.47,
    "eps_estimate_next_quarter": -0.57,
    "fifty_day_moving_average": 5.68,
    "fifty_two_week_high": 14.19,
    "fifty_two_week_low": 5.22,
    "percent_change_from_200_day_moving_average": -0.11630000000000001,
    "percent_change_from_50_day_moving_average": -0.030600000000000002,
    "shares_owned": "N/A",
    "short_ratio": 9.92,
    "two_hundred_day_moving_average": 6.24,
    "volume": 92260.0,
    "market_cap": 101140000.0,
    "price_to_sales_ttm": 4.15,
    "price_to_book_mrq": 1.99,
    "roa_ttm": -0.1661,
    "roe_ttm": -0.3397,
    "shares_outstanding": 18360000.0,
    "pcnt_held_by_insiders": 0.2893,
    "pcnt_held_by_institutions": 0.511,
    "pcnt_short_of_float": 0.0438,
    "operating_cash_flow_ttm": -18410000.0,
    "levered_cash_flow_ttm": -11640000.0,
    "book_value_per_share_mrq": 2.92,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Achaogen, Inc."
  },
  "AKBA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.15,
    "ebitda": -51530000.0,
    "eps_estimate_current_year": -1.76,
    "eps_estimate_next_quarter": -0.75,
    "fifty_day_moving_average": 9.91,
    "fifty_two_week_high": 14.2,
    "fifty_two_week_low": 5.91,
    "percent_change_from_200_day_moving_average": 0.3171,
    "percent_change_from_50_day_moving_average": 0.24559999999999998,
    "shares_owned": "N/A",
    "short_ratio": 10.02,
    "two_hundred_day_moving_average": 9.38,
    "volume": 654564.0,
    "market_cap": 378310000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.31,
    "roa_ttm": -0.23070000000000002,
    "roe_ttm": -0.3956,
    "shares_outstanding": 30630000.0,
    "pcnt_held_by_insiders": 0.33520000000000005,
    "pcnt_held_by_institutions": 0.358,
    "pcnt_short_of_float": 0.1751,
    "operating_cash_flow_ttm": -38700000.0,
    "levered_cash_flow_ttm": -20450000.0,
    "book_value_per_share_mrq": 5.05,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Akebia Therapeutics, Inc."
  },
  "AKER": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.3,
    "ebitda": -5880000.0,
    "eps_estimate_current_year": -1.24,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.07,
    "fifty_two_week_high": 5.28,
    "fifty_two_week_low": 1.22,
    "percent_change_from_200_day_moving_average": -0.6039,
    "percent_change_from_50_day_moving_average": -0.37689999999999996,
    "shares_owned": "N/A",
    "short_ratio": 0.36,
    "two_hundred_day_moving_average": 3.26,
    "volume": 8547.0,
    "market_cap": 6640000.0,
    "price_to_sales_ttm": 2.11,
    "price_to_book_mrq": 0.67,
    "roa_ttm": -0.27899999999999997,
    "roe_ttm": -0.5207999999999999,
    "shares_outstanding": 5140000.0,
    "pcnt_held_by_insiders": 0.19399999999999998,
    "pcnt_held_by_institutions": 0.08800000000000001,
    "pcnt_short_of_float": 0.0019,
    "operating_cash_flow_ttm": -5130000.0,
    "levered_cash_flow_ttm": -2029999.9999999998,
    "book_value_per_share_mrq": 1.9,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Akers Biosciences Inc."
  },
  "AKRX": {
    "p_e_ratio": 107.87,
    "peg_ratio": 0.82,
    "earnings_per_share": 0.33,
    "ebitda": 208270000.0,
    "eps_estimate_current_year": 1.94,
    "eps_estimate_next_quarter": 0.47,
    "fifty_day_moving_average": 32.19,
    "fifty_two_week_high": 57.1,
    "fifty_two_week_low": 19.08,
    "percent_change_from_200_day_moving_average": -0.044800000000000006,
    "percent_change_from_50_day_moving_average": 0.1192,
    "shares_owned": "N/A",
    "short_ratio": 7.32,
    "two_hundred_day_moving_average": 37.72,
    "volume": 2817779.0,
    "market_cap": 4120000000.0,
    "price_to_sales_ttm": 6.74,
    "price_to_book_mrq": 10.14,
    "roa_ttm": 0.08,
    "roe_ttm": 0.1108,
    "shares_outstanding": 114430000.0,
    "pcnt_held_by_insiders": 0.2733,
    "pcnt_held_by_institutions": 0.752,
    "pcnt_short_of_float": 0.1216,
    "operating_cash_flow_ttm": 30920000.0,
    "levered_cash_flow_ttm": -201080000.0,
    "book_value_per_share_mrq": 3.46,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Akorn, Inc."
  },
  "ALDR": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.73,
    "earnings_per_share": -1.77,
    "ebitda": -66120000.00000001,
    "eps_estimate_current_year": -2.11,
    "eps_estimate_next_quarter": -0.64,
    "fifty_day_moving_average": 35.83,
    "fifty_two_week_high": 54.9,
    "fifty_two_week_low": 22.23,
    "percent_change_from_200_day_moving_average": -0.08539999999999999,
    "percent_change_from_50_day_moving_average": 0.0116,
    "shares_owned": "N/A",
    "short_ratio": 10.36,
    "two_hundred_day_moving_average": 39.63,
    "volume": 843300.0,
    "market_cap": 1580000000.0,
    "price_to_sales_ttm": 245.23,
    "price_to_book_mrq": 3.83,
    "roa_ttm": -0.16649999999999998,
    "roe_ttm": -0.278,
    "shares_outstanding": 43610000.0,
    "pcnt_held_by_insiders": 0.3394,
    "pcnt_held_by_institutions": 0.738,
    "pcnt_short_of_float": 0.2231,
    "operating_cash_flow_ttm": -66610000.0,
    "levered_cash_flow_ttm": -40070000.0,
    "book_value_per_share_mrq": 9.44,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Alder Biopharmaceuticals Inc."
  },
  "ALDX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.35,
    "ebitda": -10050000.0,
    "eps_estimate_current_year": -1.3,
    "eps_estimate_next_quarter": -0.43,
    "fifty_day_moving_average": 7.12,
    "fifty_two_week_high": 13.5,
    "fifty_two_week_low": 4.84,
    "percent_change_from_200_day_moving_average": -0.0895,
    "percent_change_from_50_day_moving_average": -0.051399999999999994,
    "shares_owned": "N/A",
    "short_ratio": 2.69,
    "two_hundred_day_moving_average": 7.41,
    "volume": 6699.0,
    "market_cap": 65560000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.35,
    "roa_ttm": -0.3016,
    "roe_ttm": -0.5508,
    "shares_outstanding": 9710000.0,
    "pcnt_held_by_insiders": 0.38539999999999996,
    "pcnt_held_by_institutions": 0.435,
    "pcnt_short_of_float": 0.011899999999999999,
    "operating_cash_flow_ttm": -7940000.0,
    "levered_cash_flow_ttm": -4179999.9999999995,
    "book_value_per_share_mrq": 2.95,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Aldeyra Therapeutics, Inc."
  },
  "ALGN": {
    "p_e_ratio": 38.88,
    "peg_ratio": 2.26,
    "earnings_per_share": 1.65,
    "ebitda": 198320000.0,
    "eps_estimate_current_year": 1.67,
    "eps_estimate_next_quarter": 0.46,
    "fifty_day_moving_average": 66.09,
    "fifty_two_week_high": 68.48,
    "fifty_two_week_low": 51.65,
    "percent_change_from_200_day_moving_average": 0.0385,
    "percent_change_from_50_day_moving_average": -0.0292,
    "shares_owned": "N/A",
    "short_ratio": 11.72,
    "two_hundred_day_moving_average": 61.78,
    "volume": 659659.0,
    "market_cap": 5100000000.0,
    "price_to_sales_ttm": 6.33,
    "price_to_book_mrq": 6.46,
    "roa_ttm": 0.1114,
    "roe_ttm": 0.1771,
    "shares_outstanding": 79490000.0,
    "pcnt_held_by_insiders": 0.1043,
    "pcnt_held_by_institutions": 0.927,
    "pcnt_short_of_float": 0.09140000000000001,
    "operating_cash_flow_ttm": 230250000.0,
    "levered_cash_flow_ttm": 144630000.0,
    "book_value_per_share_mrq": 10.03,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Align Technology Inc."
  },
  "ALIM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.68,
    "ebitda": -37790000.0,
    "eps_estimate_current_year": -0.66,
    "eps_estimate_next_quarter": -0.16,
    "fifty_day_moving_average": 3.05,
    "fifty_two_week_high": 5.95,
    "fifty_two_week_low": 1.94,
    "percent_change_from_200_day_moving_average": -0.20170000000000002,
    "percent_change_from_50_day_moving_average": -0.07,
    "shares_owned": "N/A",
    "short_ratio": 14.91,
    "two_hundred_day_moving_average": 3.56,
    "volume": 1808009.0,
    "market_cap": 126510000.0,
    "price_to_sales_ttm": 7.18,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.2913,
    "roe_ttm": -1.4039,
    "shares_outstanding": 44550000.0,
    "pcnt_held_by_insiders": 0.3666,
    "pcnt_held_by_institutions": 0.601,
    "pcnt_short_of_float": 0.0907,
    "operating_cash_flow_ttm": -45620000.0,
    "levered_cash_flow_ttm": -79970000.0,
    "book_value_per_share_mrq": -0.8,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Alimera Sciences, Inc."
  },
  "ALNY": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.59,
    "earnings_per_share": -2.69,
    "ebitda": -231890000.0,
    "eps_estimate_current_year": -3.28,
    "eps_estimate_next_quarter": -0.97,
    "fifty_day_moving_average": 99.77,
    "fifty_two_week_high": 140.0,
    "fifty_two_week_low": 71.14,
    "percent_change_from_200_day_moving_average": -0.16440000000000002,
    "percent_change_from_50_day_moving_average": -0.1085,
    "shares_owned": "N/A",
    "short_ratio": 4.48,
    "two_hundred_day_moving_average": 106.45,
    "volume": 1491855.0,
    "market_cap": 7540000000.0,
    "price_to_sales_ttm": 129.8,
    "price_to_book_mrq": 5.65,
    "roa_ttm": -0.1286,
    "roe_ttm": -0.19829999999999998,
    "shares_outstanding": 84740000.0,
    "pcnt_held_by_insiders": 0.1286,
    "pcnt_held_by_institutions": 0.79,
    "pcnt_short_of_float": 0.0638,
    "operating_cash_flow_ttm": -172710000.0,
    "levered_cash_flow_ttm": -121390000.0,
    "book_value_per_share_mrq": 15.6,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Alnylam Pharmaceuticals, Inc."
  },
  "ALOG": {
    "p_e_ratio": 33.19,
    "peg_ratio": 1.33,
    "earnings_per_share": 2.48,
    "ebitda": 63820000.0,
    "eps_estimate_current_year": 4.18,
    "eps_estimate_next_quarter": 1.11,
    "fifty_day_moving_average": 85.15,
    "fifty_two_week_high": 92.31,
    "fifty_two_week_low": 75.47,
    "percent_change_from_200_day_moving_average": -0.0053,
    "percent_change_from_50_day_moving_average": -0.0338,
    "shares_owned": "N/A",
    "short_ratio": 12.36,
    "two_hundred_day_moving_average": 82.71,
    "volume": 242177.0,
    "market_cap": 1020000000.0,
    "price_to_sales_ttm": 1.92,
    "price_to_book_mrq": 1.95,
    "roa_ttm": 0.0415,
    "roe_ttm": 0.0601,
    "shares_outstanding": 12410000.0,
    "pcnt_held_by_insiders": 0.010700000000000001,
    "pcnt_held_by_institutions": 1.033,
    "pcnt_short_of_float": 0.0754,
    "operating_cash_flow_ttm": 38390000.0,
    "levered_cash_flow_ttm": 25190000.0,
    "book_value_per_share_mrq": 42.68,
    "next_earnings_announcement_date": [
      "2016-03-08",
      "2016-03-14"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Analogic Corporation"
  },
  "ALQA": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.11,
    "earnings_per_share": -1.34,
    "ebitda": -22910000.0,
    "eps_estimate_current_year": -1.3,
    "eps_estimate_next_quarter": -0.25,
    "fifty_day_moving_average": 2.62,
    "fifty_two_week_high": 6.55,
    "fifty_two_week_low": 1.86,
    "percent_change_from_200_day_moving_average": -0.4961,
    "percent_change_from_50_day_moving_average": -0.2162,
    "shares_owned": "N/A",
    "short_ratio": 4.4,
    "two_hundred_day_moving_average": 4.07,
    "volume": 121609.0,
    "market_cap": 56720000.0,
    "price_to_sales_ttm": 4.78,
    "price_to_book_mrq": 1.04,
    "roa_ttm": -0.2458,
    "roe_ttm": -0.6723,
    "shares_outstanding": 27670000.0,
    "pcnt_held_by_insiders": 0.1776,
    "pcnt_held_by_institutions": 0.39299999999999996,
    "pcnt_short_of_float": 0.0329,
    "operating_cash_flow_ttm": -20270000.0,
    "levered_cash_flow_ttm": -366590.0,
    "book_value_per_share_mrq": 1.97,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Alliqua BioMedical, Inc."
  },
  "ALR": {
    "p_e_ratio": 10.1,
    "peg_ratio": 1.74,
    "earnings_per_share": 3.79,
    "ebitda": 552000000.0,
    "eps_estimate_current_year": 2.24,
    "eps_estimate_next_quarter": 0.58,
    "fifty_day_moving_average": 41.13,
    "fifty_two_week_high": 55.99,
    "fifty_two_week_low": 36.37,
    "percent_change_from_200_day_moving_average": -0.2107,
    "percent_change_from_50_day_moving_average": -0.0709,
    "shares_owned": "N/A",
    "short_ratio": 3.34,
    "two_hundred_day_moving_average": 48.41,
    "volume": 690475.0,
    "market_cap": 3300000000.0,
    "price_to_sales_ttm": 1.35,
    "price_to_book_mrq": 2.26,
    "roa_ttm": 0.0218,
    "roe_ttm": -0.0064,
    "shares_outstanding": 86260000.0,
    "pcnt_held_by_insiders": 0.04650000000000001,
    "pcnt_held_by_institutions": 0.991,
    "pcnt_short_of_float": 0.0409,
    "operating_cash_flow_ttm": 153340000.0,
    "levered_cash_flow_ttm": 41020000.0,
    "book_value_per_share_mrq": 17.3,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Alere Inc."
  },
  "ALXA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.27,
    "ebitda": -31500000.0,
    "eps_estimate_current_year": -1.25,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.99,
    "fifty_two_week_high": 2.68,
    "fifty_two_week_low": 0.8,
    "percent_change_from_200_day_moving_average": -0.2064,
    "percent_change_from_50_day_moving_average": -0.0875,
    "shares_owned": "N/A",
    "short_ratio": 12.7,
    "two_hundred_day_moving_average": 1.13,
    "volume": 72824.0,
    "market_cap": 17620000.0,
    "price_to_sales_ttm": 3.03,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.47130000000000005,
    "roe_ttm": "N/A",
    "shares_outstanding": 19580000.0,
    "pcnt_held_by_insiders": 0.2227,
    "pcnt_held_by_institutions": 0.221,
    "pcnt_short_of_float": 0.0288,
    "operating_cash_flow_ttm": -35450000.0,
    "levered_cash_flow_ttm": -16440000.000000002,
    "book_value_per_share_mrq": -3.52,
    "next_earnings_announcement_date": [
      "2016-03-07",
      "2016-03-11"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Alexza Pharmaceuticals Inc."
  },
  "AMAG": {
    "p_e_ratio": 5.72,
    "peg_ratio": 0.02,
    "earnings_per_share": 4.86,
    "ebitda": 190520000.0,
    "eps_estimate_current_year": 4.63,
    "eps_estimate_next_quarter": 1.24,
    "fifty_day_moving_average": 28.98,
    "fifty_two_week_high": 77.73,
    "fifty_two_week_low": 25.26,
    "percent_change_from_200_day_moving_average": -0.46009999999999995,
    "percent_change_from_50_day_moving_average": -0.04,
    "shares_owned": "N/A",
    "short_ratio": 3.7,
    "two_hundred_day_moving_average": 51.52,
    "volume": 2803554.0,
    "market_cap": 965470000.0,
    "price_to_sales_ttm": 2.66,
    "price_to_book_mrq": 1.05,
    "roa_ttm": 0.0552,
    "roe_ttm": 0.3019,
    "shares_outstanding": 34700000.0,
    "pcnt_held_by_insiders": 0.1268,
    "pcnt_held_by_institutions": 1.068,
    "pcnt_short_of_float": 0.22460000000000002,
    "operating_cash_flow_ttm": 79890000.0,
    "levered_cash_flow_ttm": 177550000.0,
    "book_value_per_share_mrq": 26.51,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "AMAG Pharmaceuticals, Inc."
  },
  "AMDA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.74,
    "ebitda": -11020000.0,
    "eps_estimate_current_year": -0.44,
    "eps_estimate_next_quarter": -0.05,
    "fifty_day_moving_average": 0.1552,
    "fifty_two_week_high": 1.12,
    "fifty_two_week_low": 0.09,
    "percent_change_from_200_day_moving_average": -0.708674,
    "percent_change_from_50_day_moving_average": -0.299483,
    "shares_owned": "N/A",
    "short_ratio": 0.17,
    "two_hundred_day_moving_average": 0.3731,
    "volume": 5686933.0,
    "market_cap": 14030000.0,
    "price_to_sales_ttm": 0.7,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.20829999999999999,
    "roe_ttm": -6.082999999999999,
    "shares_outstanding": 129039999.99999999,
    "pcnt_held_by_insiders": 0.0696,
    "pcnt_held_by_institutions": 0.047,
    "pcnt_short_of_float": 0.023,
    "operating_cash_flow_ttm": -10150000.0,
    "levered_cash_flow_ttm": -2230000.0,
    "book_value_per_share_mrq": -0.02,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Amedica Corporation"
  },
  "AMED": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.39,
    "earnings_per_share": -0.21,
    "ebitda": 89110000.0,
    "eps_estimate_current_year": 1.43,
    "eps_estimate_next_quarter": 0.39,
    "fifty_day_moving_average": 40.82,
    "fifty_two_week_high": 48.34,
    "fifty_two_week_low": 24.81,
    "percent_change_from_200_day_moving_average": 0.006,
    "percent_change_from_50_day_moving_average": 0.0016,
    "shares_owned": "N/A",
    "short_ratio": 3.62,
    "two_hundred_day_moving_average": 40.64,
    "volume": 638747.0,
    "market_cap": 1380000000.0,
    "price_to_sales_ttm": 1.13,
    "price_to_book_mrq": 3.54,
    "roa_ttm": 0.0622,
    "roe_ttm": -0.015600000000000001,
    "shares_outstanding": 33690000.0,
    "pcnt_held_by_insiders": 0.0213,
    "pcnt_held_by_institutions": 0.895,
    "pcnt_short_of_float": 0.054299999999999994,
    "operating_cash_flow_ttm": 92340000.0,
    "levered_cash_flow_ttm": 21680000.0,
    "book_value_per_share_mrq": 11.68,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Home Health Care",
    "company_name": "Amedisys Inc."
  },
  "AMEH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.93,
    "ebitda": -2920000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 6.14,
    "fifty_two_week_high": 10.0,
    "fifty_two_week_low": 0.45,
    "percent_change_from_200_day_moving_average": -0.22940000000000002,
    "percent_change_from_50_day_moving_average": -0.1445,
    "shares_owned": "N/A",
    "short_ratio": 0.0,
    "two_hundred_day_moving_average": 6.81,
    "volume": 0.0,
    "market_cap": 25530000.0,
    "price_to_sales_ttm": 0.66,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.1344,
    "roe_ttm": "N/A",
    "shares_outstanding": 4860000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": null,
    "operating_cash_flow_ttm": 1520000.0,
    "levered_cash_flow_ttm": 4700000.0,
    "book_value_per_share_mrq": -1.17,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "Apollo Medical Holdings, Inc."
  },
  "AMPE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.61,
    "ebitda": -32110000.0,
    "eps_estimate_current_year": -0.61,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.39,
    "fifty_two_week_high": 9.01,
    "fifty_two_week_low": 1.94,
    "percent_change_from_200_day_moving_average": 0.1494,
    "percent_change_from_50_day_moving_average": 0.0023,
    "shares_owned": "N/A",
    "short_ratio": 31.34,
    "two_hundred_day_moving_average": 2.96,
    "volume": 85905.0,
    "market_cap": 176790000.0,
    "price_to_sales_ttm": 245.19,
    "price_to_book_mrq": 3.9,
    "roa_ttm": -0.30870000000000003,
    "roe_ttm": -0.5571,
    "shares_outstanding": 52000000.0,
    "pcnt_held_by_insiders": 0.115,
    "pcnt_held_by_institutions": 0.192,
    "pcnt_short_of_float": 0.1528,
    "operating_cash_flow_ttm": -24440000.0,
    "levered_cash_flow_ttm": -13200000.0,
    "book_value_per_share_mrq": 0.86,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ampio Pharmaceuticals, Inc."
  },
  "AMPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.29,
    "ebitda": -11190000.0,
    "eps_estimate_current_year": -0.19,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 13.97,
    "fifty_two_week_high": 18.3,
    "fifty_two_week_low": 10.57,
    "percent_change_from_200_day_moving_average": -0.0213,
    "percent_change_from_50_day_moving_average": 0.016399999999999998,
    "shares_owned": "N/A",
    "short_ratio": 5.51,
    "two_hundred_day_moving_average": 14.51,
    "volume": 806851.0,
    "market_cap": 639280000.0,
    "price_to_sales_ttm": 2.77,
    "price_to_book_mrq": 2.26,
    "roa_ttm": -0.0392,
    "roe_ttm": -0.0453,
    "shares_outstanding": 45020000.0,
    "pcnt_held_by_insiders": 0.2724,
    "pcnt_held_by_institutions": 0.305,
    "pcnt_short_of_float": 0.037200000000000004,
    "operating_cash_flow_ttm": 19720000.0,
    "levered_cash_flow_ttm": 6030000.0,
    "book_value_per_share_mrq": 6.28,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Amphastar Pharmaceuticals, Inc."
  },
  "AMRI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 1.21,
    "earnings_per_share": -0.18,
    "ebitda": 44290000.0,
    "eps_estimate_current_year": 0.93,
    "eps_estimate_next_quarter": 0.24,
    "fifty_day_moving_average": 19.64,
    "fifty_two_week_high": 22.48,
    "fifty_two_week_low": 14.34,
    "percent_change_from_200_day_moving_average": -0.001,
    "percent_change_from_50_day_moving_average": 0.0031,
    "shares_owned": "N/A",
    "short_ratio": 20.79,
    "two_hundred_day_moving_average": 19.72,
    "volume": 457670.0,
    "market_cap": 699390000.0,
    "price_to_sales_ttm": 1.89,
    "price_to_book_mrq": 2.37,
    "roa_ttm": 0.018799999999999997,
    "roe_ttm": -0.0223,
    "shares_outstanding": 35500000.0,
    "pcnt_held_by_insiders": 0.1591,
    "pcnt_held_by_institutions": 0.973,
    "pcnt_short_of_float": 0.25780000000000003,
    "operating_cash_flow_ttm": 36490000.0,
    "levered_cash_flow_ttm": -31500000.0,
    "book_value_per_share_mrq": 8.37,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Albany Molecular Research Inc."
  },
  "AMRN": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.02,
    "earnings_per_share": -0.82,
    "ebitda": -98990000.0,
    "eps_estimate_current_year": -0.57,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.98,
    "fifty_two_week_high": 3.33,
    "fifty_two_week_low": 0.93,
    "percent_change_from_200_day_moving_average": -0.1263,
    "percent_change_from_50_day_moving_average": -0.0403,
    "shares_owned": "N/A",
    "short_ratio": 16.17,
    "two_hundred_day_moving_average": 2.17,
    "volume": 6235981.0,
    "market_cap": 348320000.0,
    "price_to_sales_ttm": 4.97,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.3392,
    "roe_ttm": "N/A",
    "shares_outstanding": 183330000.0,
    "pcnt_held_by_insiders": 0.1016,
    "pcnt_held_by_institutions": 0.293,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -73720000.0,
    "levered_cash_flow_ttm": -47810000.0,
    "book_value_per_share_mrq": -0.74,
    "next_earnings_announcement_date": [
      "2016-03-01",
      "2016-03-07"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Amarin Corporation plc"
  },
  "AMS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.32,
    "ebitda": 9090000.0,
    "eps_estimate_current_year": 0.03,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.82,
    "fifty_two_week_high": 3.05,
    "fifty_two_week_low": 1.5,
    "percent_change_from_200_day_moving_average": -0.266,
    "percent_change_from_50_day_moving_average": -0.12619999999999998,
    "shares_owned": "N/A",
    "short_ratio": 1.13,
    "two_hundred_day_moving_average": 2.17,
    "volume": 3002.0,
    "market_cap": 8530000.0,
    "price_to_sales_ttm": 0.52,
    "price_to_book_mrq": 0.43,
    "roa_ttm": 0.029900000000000003,
    "roe_ttm": -0.035699999999999996,
    "shares_outstanding": 5360000.0,
    "pcnt_held_by_insiders": 0.3701,
    "pcnt_held_by_institutions": 0.073,
    "pcnt_short_of_float": 0.001,
    "operating_cash_flow_ttm": 8520000.0,
    "levered_cash_flow_ttm": 9970000.0,
    "book_value_per_share_mrq": 3.69,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "American Shared Hospital Services"
  },
  "AMSG": {
    "p_e_ratio": 31.58,
    "peg_ratio": 1.24,
    "earnings_per_share": 2.42,
    "ebitda": 648770000.0,
    "eps_estimate_current_year": 3.66,
    "eps_estimate_next_quarter": 0.77,
    "fifty_day_moving_average": 81.5,
    "fifty_two_week_high": 87.42,
    "fifty_two_week_low": 52.42,
    "percent_change_from_200_day_moving_average": -0.008100000000000001,
    "percent_change_from_50_day_moving_average": -0.0623,
    "shares_owned": "N/A",
    "short_ratio": 4.5,
    "two_hundred_day_moving_average": 77.04,
    "volume": 3093046.0,
    "market_cap": 4150000000.0000005,
    "price_to_sales_ttm": 1.57,
    "price_to_book_mrq": 2.37,
    "roa_ttm": 0.061900000000000004,
    "roe_ttm": 0.1444,
    "shares_outstanding": 54290000.0,
    "pcnt_held_by_insiders": 0.0219,
    "pcnt_held_by_institutions": 1.038,
    "pcnt_short_of_float": 0.0724,
    "operating_cash_flow_ttm": 563520000.0,
    "levered_cash_flow_ttm": 460040000.0,
    "book_value_per_share_mrq": 33.85,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "AmSurg Corp."
  },
  "ANAC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 5.47,
    "earnings_per_share": -1.2,
    "ebitda": -55830000.0,
    "eps_estimate_current_year": -1.26,
    "eps_estimate_next_quarter": -0.04,
    "fifty_day_moving_average": 111.59,
    "fifty_two_week_high": 156.93,
    "fifty_two_week_low": 29.65,
    "percent_change_from_200_day_moving_average": -0.08130000000000001,
    "percent_change_from_50_day_moving_average": -0.0622,
    "shares_owned": "N/A",
    "short_ratio": 3.8,
    "two_hundred_day_moving_average": 113.91,
    "volume": 965167.0,
    "market_cap": 4620000000.0,
    "price_to_sales_ttm": 67.3,
    "price_to_book_mrq": 85.43,
    "roa_ttm": -0.2032,
    "roe_ttm": -0.88,
    "shares_outstanding": 44120000.0,
    "pcnt_held_by_insiders": 0.10619999999999999,
    "pcnt_held_by_institutions": 0.86,
    "pcnt_short_of_float": 0.0816,
    "operating_cash_flow_ttm": -57860000.0,
    "levered_cash_flow_ttm": -33900000.0,
    "book_value_per_share_mrq": 1.26,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Anacor Pharmaceuticals, Inc."
  },
  "ANGO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 1.36,
    "earnings_per_share": -0.12,
    "ebitda": 49310000.0,
    "eps_estimate_current_year": 0.62,
    "eps_estimate_next_quarter": 0.17,
    "fifty_day_moving_average": 12.16,
    "fifty_two_week_high": 19.8,
    "fifty_two_week_low": 11.14,
    "percent_change_from_200_day_moving_average": -0.12890000000000001,
    "percent_change_from_50_day_moving_average": 0.0168,
    "shares_owned": "N/A",
    "short_ratio": 2.28,
    "two_hundred_day_moving_average": 14.19,
    "volume": 363995.0,
    "market_cap": 448420000.0,
    "price_to_sales_ttm": 1.32,
    "price_to_book_mrq": 0.84,
    "roa_ttm": 0.0161,
    "roe_ttm": -0.0083,
    "shares_outstanding": 36280000.0,
    "pcnt_held_by_insiders": 0.29469999999999996,
    "pcnt_held_by_institutions": 0.6940000000000001,
    "pcnt_short_of_float": 0.018000000000000002,
    "operating_cash_flow_ttm": 25590000.0,
    "levered_cash_flow_ttm": 30080000.0,
    "book_value_per_share_mrq": 15.14,
    "next_earnings_announcement_date": [
      "2016-01-06",
      "2016-01-11"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "AngioDynamics Inc."
  },
  "ANIK": {
    "p_e_ratio": 20.76,
    "peg_ratio": 1.34,
    "earnings_per_share": 1.82,
    "ebitda": 47080000.0,
    "eps_estimate_current_year": 1.88,
    "eps_estimate_next_quarter": 0.25,
    "fifty_day_moving_average": 40.75,
    "fifty_two_week_high": 45.35,
    "fifty_two_week_low": 30.93,
    "percent_change_from_200_day_moving_average": 0.0499,
    "percent_change_from_50_day_moving_average": -0.0719,
    "shares_owned": "N/A",
    "short_ratio": 15.6,
    "two_hundred_day_moving_average": 36.02,
    "volume": 340814.0,
    "market_cap": 553600000.0,
    "price_to_sales_ttm": 6.48,
    "price_to_book_mrq": 2.84,
    "roa_ttm": 0.1321,
    "roe_ttm": 0.149,
    "shares_outstanding": 14640000.0,
    "pcnt_held_by_insiders": 0.0417,
    "pcnt_held_by_institutions": 0.833,
    "pcnt_short_of_float": 0.17920000000000003,
    "operating_cash_flow_ttm": 38550000.0,
    "levered_cash_flow_ttm": 36100000.0,
    "book_value_per_share_mrq": 13.31,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Anika Therapeutics Inc."
  },
  "ANIP": {
    "p_e_ratio": 15.35,
    "peg_ratio": 0.99,
    "earnings_per_share": 2.88,
    "ebitda": 41980000.0,
    "eps_estimate_current_year": 2.7,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 42.82,
    "fifty_two_week_high": 73.54,
    "fifty_two_week_low": 36.15,
    "percent_change_from_200_day_moving_average": -0.13949999999999999,
    "percent_change_from_50_day_moving_average": 0.0329,
    "shares_owned": "N/A",
    "short_ratio": 4.59,
    "two_hundred_day_moving_average": 51.4,
    "volume": 568874.0,
    "market_cap": 508170000.0,
    "price_to_sales_ttm": 6.3,
    "price_to_book_mrq": 3.21,
    "roa_ttm": 0.1148,
    "roe_ttm": 0.26239999999999997,
    "shares_outstanding": 11490000.0,
    "pcnt_held_by_insiders": 0.3408,
    "pcnt_held_by_institutions": 0.58,
    "pcnt_short_of_float": 0.1941,
    "operating_cash_flow_ttm": 23300000.0,
    "levered_cash_flow_ttm": -25720000.0,
    "book_value_per_share_mrq": 13.57,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ANI Pharmaceuticals, Inc."
  },
  "ANTH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.13,
    "ebitda": -34250000.0,
    "eps_estimate_current_year": -1.14,
    "eps_estimate_next_quarter": -0.28,
    "fifty_day_moving_average": 5.3,
    "fifty_two_week_high": 11.65,
    "fifty_two_week_low": 1.46,
    "percent_change_from_200_day_moving_average": -0.3298,
    "percent_change_from_50_day_moving_average": -0.0645,
    "shares_owned": "N/A",
    "short_ratio": 5.54,
    "two_hundred_day_moving_average": 7.4,
    "volume": 1593998.0,
    "market_cap": 197780000.0,
    "price_to_sales_ttm": 159.25,
    "price_to_book_mrq": 4.45,
    "roa_ttm": -0.5806,
    "roe_ttm": -1.4199000000000002,
    "shares_outstanding": 39880000.0,
    "pcnt_held_by_insiders": 0.1246,
    "pcnt_held_by_institutions": 0.445,
    "pcnt_short_of_float": 0.0851,
    "operating_cash_flow_ttm": -27690000.0,
    "levered_cash_flow_ttm": -12410000.0,
    "book_value_per_share_mrq": 1.14,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Anthera Pharmaceuticals, Inc."
  },
  "APHB": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.75,
    "ebitda": -9260000.0,
    "eps_estimate_current_year": -2.73,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.18,
    "fifty_two_week_high": 5.0,
    "fifty_two_week_low": 0.07,
    "percent_change_from_200_day_moving_average": 21.5869,
    "percent_change_from_50_day_moving_average": 23.976799999999997,
    "shares_owned": "N/A",
    "short_ratio": 0.2,
    "two_hundred_day_moving_average": 0.2,
    "volume": 32473.0,
    "market_cap": 27120000.0,
    "price_to_sales_ttm": 65.66,
    "price_to_book_mrq": 1.88,
    "roa_ttm": -0.1813,
    "roe_ttm": 0.0431,
    "shares_outstanding": 5880000.0,
    "pcnt_held_by_insiders": 0.2192,
    "pcnt_held_by_institutions": 0.2,
    "pcnt_short_of_float": 0.0026,
    "operating_cash_flow_ttm": -10660000.0,
    "levered_cash_flow_ttm": -6140000.0,
    "book_value_per_share_mrq": 2.66,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "AmpliPhi Biosciences Corporation"
  },
  "APPY": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.26,
    "ebitda": -7880000.0,
    "eps_estimate_current_year": -0.37,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.31,
    "fifty_two_week_high": 2.09,
    "fifty_two_week_low": 0.22,
    "percent_change_from_200_day_moving_average": -0.1778,
    "percent_change_from_50_day_moving_average": 0.044800000000000006,
    "shares_owned": "N/A",
    "short_ratio": 2.71,
    "two_hundred_day_moving_average": 0.39,
    "volume": 105182.0,
    "market_cap": 9920000.0,
    "price_to_sales_ttm": 55.91,
    "price_to_book_mrq": 0.51,
    "roa_ttm": -0.18789999999999998,
    "roe_ttm": -0.36450000000000005,
    "shares_outstanding": 30990000.0,
    "pcnt_held_by_insiders": 0.0023,
    "pcnt_held_by_institutions": 0.10099999999999999,
    "pcnt_short_of_float": 0.0202,
    "operating_cash_flow_ttm": -7170000.0,
    "levered_cash_flow_ttm": -4490000.0,
    "book_value_per_share_mrq": 0.61,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Venaxis, Inc."
  },
  "APRI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.71,
    "ebitda": -34620000.0,
    "eps_estimate_current_year": -0.45,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 1.12,
    "fifty_two_week_high": 2.75,
    "fifty_two_week_low": 0.82,
    "percent_change_from_200_day_moving_average": -0.3146,
    "percent_change_from_50_day_moving_average": -0.11939999999999999,
    "shares_owned": "N/A",
    "short_ratio": 21.39,
    "two_hundred_day_moving_average": 1.44,
    "volume": 96091.0,
    "market_cap": 49910000.0,
    "price_to_sales_ttm": 11.39,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -1.4847,
    "roe_ttm": "-1,663.60%",
    "shares_outstanding": 50410000.0,
    "pcnt_held_by_insiders": 0.12050000000000001,
    "pcnt_held_by_institutions": 0.19399999999999998,
    "pcnt_short_of_float": 0.07200000000000001,
    "operating_cash_flow_ttm": -30450000.0,
    "levered_cash_flow_ttm": -22170000.0,
    "book_value_per_share_mrq": -0.16,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Apricus Biosciences, Inc."
  },
  "AQXP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.21,
    "ebitda": -23440000.0,
    "eps_estimate_current_year": -1.8,
    "eps_estimate_next_quarter": -0.41,
    "fifty_day_moving_average": 12.64,
    "fifty_two_week_high": 55.75,
    "fifty_two_week_low": 1.38,
    "percent_change_from_200_day_moving_average": 0.0867,
    "percent_change_from_50_day_moving_average": -0.0011,
    "shares_owned": "N/A",
    "short_ratio": 1.97,
    "two_hundred_day_moving_average": 11.62,
    "volume": 717945.0,
    "market_cap": 217390000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.86,
    "roa_ttm": -0.17679999999999998,
    "roe_ttm": -0.3074,
    "shares_outstanding": 17210000.0,
    "pcnt_held_by_insiders": 0.7893000000000001,
    "pcnt_held_by_institutions": 0.157,
    "pcnt_short_of_float": 0.0966,
    "operating_cash_flow_ttm": -23790000.0,
    "levered_cash_flow_ttm": -14100000.0,
    "book_value_per_share_mrq": 6.63,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Aquinox Pharmaceuticals Inc."
  },
  "ARAY": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.11,
    "earnings_per_share": -0.4,
    "ebitda": 446000.0,
    "eps_estimate_current_year": -0.25,
    "eps_estimate_next_quarter": -0.05,
    "fifty_day_moving_average": 6.9,
    "fifty_two_week_high": 10.01,
    "fifty_two_week_low": 4.8,
    "percent_change_from_200_day_moving_average": 0.1076,
    "percent_change_from_50_day_moving_average": 0.0347,
    "shares_owned": "N/A",
    "short_ratio": 12.16,
    "two_hundred_day_moving_average": 6.45,
    "volume": 1602171.0,
    "market_cap": 570270000.0,
    "price_to_sales_ttm": 1.46,
    "price_to_book_mrq": 8.83,
    "roa_ttm": -0.0146,
    "roe_ttm": -0.4368,
    "shares_outstanding": 79870000.0,
    "pcnt_held_by_insiders": 0.0194,
    "pcnt_held_by_institutions": 0.991,
    "pcnt_short_of_float": 0.1722,
    "operating_cash_flow_ttm": 10240000.0,
    "levered_cash_flow_ttm": 3430000.0,
    "book_value_per_share_mrq": 0.8,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Accuray Incorporated"
  },
  "ARDM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.59,
    "ebitda": -8350000.0,
    "eps_estimate_current_year": -1.09,
    "eps_estimate_next_quarter": -0.56,
    "fifty_day_moving_average": 5.57,
    "fifty_two_week_high": 8.22,
    "fifty_two_week_low": 3.51,
    "percent_change_from_200_day_moving_average": -0.4155,
    "percent_change_from_50_day_moving_average": -0.2854,
    "shares_owned": "N/A",
    "short_ratio": 1.39,
    "two_hundred_day_moving_average": 6.81,
    "volume": 120695.0,
    "market_cap": 58610000.0,
    "price_to_sales_ttm": 1.72,
    "price_to_book_mrq": 1.68,
    "roa_ttm": -0.1096,
    "roe_ttm": -0.242,
    "shares_outstanding": 14730000.0,
    "pcnt_held_by_insiders": 0.10220000000000001,
    "pcnt_held_by_institutions": 0.382,
    "pcnt_short_of_float": 0.001,
    "operating_cash_flow_ttm": -8720000.0,
    "levered_cash_flow_ttm": -2590000.0,
    "book_value_per_share_mrq": 2.17,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Delivery",
    "company_name": "Aradigm Corporation"
  },
  "ARDX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.44,
    "earnings_per_share": -0.76,
    "ebitda": -15810000.0,
    "eps_estimate_current_year": -1.47,
    "eps_estimate_next_quarter": -0.38,
    "fifty_day_moving_average": 18.64,
    "fifty_two_week_high": 27.99,
    "fifty_two_week_low": 7.95,
    "percent_change_from_200_day_moving_average": 0.0819,
    "percent_change_from_50_day_moving_average": 0.052199999999999996,
    "shares_owned": "N/A",
    "short_ratio": 9.25,
    "two_hundred_day_moving_average": 18.13,
    "volume": 970923.0,
    "market_cap": 509010000.0,
    "price_to_sales_ttm": 16.67,
    "price_to_book_mrq": 4.04,
    "roa_ttm": -0.08039999999999999,
    "roe_ttm": -0.1761,
    "shares_outstanding": 25960000.0,
    "pcnt_held_by_insiders": 0.1722,
    "pcnt_held_by_institutions": 0.8009999999999999,
    "pcnt_short_of_float": 0.1036,
    "operating_cash_flow_ttm": -54030000.0,
    "levered_cash_flow_ttm": -17410000.0,
    "book_value_per_share_mrq": 4.82,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ardelyx, Inc."
  },
  "ARGS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.64,
    "ebitda": -70570000.0,
    "eps_estimate_current_year": -3.61,
    "eps_estimate_next_quarter": -0.75,
    "fifty_day_moving_average": 3.76,
    "fifty_two_week_high": 10.56,
    "fifty_two_week_low": 1.61,
    "percent_change_from_200_day_moving_average": -0.67,
    "percent_change_from_50_day_moving_average": -0.5085000000000001,
    "shares_owned": "N/A",
    "short_ratio": 11.75,
    "two_hundred_day_moving_average": 5.61,
    "volume": 239097.0,
    "market_cap": 38360000.0,
    "price_to_sales_ttm": 51.29,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.7353000000000001,
    "roe_ttm": -4.4838,
    "shares_outstanding": 20740000.0,
    "pcnt_held_by_insiders": 0.5917,
    "pcnt_held_by_institutions": 0.239,
    "pcnt_short_of_float": 0.0292,
    "operating_cash_flow_ttm": -60280000.0,
    "levered_cash_flow_ttm": -46020000.0,
    "book_value_per_share_mrq": -0.67,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Argos Therapeutics, Inc."
  },
  "ARIA": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.12,
    "earnings_per_share": -0.94,
    "ebitda": -172950000.0,
    "eps_estimate_current_year": -1.21,
    "eps_estimate_next_quarter": -0.34,
    "fifty_day_moving_average": 6.48,
    "fifty_two_week_high": 10.07,
    "fifty_two_week_low": 5.55,
    "percent_change_from_200_day_moving_average": -0.16899999999999998,
    "percent_change_from_50_day_moving_average": -0.049400000000000006,
    "shares_owned": "N/A",
    "short_ratio": 11.4,
    "two_hundred_day_moving_average": 7.41,
    "volume": 11016072.0,
    "market_cap": 1170000000.0,
    "price_to_sales_ttm": 7.9,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.20829999999999999,
    "roe_ttm": "-1,126.11%",
    "shares_outstanding": 189290000.0,
    "pcnt_held_by_insiders": 0.1331,
    "pcnt_held_by_institutions": 0.7090000000000001,
    "pcnt_short_of_float": 0.17350000000000002,
    "operating_cash_flow_ttm": -46520000.0,
    "levered_cash_flow_ttm": -60100000.0,
    "book_value_per_share_mrq": -0.26,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ariad Pharmaceuticals Inc."
  },
  "ARNA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.2,
    "earnings_per_share": -0.47,
    "ebitda": -94480000.0,
    "eps_estimate_current_year": -0.45,
    "eps_estimate_next_quarter": -0.1,
    "fifty_day_moving_average": 1.98,
    "fifty_two_week_high": 6.28,
    "fifty_two_week_low": 1.6,
    "percent_change_from_200_day_moving_average": -0.3674,
    "percent_change_from_50_day_moving_average": -0.04190000000000001,
    "shares_owned": "N/A",
    "short_ratio": 6.87,
    "two_hundred_day_moving_average": 3.0,
    "volume": 15315281.0,
    "market_cap": 460840000.0,
    "price_to_sales_ttm": 11.16,
    "price_to_book_mrq": 5.4,
    "roa_ttm": -0.2238,
    "roe_ttm": -1.3828,
    "shares_outstanding": 242550000.0,
    "pcnt_held_by_insiders": 0.0059,
    "pcnt_held_by_institutions": 0.586,
    "pcnt_short_of_float": 0.1177,
    "operating_cash_flow_ttm": -95640000.0,
    "levered_cash_flow_ttm": -55610000.0,
    "book_value_per_share_mrq": 0.34,
    "next_earnings_announcement_date": [
      "2016-02-29",
      "2016-03-04"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Arena Pharmaceuticals, Inc."
  },
  "ARQL": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.78,
    "earnings_per_share": -0.23,
    "ebitda": -16290000.0,
    "eps_estimate_current_year": -0.24,
    "eps_estimate_next_quarter": -0.07,
    "fifty_day_moving_average": 2.32,
    "fifty_two_week_high": 2.65,
    "fifty_two_week_low": 1.05,
    "percent_change_from_200_day_moving_average": 0.0564,
    "percent_change_from_50_day_moving_average": -0.1158,
    "shares_owned": "N/A",
    "short_ratio": 4.94,
    "two_hundred_day_moving_average": 1.94,
    "volume": 200729.0,
    "market_cap": 128930000.0,
    "price_to_sales_ttm": 11.75,
    "price_to_book_mrq": 4.28,
    "roa_ttm": -0.1784,
    "roe_ttm": -0.3857,
    "shares_outstanding": 62890000.0,
    "pcnt_held_by_insiders": 0.0646,
    "pcnt_held_by_institutions": 0.5379999999999999,
    "pcnt_short_of_float": 0.0148,
    "operating_cash_flow_ttm": -23970000.0,
    "levered_cash_flow_ttm": -12490000.0,
    "book_value_per_share_mrq": 0.5,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ArQule Inc."
  },
  "ARRY": {
    "p_e_ratio": 39.12,
    "peg_ratio": -0.95,
    "earnings_per_share": 0.11,
    "ebitda": -94930000.0,
    "eps_estimate_current_year": -0.48,
    "eps_estimate_next_quarter": -0.16,
    "fifty_day_moving_average": 4.31,
    "fifty_two_week_high": 8.59,
    "fifty_two_week_low": 3.72,
    "percent_change_from_200_day_moving_average": -0.21719999999999998,
    "percent_change_from_50_day_moving_average": 0.026600000000000002,
    "shares_owned": "N/A",
    "short_ratio": 9.77,
    "two_hundred_day_moving_average": 5.65,
    "volume": 7542440.0,
    "market_cap": 630370000.0,
    "price_to_sales_ttm": 12.43,
    "price_to_book_mrq": 27.04,
    "roa_ttm": -0.3812,
    "roe_ttm": "N/A",
    "shares_outstanding": 142620000.0,
    "pcnt_held_by_insiders": 0.11779999999999999,
    "pcnt_held_by_institutions": 0.922,
    "pcnt_short_of_float": 0.20850000000000002,
    "operating_cash_flow_ttm": -6230000.0,
    "levered_cash_flow_ttm": -67960000.0,
    "book_value_per_share_mrq": 0.17,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Array BioPharma Inc."
  },
  "ARWR": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.49,
    "earnings_per_share": -1.6,
    "ebitda": -81600000.0,
    "eps_estimate_current_year": -1.7,
    "eps_estimate_next_quarter": -0.43,
    "fifty_day_moving_average": 5.7,
    "fifty_two_week_high": 9.36,
    "fifty_two_week_low": 4.35,
    "percent_change_from_200_day_moving_average": -0.0195,
    "percent_change_from_50_day_moving_average": 0.049100000000000005,
    "shares_owned": "N/A",
    "short_ratio": 13.71,
    "two_hundred_day_moving_average": 6.1,
    "volume": 2309400.0,
    "market_cap": 356140000.0,
    "price_to_sales_ttm": 954.11,
    "price_to_book_mrq": 3.31,
    "roa_ttm": -0.33299999999999996,
    "roe_ttm": -0.6672,
    "shares_outstanding": 59550000.0,
    "pcnt_held_by_insiders": 0.020499999999999997,
    "pcnt_held_by_institutions": 0.467,
    "pcnt_short_of_float": 0.2534,
    "operating_cash_flow_ttm": -65709999.99999999,
    "levered_cash_flow_ttm": -41240000.0,
    "book_value_per_share_mrq": 1.85,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Arrowhead Research Corp."
  },
  "ASMB": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.92,
    "ebitda": -27240000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 8.9,
    "fifty_two_week_high": 20.5,
    "fifty_two_week_low": 6.56,
    "percent_change_from_200_day_moving_average": -0.39030000000000004,
    "percent_change_from_50_day_moving_average": -0.11460000000000001,
    "shares_owned": "N/A",
    "short_ratio": 9.61,
    "two_hundred_day_moving_average": 12.92,
    "volume": 76006.0,
    "market_cap": 135740000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.06,
    "roa_ttm": -0.1705,
    "roe_ttm": -0.3121,
    "shares_outstanding": 17230000.0,
    "pcnt_held_by_insiders": 0.2039,
    "pcnt_held_by_institutions": 0.613,
    "pcnt_short_of_float": 0.0762,
    "operating_cash_flow_ttm": -16840000.0,
    "levered_cash_flow_ttm": -7150000.0,
    "book_value_per_share_mrq": 7.28,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Assembly Biosciences, Inc."
  },
  "ASND": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.45,
    "earnings_per_share": -1.13,
    "ebitda": -37230000.0,
    "eps_estimate_current_year": -1.6,
    "eps_estimate_next_quarter": -0.57,
    "fifty_day_moving_average": 17.62,
    "fifty_two_week_high": 23.81,
    "fifty_two_week_low": 14.75,
    "percent_change_from_200_day_moving_average": -0.0727,
    "percent_change_from_50_day_moving_average": -0.035699999999999996,
    "shares_owned": "N/A",
    "short_ratio": 8.29,
    "two_hundred_day_moving_average": 18.32,
    "volume": 35936.0,
    "market_cap": 426920000.0,
    "price_to_sales_ttm": 44.63,
    "price_to_book_mrq": 3.04,
    "roa_ttm": -0.2777,
    "roe_ttm": -0.38689999999999997,
    "shares_outstanding": 25130000.0,
    "pcnt_held_by_insiders": 0.06849999999999999,
    "pcnt_held_by_institutions": 0.368,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -44600000.0,
    "levered_cash_flow_ttm": -33259999.999999996,
    "book_value_per_share_mrq": 5.68,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ascendis Pharma A/S"
  },
  "AST": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.4,
    "ebitda": -14600000.0,
    "eps_estimate_current_year": -0.41,
    "eps_estimate_next_quarter": -0.14,
    "fifty_day_moving_average": 4.71,
    "fifty_two_week_high": 15.1,
    "fifty_two_week_low": 3.05,
    "percent_change_from_200_day_moving_average": -0.12480000000000001,
    "percent_change_from_50_day_moving_average": -0.071,
    "shares_owned": "N/A",
    "short_ratio": 12.12,
    "two_hundred_day_moving_average": 5.0,
    "volume": 218008.0,
    "market_cap": 164870000.0,
    "price_to_sales_ttm": 39.97,
    "price_to_book_mrq": 3.82,
    "roa_ttm": -0.2302,
    "roe_ttm": -0.3529,
    "shares_outstanding": 37640000.0,
    "pcnt_held_by_insiders": 0.6933,
    "pcnt_held_by_institutions": 0.113,
    "pcnt_short_of_float": 0.13449999999999998,
    "operating_cash_flow_ttm": -10200000.0,
    "levered_cash_flow_ttm": -11450000.0,
    "book_value_per_share_mrq": 1.12,
    "next_earnings_announcement_date": [
      "2016-03-08",
      "2016-03-14"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Asterias Biotherapeutics, Inc."
  },
  "ATEC": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.22,
    "earnings_per_share": -1.73,
    "ebitda": 22830000.0,
    "eps_estimate_current_year": -0.08,
    "eps_estimate_next_quarter": -0.04,
    "fifty_day_moving_average": 0.25,
    "fifty_two_week_high": 1.54,
    "fifty_two_week_low": 0.18,
    "percent_change_from_200_day_moving_average": -0.6881,
    "percent_change_from_50_day_moving_average": -0.1329,
    "shares_owned": "N/A",
    "short_ratio": 6.76,
    "two_hundred_day_moving_average": 0.71,
    "volume": 706788.0,
    "market_cap": 22160000.0,
    "price_to_sales_ttm": 0.11,
    "price_to_book_mrq": "N/A",
    "roa_ttm": 0.0109,
    "roe_ttm": -1.9388999999999998,
    "shares_outstanding": 100730000.0,
    "pcnt_held_by_insiders": 0.34409999999999996,
    "pcnt_held_by_institutions": 0.315,
    "pcnt_short_of_float": 0.0349,
    "operating_cash_flow_ttm": 5580000.0,
    "levered_cash_flow_ttm": -6200000.0,
    "book_value_per_share_mrq": -0.26,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Alphatec Holdings, Inc."
  },
  "ATHX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.11,
    "earnings_per_share": -0.33,
    "ebitda": -27410000.0,
    "eps_estimate_current_year": -0.34,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 1.04,
    "fifty_two_week_high": 3.43,
    "fifty_two_week_low": 0.9,
    "percent_change_from_200_day_moving_average": -0.0956,
    "percent_change_from_50_day_moving_average": -0.0123,
    "shares_owned": "N/A",
    "short_ratio": 9.74,
    "two_hundred_day_moving_average": 1.14,
    "volume": 360720.0,
    "market_cap": 85780000.0,
    "price_to_sales_ttm": 54.36,
    "price_to_book_mrq": 5.54,
    "roa_ttm": -0.5296,
    "roe_ttm": -1.2556,
    "shares_outstanding": 83290000.0,
    "pcnt_held_by_insiders": 0.0993,
    "pcnt_held_by_institutions": 0.092,
    "pcnt_short_of_float": 0.035,
    "operating_cash_flow_ttm": -14540000.0,
    "levered_cash_flow_ttm": -4360000.0,
    "book_value_per_share_mrq": 0.19,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Athersys, Inc."
  },
  "ATNM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.56,
    "ebitda": -26720000.0,
    "eps_estimate_current_year": -0.54,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.12,
    "fifty_two_week_high": 6.6,
    "fifty_two_week_low": 1.52,
    "percent_change_from_200_day_moving_average": 0.0002,
    "percent_change_from_50_day_moving_average": 0.0725,
    "shares_owned": "N/A",
    "short_ratio": 6.22,
    "two_hundred_day_moving_average": 2.27,
    "volume": 1011678.0,
    "market_cap": 95380000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.07,
    "roa_ttm": -0.8892,
    "roe_ttm": -1.5761,
    "shares_outstanding": 42020000.0,
    "pcnt_held_by_insiders": 0.0038,
    "pcnt_held_by_institutions": 0.062,
    "pcnt_short_of_float": 0.061900000000000004,
    "operating_cash_flow_ttm": -19630000.0,
    "levered_cash_flow_ttm": -15990000.0,
    "book_value_per_share_mrq": 0.55,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Actinium Pharmaceuticals, Inc."
  },
  "ATOS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.62,
    "ebitda": -13920000.0,
    "eps_estimate_current_year": -0.5,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.51,
    "fifty_two_week_high": 2.65,
    "fifty_two_week_low": 0.33,
    "percent_change_from_200_day_moving_average": -0.5952000000000001,
    "percent_change_from_50_day_moving_average": -0.32020000000000004,
    "shares_owned": "N/A",
    "short_ratio": 1.7,
    "two_hundred_day_moving_average": 0.86,
    "volume": 757582.0,
    "market_cap": 10660000.0,
    "price_to_sales_ttm": 2.04,
    "price_to_book_mrq": 1.31,
    "roa_ttm": -0.6142,
    "roe_ttm": -1.3677000000000001,
    "shares_outstanding": 30450000.0,
    "pcnt_held_by_insiders": 0.16469999999999999,
    "pcnt_held_by_institutions": 0.035,
    "pcnt_short_of_float": 0.0154,
    "operating_cash_flow_ttm": -12720000.0,
    "levered_cash_flow_ttm": -7440000.0,
    "book_value_per_share_mrq": 0.3,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Atossa Genetics, Inc."
  },
  "ATRA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.07,
    "ebitda": -42750000.0,
    "eps_estimate_current_year": -1.79,
    "eps_estimate_next_quarter": -0.53,
    "fifty_day_moving_average": 32.17,
    "fifty_two_week_high": 65.56,
    "fifty_two_week_low": 17.2,
    "percent_change_from_200_day_moving_average": -0.42460000000000003,
    "percent_change_from_50_day_moving_average": -0.2515,
    "shares_owned": "N/A",
    "short_ratio": 8.26,
    "two_hundred_day_moving_average": 41.85,
    "volume": 1582579.0,
    "market_cap": 689440000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.93,
    "roa_ttm": -0.1355,
    "roe_ttm": -0.2414,
    "shares_outstanding": 28630000.0,
    "pcnt_held_by_insiders": 0.1005,
    "pcnt_held_by_institutions": 0.49,
    "pcnt_short_of_float": 0.1613,
    "operating_cash_flow_ttm": -30720000.0,
    "levered_cash_flow_ttm": -15310000.0,
    "book_value_per_share_mrq": 11.78,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Atara Biotherapeutics, Inc."
  },
  "ATRC": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.18,
    "earnings_per_share": -0.8,
    "ebitda": -17760000.0,
    "eps_estimate_current_year": -0.95,
    "eps_estimate_next_quarter": -0.27,
    "fifty_day_moving_average": 21.11,
    "fifty_two_week_high": 28.15,
    "fifty_two_week_low": 17.22,
    "percent_change_from_200_day_moving_average": -0.0212,
    "percent_change_from_50_day_moving_average": 0.062400000000000004,
    "shares_owned": "N/A",
    "short_ratio": 14.17,
    "two_hundred_day_moving_average": 22.92,
    "volume": 304323.0,
    "market_cap": 722610000.0,
    "price_to_sales_ttm": 5.82,
    "price_to_book_mrq": 5.03,
    "roa_ttm": -0.0901,
    "roe_ttm": -0.1661,
    "shares_outstanding": 32220000.0,
    "pcnt_held_by_insiders": 0.0541,
    "pcnt_held_by_institutions": 0.9690000000000001,
    "pcnt_short_of_float": 0.0998,
    "operating_cash_flow_ttm": -5780000.0,
    "levered_cash_flow_ttm": -9950000.0,
    "book_value_per_share_mrq": 4.41,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "AtriCure, Inc."
  },
  "ATRI": {
    "p_e_ratio": 25.19,
    "peg_ratio": 0.0,
    "earnings_per_share": 15.24,
    "ebitda": 51500000.0,
    "eps_estimate_current_year": 9.9,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 389.86,
    "fifty_two_week_high": 428.85,
    "fifty_two_week_low": 315.01,
    "percent_change_from_200_day_moving_average": -0.0027,
    "percent_change_from_50_day_moving_average": -0.015,
    "shares_owned": "N/A",
    "short_ratio": 6.22,
    "two_hundred_day_moving_average": 385.05,
    "volume": 12092.0,
    "market_cap": 700420000.0,
    "price_to_sales_ttm": 4.81,
    "price_to_book_mrq": 5.05,
    "roa_ttm": 0.1566,
    "roe_ttm": 0.1957,
    "shares_outstanding": 1820000.0,
    "pcnt_held_by_insiders": 0.2339,
    "pcnt_held_by_institutions": 0.54,
    "pcnt_short_of_float": 0.044500000000000005,
    "operating_cash_flow_ttm": 38450000.0,
    "levered_cash_flow_ttm": 25000000.0,
    "book_value_per_share_mrq": 76.28,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "ATRION Corp."
  },
  "ATRS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.13,
    "earnings_per_share": -0.17,
    "ebitda": -22490000.0,
    "eps_estimate_current_year": -0.13,
    "eps_estimate_next_quarter": -0.02,
    "fifty_day_moving_average": 1.34,
    "fifty_two_week_high": 3.04,
    "fifty_two_week_low": 1.22,
    "percent_change_from_200_day_moving_average": -0.2993,
    "percent_change_from_50_day_moving_average": -0.0579,
    "shares_owned": "N/A",
    "short_ratio": 12.24,
    "two_hundred_day_moving_average": 1.8,
    "volume": 1327155.0,
    "market_cap": 195080000.0,
    "price_to_sales_ttm": 4.8,
    "price_to_book_mrq": 2.79,
    "roa_ttm": -0.1888,
    "roe_ttm": -0.39189999999999997,
    "shares_outstanding": 154830000.0,
    "pcnt_held_by_insiders": 0.1971,
    "pcnt_held_by_institutions": 0.355,
    "pcnt_short_of_float": 0.085,
    "operating_cash_flow_ttm": -31710000.0,
    "levered_cash_flow_ttm": -31090000.0,
    "book_value_per_share_mrq": 0.47,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Antares Pharma Inc."
  },
  "AUPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.66,
    "ebitda": -21290000.0,
    "eps_estimate_current_year": -0.66,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 2.59,
    "fifty_two_week_high": 5.65,
    "fifty_two_week_low": 2.09,
    "percent_change_from_200_day_moving_average": -0.1802,
    "percent_change_from_50_day_moving_average": -0.0034000000000000002,
    "shares_owned": "N/A",
    "short_ratio": 2.14,
    "two_hundred_day_moving_average": 3.15,
    "volume": 31612.0,
    "market_cap": 83300000.0,
    "price_to_sales_ttm": 317.61,
    "price_to_book_mrq": 3.32,
    "roa_ttm": -0.29960000000000003,
    "roe_ttm": -0.5739,
    "shares_outstanding": 32290000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -16270000.0,
    "levered_cash_flow_ttm": -7100000.0,
    "book_value_per_share_mrq": 0.73,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Aurinia Pharmaceuticals Inc."
  },
  "AVEO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.41,
    "ebitda": -4420000.0,
    "eps_estimate_current_year": -0.19,
    "eps_estimate_next_quarter": -0.1,
    "fifty_day_moving_average": 1.16,
    "fifty_two_week_high": 3.5,
    "fifty_two_week_low": 0.75,
    "percent_change_from_200_day_moving_average": -0.2808,
    "percent_change_from_50_day_moving_average": -0.1092,
    "shares_owned": "N/A",
    "short_ratio": 3.08,
    "two_hundred_day_moving_average": 1.43,
    "volume": 615660.0,
    "market_cap": 59920000.0,
    "price_to_sales_ttm": 4.08,
    "price_to_book_mrq": 2.65,
    "roa_ttm": -0.1308,
    "roe_ttm": -0.7672,
    "shares_outstanding": 58180000.0,
    "pcnt_held_by_insiders": 0.0379,
    "pcnt_held_by_institutions": 0.304,
    "pcnt_short_of_float": 0.0304,
    "operating_cash_flow_ttm": -29270000.0,
    "levered_cash_flow_ttm": -22670000.0,
    "book_value_per_share_mrq": 0.41,
    "next_earnings_announcement_date": [
      "2016-03-04",
      "2016-03-08"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "AVEO Pharmaceuticals, Inc."
  },
  "AVGR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -5.38,
    "ebitda": -34080000.0,
    "eps_estimate_current_year": -4.1,
    "eps_estimate_next_quarter": -0.94,
    "fifty_day_moving_average": 16.84,
    "fifty_two_week_high": 20.38,
    "fifty_two_week_low": 9.35,
    "percent_change_from_200_day_moving_average": 0.2829,
    "percent_change_from_50_day_moving_average": 0.1436,
    "shares_owned": "N/A",
    "short_ratio": 13.7,
    "two_hundred_day_moving_average": 15.01,
    "volume": 181851.0,
    "market_cap": 243100000.0,
    "price_to_sales_ttm": 22.65,
    "price_to_book_mrq": 9.25,
    "roa_ttm": -0.5108,
    "roe_ttm": -7.9311,
    "shares_outstanding": 12620000.0,
    "pcnt_held_by_insiders": 0.2588,
    "pcnt_held_by_institutions": 0.38799999999999996,
    "pcnt_short_of_float": 0.1151,
    "operating_cash_flow_ttm": -35420000.0,
    "levered_cash_flow_ttm": -19470000.0,
    "book_value_per_share_mrq": 2.12,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Avinger, Inc."
  },
  "AVXL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.19,
    "ebitda": -3780000.0,
    "eps_estimate_current_year": -0.11,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 7.05,
    "fifty_two_week_high": 14.84,
    "fifty_two_week_low": 3.16,
    "percent_change_from_200_day_moving_average": 0.0418,
    "percent_change_from_50_day_moving_average": 0.0622,
    "shares_owned": "N/A",
    "short_ratio": 0.0,
    "two_hundred_day_moving_average": 7.19,
    "volume": 3265858.0,
    "market_cap": 234480000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 24.46,
    "roa_ttm": -0.2733,
    "roe_ttm": -2.3538,
    "shares_outstanding": 31310000.0,
    "pcnt_held_by_insiders": 0.2433,
    "pcnt_held_by_institutions": 0.006999999999999999,
    "pcnt_short_of_float": null,
    "operating_cash_flow_ttm": -3710000.0,
    "levered_cash_flow_ttm": 1680000.0,
    "book_value_per_share_mrq": 0.31,
    "next_earnings_announcement_date": [
      "2016-12-28",
      "2016-01-01"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Anavex Life Sciences Corp."
  },
  "AXDX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.92,
    "ebitda": -40310000.0,
    "eps_estimate_current_year": -0.98,
    "eps_estimate_next_quarter": -0.3,
    "fifty_day_moving_average": 18.33,
    "fifty_two_week_high": 31.29,
    "fifty_two_week_low": 14.77,
    "percent_change_from_200_day_moving_average": 0.0436,
    "percent_change_from_50_day_moving_average": 0.18289999999999998,
    "shares_owned": "N/A",
    "short_ratio": 51.2,
    "two_hundred_day_moving_average": 20.77,
    "volume": 496246.0,
    "market_cap": 1110000000.0,
    "price_to_sales_ttm": 4868.57,
    "price_to_book_mrq": 24.72,
    "roa_ttm": -0.43579999999999997,
    "roe_ttm": -0.7309,
    "shares_outstanding": 51170000.0,
    "pcnt_held_by_insiders": 0.4594,
    "pcnt_held_by_institutions": 0.35,
    "pcnt_short_of_float": 0.3796,
    "operating_cash_flow_ttm": -30030000.0,
    "levered_cash_flow_ttm": -19040000.0,
    "book_value_per_share_mrq": 0.9,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Accelerate Diagnostics, Inc."
  },
  "AXGN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.7,
    "ebitda": -9090000.0,
    "eps_estimate_current_year": -0.49,
    "eps_estimate_next_quarter": -0.1,
    "fifty_day_moving_average": 5.19,
    "fifty_two_week_high": 5.95,
    "fifty_two_week_low": 2.9,
    "percent_change_from_200_day_moving_average": 0.21170000000000003,
    "percent_change_from_50_day_moving_average": -0.0086,
    "shares_owned": "N/A",
    "short_ratio": 0.58,
    "two_hundred_day_moving_average": 4.25,
    "volume": 55426.0,
    "market_cap": 153910000.0,
    "price_to_sales_ttm": 6.35,
    "price_to_book_mrq": 13.82,
    "roa_ttm": -0.191,
    "roe_ttm": "-3,280.42%",
    "shares_outstanding": 29890000.0,
    "pcnt_held_by_insiders": 0.3089,
    "pcnt_held_by_institutions": 0.26899999999999996,
    "pcnt_short_of_float": 0.0032,
    "operating_cash_flow_ttm": -11220000.0,
    "levered_cash_flow_ttm": -8650000.0,
    "book_value_per_share_mrq": 0.37,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "AxoGen, Inc."
  },
  "AXN": {
    "p_e_ratio": 9.8,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.1,
    "ebitda": 11270000.0,
    "eps_estimate_current_year": -0.06,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.22,
    "fifty_two_week_high": 3.48,
    "fifty_two_week_low": 0.24,
    "percent_change_from_200_day_moving_average": -0.35409999999999997,
    "percent_change_from_50_day_moving_average": -0.1893,
    "shares_owned": "N/A",
    "short_ratio": 1.03,
    "two_hundred_day_moving_average": 1.53,
    "volume": 176483.0,
    "market_cap": 73560000.0,
    "price_to_sales_ttm": 2.37,
    "price_to_book_mrq": 4.63,
    "roa_ttm": 0.1411,
    "roe_ttm": 1.0066,
    "shares_outstanding": 74300000.0,
    "pcnt_held_by_insiders": 0.4205,
    "pcnt_held_by_institutions": 0.003,
    "pcnt_short_of_float": 0.0139,
    "operating_cash_flow_ttm": 5700000.0,
    "levered_cash_flow_ttm": -1110000.0,
    "book_value_per_share_mrq": 0.2,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Aoxing Pharmaceutical Company, Inc."
  },
  "AXON": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.16,
    "ebitda": 0.0,
    "eps_estimate_current_year": -0.78,
    "eps_estimate_next_quarter": -0.18,
    "fifty_day_moving_average": 17.55,
    "fifty_two_week_high": 31.17,
    "fifty_two_week_low": 9.99,
    "percent_change_from_200_day_moving_average": 0.1326,
    "percent_change_from_50_day_moving_average": 0.0235,
    "shares_owned": "N/A",
    "short_ratio": 14.82,
    "two_hundred_day_moving_average": 15.86,
    "volume": 823934.0,
    "market_cap": 1780000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 6.46,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 99150000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.24559999999999998,
    "operating_cash_flow_ttm": -1640000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 3.15,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Axovant Sciences Ltd."
  },
  "AXSM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.93,
    "ebitda": 0.0,
    "eps_estimate_current_year": -0.97,
    "eps_estimate_next_quarter": -0.3,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 9.21,
    "fifty_two_week_low": 8.3,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 0.04,
    "two_hundred_day_moving_average": 0.0,
    "volume": 62658.0,
    "market_cap": 174340000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 19140000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0004,
    "operating_cash_flow_ttm": -7140000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -1.03,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Axsome Therapeutics, Inc."
  },
  "BABY": {
    "p_e_ratio": 39.68,
    "peg_ratio": 1.51,
    "earnings_per_share": 1.21,
    "ebitda": 73510000.0,
    "eps_estimate_current_year": 1.52,
    "eps_estimate_next_quarter": 0.4,
    "fifty_day_moving_average": 48.24,
    "fifty_two_week_high": 51.05,
    "fifty_two_week_low": 29.34,
    "percent_change_from_200_day_moving_average": 0.0947,
    "percent_change_from_50_day_moving_average": -0.005600000000000001,
    "shares_owned": "N/A",
    "short_ratio": 7.39,
    "two_hundred_day_moving_average": 43.82,
    "volume": 966674.0,
    "market_cap": 1560000000.0,
    "price_to_sales_ttm": 4.43,
    "price_to_book_mrq": 4.3,
    "roa_ttm": 0.0855,
    "roe_ttm": 0.1118,
    "shares_outstanding": 32439999.999999996,
    "pcnt_held_by_insiders": 0.0354,
    "pcnt_held_by_institutions": 0.9009999999999999,
    "pcnt_short_of_float": 0.064,
    "operating_cash_flow_ttm": 43890000.0,
    "levered_cash_flow_ttm": 36320000.0,
    "book_value_per_share_mrq": 11.74,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Natus Medical Inc."
  },
  "BCLI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.56,
    "ebitda": -9710000.0,
    "eps_estimate_current_year": -0.65,
    "eps_estimate_next_quarter": -0.25,
    "fifty_day_moving_average": 2.76,
    "fifty_two_week_high": 8.47,
    "fifty_two_week_low": 2.17,
    "percent_change_from_200_day_moving_average": -0.111,
    "percent_change_from_50_day_moving_average": -0.0116,
    "shares_owned": "N/A",
    "short_ratio": 8.66,
    "two_hundred_day_moving_average": 3.07,
    "volume": 24709.0,
    "market_cap": 50500000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.25,
    "roa_ttm": -0.4119,
    "roe_ttm": -0.8053,
    "shares_outstanding": 18500000.0,
    "pcnt_held_by_insiders": 0.1519,
    "pcnt_held_by_institutions": 0.09699999999999999,
    "pcnt_short_of_float": 0.0341,
    "operating_cash_flow_ttm": -8119999.999999999,
    "levered_cash_flow_ttm": -4560000.0,
    "book_value_per_share_mrq": 0.84,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Brainstorm Cell Therapeutics Inc."
  },
  "BCRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.67,
    "earnings_per_share": -0.5,
    "ebitda": -37230000.0,
    "eps_estimate_current_year": -0.62,
    "eps_estimate_next_quarter": -0.18,
    "fifty_day_moving_average": 9.98,
    "fifty_two_week_high": 16.83,
    "fifty_two_week_low": 7.85,
    "percent_change_from_200_day_moving_average": -0.1438,
    "percent_change_from_50_day_moving_average": 0.028900000000000002,
    "shares_owned": "N/A",
    "short_ratio": 14.1,
    "two_hundred_day_moving_average": 11.99,
    "volume": 3743769.0,
    "market_cap": 753170000.0,
    "price_to_sales_ttm": 15.37,
    "price_to_book_mrq": 11.79,
    "roa_ttm": -0.16940000000000002,
    "roe_ttm": -0.49570000000000003,
    "shares_outstanding": 73340000.0,
    "pcnt_held_by_insiders": 0.0138,
    "pcnt_held_by_institutions": 0.875,
    "pcnt_short_of_float": 0.2125,
    "operating_cash_flow_ttm": -12180000.0,
    "levered_cash_flow_ttm": -7280000.0,
    "book_value_per_share_mrq": 0.87,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "BioCryst Pharmaceuticals, Inc."
  },
  "BDSI": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.61,
    "earnings_per_share": -1.26,
    "ebitda": -63200000.0,
    "eps_estimate_current_year": -0.32,
    "eps_estimate_next_quarter": -0.36,
    "fifty_day_moving_average": 5.62,
    "fifty_two_week_high": 15.5,
    "fifty_two_week_low": 4.64,
    "percent_change_from_200_day_moving_average": -0.2913,
    "percent_change_from_50_day_moving_average": -0.13390000000000002,
    "shares_owned": "N/A",
    "short_ratio": 11.06,
    "two_hundred_day_moving_average": 6.87,
    "volume": 6049898.0,
    "market_cap": 256480000.00000003,
    "price_to_sales_ttm": 14.55,
    "price_to_book_mrq": 13.72,
    "roa_ttm": -0.4646,
    "roe_ttm": -1.7737,
    "shares_outstanding": 52670000.0,
    "pcnt_held_by_insiders": 0.0832,
    "pcnt_held_by_institutions": 0.8009999999999999,
    "pcnt_short_of_float": 0.2883,
    "operating_cash_flow_ttm": -50750000.0,
    "levered_cash_flow_ttm": -33270000.000000004,
    "book_value_per_share_mrq": 0.37,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "BioDelivery Sciences International, Inc."
  },
  "BEAT": {
    "p_e_ratio": 111.89,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.11,
    "ebitda": 24320000.0,
    "eps_estimate_current_year": 0.42,
    "eps_estimate_next_quarter": 0.12,
    "fifty_day_moving_average": 12.81,
    "fifty_two_week_high": 16.96,
    "fifty_two_week_low": 7.86,
    "percent_change_from_200_day_moving_average": -0.0333,
    "percent_change_from_50_day_moving_average": -0.0742,
    "shares_owned": "N/A",
    "short_ratio": 4.29,
    "two_hundred_day_moving_average": 12.27,
    "volume": 318505.0,
    "market_cap": 323300000.0,
    "price_to_sales_ttm": 1.98,
    "price_to_book_mrq": 4.61,
    "roa_ttm": 0.061799999999999994,
    "roe_ttm": 0.0432,
    "shares_outstanding": 27260000.0,
    "pcnt_held_by_insiders": 0.0447,
    "pcnt_held_by_institutions": 0.7509999999999999,
    "pcnt_short_of_float": 0.037200000000000004,
    "operating_cash_flow_ttm": 11390000.0,
    "levered_cash_flow_ttm": 2640000.0,
    "book_value_per_share_mrq": 2.62,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "BioTelemetry, Inc."
  },
  "BGMD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.82,
    "ebitda": -4740000.0,
    "eps_estimate_current_year": -0.1,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.63,
    "fifty_two_week_high": 4.88,
    "fifty_two_week_low": 0.34,
    "percent_change_from_200_day_moving_average": -0.47350000000000003,
    "percent_change_from_50_day_moving_average": -0.013600000000000001,
    "shares_owned": "N/A",
    "short_ratio": 2.66,
    "two_hundred_day_moving_average": 1.18,
    "volume": 19815.0,
    "market_cap": 5370000.0,
    "price_to_sales_ttm": 3.73,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.5538000000000001,
    "roe_ttm": -3.7938,
    "shares_outstanding": 8660000.0,
    "pcnt_held_by_insiders": 0.2583,
    "pcnt_held_by_institutions": 0.071,
    "pcnt_short_of_float": 0.1014,
    "operating_cash_flow_ttm": -3620000.0,
    "levered_cash_flow_ttm": -1740000.0,
    "book_value_per_share_mrq": -0.12,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "BG Medicine, Inc."
  },
  "BIND": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.95,
    "ebitda": -36620000.0,
    "eps_estimate_current_year": -1.98,
    "eps_estimate_next_quarter": -0.5,
    "fifty_day_moving_average": 4.2,
    "fifty_two_week_high": 10.04,
    "fifty_two_week_low": 2.1,
    "percent_change_from_200_day_moving_average": -0.46020000000000005,
    "percent_change_from_50_day_moving_average": -0.3831,
    "shares_owned": "N/A",
    "short_ratio": 13.19,
    "two_hundred_day_moving_average": 4.8,
    "volume": 150699.0,
    "market_cap": 53830000.0,
    "price_to_sales_ttm": 4.44,
    "price_to_book_mrq": 2.23,
    "roa_ttm": -0.4,
    "roe_ttm": -1.0621,
    "shares_outstanding": 20780000.0,
    "pcnt_held_by_insiders": 0.26739999999999997,
    "pcnt_held_by_institutions": 0.19899999999999998,
    "pcnt_short_of_float": 0.057300000000000004,
    "operating_cash_flow_ttm": -35580000.0,
    "levered_cash_flow_ttm": -28290000.0,
    "book_value_per_share_mrq": 1.15,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "BIND Therapeutics, Inc."
  },
  "BIO": {
    "p_e_ratio": 38.52,
    "peg_ratio": 3.86,
    "earnings_per_share": 3.51,
    "ebitda": 310030000.0,
    "eps_estimate_current_year": 3.57,
    "eps_estimate_next_quarter": 0.79,
    "fifty_day_moving_average": 138.59,
    "fifty_two_week_high": 152.38,
    "fifty_two_week_low": 112.51,
    "percent_change_from_200_day_moving_average": -0.0527,
    "percent_change_from_50_day_moving_average": -0.0258,
    "shares_owned": "N/A",
    "short_ratio": 9.86,
    "two_hundred_day_moving_average": 142.52,
    "volume": 170903.0,
    "market_cap": 3960000000.0,
    "price_to_sales_ttm": 1.97,
    "price_to_book_mrq": 1.66,
    "roa_ttm": 0.0305,
    "roe_ttm": 0.0446,
    "shares_outstanding": 24180000.0,
    "pcnt_held_by_insiders": 0.943,
    "pcnt_held_by_institutions": 0.009000000000000001,
    "pcnt_short_of_float": 0.052300000000000006,
    "operating_cash_flow_ttm": 190470000.0,
    "levered_cash_flow_ttm": 109570000.0,
    "book_value_per_share_mrq": 82.91,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Bio-Rad Laboratories, Inc."
  },
  "BIOC": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.03,
    "earnings_per_share": -1.25,
    "ebitda": -15370000.0,
    "eps_estimate_current_year": 0.4,
    "eps_estimate_next_quarter": -0.25,
    "fifty_day_moving_average": 1.85,
    "fifty_two_week_high": 4.91,
    "fifty_two_week_low": 1.09,
    "percent_change_from_200_day_moving_average": -0.3522,
    "percent_change_from_50_day_moving_average": -0.1948,
    "shares_owned": "N/A",
    "short_ratio": 7.13,
    "two_hundred_day_moving_average": 2.3,
    "volume": 116094.0,
    "market_cap": 28020000.0,
    "price_to_sales_ttm": 57.96,
    "price_to_book_mrq": 3.9,
    "roa_ttm": -0.8117,
    "roe_ttm": -3.1565,
    "shares_outstanding": 18810000.0,
    "pcnt_held_by_insiders": 0.1826,
    "pcnt_held_by_institutions": 0.111,
    "pcnt_short_of_float": 0.1252,
    "operating_cash_flow_ttm": -14140000.0,
    "levered_cash_flow_ttm": -7290000.0,
    "book_value_per_share_mrq": 0.37,
    "next_earnings_announcement_date": [
      "2016-03-07",
      "2016-03-11"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Biocept, Inc."
  },
  "BIOD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.46,
    "ebitda": -19490000.0,
    "eps_estimate_current_year": -0.35,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 0.317,
    "fifty_two_week_high": 2.0,
    "fifty_two_week_low": 0.22,
    "percent_change_from_200_day_moving_average": -0.5497,
    "percent_change_from_50_day_moving_average": -0.032850000000000004,
    "shares_owned": "N/A",
    "short_ratio": 0.54,
    "two_hundred_day_moving_average": 0.682,
    "volume": 13811082.0,
    "market_cap": 19080000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 0.36,
    "roa_ttm": -0.3696,
    "roe_ttm": -0.601,
    "shares_outstanding": 62150000.0,
    "pcnt_held_by_insiders": 0.056600000000000004,
    "pcnt_held_by_institutions": 0.843,
    "pcnt_short_of_float": 0.0232,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.64,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Biodel Inc."
  },
  "BIOL": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.1,
    "earnings_per_share": -0.39,
    "ebitda": -17130000.0,
    "eps_estimate_current_year": -0.34,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 0.85,
    "fifty_two_week_high": 2.8,
    "fifty_two_week_low": 0.6,
    "percent_change_from_200_day_moving_average": -0.429,
    "percent_change_from_50_day_moving_average": -0.1389,
    "shares_owned": "N/A",
    "short_ratio": 15.58,
    "two_hundred_day_moving_average": 1.28,
    "volume": 877183.0,
    "market_cap": 42510000.0,
    "price_to_sales_ttm": 0.88,
    "price_to_book_mrq": 1.57,
    "roa_ttm": -0.2902,
    "roe_ttm": -1.1711,
    "shares_outstanding": 58230000.0,
    "pcnt_held_by_insiders": 0.2192,
    "pcnt_held_by_institutions": 0.47600000000000003,
    "pcnt_short_of_float": 0.08789999999999999,
    "operating_cash_flow_ttm": -20880000.0,
    "levered_cash_flow_ttm": -11440000.0,
    "book_value_per_share_mrq": 0.45,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "BIOLASE, Inc."
  },
  "BIOS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.45,
    "earnings_per_share": -5.13,
    "ebitda": -30210000.0,
    "eps_estimate_current_year": -0.28,
    "eps_estimate_next_quarter": -0.07,
    "fifty_day_moving_average": 2.13,
    "fifty_two_week_high": 7.01,
    "fifty_two_week_low": 1.3,
    "percent_change_from_200_day_moving_average": -0.376,
    "percent_change_from_50_day_moving_average": -0.26789999999999997,
    "shares_owned": "N/A",
    "short_ratio": 15.72,
    "two_hundred_day_moving_average": 2.5,
    "volume": 872083.0,
    "market_cap": 107250000.0,
    "price_to_sales_ttm": 0.1,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.0443,
    "roe_ttm": -2.4678,
    "shares_outstanding": 68750000.0,
    "pcnt_held_by_insiders": 0.2229,
    "pcnt_held_by_institutions": 0.8009999999999999,
    "pcnt_short_of_float": 0.3343,
    "operating_cash_flow_ttm": -67080000.0,
    "levered_cash_flow_ttm": -12680000.0,
    "book_value_per_share_mrq": -0.89,
    "next_earnings_announcement_date": [
      "2016-02-29",
      "2016-03-04"
    ],
    "sector": "Healthcare",
    "industry": "Home Health Care",
    "company_name": "BioScrip, Inc."
  },
  "BITI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.1,
    "ebitda": -29770000.0,
    "eps_estimate_current_year": -2.59,
    "eps_estimate_next_quarter": -0.39,
    "fifty_day_moving_average": 13.82,
    "fifty_two_week_high": 25.39,
    "fifty_two_week_low": 12.43,
    "percent_change_from_200_day_moving_average": -0.147,
    "percent_change_from_50_day_moving_average": 0.013300000000000001,
    "shares_owned": "N/A",
    "short_ratio": 8.84,
    "two_hundred_day_moving_average": 16.41,
    "volume": 6994.0,
    "market_cap": 171650000.0,
    "price_to_sales_ttm": 32.94,
    "price_to_book_mrq": 115.49,
    "roa_ttm": -0.1284,
    "roe_ttm": -0.5694,
    "shares_outstanding": 12260000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -29140000.0,
    "levered_cash_flow_ttm": -14530000.0,
    "book_value_per_share_mrq": 0.12,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Biotie Therapies Corp."
  },
  "BKD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.51,
    "earnings_per_share": -2.12,
    "ebitda": 809320000.0,
    "eps_estimate_current_year": 2.39,
    "eps_estimate_next_quarter": 0.66,
    "fifty_day_moving_average": 21.47,
    "fifty_two_week_high": 39.89,
    "fifty_two_week_low": 16.58,
    "percent_change_from_200_day_moving_average": -0.3421,
    "percent_change_from_50_day_moving_average": -0.1562,
    "shares_owned": "N/A",
    "short_ratio": 2.62,
    "two_hundred_day_moving_average": 27.54,
    "volume": 3880356.0,
    "market_cap": 3350000000.0,
    "price_to_sales_ttm": 0.79,
    "price_to_book_mrq": 1.28,
    "roa_ttm": -0.0004,
    "roe_ttm": -0.1393,
    "shares_outstanding": 184780000.0,
    "pcnt_held_by_insiders": 0.0127,
    "pcnt_held_by_institutions": 1.031,
    "pcnt_short_of_float": 0.0525,
    "operating_cash_flow_ttm": 287990000.0,
    "levered_cash_flow_ttm": 34540000.0,
    "book_value_per_share_mrq": 14.22,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "Brookdale Senior Living Inc."
  },
  "BLCM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -5.12,
    "ebitda": -37360000.0,
    "eps_estimate_current_year": -1.64,
    "eps_estimate_next_quarter": -0.51,
    "fifty_day_moving_average": 19.64,
    "fifty_two_week_high": 33.63,
    "fifty_two_week_low": 12.25,
    "percent_change_from_200_day_moving_average": 0.0321,
    "percent_change_from_50_day_moving_average": -0.0060999999999999995,
    "shares_owned": "N/A",
    "short_ratio": 3.91,
    "two_hundred_day_moving_average": 18.91,
    "volume": 1186685.0,
    "market_cap": 517299999.99999994,
    "price_to_sales_ttm": 1930.12,
    "price_to_book_mrq": 3.05,
    "roa_ttm": -0.12279999999999999,
    "roe_ttm": -0.6143,
    "shares_outstanding": 26500000.0,
    "pcnt_held_by_insiders": 0.2429,
    "pcnt_held_by_institutions": 0.61,
    "pcnt_short_of_float": 0.1054,
    "operating_cash_flow_ttm": -73740000.0,
    "levered_cash_flow_ttm": -20620000.0,
    "book_value_per_share_mrq": 6.27,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Bellicum Pharmaceuticals, Inc."
  },
  "BLFS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.33,
    "ebitda": -4290000.0,
    "eps_estimate_current_year": -0.37,
    "eps_estimate_next_quarter": -0.07,
    "fifty_day_moving_average": 2.25,
    "fifty_two_week_high": 4.44,
    "fifty_two_week_low": 1.5,
    "percent_change_from_200_day_moving_average": 0.0158,
    "percent_change_from_50_day_moving_average": -0.005600000000000001,
    "shares_owned": "N/A",
    "short_ratio": 9.47,
    "two_hundred_day_moving_average": 2.21,
    "volume": 5302.0,
    "market_cap": 27430000.0,
    "price_to_sales_ttm": 4.28,
    "price_to_book_mrq": 2.93,
    "roa_ttm": -0.21,
    "roe_ttm": -0.3914,
    "shares_outstanding": 12240000.0,
    "pcnt_held_by_insiders": 0.5144,
    "pcnt_held_by_institutions": 0.034,
    "pcnt_short_of_float": 0.081,
    "operating_cash_flow_ttm": -4400000.0,
    "levered_cash_flow_ttm": -3930000.0,
    "book_value_per_share_mrq": 0.75,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "BioLife Solutions, Inc."
  },
  "BLPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -4.41,
    "ebitda": -46820000.0,
    "eps_estimate_current_year": -4.05,
    "eps_estimate_next_quarter": -1.33,
    "fifty_day_moving_average": 3.06,
    "fifty_two_week_high": 12.92,
    "fifty_two_week_low": 2.47,
    "percent_change_from_200_day_moving_average": -0.43320000000000003,
    "percent_change_from_50_day_moving_average": -0.0924,
    "shares_owned": "N/A",
    "short_ratio": 1.08,
    "two_hundred_day_moving_average": 4.9,
    "volume": 48612.0,
    "market_cap": 36420000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 0.88,
    "roa_ttm": -0.6031,
    "roe_ttm": -1.2802,
    "shares_outstanding": 13100000.0,
    "pcnt_held_by_insiders": 0.29109999999999997,
    "pcnt_held_by_institutions": 0.573,
    "pcnt_short_of_float": 0.023399999999999997,
    "operating_cash_flow_ttm": -41360000.0,
    "levered_cash_flow_ttm": -27370000.0,
    "book_value_per_share_mrq": 3.12,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Bellerophon Therapeutics LLC"
  },
  "BLRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.3,
    "ebitda": -15340000.0,
    "eps_estimate_current_year": -0.27,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 1.35,
    "fifty_two_week_high": 3.28,
    "fifty_two_week_low": 1.03,
    "percent_change_from_200_day_moving_average": -0.20489999999999997,
    "percent_change_from_50_day_moving_average": -0.0181,
    "shares_owned": "N/A",
    "short_ratio": 2.23,
    "two_hundred_day_moving_average": 1.67,
    "volume": 116854.0,
    "market_cap": 72680000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.41,
    "roa_ttm": -0.2279,
    "roe_ttm": -0.3603,
    "shares_outstanding": 54650000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -14380000.0,
    "levered_cash_flow_ttm": -11060000.0,
    "book_value_per_share_mrq": 0.93,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "BioLineRx, Ltd."
  },
  "BLUE": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.06,
    "earnings_per_share": -4.24,
    "ebitda": -126940000.0,
    "eps_estimate_current_year": -4.52,
    "eps_estimate_next_quarter": -1.1,
    "fifty_day_moving_average": 74.55,
    "fifty_two_week_high": 197.35,
    "fifty_two_week_low": 48.85,
    "percent_change_from_200_day_moving_average": -0.4946,
    "percent_change_from_50_day_moving_average": -0.1757,
    "shares_owned": "N/A",
    "short_ratio": 2.24,
    "two_hundred_day_moving_average": 121.59,
    "volume": 2011473.0,
    "market_cap": 2250000000.0,
    "price_to_sales_ttm": 119.72,
    "price_to_book_mrq": 2.56,
    "roa_ttm": -0.1243,
    "roe_ttm": -0.2416,
    "shares_outstanding": 36680000.0,
    "pcnt_held_by_insiders": 0.0315,
    "pcnt_held_by_institutions": 0.981,
    "pcnt_short_of_float": 0.1509,
    "operating_cash_flow_ttm": -81010000.0,
    "levered_cash_flow_ttm": -51220000.0,
    "book_value_per_share_mrq": 24.26,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "bluebird bio, Inc."
  },
  "BNTC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.44,
    "ebitda": -7780000.0,
    "eps_estimate_current_year": -1.13,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 5.04,
    "fifty_two_week_high": 16.48,
    "fifty_two_week_low": 4.24,
    "percent_change_from_200_day_moving_average": -0.4868,
    "percent_change_from_50_day_moving_average": -0.1373,
    "shares_owned": "N/A",
    "short_ratio": 0.49,
    "two_hundred_day_moving_average": 8.48,
    "volume": 8610.0,
    "market_cap": 25200000.0,
    "price_to_sales_ttm": 10.72,
    "price_to_book_mrq": 1.52,
    "roa_ttm": -0.2293,
    "roe_ttm": -0.40090000000000003,
    "shares_outstanding": 5790000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -6900000.0,
    "levered_cash_flow_ttm": -3770000.0,
    "book_value_per_share_mrq": 2.94,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Benitec Biopharma Limited"
  },
  "BOTA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.52,
    "ebitda": -4930000.0,
    "eps_estimate_current_year": -0.3,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.97,
    "fifty_two_week_high": 3.0,
    "fifty_two_week_low": 1.7,
    "percent_change_from_200_day_moving_average": -0.10400000000000001,
    "percent_change_from_50_day_moving_average": -0.0385,
    "shares_owned": "N/A",
    "short_ratio": 1.72,
    "two_hundred_day_moving_average": 2.11,
    "volume": 159680.0,
    "market_cap": 73020000.0,
    "price_to_sales_ttm": 2.79,
    "price_to_book_mrq": 1.13,
    "roa_ttm": -0.0438,
    "roe_ttm": -0.2659,
    "shares_outstanding": 38640000.0,
    "pcnt_held_by_insiders": 0.1002,
    "pcnt_held_by_institutions": 0.39399999999999996,
    "pcnt_short_of_float": 0.0009,
    "operating_cash_flow_ttm": 2900000.0,
    "levered_cash_flow_ttm": -287500.0,
    "book_value_per_share_mrq": 1.64,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Biota Pharmaceuticals, Inc."
  },
  "BPMC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.16,
    "ebitda": -49700000.0,
    "eps_estimate_current_year": -4.62,
    "eps_estimate_next_quarter": -0.62,
    "fifty_day_moving_average": 22.38,
    "fifty_two_week_high": 37.17,
    "fifty_two_week_low": 19.08,
    "percent_change_from_200_day_moving_average": -0.0313,
    "percent_change_from_50_day_moving_average": 0.1186,
    "shares_owned": "N/A",
    "short_ratio": 5.44,
    "two_hundred_day_moving_average": 25.84,
    "volume": 1082802.0,
    "market_cap": 678330000.0,
    "price_to_sales_ttm": 100.43,
    "price_to_book_mrq": 4.26,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 27100000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0906,
    "operating_cash_flow_ttm": -30210000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 5.88,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Blueprint Medicines Corporation"
  },
  "BPMX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.33,
    "ebitda": -18990000.0,
    "eps_estimate_current_year": -0.94,
    "eps_estimate_next_quarter": -0.21,
    "fifty_day_moving_average": 1.27,
    "fifty_two_week_high": 4.5,
    "fifty_two_week_low": 0.91,
    "percent_change_from_200_day_moving_average": -0.1235,
    "percent_change_from_50_day_moving_average": 0.2322,
    "shares_owned": "N/A",
    "short_ratio": 2.46,
    "two_hundred_day_moving_average": 1.78,
    "volume": 83345.0,
    "market_cap": 32900000.0,
    "price_to_sales_ttm": 828.13,
    "price_to_book_mrq": 44.72,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 21090000.0,
    "pcnt_held_by_insiders": 0.0106,
    "pcnt_held_by_institutions": 0.028999999999999998,
    "pcnt_short_of_float": 0.0113,
    "operating_cash_flow_ttm": -15030000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.04,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "BioPharmX Corporation"
  },
  "BPTH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.06,
    "ebitda": -5420000.0,
    "eps_estimate_current_year": -0.05,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.57,
    "fifty_two_week_high": 2.84,
    "fifty_two_week_low": 0.99,
    "percent_change_from_200_day_moving_average": 0.11220000000000001,
    "percent_change_from_50_day_moving_average": -0.07629999999999999,
    "shares_owned": "N/A",
    "short_ratio": 10.54,
    "two_hundred_day_moving_average": 1.3,
    "volume": 69947.0,
    "market_cap": 130160000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 11.84,
    "roa_ttm": -0.2515,
    "roe_ttm": -0.41229999999999994,
    "shares_outstanding": 89760000.0,
    "pcnt_held_by_insiders": 0.0859,
    "pcnt_held_by_institutions": 0.131,
    "pcnt_short_of_float": 0.005,
    "operating_cash_flow_ttm": -5160000.0,
    "levered_cash_flow_ttm": -3130000.0,
    "book_value_per_share_mrq": 0.13,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Delivery",
    "company_name": "Bio-Path Holdings, Inc."
  },
  "BRKR": {
    "p_e_ratio": 59.77,
    "peg_ratio": 2.38,
    "earnings_per_share": 0.39,
    "ebitda": 217800000.0,
    "eps_estimate_current_year": 0.78,
    "eps_estimate_next_quarter": 0.16,
    "fifty_day_moving_average": 21.74,
    "fifty_two_week_high": 24.01,
    "fifty_two_week_low": 15.78,
    "percent_change_from_200_day_moving_average": 0.16940000000000002,
    "percent_change_from_50_day_moving_average": 0.0724,
    "shares_owned": "N/A",
    "short_ratio": 3.74,
    "two_hundred_day_moving_average": 19.93,
    "volume": 1189409.0,
    "market_cap": 3910000000.0,
    "price_to_sales_ttm": 2.38,
    "price_to_book_mrq": 5.18,
    "roa_ttm": 0.0552,
    "roe_ttm": 0.08779999999999999,
    "shares_outstanding": 167880000.0,
    "pcnt_held_by_insiders": 0.3446,
    "pcnt_held_by_institutions": 0.703,
    "pcnt_short_of_float": 0.0452,
    "operating_cash_flow_ttm": 148900000.0,
    "levered_cash_flow_ttm": 165410000.0,
    "book_value_per_share_mrq": 4.54,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Bruker Corporation"
  },
  "BSPM": {
    "p_e_ratio": 9.5939,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.049,
    "ebitda": -611863.0,
    "eps_estimate_current_year": 0.6,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.6077,
    "fifty_two_week_high": 1.84,
    "fifty_two_week_low": 0.45,
    "percent_change_from_200_day_moving_average": -0.40504399999999996,
    "percent_change_from_50_day_moving_average": -0.226445,
    "shares_owned": "N/A",
    "short_ratio": 0.48,
    "two_hundred_day_moving_average": 0.7901,
    "volume": 65201.0,
    "market_cap": 7280000.0,
    "price_to_sales_ttm": 0.19,
    "price_to_book_mrq": 0.11,
    "roa_ttm": -0.0177,
    "roe_ttm": 0.0109,
    "shares_outstanding": 15480000.0,
    "pcnt_held_by_insiders": 0.1928,
    "pcnt_held_by_institutions": 0.051,
    "pcnt_short_of_float": 0.0013,
    "operating_cash_flow_ttm": 3650000.0,
    "levered_cash_flow_ttm": -1320000.0,
    "book_value_per_share_mrq": 4.39,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Biostar Pharmaceuticals, Inc."
  },
  "BSTC": {
    "p_e_ratio": 35.02,
    "peg_ratio": 0.0,
    "earnings_per_share": 1.23,
    "ebitda": 13720000.0,
    "eps_estimate_current_year": 1.89,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 49.77,
    "fifty_two_week_high": 72.07,
    "fifty_two_week_low": 35.16,
    "percent_change_from_200_day_moving_average": -0.1752,
    "percent_change_from_50_day_moving_average": -0.1358,
    "shares_owned": "N/A",
    "short_ratio": 4.95,
    "two_hundred_day_moving_average": 52.14,
    "volume": 105510.0,
    "market_cap": 297540000.0,
    "price_to_sales_ttm": 14.44,
    "price_to_book_mrq": 7.3,
    "roa_ttm": 0.24109999999999998,
    "roe_ttm": 0.2607,
    "shares_outstanding": 6920000.0,
    "pcnt_held_by_insiders": 0.42560000000000003,
    "pcnt_held_by_institutions": 0.46299999999999997,
    "pcnt_short_of_float": 0.094,
    "operating_cash_flow_ttm": 8390000.0,
    "levered_cash_flow_ttm": 7030000.0,
    "book_value_per_share_mrq": 6.08,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "BioSpecifics Technologies Corp."
  },
  "BTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.57,
    "ebitda": -50280000.0,
    "eps_estimate_current_year": "nan",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.57,
    "fifty_two_week_high": 5.95,
    "fifty_two_week_low": 2.2,
    "percent_change_from_200_day_moving_average": 0.0729,
    "percent_change_from_50_day_moving_average": 0.0529,
    "shares_owned": "N/A",
    "short_ratio": 37.32,
    "two_hundred_day_moving_average": 3.5,
    "volume": 948441.0,
    "market_cap": 356800000.0,
    "price_to_sales_ttm": 41.28,
    "price_to_book_mrq": 23.58,
    "roa_ttm": -0.5519,
    "roe_ttm": -1.0837999999999999,
    "shares_outstanding": 94890000.0,
    "pcnt_held_by_insiders": 0.4622,
    "pcnt_held_by_institutions": 0.149,
    "pcnt_short_of_float": 0.1398,
    "operating_cash_flow_ttm": -39710000.0,
    "levered_cash_flow_ttm": -22530000.0,
    "book_value_per_share_mrq": 0.16,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "BioTime, Inc."
  },
  "BUR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.14,
    "ebitda": -5020000.0,
    "eps_estimate_current_year": -0.23,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.61,
    "fifty_two_week_high": 3.04,
    "fifty_two_week_low": 1.22,
    "percent_change_from_200_day_moving_average": -0.17809999999999998,
    "percent_change_from_50_day_moving_average": -0.025,
    "shares_owned": "N/A",
    "short_ratio": 5.73,
    "two_hundred_day_moving_average": 1.91,
    "volume": 43488.0,
    "market_cap": 56040000.0,
    "price_to_sales_ttm": 773.39,
    "price_to_book_mrq": 12.69,
    "roa_ttm": -0.6175999999999999,
    "roe_ttm": -1.0122,
    "shares_outstanding": 35700000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -3760000.0,
    "levered_cash_flow_ttm": -2220000.0,
    "book_value_per_share_mrq": 0.13,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Burcon Nutrascience Corporation"
  },
  "BVX": {
    "p_e_ratio": 16.09,
    "peg_ratio": -0.41,
    "earnings_per_share": 0.11,
    "ebitda": -6580000.0,
    "eps_estimate_current_year": -0.29,
    "eps_estimate_next_quarter": -0.05,
    "fifty_day_moving_average": 1.9,
    "fifty_two_week_high": 4.01,
    "fifty_two_week_low": 1.72,
    "percent_change_from_200_day_moving_average": -0.1993,
    "percent_change_from_50_day_moving_average": -0.0676,
    "shares_owned": "N/A",
    "short_ratio": 1.3,
    "two_hundred_day_moving_average": 2.21,
    "volume": 21023.0,
    "market_cap": 48130000.0,
    "price_to_sales_ttm": 1.67,
    "price_to_book_mrq": 1.95,
    "roa_ttm": -0.1442,
    "roe_ttm": -0.5324,
    "shares_outstanding": 27190000.0,
    "pcnt_held_by_insiders": 0.14429999999999998,
    "pcnt_held_by_institutions": 0.29100000000000004,
    "pcnt_short_of_float": 0.0034000000000000002,
    "operating_cash_flow_ttm": -4570000.0,
    "levered_cash_flow_ttm": -3070000.0,
    "book_value_per_share_mrq": 0.91,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Bovie Medical Corporation"
  },
  "CALA": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.05,
    "earnings_per_share": -1.75,
    "ebitda": -31110000.0,
    "eps_estimate_current_year": -1.92,
    "eps_estimate_next_quarter": -0.61,
    "fifty_day_moving_average": 7.45,
    "fifty_two_week_high": 27.66,
    "fifty_two_week_low": 4.31,
    "percent_change_from_200_day_moving_average": 0.06,
    "percent_change_from_50_day_moving_average": 0.0062,
    "shares_owned": "N/A",
    "short_ratio": 7.79,
    "two_hundred_day_moving_average": 7.08,
    "volume": 219728.0,
    "market_cap": 136010000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.64,
    "roa_ttm": -0.31739999999999996,
    "roe_ttm": -0.5519,
    "shares_outstanding": 18140000.0,
    "pcnt_held_by_insiders": 0.38439999999999996,
    "pcnt_held_by_institutions": 0.461,
    "pcnt_short_of_float": 0.46509999999999996,
    "operating_cash_flow_ttm": -24490000.0,
    "levered_cash_flow_ttm": -15880000.0,
    "book_value_per_share_mrq": 4.33,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Calithera Biosciences, Inc."
  },
  "CANF": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.68,
    "ebitda": -6010000.0,
    "eps_estimate_current_year": -0.11,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 4.89,
    "fifty_two_week_high": 64.71,
    "fifty_two_week_low": 1.46,
    "percent_change_from_200_day_moving_average": -0.0296,
    "percent_change_from_50_day_moving_average": -0.3759,
    "shares_owned": "N/A",
    "short_ratio": 0.27,
    "two_hundred_day_moving_average": 3.14,
    "volume": 140117.0,
    "market_cap": 32840000.000000004,
    "price_to_sales_ttm": 234.97,
    "price_to_book_mrq": 4.72,
    "roa_ttm": -0.377,
    "roe_ttm": -1.4482,
    "shares_outstanding": 10770000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.64,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Can-Fite BioPharma Ltd."
  },
  "CAPN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.9,
    "ebitda": -10430000.0,
    "eps_estimate_current_year": -0.76,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.83,
    "fifty_two_week_high": 9.9,
    "fifty_two_week_low": 1.02,
    "percent_change_from_200_day_moving_average": -0.3406,
    "percent_change_from_50_day_moving_average": -0.12560000000000002,
    "shares_owned": "N/A",
    "short_ratio": 4.09,
    "two_hundred_day_moving_average": 2.43,
    "volume": 30213.0,
    "market_cap": 19790000.0,
    "price_to_sales_ttm": 51.02,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -1.4606999999999999,
    "roe_ttm": "N/A",
    "shares_outstanding": 12370000.0,
    "pcnt_held_by_insiders": 0.9871,
    "pcnt_held_by_institutions": 0.055,
    "pcnt_short_of_float": 0.23309999999999997,
    "operating_cash_flow_ttm": -8480000.0,
    "levered_cash_flow_ttm": -543350.0,
    "book_value_per_share_mrq": -0.11,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Capnia, Inc."
  },
  "CAPR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.77,
    "ebitda": -11100000.0,
    "eps_estimate_current_year": -0.8,
    "eps_estimate_next_quarter": -0.2,
    "fifty_day_moving_average": 3.97,
    "fifty_two_week_high": 10.68,
    "fifty_two_week_low": 3.05,
    "percent_change_from_200_day_moving_average": -0.195,
    "percent_change_from_50_day_moving_average": -0.09720000000000001,
    "shares_owned": "N/A",
    "short_ratio": 2.77,
    "two_hundred_day_moving_average": 4.45,
    "volume": 32222.0,
    "market_cap": 58350000.0,
    "price_to_sales_ttm": 9.7,
    "price_to_book_mrq": 29.32,
    "roa_ttm": -0.38689999999999997,
    "roe_ttm": "N/A",
    "shares_outstanding": 16300000.0,
    "pcnt_held_by_insiders": 0.6305,
    "pcnt_held_by_institutions": 0.035,
    "pcnt_short_of_float": 0.0102,
    "operating_cash_flow_ttm": -9320000.0,
    "levered_cash_flow_ttm": -1910000.0,
    "book_value_per_share_mrq": 0.12,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Capricor Therapeutics, Inc."
  },
  "CARA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.82,
    "ebitda": -19020000.0,
    "eps_estimate_current_year": -0.98,
    "eps_estimate_next_quarter": -0.38,
    "fifty_day_moving_average": 15.57,
    "fifty_two_week_high": 23.61,
    "fifty_two_week_low": 9.0,
    "percent_change_from_200_day_moving_average": -0.045700000000000005,
    "percent_change_from_50_day_moving_average": -0.0147,
    "shares_owned": "N/A",
    "short_ratio": 3.81,
    "two_hundred_day_moving_average": 16.07,
    "volume": 301062.0,
    "market_cap": 417730000.0,
    "price_to_sales_ttm": 88.44,
    "price_to_book_mrq": 3.66,
    "roa_ttm": -0.1373,
    "roe_ttm": -0.2285,
    "shares_outstanding": 27230000.0,
    "pcnt_held_by_insiders": 0.2945,
    "pcnt_held_by_institutions": 0.457,
    "pcnt_short_of_float": 0.0541,
    "operating_cash_flow_ttm": -23130000.0,
    "levered_cash_flow_ttm": -15750000.0,
    "book_value_per_share_mrq": 4.18,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cara Therapeutics Inc."
  },
  "CASI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.22,
    "ebitda": -6970000.0,
    "eps_estimate_current_year": -0.19,
    "eps_estimate_next_quarter": -0.04,
    "fifty_day_moving_average": 1.11,
    "fifty_two_week_high": 2.13,
    "fifty_two_week_low": 0.83,
    "percent_change_from_200_day_moving_average": -0.23920000000000002,
    "percent_change_from_50_day_moving_average": -0.07519999999999999,
    "shares_owned": "N/A",
    "short_ratio": 2.53,
    "two_hundred_day_moving_average": 1.35,
    "volume": 26167.0,
    "market_cap": 33420000.0,
    "price_to_sales_ttm": 445.04,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.4509,
    "roe_ttm": "N/A",
    "shares_outstanding": 32450000.000000004,
    "pcnt_held_by_insiders": 0.2834,
    "pcnt_held_by_institutions": 0.07400000000000001,
    "pcnt_short_of_float": 0.0067,
    "operating_cash_flow_ttm": -5320000.0,
    "levered_cash_flow_ttm": -2710000.0,
    "book_value_per_share_mrq": -0.15,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "CASI Pharmaceuticals, Inc."
  },
  "CASM": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.33,
    "earnings_per_share": -0.35,
    "ebitda": -4470000.0,
    "eps_estimate_current_year": -0.33,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.47,
    "fifty_two_week_high": 1.98,
    "fifty_two_week_low": 1.01,
    "percent_change_from_200_day_moving_average": 0.2698,
    "percent_change_from_50_day_moving_average": 0.105,
    "shares_owned": "N/A",
    "short_ratio": 0.53,
    "two_hundred_day_moving_average": 1.28,
    "volume": 8170.0,
    "market_cap": 43410000.0,
    "price_to_sales_ttm": 1.8,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.21489999999999998,
    "roe_ttm": -1.1456,
    "shares_outstanding": 26800000.0,
    "pcnt_held_by_insiders": 0.21719999999999998,
    "pcnt_held_by_institutions": 0.384,
    "pcnt_short_of_float": 0.0037,
    "operating_cash_flow_ttm": -3260000.0,
    "levered_cash_flow_ttm": -2040000.0,
    "book_value_per_share_mrq": -0.25,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "CAS Medical Systems Inc."
  },
  "CATB": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -6.74,
    "ebitda": -28020000.0,
    "eps_estimate_current_year": -3.58,
    "eps_estimate_next_quarter": -0.64,
    "fifty_day_moving_average": 7.94,
    "fifty_two_week_high": 16.96,
    "fifty_two_week_low": 6.32,
    "percent_change_from_200_day_moving_average": -0.0103,
    "percent_change_from_50_day_moving_average": 0.2587,
    "shares_owned": "N/A",
    "short_ratio": 8.28,
    "two_hundred_day_moving_average": 10.09,
    "volume": 32283.0,
    "market_cap": 152830000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.34,
    "roa_ttm": -0.371,
    "roe_ttm": -0.8017,
    "shares_outstanding": 15300000.0,
    "pcnt_held_by_insiders": 0.042,
    "pcnt_held_by_institutions": 0.833,
    "pcnt_short_of_float": 0.024399999999999998,
    "operating_cash_flow_ttm": -26970000.0,
    "levered_cash_flow_ttm": -16399999.999999998,
    "book_value_per_share_mrq": 3.89,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Catabasis Pharmaceuticals, Inc."
  },
  "CBAY": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.37,
    "ebitda": -27640000.0,
    "eps_estimate_current_year": -0.9,
    "eps_estimate_next_quarter": -0.39,
    "fifty_day_moving_average": 1.46,
    "fifty_two_week_high": 13.39,
    "fifty_two_week_low": 1.21,
    "percent_change_from_200_day_moving_average": -0.35979999999999995,
    "percent_change_from_50_day_moving_average": 0.0208,
    "shares_owned": "N/A",
    "short_ratio": 1.49,
    "two_hundred_day_moving_average": 2.33,
    "volume": 168310.0,
    "market_cap": 33330000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.05,
    "roa_ttm": -0.3697,
    "roe_ttm": -0.7471,
    "shares_outstanding": 22370000.0,
    "pcnt_held_by_insiders": 0.0527,
    "pcnt_held_by_institutions": 0.3,
    "pcnt_short_of_float": 0.0219,
    "operating_cash_flow_ttm": -25600000.0,
    "levered_cash_flow_ttm": -23030000.0,
    "book_value_per_share_mrq": 1.43,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cymabay Therapeutics, Inc."
  },
  "CBIO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.0,
    "ebitda": -10470000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 2.15,
    "fifty_two_week_low": 1.89,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 1.6,
    "two_hundred_day_moving_average": 0.0,
    "volume": 390339.0,
    "market_cap": 22860000.0,
    "price_to_sales_ttm": 9.88,
    "price_to_book_mrq": 0.63,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 11430000.0,
    "pcnt_held_by_insiders": 0.374,
    "pcnt_held_by_institutions": 0.248,
    "pcnt_short_of_float": 0.003,
    "operating_cash_flow_ttm": -16040000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 3.17,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Catalyst Biosciences, Inc."
  },
  "CBLI": {
    "p_e_ratio": 339.09,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.01,
    "ebitda": -12750000.0,
    "eps_estimate_current_year": -0.16,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.93,
    "fifty_two_week_high": 7.6,
    "fifty_two_week_low": 1.84,
    "percent_change_from_200_day_moving_average": -0.0559,
    "percent_change_from_50_day_moving_average": -0.0501,
    "shares_owned": "N/A",
    "short_ratio": 12.44,
    "two_hundred_day_moving_average": 3.95,
    "volume": 22987.0,
    "market_cap": 39040000.0,
    "price_to_sales_ttm": 13.61,
    "price_to_book_mrq": 3.62,
    "roa_ttm": -0.41850000000000004,
    "roe_ttm": -0.0776,
    "shares_outstanding": 10470000.0,
    "pcnt_held_by_insiders": 0.0383,
    "pcnt_held_by_institutions": 0.03,
    "pcnt_short_of_float": 0.2926,
    "operating_cash_flow_ttm": -12000000.0,
    "levered_cash_flow_ttm": -3910000.0,
    "book_value_per_share_mrq": 1.02,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cleveland BioLabs, Inc."
  },
  "CBM": {
    "p_e_ratio": 23.69,
    "peg_ratio": 1.59,
    "earnings_per_share": 2.08,
    "ebitda": 111030000.0,
    "eps_estimate_current_year": 2.13,
    "eps_estimate_next_quarter": 0.37,
    "fifty_day_moving_average": 50.66,
    "fifty_two_week_high": 55.6,
    "fifty_two_week_low": 21.12,
    "percent_change_from_200_day_moving_average": 0.052199999999999996,
    "percent_change_from_50_day_moving_average": -0.028399999999999998,
    "shares_owned": "N/A",
    "short_ratio": 4.4,
    "two_hundred_day_moving_average": 46.78,
    "volume": 1136214.0,
    "market_cap": 1550000000.0,
    "price_to_sales_ttm": 3.95,
    "price_to_book_mrq": 5.61,
    "roa_ttm": 0.1165,
    "roe_ttm": 0.2619,
    "shares_outstanding": 31530000.0,
    "pcnt_held_by_insiders": 0.018600000000000002,
    "pcnt_held_by_institutions": 0.907,
    "pcnt_short_of_float": 0.0552,
    "operating_cash_flow_ttm": 103640000.0,
    "levered_cash_flow_ttm": 53860000.0,
    "book_value_per_share_mrq": 9.08,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cambrex Corporation."
  },
  "CBMG": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.81,
    "ebitda": -16170000.000000002,
    "eps_estimate_current_year": -1.68,
    "eps_estimate_next_quarter": -0.42,
    "fifty_day_moving_average": 22.35,
    "fifty_two_week_high": 49.0,
    "fifty_two_week_low": 11.5,
    "percent_change_from_200_day_moving_average": -0.09910000000000001,
    "percent_change_from_50_day_moving_average": 0.0116,
    "shares_owned": "N/A",
    "short_ratio": 8.62,
    "two_hundred_day_moving_average": 25.1,
    "volume": 88452.0,
    "market_cap": 264079999.99999997,
    "price_to_sales_ttm": 108.22,
    "price_to_book_mrq": 4.31,
    "roa_ttm": -0.22039999999999998,
    "roe_ttm": -0.42719999999999997,
    "shares_outstanding": 11680000.0,
    "pcnt_held_by_insiders": 0.3362,
    "pcnt_held_by_institutions": 0.07,
    "pcnt_short_of_float": 0.037599999999999995,
    "operating_cash_flow_ttm": -10740000.0,
    "levered_cash_flow_ttm": -8890000.0,
    "book_value_per_share_mrq": 4.88,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Cellular Biomedicine Group Inc."
  },
  "CBMX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.63,
    "ebitda": -5880000.0,
    "eps_estimate_current_year": -0.57,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.84,
    "fifty_two_week_high": 2.16,
    "fifty_two_week_low": 0.65,
    "percent_change_from_200_day_moving_average": -0.44179999999999997,
    "percent_change_from_50_day_moving_average": -0.1929,
    "shares_owned": "N/A",
    "short_ratio": 6.04,
    "two_hundred_day_moving_average": 1.22,
    "volume": 65489.0,
    "market_cap": 8620000.0,
    "price_to_sales_ttm": 0.96,
    "price_to_book_mrq": 1.27,
    "roa_ttm": -0.3857,
    "roe_ttm": -0.8403,
    "shares_outstanding": 12680000.0,
    "pcnt_held_by_insiders": 0.2502,
    "pcnt_held_by_institutions": 0.126,
    "pcnt_short_of_float": 0.013500000000000002,
    "operating_cash_flow_ttm": -6160000.0,
    "levered_cash_flow_ttm": -3570000.0,
    "book_value_per_share_mrq": 0.57,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "CombiMatrix Corporation"
  },
  "CBPO": {
    "p_e_ratio": 40.61,
    "peg_ratio": 1.74,
    "earnings_per_share": 3.16,
    "ebitda": 138490000.0,
    "eps_estimate_current_year": 3.29,
    "eps_estimate_next_quarter": 1.03,
    "fifty_day_moving_average": 119.31,
    "fifty_two_week_high": 133.4,
    "fifty_two_week_low": 63.15,
    "percent_change_from_200_day_moving_average": 0.1724,
    "percent_change_from_50_day_moving_average": 0.0754,
    "shares_owned": "N/A",
    "short_ratio": 0.96,
    "two_hundred_day_moving_average": 109.43,
    "volume": 956040.0,
    "market_cap": 3400000000.0,
    "price_to_sales_ttm": 12.21,
    "price_to_book_mrq": 9.49,
    "roa_ttm": 0.1684,
    "roe_ttm": 0.3134,
    "shares_outstanding": 26530000.0,
    "pcnt_held_by_insiders": 0.2378,
    "pcnt_held_by_institutions": 0.6779999999999999,
    "pcnt_short_of_float": 0.0134,
    "operating_cash_flow_ttm": 101670000.0,
    "levered_cash_flow_ttm": 96510000.0,
    "book_value_per_share_mrq": 13.88,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "China Biologic Products, Inc."
  },
  "CBYL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.12,
    "ebitda": -19170000.0,
    "eps_estimate_current_year": -1.17,
    "eps_estimate_next_quarter": -0.31,
    "fifty_day_moving_average": 3.75,
    "fifty_two_week_high": 9.22,
    "fifty_two_week_low": 2.8,
    "percent_change_from_200_day_moving_average": -0.3814,
    "percent_change_from_50_day_moving_average": -0.0987,
    "shares_owned": "N/A",
    "short_ratio": 13.91,
    "two_hundred_day_moving_average": 5.46,
    "volume": 45032.0,
    "market_cap": 88970000.0,
    "price_to_sales_ttm": 2977.21,
    "price_to_book_mrq": 1.58,
    "roa_ttm": -0.33049999999999996,
    "roe_ttm": -0.8676999999999999,
    "shares_outstanding": 26320000.0,
    "pcnt_held_by_insiders": 0.5002,
    "pcnt_held_by_institutions": 0.451,
    "pcnt_short_of_float": 0.023700000000000002,
    "operating_cash_flow_ttm": -20130000.0,
    "levered_cash_flow_ttm": -13310000.0,
    "book_value_per_share_mrq": 2.08,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Carbylan Therapeutics, Inc."
  },
  "CCM": {
    "p_e_ratio": 11.84,
    "peg_ratio": 1.18,
    "earnings_per_share": 0.47,
    "ebitda": 44990000.0,
    "eps_estimate_current_year": 0.23,
    "eps_estimate_next_quarter": 0.12,
    "fifty_day_moving_average": 4.89,
    "fifty_two_week_high": 8.23,
    "fifty_two_week_low": 4.4,
    "percent_change_from_200_day_moving_average": 0.013300000000000001,
    "percent_change_from_50_day_moving_average": 0.1461,
    "shares_owned": "N/A",
    "short_ratio": 1.44,
    "two_hundred_day_moving_average": 5.53,
    "volume": 212945.0,
    "market_cap": 251620000.0,
    "price_to_sales_ttm": 3.9,
    "price_to_book_mrq": 0.85,
    "roa_ttm": 0.013999999999999999,
    "roe_ttm": 0.0426,
    "shares_outstanding": 44930000.0,
    "pcnt_held_by_insiders": 0.2904,
    "pcnt_held_by_institutions": 0.146,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 6.39,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Hospitals",
    "company_name": "Concord Medical Services Holdings Limited"
  },
  "CCXI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.1,
    "ebitda": -47820000.0,
    "eps_estimate_current_year": -1.1,
    "eps_estimate_next_quarter": -0.3,
    "fifty_day_moving_average": 7.1,
    "fifty_two_week_high": 9.46,
    "fifty_two_week_low": 5.4,
    "percent_change_from_200_day_moving_average": 0.045899999999999996,
    "percent_change_from_50_day_moving_average": 0.08130000000000001,
    "shares_owned": "N/A",
    "short_ratio": 9.6,
    "two_hundred_day_moving_average": 7.34,
    "volume": 263889.0,
    "market_cap": 338930000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.22,
    "roa_ttm": -0.2822,
    "roe_ttm": -0.4792,
    "shares_outstanding": 44130000.0,
    "pcnt_held_by_insiders": 0.36829999999999996,
    "pcnt_held_by_institutions": 0.6,
    "pcnt_short_of_float": 0.1373,
    "operating_cash_flow_ttm": -39990000.0,
    "levered_cash_flow_ttm": -23840000.0,
    "book_value_per_share_mrq": 1.85,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ChemoCentryx, Inc."
  },
  "CDTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.99,
    "ebitda": -26660000.0,
    "eps_estimate_current_year": -2.78,
    "eps_estimate_next_quarter": -0.8,
    "fifty_day_moving_average": 15.24,
    "fifty_two_week_high": 19.13,
    "fifty_two_week_low": 11.23,
    "percent_change_from_200_day_moving_average": 0.1355,
    "percent_change_from_50_day_moving_average": 0.0922,
    "shares_owned": "N/A",
    "short_ratio": 12.16,
    "two_hundred_day_moving_average": 14.65,
    "volume": 146823.0,
    "market_cap": 228300000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.03,
    "roa_ttm": -0.2353,
    "roe_ttm": -0.39039999999999997,
    "shares_outstanding": 13720000.0,
    "pcnt_held_by_insiders": 0.0992,
    "pcnt_held_by_institutions": 0.43700000000000006,
    "pcnt_short_of_float": 0.0358,
    "operating_cash_flow_ttm": -22390000.0,
    "levered_cash_flow_ttm": -12420000.0,
    "book_value_per_share_mrq": 8.22,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cidara Therapeutics, Inc."
  },
  "CDXS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.56,
    "earnings_per_share": -0.13,
    "ebitda": 1160000.0,
    "eps_estimate_current_year": -0.18,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 3.74,
    "fifty_two_week_high": 5.65,
    "fifty_two_week_low": 2.45,
    "percent_change_from_200_day_moving_average": 0.0862,
    "percent_change_from_50_day_moving_average": 0.08689999999999999,
    "shares_owned": "N/A",
    "short_ratio": 4.93,
    "two_hundred_day_moving_average": 3.75,
    "volume": 109598.0,
    "market_cap": 164050000.0,
    "price_to_sales_ttm": 3.81,
    "price_to_book_mrq": 7.27,
    "roa_ttm": -0.061900000000000004,
    "roe_ttm": -0.2137,
    "shares_outstanding": 40310000.0,
    "pcnt_held_by_insiders": 0.3457,
    "pcnt_held_by_institutions": 0.312,
    "pcnt_short_of_float": 0.0077,
    "operating_cash_flow_ttm": -2510000.0,
    "levered_cash_flow_ttm": 263620.0,
    "book_value_per_share_mrq": 0.58,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Codexis, Inc."
  },
  "CEMI": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.76,
    "earnings_per_share": -0.23,
    "ebitda": -1840000.0,
    "eps_estimate_current_year": -0.27,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 5.17,
    "fifty_two_week_high": 5.53,
    "fifty_two_week_low": 3.33,
    "percent_change_from_200_day_moving_average": 0.10769999999999999,
    "percent_change_from_50_day_moving_average": 0.0213,
    "shares_owned": "N/A",
    "short_ratio": 0.48,
    "two_hundred_day_moving_average": 4.77,
    "volume": 14205.0,
    "market_cap": 50840000.0,
    "price_to_sales_ttm": 1.84,
    "price_to_book_mrq": 2.72,
    "roa_ttm": -0.0809,
    "roe_ttm": -0.11699999999999999,
    "shares_outstanding": 9630000.0,
    "pcnt_held_by_insiders": 0.1902,
    "pcnt_held_by_institutions": 0.192,
    "pcnt_short_of_float": 0.0011,
    "operating_cash_flow_ttm": -1250000.0,
    "levered_cash_flow_ttm": -1640000.0,
    "book_value_per_share_mrq": 1.9,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Chembio Diagnostics, Inc."
  },
  "CEMP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.08,
    "ebitda": -84230000.0,
    "eps_estimate_current_year": -2.23,
    "eps_estimate_next_quarter": -0.57,
    "fifty_day_moving_average": 29.42,
    "fifty_two_week_high": 46.99,
    "fifty_two_week_low": 15.43,
    "percent_change_from_200_day_moving_average": -0.096,
    "percent_change_from_50_day_moving_average": 0.0134,
    "shares_owned": "N/A",
    "short_ratio": 7.9,
    "two_hundred_day_moving_average": 32.98,
    "volume": 1572073.0,
    "market_cap": 1310000000.0,
    "price_to_sales_ttm": 52.9,
    "price_to_book_mrq": 9.24,
    "roa_ttm": -0.3924,
    "roe_ttm": -0.9856999999999999,
    "shares_outstanding": 43970000.0,
    "pcnt_held_by_insiders": 0.2024,
    "pcnt_held_by_institutions": 0.675,
    "pcnt_short_of_float": 0.26030000000000003,
    "operating_cash_flow_ttm": -72700000.0,
    "levered_cash_flow_ttm": -40630000.0,
    "book_value_per_share_mrq": 3.12,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cempra, Inc."
  },
  "CERC": {
    "p_e_ratio": 0.64,
    "peg_ratio": 0.0,
    "earnings_per_share": 4.89,
    "ebitda": -11140000.0,
    "eps_estimate_current_year": -1.17,
    "eps_estimate_next_quarter": -0.27,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 3.53,
    "fifty_two_week_low": 3.12,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 0.59,
    "two_hundred_day_moving_average": 0.0,
    "volume": 16670.0,
    "market_cap": 26930000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 8630000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -10580000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -50.56,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Cerecor Inc."
  },
  "CERS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.67,
    "ebitda": -57360000.0,
    "eps_estimate_current_year": -0.62,
    "eps_estimate_next_quarter": -0.16,
    "fifty_day_moving_average": 5.54,
    "fifty_two_week_high": 7.03,
    "fifty_two_week_low": 3.82,
    "percent_change_from_200_day_moving_average": 0.132,
    "percent_change_from_50_day_moving_average": 0.0659,
    "shares_owned": "N/A",
    "short_ratio": 20.98,
    "two_hundred_day_moving_average": 5.21,
    "volume": 1351199.0,
    "market_cap": 573110000.0,
    "price_to_sales_ttm": 16.87,
    "price_to_book_mrq": 6.03,
    "roa_ttm": -0.34380000000000005,
    "roe_ttm": -0.8584999999999999,
    "shares_outstanding": 97140000.0,
    "pcnt_held_by_insiders": 0.0165,
    "pcnt_held_by_institutions": 0.731,
    "pcnt_short_of_float": 0.2163,
    "operating_cash_flow_ttm": -50980000.0,
    "levered_cash_flow_ttm": -28970000.0,
    "book_value_per_share_mrq": 0.98,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cerus Corporation"
  },
  "CERU": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.53,
    "ebitda": -34290000.0,
    "eps_estimate_current_year": -1.59,
    "eps_estimate_next_quarter": -0.37,
    "fifty_day_moving_average": 3.37,
    "fifty_two_week_high": 10.87,
    "fifty_two_week_low": 2.77,
    "percent_change_from_200_day_moving_average": -0.05,
    "percent_change_from_50_day_moving_average": 0.12279999999999999,
    "shares_owned": "N/A",
    "short_ratio": 6.8,
    "two_hundred_day_moving_average": 3.98,
    "volume": 38422.0,
    "market_cap": 103370000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.72,
    "roa_ttm": -0.3072,
    "roe_ttm": -0.654,
    "shares_outstanding": 27350000.0,
    "pcnt_held_by_insiders": 0.33409999999999995,
    "pcnt_held_by_institutions": 0.47200000000000003,
    "pcnt_short_of_float": 0.0177,
    "operating_cash_flow_ttm": -29310000.0,
    "levered_cash_flow_ttm": -16880000.0,
    "book_value_per_share_mrq": 2.14,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cerulean Pharma Inc."
  },
  "CFMS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.09,
    "earnings_per_share": -4.24,
    "ebitda": -50680000.0,
    "eps_estimate_current_year": -3.75,
    "eps_estimate_next_quarter": -0.35,
    "fifty_day_moving_average": 20.93,
    "fifty_two_week_high": 26.93,
    "fifty_two_week_low": 13.33,
    "percent_change_from_200_day_moving_average": -0.011000000000000001,
    "percent_change_from_50_day_moving_average": -0.0446,
    "shares_owned": "N/A",
    "short_ratio": 18.83,
    "two_hundred_day_moving_average": 20.22,
    "volume": 159246.0,
    "market_cap": 814240000.0,
    "price_to_sales_ttm": 13.3,
    "price_to_book_mrq": 5.24,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 40710000.0,
    "pcnt_held_by_insiders": 0.1059,
    "pcnt_held_by_institutions": 0.066,
    "pcnt_short_of_float": 0.08470000000000001,
    "operating_cash_flow_ttm": -44810000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 3.81,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "ConforMIS, Inc."
  },
  "CFRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.02,
    "ebitda": -21270000.0,
    "eps_estimate_current_year": -0.95,
    "eps_estimate_next_quarter": -0.22,
    "fifty_day_moving_average": 3.97,
    "fifty_two_week_high": 6.24,
    "fifty_two_week_low": 2.8,
    "percent_change_from_200_day_moving_average": 0.07730000000000001,
    "percent_change_from_50_day_moving_average": 0.23829999999999998,
    "shares_owned": "N/A",
    "short_ratio": 2.31,
    "two_hundred_day_moving_average": 4.57,
    "volume": 110005.0,
    "market_cap": 135210000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.55,
    "roa_ttm": -0.40990000000000004,
    "roe_ttm": -0.7722,
    "shares_outstanding": 27480000.0,
    "pcnt_held_by_insiders": 0.36560000000000004,
    "pcnt_held_by_institutions": 0.157,
    "pcnt_short_of_float": 0.013600000000000001,
    "operating_cash_flow_ttm": -20110000.0,
    "levered_cash_flow_ttm": -11820000.0,
    "book_value_per_share_mrq": 1.12,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ContraFect Corporation"
  },
  "CGEN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.45,
    "ebitda": -20430000.0,
    "eps_estimate_current_year": -0.51,
    "eps_estimate_next_quarter": -0.13,
    "fifty_day_moving_average": 6.95,
    "fifty_two_week_high": 9.65,
    "fifty_two_week_low": 4.64,
    "percent_change_from_200_day_moving_average": 0.0282,
    "percent_change_from_50_day_moving_average": -0.060899999999999996,
    "shares_owned": "N/A",
    "short_ratio": 8.26,
    "two_hundred_day_moving_average": 6.35,
    "volume": 271462.0,
    "market_cap": 329510000.0,
    "price_to_sales_ttm": 43.65,
    "price_to_book_mrq": 3.67,
    "roa_ttm": -0.1258,
    "roe_ttm": -0.2164,
    "shares_outstanding": 50460000.0,
    "pcnt_held_by_insiders": 0.10039999999999999,
    "pcnt_held_by_institutions": 0.165,
    "pcnt_short_of_float": 0.0373,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 1.77,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Compugen Ltd."
  },
  "CGIX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.04,
    "earnings_per_share": -2.04,
    "ebitda": -18990000.0,
    "eps_estimate_current_year": -1.97,
    "eps_estimate_next_quarter": -0.38,
    "fifty_day_moving_average": 3.58,
    "fifty_two_week_high": 12.75,
    "fifty_two_week_low": 2.75,
    "percent_change_from_200_day_moving_average": -0.6620999999999999,
    "percent_change_from_50_day_moving_average": -0.2096,
    "shares_owned": "N/A",
    "short_ratio": 0.8,
    "two_hundred_day_moving_average": 8.38,
    "volume": 124461.0,
    "market_cap": 38630000.0,
    "price_to_sales_ttm": 1.84,
    "price_to_book_mrq": 1.26,
    "roa_ttm": -0.2898,
    "roe_ttm": -0.6507999999999999,
    "shares_outstanding": 13650000.0,
    "pcnt_held_by_insiders": 0.2889,
    "pcnt_held_by_institutions": 0.165,
    "pcnt_short_of_float": 0.0418,
    "operating_cash_flow_ttm": -14380000.0,
    "levered_cash_flow_ttm": -9450000.0,
    "book_value_per_share_mrq": 2.26,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Cancer Genetics, Inc."
  },
  "CGNT": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.25,
    "earnings_per_share": -0.5,
    "ebitda": -4920000.0,
    "eps_estimate_current_year": -0.35,
    "eps_estimate_next_quarter": 0.03,
    "fifty_day_moving_average": 1.44,
    "fifty_two_week_high": 5.05,
    "fifty_two_week_low": 1.1,
    "percent_change_from_200_day_moving_average": -0.1067,
    "percent_change_from_50_day_moving_average": -0.0762,
    "shares_owned": "N/A",
    "short_ratio": 2.16,
    "two_hundred_day_moving_average": 1.49,
    "volume": 44087.0,
    "market_cap": 34660000.0,
    "price_to_sales_ttm": 0.95,
    "price_to_book_mrq": 1.99,
    "roa_ttm": -0.1223,
    "roe_ttm": -0.7408,
    "shares_outstanding": 26060000.0,
    "pcnt_held_by_insiders": 0.1234,
    "pcnt_held_by_institutions": 0.303,
    "pcnt_short_of_float": 0.005600000000000001,
    "operating_cash_flow_ttm": -7030000.0,
    "levered_cash_flow_ttm": -6880000.0,
    "book_value_per_share_mrq": 0.67,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Cogentix Medical, Inc."
  },
  "CHE": {
    "p_e_ratio": 23.49,
    "peg_ratio": 2.21,
    "earnings_per_share": 6.32,
    "ebitda": 217660000.0,
    "eps_estimate_current_year": 6.8,
    "eps_estimate_next_quarter": 1.68,
    "fifty_day_moving_average": 153.54,
    "fifty_two_week_high": 160.12,
    "fifty_two_week_low": 100.49,
    "percent_change_from_200_day_moving_average": 0.0509,
    "percent_change_from_50_day_moving_average": -0.0334,
    "shares_owned": "N/A",
    "short_ratio": 17.2,
    "two_hundred_day_moving_average": 141.22,
    "volume": 240365.0,
    "market_cap": 2510000000.0,
    "price_to_sales_ttm": 1.66,
    "price_to_book_mrq": 5.19,
    "roa_ttm": 0.13419999999999999,
    "roe_ttm": 0.23920000000000002,
    "shares_outstanding": 16880000.0,
    "pcnt_held_by_insiders": 0.0344,
    "pcnt_held_by_institutions": 1.0959999999999999,
    "pcnt_short_of_float": 0.1536,
    "operating_cash_flow_ttm": 172350000.0,
    "levered_cash_flow_ttm": 130370000.0,
    "book_value_per_share_mrq": 28.95,
    "next_earnings_announcement_date": [
      "2016-02-15",
      "2016-02-19"
    ],
    "sector": "Healthcare",
    "industry": "Home Health Care",
    "company_name": "Chemed Corp."
  },
  "CHEK": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.011,
    "ebitda": -11090000.0,
    "eps_estimate_current_year": -1.02,
    "eps_estimate_next_quarter": -0.32,
    "fifty_day_moving_average": 2.3524,
    "fifty_two_week_high": 6.3,
    "fifty_two_week_low": 1.8,
    "percent_change_from_200_day_moving_average": -0.293504,
    "percent_change_from_50_day_moving_average": -0.1052,
    "shares_owned": "N/A",
    "short_ratio": 0.27,
    "two_hundred_day_moving_average": 2.9794,
    "volume": 14282.0,
    "market_cap": 22740000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.73,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 10810000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0002,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.72,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Check-Cap Ltd."
  },
  "CHMA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -6.12,
    "ebitda": -30340000.0,
    "eps_estimate_current_year": -2.72,
    "eps_estimate_next_quarter": -0.52,
    "fifty_day_moving_average": 21.9,
    "fifty_two_week_high": 30.52,
    "fifty_two_week_low": 17.13,
    "percent_change_from_200_day_moving_average": -0.1152,
    "percent_change_from_50_day_moving_average": -0.056600000000000004,
    "shares_owned": "N/A",
    "short_ratio": 8.54,
    "two_hundred_day_moving_average": 23.35,
    "volume": 741290.0,
    "market_cap": 494530000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.23,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 23940000.0,
    "pcnt_held_by_insiders": 0.15,
    "pcnt_held_by_institutions": 0.055999999999999994,
    "pcnt_short_of_float": 0.040999999999999995,
    "operating_cash_flow_ttm": -23510000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 6.49,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Chiasma, Inc."
  },
  "CHRS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -6.18,
    "ebitda": -191780000.0,
    "eps_estimate_current_year": -5.76,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 27.69,
    "fifty_two_week_high": 38.1,
    "fifty_two_week_low": 12.8,
    "percent_change_from_200_day_moving_average": -0.20600000000000002,
    "percent_change_from_50_day_moving_average": -0.19079999999999997,
    "shares_owned": "N/A",
    "short_ratio": 11.55,
    "two_hundred_day_moving_average": 28.22,
    "volume": 1343404.0,
    "market_cap": 871590000.0,
    "price_to_sales_ttm": 34.41,
    "price_to_book_mrq": 22.28,
    "roa_ttm": -0.7288,
    "roe_ttm": -8.1424,
    "shares_outstanding": 38890000.0,
    "pcnt_held_by_insiders": 0.3711,
    "pcnt_held_by_institutions": 0.39299999999999996,
    "pcnt_short_of_float": 0.11779999999999999,
    "operating_cash_flow_ttm": -146840000.0,
    "levered_cash_flow_ttm": -92330000.0,
    "book_value_per_share_mrq": 1.05,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Coherus Biosciences, Inc."
  },
  "CIVI": {
    "p_e_ratio": 347.95,
    "peg_ratio": 3.9,
    "earnings_per_share": 0.08,
    "ebitda": 142310000.0,
    "eps_estimate_current_year": 0.74,
    "eps_estimate_next_quarter": 0.19,
    "fifty_day_moving_average": 26.54,
    "fifty_two_week_high": 29.38,
    "fifty_two_week_low": 16.49,
    "percent_change_from_200_day_moving_average": 0.1913,
    "percent_change_from_50_day_moving_average": 0.0882,
    "shares_owned": "N/A",
    "short_ratio": 4.1,
    "two_hundred_day_moving_average": 24.24,
    "volume": 205396.0,
    "market_cap": 1070000000.0000001,
    "price_to_sales_ttm": 0.77,
    "price_to_book_mrq": 8.72,
    "roa_ttm": 0.039,
    "roe_ttm": 0.0344,
    "shares_outstanding": 37100000.0,
    "pcnt_held_by_insiders": 0.0678,
    "pcnt_held_by_institutions": 0.32299999999999995,
    "pcnt_short_of_float": 0.061799999999999994,
    "operating_cash_flow_ttm": 90480000.0,
    "levered_cash_flow_ttm": 59180000.0,
    "book_value_per_share_mrq": 3.27,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "Civitas Solutions, Inc."
  },
  "CLBS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.01,
    "earnings_per_share": -1.37,
    "ebitda": -57790000.0,
    "eps_estimate_current_year": -1.27,
    "eps_estimate_next_quarter": -0.3,
    "fifty_day_moving_average": 1.18,
    "fifty_two_week_high": 4.26,
    "fifty_two_week_low": 1.01,
    "percent_change_from_200_day_moving_average": -0.31489999999999996,
    "percent_change_from_50_day_moving_average": -0.09390000000000001,
    "shares_owned": "N/A",
    "short_ratio": 7.01,
    "two_hundred_day_moving_average": 1.56,
    "volume": 527617.0,
    "market_cap": 59250000.0,
    "price_to_sales_ttm": 2.91,
    "price_to_book_mrq": 1.06,
    "roa_ttm": -0.3002,
    "roe_ttm": -1.0161,
    "shares_outstanding": 55370000.0,
    "pcnt_held_by_insiders": 0.0746,
    "pcnt_held_by_institutions": 0.16399999999999998,
    "pcnt_short_of_float": 0.0391,
    "operating_cash_flow_ttm": -41430000.0,
    "levered_cash_flow_ttm": -24280000.0,
    "book_value_per_share_mrq": 1.0,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Caladrius Biosciences, Inc."
  },
  "CLCD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.76,
    "ebitda": -20150000.0,
    "eps_estimate_current_year": -3.19,
    "eps_estimate_next_quarter": -0.63,
    "fifty_day_moving_average": 5.44,
    "fifty_two_week_high": 9.46,
    "fifty_two_week_low": 3.57,
    "percent_change_from_200_day_moving_average": 0.0255,
    "percent_change_from_50_day_moving_average": 0.24489999999999998,
    "shares_owned": "N/A",
    "short_ratio": 2.38,
    "two_hundred_day_moving_average": 6.6,
    "volume": 4750.0,
    "market_cap": 102590000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.48,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 15150000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0147,
    "operating_cash_flow_ttm": -13120000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 4.52,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "CoLucid Pharmaceuticals, Inc."
  },
  "CLDN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.15,
    "ebitda": -43110000.0,
    "eps_estimate_current_year": -1.54,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.29,
    "fifty_two_week_high": 28.25,
    "fifty_two_week_low": 1.0,
    "percent_change_from_200_day_moving_average": 0.1508,
    "percent_change_from_50_day_moving_average": 0.1839,
    "shares_owned": "N/A",
    "short_ratio": 0.58,
    "two_hundred_day_moving_average": 1.33,
    "volume": 1181093.0,
    "market_cap": 36590000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.05,
    "roa_ttm": -0.4025,
    "roe_ttm": -0.8617,
    "shares_outstanding": 23920000.0,
    "pcnt_held_by_insiders": 0.3059,
    "pcnt_held_by_institutions": 0.255,
    "pcnt_short_of_float": 0.041299999999999996,
    "operating_cash_flow_ttm": -46620000.0,
    "levered_cash_flow_ttm": -26110000.0,
    "book_value_per_share_mrq": 1.52,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Celladon Corporation"
  },
  "CLDX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.33,
    "ebitda": -124370000.0,
    "eps_estimate_current_year": -1.32,
    "eps_estimate_next_quarter": -0.35,
    "fifty_day_moving_average": 15.28,
    "fifty_two_week_high": 32.82,
    "fifty_two_week_low": 10.11,
    "percent_change_from_200_day_moving_average": -0.1414,
    "percent_change_from_50_day_moving_average": 0.0158,
    "shares_owned": "N/A",
    "short_ratio": 8.22,
    "two_hundred_day_moving_average": 18.08,
    "volume": 2033589.0,
    "market_cap": 1530000000.0,
    "price_to_sales_ttm": 286.62,
    "price_to_book_mrq": 4.65,
    "roa_ttm": -0.2566,
    "roe_ttm": -0.45280000000000004,
    "shares_outstanding": 98650000.0,
    "pcnt_held_by_insiders": 0.0054,
    "pcnt_held_by_institutions": 0.892,
    "pcnt_short_of_float": 0.23379999999999998,
    "operating_cash_flow_ttm": -107360000.0,
    "levered_cash_flow_ttm": -67010000.00000001,
    "book_value_per_share_mrq": 3.23,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Celldex Therapeutics, Inc."
  },
  "CLLS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.83,
    "ebitda": -30290000.0,
    "eps_estimate_current_year": -0.99,
    "eps_estimate_next_quarter": -0.31,
    "fifty_day_moving_average": 32.99,
    "fifty_two_week_high": 50.0,
    "fifty_two_week_low": 23.52,
    "percent_change_from_200_day_moving_average": -0.1577,
    "percent_change_from_50_day_moving_average": -0.158,
    "shares_owned": "N/A",
    "short_ratio": 2.63,
    "two_hundred_day_moving_average": 32.98,
    "volume": 91046.0,
    "market_cap": 974910000.0,
    "price_to_sales_ttm": 25.62,
    "price_to_book_mrq": 3.78,
    "roa_ttm": -0.0832,
    "roe_ttm": -0.1685,
    "shares_outstanding": 35090000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 7.39,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Cellectis S.A."
  },
  "CLRB": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.293,
    "ebitda": -8680000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.2469,
    "fifty_two_week_high": 3.89,
    "fifty_two_week_low": 0.79,
    "percent_change_from_200_day_moving_average": -0.611047,
    "percent_change_from_50_day_moving_average": -0.252923,
    "shares_owned": "N/A",
    "short_ratio": 0.45,
    "two_hundred_day_moving_average": 2.3949,
    "volume": 87685.0,
    "market_cap": 7990000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 9.67,
    "roa_ttm": -0.5096,
    "roe_ttm": -1.8552000000000002,
    "shares_outstanding": 8580000.0,
    "pcnt_held_by_insiders": 0.3256,
    "pcnt_held_by_institutions": 0.45299999999999996,
    "pcnt_short_of_float": 0.0037,
    "operating_cash_flow_ttm": -8860000.0,
    "levered_cash_flow_ttm": -4910000.0,
    "book_value_per_share_mrq": 0.09,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cellectar Biosciences, Inc."
  },
  "CLSN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.08,
    "ebitda": -16990000.0,
    "eps_estimate_current_year": -1.03,
    "eps_estimate_next_quarter": -0.19,
    "fifty_day_moving_average": 1.9,
    "fifty_two_week_high": 3.57,
    "fifty_two_week_low": 1.61,
    "percent_change_from_200_day_moving_average": -0.1018,
    "percent_change_from_50_day_moving_average": -0.0105,
    "shares_owned": "N/A",
    "short_ratio": 7.74,
    "two_hundred_day_moving_average": 2.09,
    "volume": 147740.0,
    "market_cap": 43690000.0,
    "price_to_sales_ttm": 83.19,
    "price_to_book_mrq": 1.64,
    "roa_ttm": -0.17129999999999998,
    "roe_ttm": -0.7313,
    "shares_outstanding": 23240000.0,
    "pcnt_held_by_insiders": 0.121,
    "pcnt_held_by_institutions": 0.18600000000000003,
    "pcnt_short_of_float": 0.0642,
    "operating_cash_flow_ttm": -23440000.0,
    "levered_cash_flow_ttm": -11040000.0,
    "book_value_per_share_mrq": 1.09,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Celsion Corp."
  },
  "CLVS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -8.25,
    "ebitda": -274010000.0,
    "eps_estimate_current_year": -9.04,
    "eps_estimate_next_quarter": -3.0,
    "fifty_day_moving_average": 53.28,
    "fifty_two_week_high": 116.75,
    "fifty_two_week_low": 24.5,
    "percent_change_from_200_day_moving_average": -0.5875,
    "percent_change_from_50_day_moving_average": -0.38439999999999996,
    "shares_owned": "N/A",
    "short_ratio": 1.35,
    "two_hundred_day_moving_average": 79.51,
    "volume": 3381983.0,
    "market_cap": 1260000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.08,
    "roa_ttm": -0.1993,
    "roe_ttm": -0.7182,
    "shares_outstanding": 38320000.0,
    "pcnt_held_by_insiders": 0.1002,
    "pcnt_held_by_institutions": 0.843,
    "pcnt_short_of_float": 0.23079999999999998,
    "operating_cash_flow_ttm": -211330000.0,
    "levered_cash_flow_ttm": -95100000.0,
    "book_value_per_share_mrq": 10.82,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Clovis Oncology, Inc."
  },
  "CMN": {
    "p_e_ratio": 50.57,
    "peg_ratio": 2.43,
    "earnings_per_share": 1.22,
    "ebitda": 115440000.0,
    "eps_estimate_current_year": 1.44,
    "eps_estimate_next_quarter": 0.36,
    "fifty_day_moving_average": 63.51,
    "fifty_two_week_high": 68.58,
    "fifty_two_week_low": 39.26,
    "percent_change_from_200_day_moving_average": 0.10490000000000001,
    "percent_change_from_50_day_moving_average": -0.028399999999999998,
    "shares_owned": "N/A",
    "short_ratio": 5.2,
    "two_hundred_day_moving_average": 55.84,
    "volume": 295869.0,
    "market_cap": 2570000000.0,
    "price_to_sales_ttm": 4.51,
    "price_to_book_mrq": 6.23,
    "roa_ttm": 0.09179999999999999,
    "roe_ttm": 0.1285,
    "shares_outstanding": 41710000.0,
    "pcnt_held_by_insiders": 0.2175,
    "pcnt_held_by_institutions": 0.789,
    "pcnt_short_of_float": 0.0231,
    "operating_cash_flow_ttm": 61480000.0,
    "levered_cash_flow_ttm": 57110000.0,
    "book_value_per_share_mrq": 10.1,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Cantel Medical Corp."
  },
  "CMRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.37,
    "ebitda": -99110000.0,
    "eps_estimate_current_year": -2.54,
    "eps_estimate_next_quarter": -0.77,
    "fifty_day_moving_average": 38.63,
    "fifty_two_week_high": 58.04,
    "fifty_two_week_low": 33.02,
    "percent_change_from_200_day_moving_average": -0.1826,
    "percent_change_from_50_day_moving_average": -0.0704,
    "shares_owned": "N/A",
    "short_ratio": 10.55,
    "two_hundred_day_moving_average": 43.93,
    "volume": 828558.0,
    "market_cap": 1660000000.0,
    "price_to_sales_ttm": 187.4,
    "price_to_book_mrq": 4.46,
    "roa_ttm": -0.2127,
    "roe_ttm": -0.3649,
    "shares_outstanding": 46150000.0,
    "pcnt_held_by_insiders": 0.0907,
    "pcnt_held_by_institutions": 0.8959999999999999,
    "pcnt_short_of_float": 0.0894,
    "operating_cash_flow_ttm": -83660000.0,
    "levered_cash_flow_ttm": -47770000.0,
    "book_value_per_share_mrq": 8.02,
    "next_earnings_announcement_date": [
      "2016-03-04",
      "2016-03-08"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Chimerix, Inc."
  },
  "CNAT": {
    "p_e_ratio": "N/A",
    "peg_ratio": -2.04,
    "earnings_per_share": -1.34,
    "ebitda": -23340000.0,
    "eps_estimate_current_year": -1.4,
    "eps_estimate_next_quarter": -0.4,
    "fifty_day_moving_average": 3.26,
    "fifty_two_week_high": 11.74,
    "fifty_two_week_low": 2.5,
    "percent_change_from_200_day_moving_average": -0.3098,
    "percent_change_from_50_day_moving_average": -0.0819,
    "shares_owned": "N/A",
    "short_ratio": 4.06,
    "two_hundred_day_moving_average": 4.33,
    "volume": 138505.0,
    "market_cap": 59410000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.42,
    "roa_ttm": -0.3332,
    "roe_ttm": -0.6042000000000001,
    "shares_outstanding": 19870000.0,
    "pcnt_held_by_insiders": 0.2683,
    "pcnt_held_by_institutions": 0.344,
    "pcnt_short_of_float": 0.0849,
    "operating_cash_flow_ttm": -20320000.0,
    "levered_cash_flow_ttm": -12190000.0,
    "book_value_per_share_mrq": 2.01,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Conatus Pharmaceuticals Inc."
  },
  "CNC": {
    "p_e_ratio": 22.55,
    "peg_ratio": 1.43,
    "earnings_per_share": 2.87,
    "ebitda": 853000000.0,
    "eps_estimate_current_year": 2.88,
    "eps_estimate_next_quarter": 0.69,
    "fifty_day_moving_average": 58.9,
    "fifty_two_week_high": 83.0,
    "fifty_two_week_low": 50.93,
    "percent_change_from_200_day_moving_average": -0.0042,
    "percent_change_from_50_day_moving_average": 0.0993,
    "shares_owned": "N/A",
    "short_ratio": 9.09,
    "two_hundred_day_moving_average": 65.02,
    "volume": 5103608.0,
    "market_cap": 7720000000.0,
    "price_to_sales_ttm": 0.37,
    "price_to_book_mrq": 3.6,
    "roa_ttm": 0.0731,
    "roe_ttm": 0.1754,
    "shares_outstanding": 119200000.0,
    "pcnt_held_by_insiders": 0.020099999999999996,
    "pcnt_held_by_institutions": 0.937,
    "pcnt_short_of_float": 0.1168,
    "operating_cash_flow_ttm": 827000000.0,
    "levered_cash_flow_ttm": 714580000.0,
    "book_value_per_share_mrq": 17.21,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Health Care Plans",
    "company_name": "Centene Corp."
  },
  "CNCE": {
    "p_e_ratio": 29.52,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.69,
    "ebitda": -34130000.0,
    "eps_estimate_current_year": 1.03,
    "eps_estimate_next_quarter": -0.52,
    "fifty_day_moving_average": 22.11,
    "fifty_two_week_high": 25.04,
    "fifty_two_week_low": 11.27,
    "percent_change_from_200_day_moving_average": 0.0861,
    "percent_change_from_50_day_moving_average": -0.0733,
    "shares_owned": "N/A",
    "short_ratio": 3.15,
    "two_hundred_day_moving_average": 18.87,
    "volume": 246508.0,
    "market_cap": 452500000.0,
    "price_to_sales_ttm": 58.04,
    "price_to_book_mrq": 3.41,
    "roa_ttm": -0.1796,
    "roe_ttm": 0.1518,
    "shares_outstanding": 22080000.0,
    "pcnt_held_by_insiders": 0.2889,
    "pcnt_held_by_institutions": 0.565,
    "pcnt_short_of_float": 0.050199999999999995,
    "operating_cash_flow_ttm": 14040000.0,
    "levered_cash_flow_ttm": -23040000.0,
    "book_value_per_share_mrq": 5.84,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Concert Pharmaceuticals, Inc."
  },
  "CNMD": {
    "p_e_ratio": 34.92,
    "peg_ratio": 2.29,
    "earnings_per_share": 1.22,
    "ebitda": 123640000.0,
    "eps_estimate_current_year": 1.67,
    "eps_estimate_next_quarter": 0.46,
    "fifty_day_moving_average": 41.69,
    "fifty_two_week_high": 60.66,
    "fifty_two_week_low": 37.94,
    "percent_change_from_200_day_moving_average": -0.1591,
    "percent_change_from_50_day_moving_average": 0.0219,
    "shares_owned": "N/A",
    "short_ratio": 7.04,
    "two_hundred_day_moving_average": 50.66,
    "volume": 361896.0,
    "market_cap": 1180000000.0,
    "price_to_sales_ttm": 1.64,
    "price_to_book_mrq": 2.04,
    "roa_ttm": 0.0452,
    "roe_ttm": 0.0581,
    "shares_outstanding": 27700000.0,
    "pcnt_held_by_insiders": 0.0194,
    "pcnt_held_by_institutions": 0.991,
    "pcnt_short_of_float": 0.05,
    "operating_cash_flow_ttm": 64370000.00000001,
    "levered_cash_flow_ttm": 74790000.0,
    "book_value_per_share_mrq": 20.84,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "CONMED Corporation"
  },
  "CNXR": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.68,
    "earnings_per_share": -0.44,
    "ebitda": 4820000.0,
    "eps_estimate_current_year": -0.26,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 4.16,
    "fifty_two_week_high": 14.39,
    "fifty_two_week_low": 3.11,
    "percent_change_from_200_day_moving_average": -0.5072,
    "percent_change_from_50_day_moving_average": -0.1916,
    "shares_owned": "N/A",
    "short_ratio": 12.92,
    "two_hundred_day_moving_average": 6.82,
    "volume": 123588.0,
    "market_cap": 73650000.0,
    "price_to_sales_ttm": 0.81,
    "price_to_book_mrq": "N/A",
    "roa_ttm": 0.0011,
    "roe_ttm": "N/A",
    "shares_outstanding": 21920000.0,
    "pcnt_held_by_insiders": 0.3843,
    "pcnt_held_by_institutions": 0.5529999999999999,
    "pcnt_short_of_float": 0.1532,
    "operating_cash_flow_ttm": -19590000.0,
    "levered_cash_flow_ttm": -7480000.0,
    "book_value_per_share_mrq": -1.68,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Health Care Plans",
    "company_name": "Connecture, Inc."
  },
  "CO": {
    "p_e_ratio": 38.86,
    "peg_ratio": 1.38,
    "earnings_per_share": 0.17,
    "ebitda": 41490000.0,
    "eps_estimate_current_year": 0.15,
    "eps_estimate_next_quarter": 0.05,
    "fifty_day_moving_average": 6.35,
    "fifty_two_week_high": 7.69,
    "fifty_two_week_low": 4.13,
    "percent_change_from_200_day_moving_average": 0.0308,
    "percent_change_from_50_day_moving_average": 0.016200000000000003,
    "shares_owned": "N/A",
    "short_ratio": 1.14,
    "two_hundred_day_moving_average": 6.26,
    "volume": 92343.0,
    "market_cap": 516539999.99999994,
    "price_to_sales_ttm": 4.41,
    "price_to_book_mrq": 1.83,
    "roa_ttm": 0.0331,
    "roe_ttm": 0.0536,
    "shares_outstanding": 80080000.0,
    "pcnt_held_by_insiders": 0.489,
    "pcnt_held_by_institutions": 0.111,
    "pcnt_short_of_float": 0.004699999999999999,
    "operating_cash_flow_ttm": 92170000.0,
    "levered_cash_flow_ttm": 23600000.0,
    "book_value_per_share_mrq": 3.4,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "China Cord Blood Corporation"
  },
  "COLL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.98,
    "ebitda": -20620000.0,
    "eps_estimate_current_year": -1.87,
    "eps_estimate_next_quarter": -0.81,
    "fifty_day_moving_average": 21.24,
    "fifty_two_week_high": 28.5,
    "fifty_two_week_low": 11.92,
    "percent_change_from_200_day_moving_average": 0.3368,
    "percent_change_from_50_day_moving_average": 0.20120000000000002,
    "shares_owned": "N/A",
    "short_ratio": 6.46,
    "two_hundred_day_moving_average": 19.08,
    "volume": 741356.0,
    "market_cap": 527770000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 5.98,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 20690000.0,
    "pcnt_held_by_insiders": 0.1606,
    "pcnt_held_by_institutions": 0.45,
    "pcnt_short_of_float": 0.0353,
    "operating_cash_flow_ttm": -20190000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 4.52,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Collegium Pharmaceutical, Inc."
  },
  "COO": {
    "p_e_ratio": 32.79,
    "peg_ratio": 1.35,
    "earnings_per_share": 4.14,
    "ebitda": 540670000.0,
    "eps_estimate_current_year": 7.75,
    "eps_estimate_next_quarter": 1.83,
    "fifty_day_moving_average": 144.06,
    "fifty_two_week_high": 190.0,
    "fifty_two_week_low": 121.01,
    "percent_change_from_200_day_moving_average": -0.1465,
    "percent_change_from_50_day_moving_average": -0.0581,
    "shares_owned": "N/A",
    "short_ratio": 5.47,
    "two_hundred_day_moving_average": 158.97,
    "volume": 1007298.0,
    "market_cap": 6550000000.0,
    "price_to_sales_ttm": 3.73,
    "price_to_book_mrq": 2.52,
    "roa_ttm": 0.049400000000000006,
    "roe_ttm": 0.078,
    "shares_outstanding": 48270000.0,
    "pcnt_held_by_insiders": 0.0066,
    "pcnt_held_by_institutions": 1.033,
    "pcnt_short_of_float": 0.0564,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 54.24,
    "next_earnings_announcement_date": [
      "2016-03-03",
      "2016-03-07"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "The Cooper Companies Inc."
  },
  "CORI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.52,
    "ebitda": -18400000.0,
    "eps_estimate_current_year": -1.21,
    "eps_estimate_next_quarter": -0.35,
    "fifty_day_moving_average": 7.65,
    "fifty_two_week_high": 16.29,
    "fifty_two_week_low": 5.62,
    "percent_change_from_200_day_moving_average": -0.32549999999999996,
    "percent_change_from_50_day_moving_average": -0.060700000000000004,
    "shares_owned": "N/A",
    "short_ratio": 7.75,
    "two_hundred_day_moving_average": 10.66,
    "volume": 81233.0,
    "market_cap": 159750000.0,
    "price_to_sales_ttm": 4.1,
    "price_to_book_mrq": 4.74,
    "roa_ttm": -0.1578,
    "roe_ttm": -1.2075,
    "shares_outstanding": 22220000.0,
    "pcnt_held_by_insiders": 0.0015,
    "pcnt_held_by_institutions": 0.716,
    "pcnt_short_of_float": 0.058899999999999994,
    "operating_cash_flow_ttm": -20720000.0,
    "levered_cash_flow_ttm": -12760000.0,
    "book_value_per_share_mrq": 1.59,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Corium International, Inc."
  },
  "CORT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.48,
    "earnings_per_share": -0.11,
    "ebitda": -8010000.0,
    "eps_estimate_current_year": -0.09,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 4.83,
    "fifty_two_week_high": 7.67,
    "fifty_two_week_low": 2.69,
    "percent_change_from_200_day_moving_average": -0.054400000000000004,
    "percent_change_from_50_day_moving_average": -0.0169,
    "shares_owned": "N/A",
    "short_ratio": 12.0,
    "two_hundred_day_moving_average": 5.02,
    "volume": 362880.0,
    "market_cap": 516690000.00000006,
    "price_to_sales_ttm": 12.02,
    "price_to_book_mrq": 39.52,
    "roa_ttm": -0.11939999999999999,
    "roe_ttm": -1.8522999999999998,
    "shares_outstanding": 108780000.0,
    "pcnt_held_by_insiders": 0.34340000000000004,
    "pcnt_held_by_institutions": 0.377,
    "pcnt_short_of_float": 0.0599,
    "operating_cash_flow_ttm": -2440000.0,
    "levered_cash_flow_ttm": -2670000.0,
    "book_value_per_share_mrq": 0.12,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Corcept Therapeutics Incorporated"
  },
  "CPHI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.572,
    "ebitda": -20310000.0,
    "eps_estimate_current_year": 0.42,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.2049,
    "fifty_two_week_high": 0.56,
    "fifty_two_week_low": 0.16,
    "percent_change_from_200_day_moving_average": -0.25625,
    "percent_change_from_50_day_moving_average": -0.128661,
    "shares_owned": "N/A",
    "short_ratio": 0.88,
    "two_hundred_day_moving_average": 0.24,
    "volume": 11327.0,
    "market_cap": 7780000.0,
    "price_to_sales_ttm": 0.37,
    "price_to_book_mrq": 0.09,
    "roa_ttm": -0.11779999999999999,
    "roe_ttm": -0.24739999999999998,
    "shares_outstanding": 43580000.0,
    "pcnt_held_by_insiders": 0.4966,
    "pcnt_held_by_institutions": 0.069,
    "pcnt_short_of_float": 0.001,
    "operating_cash_flow_ttm": 2630000.0,
    "levered_cash_flow_ttm": 12310000.0,
    "book_value_per_share_mrq": 1.99,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "China Pharma Holdings, Inc."
  },
  "CPHR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.02,
    "ebitda": 7150000.0,
    "eps_estimate_current_year": -0.05,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 4.31,
    "fifty_two_week_high": 16.33,
    "fifty_two_week_low": 3.55,
    "percent_change_from_200_day_moving_average": -0.2933,
    "percent_change_from_50_day_moving_average": 0.0154,
    "shares_owned": "N/A",
    "short_ratio": 12.57,
    "two_hundred_day_moving_average": 6.2,
    "volume": 5552.0,
    "market_cap": 113970000.0,
    "price_to_sales_ttm": 4.44,
    "price_to_book_mrq": 2.32,
    "roa_ttm": 0.033,
    "roe_ttm": -0.0085,
    "shares_outstanding": 26020000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": 7180000.0,
    "levered_cash_flow_ttm": -3340000.0,
    "book_value_per_share_mrq": 1.98,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Cipher Pharmaceuticals Inc."
  },
  "CPIX": {
    "p_e_ratio": 76.48,
    "peg_ratio": 1.94,
    "earnings_per_share": 0.07,
    "ebitda": 3880000.0,
    "eps_estimate_current_year": 0.09,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 5.72,
    "fifty_two_week_high": 7.78,
    "fifty_two_week_low": 5.03,
    "percent_change_from_200_day_moving_average": -0.1219,
    "percent_change_from_50_day_moving_average": -0.050199999999999995,
    "shares_owned": "N/A",
    "short_ratio": 4.13,
    "two_hundred_day_moving_average": 6.18,
    "volume": 20025.0,
    "market_cap": 89340000.0,
    "price_to_sales_ttm": 2.47,
    "price_to_book_mrq": 1.11,
    "roa_ttm": 0.010700000000000001,
    "roe_ttm": 0.015,
    "shares_outstanding": 16450000.0,
    "pcnt_held_by_insiders": 0.3985,
    "pcnt_held_by_institutions": 0.326,
    "pcnt_short_of_float": 0.0089,
    "operating_cash_flow_ttm": 7290000.0,
    "levered_cash_flow_ttm": 521010.0,
    "book_value_per_share_mrq": 4.7,
    "next_earnings_announcement_date": [
      "2016-03-01",
      "2016-03-07"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Cumberland Pharmaceuticals, Inc."
  },
  "CPRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.23,
    "ebitda": -18150000.0,
    "eps_estimate_current_year": -0.25,
    "eps_estimate_next_quarter": -0.07,
    "fifty_day_moving_average": 2.76,
    "fifty_two_week_high": 5.8,
    "fifty_two_week_low": 2.27,
    "percent_change_from_200_day_moving_average": -0.3146,
    "percent_change_from_50_day_moving_average": -0.0756,
    "shares_owned": "N/A",
    "short_ratio": 6.94,
    "two_hundred_day_moving_average": 3.72,
    "volume": 538795.0,
    "market_cap": 211200000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.72,
    "roa_ttm": -0.20600000000000002,
    "roe_ttm": -0.3682,
    "shares_outstanding": 82820000.0,
    "pcnt_held_by_insiders": 0.166,
    "pcnt_held_by_institutions": 0.539,
    "pcnt_short_of_float": 0.06309999999999999,
    "operating_cash_flow_ttm": -17360000.0,
    "levered_cash_flow_ttm": -10700000.0,
    "book_value_per_share_mrq": 0.73,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Catalyst Pharmaceuticals, Inc."
  },
  "CPXX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.52,
    "ebitda": -17250000.0,
    "eps_estimate_current_year": -0.57,
    "eps_estimate_next_quarter": -0.16,
    "fifty_day_moving_average": 1.69,
    "fifty_two_week_high": 3.53,
    "fifty_two_week_low": 1.3,
    "percent_change_from_200_day_moving_average": -0.2613,
    "percent_change_from_50_day_moving_average": -0.10039999999999999,
    "shares_owned": "N/A",
    "short_ratio": 3.68,
    "two_hundred_day_moving_average": 2.06,
    "volume": 122881.0,
    "market_cap": 52510000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 5.78,
    "roa_ttm": -0.435,
    "roe_ttm": -1.8174000000000001,
    "shares_outstanding": 34550000.0,
    "pcnt_held_by_insiders": 0.37579999999999997,
    "pcnt_held_by_institutions": 0.087,
    "pcnt_short_of_float": 0.0232,
    "operating_cash_flow_ttm": -14600000.0,
    "levered_cash_flow_ttm": -9410000.0,
    "book_value_per_share_mrq": 0.26,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Celator Pharmaceuticals, Inc."
  },
  "CRBP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.27,
    "ebitda": -7580000.0,
    "eps_estimate_current_year": -0.29,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.68,
    "fifty_two_week_high": 4.31,
    "fifty_two_week_low": 1.45,
    "percent_change_from_200_day_moving_average": -0.2781,
    "percent_change_from_50_day_moving_average": -0.0719,
    "shares_owned": "N/A",
    "short_ratio": 0.37,
    "two_hundred_day_moving_average": 2.16,
    "volume": 62009.0,
    "market_cap": 58660000.0,
    "price_to_sales_ttm": 209.14,
    "price_to_book_mrq": 5.32,
    "roa_ttm": -0.4539,
    "roe_ttm": -0.8370000000000001,
    "shares_outstanding": 37610000.0,
    "pcnt_held_by_insiders": 0.24309999999999998,
    "pcnt_held_by_institutions": 0.084,
    "pcnt_short_of_float": 0.002,
    "operating_cash_flow_ttm": -5070000.0,
    "levered_cash_flow_ttm": -2520000.0,
    "book_value_per_share_mrq": 0.3,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Corbus Pharmaceuticals Holdings, Inc."
  },
  "CRDC": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.03,
    "earnings_per_share": -0.211,
    "ebitda": -16730000.0,
    "eps_estimate_current_year": -0.19,
    "eps_estimate_next_quarter": -0.05,
    "fifty_day_moving_average": 0.175,
    "fifty_two_week_high": 0.74,
    "fifty_two_week_low": 0.11,
    "percent_change_from_200_day_moving_average": -0.5777300000000001,
    "percent_change_from_50_day_moving_average": -0.20949,
    "shares_owned": "N/A",
    "short_ratio": 0.82,
    "two_hundred_day_moving_average": 0.327,
    "volume": 545214.0,
    "market_cap": 12280000.0,
    "price_to_sales_ttm": 4.26,
    "price_to_book_mrq": 32.0,
    "roa_ttm": -0.32630000000000003,
    "roe_ttm": -0.708,
    "shares_outstanding": 89020000.0,
    "pcnt_held_by_insiders": 0.20350000000000001,
    "pcnt_held_by_institutions": 0.389,
    "pcnt_short_of_float": 0.0039000000000000003,
    "operating_cash_flow_ttm": -15100000.0,
    "levered_cash_flow_ttm": -9230000.0,
    "book_value_per_share_mrq": 0.0,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Cardica Inc."
  },
  "CRIS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.45,
    "ebitda": -23530000.0,
    "eps_estimate_current_year": -0.5,
    "eps_estimate_next_quarter": -0.07,
    "fifty_day_moving_average": 2.64,
    "fifty_two_week_high": 3.75,
    "fifty_two_week_low": 1.18,
    "percent_change_from_200_day_moving_average": 0.1002,
    "percent_change_from_50_day_moving_average": 0.1322,
    "shares_owned": "N/A",
    "short_ratio": 13.41,
    "two_hundred_day_moving_average": 2.72,
    "volume": 4033556.0,
    "market_cap": 383900000.0,
    "price_to_sales_ttm": 50.84,
    "price_to_book_mrq": 5.2,
    "roa_ttm": -0.1699,
    "roe_ttm": -0.9257,
    "shares_outstanding": 128400000.0,
    "pcnt_held_by_insiders": 0.1476,
    "pcnt_held_by_institutions": 0.541,
    "pcnt_short_of_float": 0.0629,
    "operating_cash_flow_ttm": -23720000.0,
    "levered_cash_flow_ttm": -13620000.0,
    "book_value_per_share_mrq": 0.59,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Curis, Inc."
  },
  "CRL": {
    "p_e_ratio": 25.59,
    "peg_ratio": 2.28,
    "earnings_per_share": 3.04,
    "ebitda": 305870000.0,
    "eps_estimate_current_year": 3.71,
    "eps_estimate_next_quarter": 0.92,
    "fifty_day_moving_average": 74.62,
    "fifty_two_week_high": 84.69,
    "fifty_two_week_low": 59.99,
    "percent_change_from_200_day_moving_average": 0.086,
    "percent_change_from_50_day_moving_average": 0.0429,
    "shares_owned": "N/A",
    "short_ratio": 3.1,
    "two_hundred_day_moving_average": 71.66,
    "volume": 532105.0,
    "market_cap": 3630000000.0,
    "price_to_sales_ttm": 2.76,
    "price_to_book_mrq": 5.25,
    "roa_ttm": 0.0693,
    "roe_ttm": 0.2054,
    "shares_outstanding": 46620000.0,
    "pcnt_held_by_insiders": 0.0175,
    "pcnt_held_by_institutions": 1.0170000000000001,
    "pcnt_short_of_float": 0.0316,
    "operating_cash_flow_ttm": 283970000.0,
    "levered_cash_flow_ttm": 215540000.0,
    "book_value_per_share_mrq": 15.11,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Charles River Laboratories International, Inc."
  },
  "CRMD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.59,
    "ebitda": -16079999.999999998,
    "eps_estimate_current_year": -0.64,
    "eps_estimate_next_quarter": -0.17,
    "fifty_day_moving_average": 2.34,
    "fifty_two_week_high": 10.4,
    "fifty_two_week_low": 1.4,
    "percent_change_from_200_day_moving_average": -0.3514,
    "percent_change_from_50_day_moving_average": -0.1359,
    "shares_owned": "N/A",
    "short_ratio": 21.42,
    "two_hundred_day_moving_average": 3.11,
    "volume": 545941.0,
    "market_cap": 71240000.0,
    "price_to_sales_ttm": 264.42,
    "price_to_book_mrq": 1.98,
    "roa_ttm": -0.4359,
    "roe_ttm": -0.7879999999999999,
    "shares_outstanding": 35270000.0,
    "pcnt_held_by_insiders": 0.0646,
    "pcnt_held_by_institutions": 0.16699999999999998,
    "pcnt_short_of_float": 0.1547,
    "operating_cash_flow_ttm": -10470000.0,
    "levered_cash_flow_ttm": -5810000.0,
    "book_value_per_share_mrq": 1.03,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "CorMedix, Inc."
  },
  "CRME": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.25,
    "earnings_per_share": -1.36,
    "ebitda": -19360000.0,
    "eps_estimate_current_year": -1.15,
    "eps_estimate_next_quarter": -0.24,
    "fifty_day_moving_average": 8.56,
    "fifty_two_week_high": 11.31,
    "fifty_two_week_low": 7.28,
    "percent_change_from_200_day_moving_average": -0.1464,
    "percent_change_from_50_day_moving_average": -0.10710000000000001,
    "shares_owned": "N/A",
    "short_ratio": 13.38,
    "two_hundred_day_moving_average": 8.95,
    "volume": 67595.0,
    "market_cap": 153920000.0,
    "price_to_sales_ttm": 6.94,
    "price_to_book_mrq": 5.99,
    "roa_ttm": -0.2459,
    "roe_ttm": -0.9368000000000001,
    "shares_outstanding": 20150000.0,
    "pcnt_held_by_insiders": 0.3565,
    "pcnt_held_by_institutions": 0.76,
    "pcnt_short_of_float": 0.0167,
    "operating_cash_flow_ttm": -14850000.0,
    "levered_cash_flow_ttm": -7570000.0,
    "book_value_per_share_mrq": 1.33,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Cardiome Pharma Corp."
  },
  "CRY": {
    "p_e_ratio": 95.0,
    "peg_ratio": 3.91,
    "earnings_per_share": 0.11,
    "ebitda": 11420000.0,
    "eps_estimate_current_year": 0.09,
    "eps_estimate_next_quarter": 0.03,
    "fifty_day_moving_average": 10.58,
    "fifty_two_week_high": 12.29,
    "fifty_two_week_low": 9.41,
    "percent_change_from_200_day_moving_average": -0.0265,
    "percent_change_from_50_day_moving_average": -0.0304,
    "shares_owned": "N/A",
    "short_ratio": 23.54,
    "two_hundred_day_moving_average": 10.54,
    "volume": 144047.0,
    "market_cap": 291950000.0,
    "price_to_sales_ttm": 2.1,
    "price_to_book_mrq": 1.98,
    "roa_ttm": 0.0187,
    "roe_ttm": 0.021099999999999997,
    "shares_outstanding": 28460000.0,
    "pcnt_held_by_insiders": 0.10099999999999999,
    "pcnt_held_by_institutions": 0.618,
    "pcnt_short_of_float": 0.039599999999999996,
    "operating_cash_flow_ttm": 14810000.0,
    "levered_cash_flow_ttm": 9780000.0,
    "book_value_per_share_mrq": 5.34,
    "next_earnings_announcement_date": [
      "2016-02-15",
      "2016-02-19"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "CryoLife Inc."
  },
  "CSBR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.608,
    "ebitda": -11060000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 4.4854,
    "fifty_two_week_high": 10.08,
    "fifty_two_week_low": 2.4,
    "percent_change_from_200_day_moving_average": -0.37286499999999995,
    "percent_change_from_50_day_moving_average": -0.219361,
    "shares_owned": "N/A",
    "short_ratio": 6.08,
    "two_hundred_day_moving_average": 5.5833,
    "volume": 331.0,
    "market_cap": 30470000.0,
    "price_to_sales_ttm": 3.2,
    "price_to_book_mrq": 8.49,
    "roa_ttm": -1.2899,
    "roe_ttm": "-1,062.12%",
    "shares_outstanding": 8700000.0,
    "pcnt_held_by_insiders": 0.6872,
    "pcnt_held_by_institutions": 0.29100000000000004,
    "pcnt_short_of_float": 0.0008,
    "operating_cash_flow_ttm": -9510000.0,
    "levered_cash_flow_ttm": -5230000.0,
    "book_value_per_share_mrq": 0.47,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Champions Oncology, Inc."
  },
  "CSII": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.39,
    "earnings_per_share": -1.19,
    "ebitda": -34800000.0,
    "eps_estimate_current_year": -1.76,
    "eps_estimate_next_quarter": -0.37,
    "fifty_day_moving_average": 14.84,
    "fifty_two_week_high": 41.28,
    "fifty_two_week_low": 11.8,
    "percent_change_from_200_day_moving_average": -0.3494,
    "percent_change_from_50_day_moving_average": -0.052199999999999996,
    "shares_owned": "N/A",
    "short_ratio": 9.88,
    "two_hundred_day_moving_average": 21.63,
    "volume": 422933.0,
    "market_cap": 457260000.0,
    "price_to_sales_ttm": 2.54,
    "price_to_book_mrq": 3.52,
    "roa_ttm": -0.1366,
    "roe_ttm": -0.2713,
    "shares_outstanding": 32500000.0,
    "pcnt_held_by_insiders": 0.0401,
    "pcnt_held_by_institutions": 0.723,
    "pcnt_short_of_float": 0.10679999999999999,
    "operating_cash_flow_ttm": -22720000.0,
    "levered_cash_flow_ttm": -32670000.0,
    "book_value_per_share_mrq": 4.03,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Cardiovascular Systems Inc."
  },
  "CSU": {
    "p_e_ratio": "N/A",
    "peg_ratio": -3.93,
    "earnings_per_share": -0.42,
    "ebitda": 71400000.0,
    "eps_estimate_current_year": -0.35,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 22.46,
    "fifty_two_week_high": 27.75,
    "fifty_two_week_low": 19.2,
    "percent_change_from_200_day_moving_average": -0.10619999999999999,
    "percent_change_from_50_day_moving_average": -0.0986,
    "shares_owned": "N/A",
    "short_ratio": 7.84,
    "two_hundred_day_moving_average": 22.66,
    "volume": 428485.0,
    "market_cap": 597760000.0,
    "price_to_sales_ttm": 1.47,
    "price_to_book_mrq": 4.24,
    "roa_ttm": 0.0126,
    "roe_ttm": -0.0864,
    "shares_outstanding": 29520000.0,
    "pcnt_held_by_insiders": 0.1201,
    "pcnt_held_by_institutions": 0.254,
    "pcnt_short_of_float": 0.055,
    "operating_cash_flow_ttm": 43700000.0,
    "levered_cash_flow_ttm": 24040000.0,
    "book_value_per_share_mrq": 4.86,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "Capital Senior Living Corp."
  },
  "CTIC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.81,
    "ebitda": -107000000.0,
    "eps_estimate_current_year": -0.59,
    "eps_estimate_next_quarter": -0.05,
    "fifty_day_moving_average": 1.19,
    "fifty_two_week_high": 2.94,
    "fifty_two_week_low": 0.8,
    "percent_change_from_200_day_moving_average": -0.2706,
    "percent_change_from_50_day_moving_average": -0.0034000000000000002,
    "shares_owned": "N/A",
    "short_ratio": 6.52,
    "two_hundred_day_moving_average": 1.63,
    "volume": 5942318.0,
    "market_cap": 275840000.0,
    "price_to_sales_ttm": 9.2,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -1.0247,
    "roe_ttm": "N/A",
    "shares_outstanding": 231800000.0,
    "pcnt_held_by_insiders": 0.1948,
    "pcnt_held_by_institutions": 0.289,
    "pcnt_short_of_float": 0.0592,
    "operating_cash_flow_ttm": -69270000.0,
    "levered_cash_flow_ttm": -23780000.0,
    "book_value_per_share_mrq": -0.13,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "CTI BioPharma Corp."
  },
  "CTLT": {
    "p_e_ratio": 13.21,
    "peg_ratio": 2.07,
    "earnings_per_share": 1.9,
    "ebitda": 415700000.0,
    "eps_estimate_current_year": 1.66,
    "eps_estimate_next_quarter": 0.46,
    "fifty_day_moving_average": 27.25,
    "fifty_two_week_high": 34.42,
    "fifty_two_week_low": 23.63,
    "percent_change_from_200_day_moving_average": -0.1253,
    "percent_change_from_50_day_moving_average": -0.0764,
    "shares_owned": "N/A",
    "short_ratio": 9.37,
    "two_hundred_day_moving_average": 28.77,
    "volume": 3119245.0,
    "market_cap": 3130000000.0,
    "price_to_sales_ttm": 1.79,
    "price_to_book_mrq": 5.5,
    "roa_ttm": 0.0571,
    "roe_ttm": 0.43119999999999997,
    "shares_outstanding": 124520000.0,
    "pcnt_held_by_insiders": 0.24,
    "pcnt_held_by_institutions": 0.759,
    "pcnt_short_of_float": 0.0583,
    "operating_cash_flow_ttm": 256500000.0,
    "levered_cash_flow_ttm": 130680000.0,
    "book_value_per_share_mrq": 4.8,
    "next_earnings_announcement_date": [
      "2016-02-09",
      "2016-02-15"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Catalent, Inc."
  },
  "CTMX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -35.05,
    "ebitda": -25240000.0,
    "eps_estimate_current_year": -2.01,
    "eps_estimate_next_quarter": -0.34,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 23.0,
    "fifty_two_week_low": 19.2,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 2.75,
    "two_hundred_day_moving_average": 0.0,
    "volume": 1168442.0,
    "market_cap": 743900000.0,
    "price_to_sales_ttm": 98.26,
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 36020000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0066,
    "operating_cash_flow_ttm": -23640000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -96.88,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "CytomX Therapeutics, Inc."
  },
  "CTRV": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.15,
    "ebitda": -17700000.0,
    "eps_estimate_current_year": -0.6,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 1.82,
    "fifty_two_week_high": 6.28,
    "fifty_two_week_low": 1.42,
    "percent_change_from_200_day_moving_average": -0.494,
    "percent_change_from_50_day_moving_average": -0.0637,
    "shares_owned": "N/A",
    "short_ratio": 1.41,
    "two_hundred_day_moving_average": 3.36,
    "volume": 199021.0,
    "market_cap": 46400000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": -5.7412,
    "roe_ttm": "N/A",
    "shares_outstanding": 27300000.0,
    "pcnt_held_by_insiders": 0.17739999999999997,
    "pcnt_held_by_institutions": 0.027000000000000003,
    "pcnt_short_of_float": 0.0213,
    "operating_cash_flow_ttm": -11430000.0,
    "levered_cash_flow_ttm": -6110000.0,
    "book_value_per_share_mrq": -0.68,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ContraVir Pharmaceuticals, Inc."
  },
  "CTSO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.69,
    "ebitda": -9860000.0,
    "eps_estimate_current_year": -0.38,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 7.18,
    "fifty_two_week_high": 15.24,
    "fifty_two_week_low": 5.17,
    "percent_change_from_200_day_moving_average": 0.0705,
    "percent_change_from_50_day_moving_average": -0.0014000000000000002,
    "shares_owned": "N/A",
    "short_ratio": 5.09,
    "two_hundred_day_moving_average": 6.7,
    "volume": 50976.0,
    "market_cap": 181870000.0,
    "price_to_sales_ttm": 46.71,
    "price_to_book_mrq": 19.33,
    "roa_ttm": -0.5534,
    "roe_ttm": -1.2763,
    "shares_outstanding": 25370000.0,
    "pcnt_held_by_insiders": 0.3188,
    "pcnt_held_by_institutions": 0.053,
    "pcnt_short_of_float": 0.0262,
    "operating_cash_flow_ttm": -9290000.0,
    "levered_cash_flow_ttm": -5130000.0,
    "book_value_per_share_mrq": 0.37,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Cytosorbents Corporation"
  },
  "CUR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.24,
    "ebitda": -19100000.0,
    "eps_estimate_current_year": -0.25,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 1.11,
    "fifty_two_week_high": 3.92,
    "fifty_two_week_low": 0.98,
    "percent_change_from_200_day_moving_average": -0.254,
    "percent_change_from_50_day_moving_average": -0.021,
    "shares_owned": "N/A",
    "short_ratio": 34.55,
    "two_hundred_day_moving_average": 1.46,
    "volume": 349093.0,
    "market_cap": 100050000.0,
    "price_to_sales_ttm": 7659.17,
    "price_to_book_mrq": 10.82,
    "roa_ttm": -0.4805,
    "roe_ttm": -1.4522,
    "shares_outstanding": 91790000.0,
    "pcnt_held_by_insiders": 0.052199999999999996,
    "pcnt_held_by_institutions": 0.203,
    "pcnt_short_of_float": 0.09140000000000001,
    "operating_cash_flow_ttm": -18510000.0,
    "levered_cash_flow_ttm": -9810000.0,
    "book_value_per_share_mrq": 0.1,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Neuralstem, Inc."
  },
  "CUTR": {
    "p_e_ratio": "N/A",
    "peg_ratio": -4.15,
    "earnings_per_share": -0.57,
    "ebitda": -6200000.0,
    "eps_estimate_current_year": -0.34,
    "eps_estimate_next_quarter": -0.1,
    "fifty_day_moving_average": 13.57,
    "fifty_two_week_high": 16.37,
    "fifty_two_week_low": 9.79,
    "percent_change_from_200_day_moving_average": -0.128,
    "percent_change_from_50_day_moving_average": -0.0754,
    "shares_owned": "N/A",
    "short_ratio": 10.86,
    "two_hundred_day_moving_average": 14.39,
    "volume": 258508.0,
    "market_cap": 162250000.0,
    "price_to_sales_ttm": 1.82,
    "price_to_book_mrq": 3.38,
    "roa_ttm": -0.051,
    "roe_ttm": -0.12480000000000001,
    "shares_outstanding": 12930000.0,
    "pcnt_held_by_insiders": 0.0571,
    "pcnt_held_by_institutions": 0.7509999999999999,
    "pcnt_short_of_float": 0.0346,
    "operating_cash_flow_ttm": -4780000.0,
    "levered_cash_flow_ttm": -257500.0,
    "book_value_per_share_mrq": 3.76,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Cutera, Inc."
  },
  "CVM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.42,
    "ebitda": -34090000.0,
    "eps_estimate_current_year": -0.42,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.4694,
    "fifty_two_week_high": 1.23,
    "fifty_two_week_low": 0.4,
    "percent_change_from_200_day_moving_average": -0.320335,
    "percent_change_from_50_day_moving_average": -0.137037,
    "shares_owned": "N/A",
    "short_ratio": 2.71,
    "two_hundred_day_moving_average": 0.596,
    "volume": 922829.0,
    "market_cap": 52650000.0,
    "price_to_sales_ttm": 84.13,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -1.2363,
    "roe_ttm": "-1,330.28%",
    "shares_outstanding": 129970000.0,
    "pcnt_held_by_insiders": 0.1519,
    "pcnt_held_by_institutions": 0.054000000000000006,
    "pcnt_short_of_float": 0.0245,
    "operating_cash_flow_ttm": -23830000.0,
    "levered_cash_flow_ttm": -11990000.0,
    "book_value_per_share_mrq": -0.05,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "CEL-SCI Corporation"
  },
  "CVRS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.25,
    "ebitda": -24920000.0,
    "eps_estimate_current_year": -0.25,
    "eps_estimate_next_quarter": -0.05,
    "fifty_day_moving_average": 3.12,
    "fifty_two_week_high": 4.58,
    "fifty_two_week_low": 2.5,
    "percent_change_from_200_day_moving_average": -0.1523,
    "percent_change_from_50_day_moving_average": -0.045700000000000005,
    "shares_owned": "N/A",
    "short_ratio": 61.47,
    "two_hundred_day_moving_average": 3.52,
    "volume": 449328.0,
    "market_cap": 353340000.0,
    "price_to_sales_ttm": 146.9,
    "price_to_book_mrq": 8.51,
    "roa_ttm": -0.3568,
    "roe_ttm": -0.8187000000000001,
    "shares_outstanding": 118570000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0736,
    "operating_cash_flow_ttm": -27300000.0,
    "levered_cash_flow_ttm": -16730000.0,
    "book_value_per_share_mrq": 0.36,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Corindus Vascular Robotics Inc."
  },
  "CYAN": {
    "p_e_ratio": 145.71,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.04,
    "ebitda": 3330000.0,
    "eps_estimate_current_year": -0.01,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 5.57,
    "fifty_two_week_high": 10.85,
    "fifty_two_week_low": 5.09,
    "percent_change_from_200_day_moving_average": -0.2741,
    "percent_change_from_50_day_moving_average": -0.0842,
    "shares_owned": "N/A",
    "short_ratio": 3.01,
    "two_hundred_day_moving_average": 7.03,
    "volume": 2310.0,
    "market_cap": 28540000.0,
    "price_to_sales_ttm": 0.84,
    "price_to_book_mrq": 1.33,
    "roa_ttm": 0.037000000000000005,
    "roe_ttm": 0.0095,
    "shares_outstanding": 5600000.0,
    "pcnt_held_by_insiders": 0.4286,
    "pcnt_held_by_institutions": 0.205,
    "pcnt_short_of_float": 0.0028000000000000004,
    "operating_cash_flow_ttm": 1030000.0,
    "levered_cash_flow_ttm": -3420000.0,
    "book_value_per_share_mrq": 3.9,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cyanotech Corp."
  },
  "CYCC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.54,
    "ebitda": -17880000.0,
    "eps_estimate_current_year": -0.43,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.6117,
    "fifty_two_week_high": 2.13,
    "fifty_two_week_low": 0.48,
    "percent_change_from_200_day_moving_average": -0.18010400000000001,
    "percent_change_from_50_day_moving_average": -0.150747,
    "shares_owned": "N/A",
    "short_ratio": 0.17,
    "two_hundred_day_moving_average": 0.6336,
    "volume": 135260.0,
    "market_cap": 18030000.0,
    "price_to_sales_ttm": 9.51,
    "price_to_book_mrq": 0.78,
    "roa_ttm": -0.38539999999999996,
    "roe_ttm": -0.6819,
    "shares_outstanding": 34700000.0,
    "pcnt_held_by_insiders": 0.1753,
    "pcnt_held_by_institutions": 0.10400000000000001,
    "pcnt_short_of_float": 0.0043,
    "operating_cash_flow_ttm": -15450000.0,
    "levered_cash_flow_ttm": -11130000.0,
    "book_value_per_share_mrq": 0.62,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cyclacel Pharmaceuticals, Inc."
  },
  "CYH": {
    "p_e_ratio": 8.54,
    "peg_ratio": 0.86,
    "earnings_per_share": 2.95,
    "ebitda": 2810000000.0,
    "eps_estimate_current_year": 3.53,
    "eps_estimate_next_quarter": 0.93,
    "fifty_day_moving_average": 27.87,
    "fifty_two_week_high": 65.0,
    "fifty_two_week_low": 24.49,
    "percent_change_from_200_day_moving_average": -0.4551,
    "percent_change_from_50_day_moving_average": -0.0962,
    "shares_owned": "N/A",
    "short_ratio": 3.3,
    "two_hundred_day_moving_average": 46.22,
    "volume": 2964881.0,
    "market_cap": 2980000000.0,
    "price_to_sales_ttm": 0.15,
    "price_to_book_mrq": 0.69,
    "roa_ttm": 0.0383,
    "roe_ttm": 0.1052,
    "shares_outstanding": 118190000.0,
    "pcnt_held_by_insiders": 0.0337,
    "pcnt_held_by_institutions": 0.9490000000000001,
    "pcnt_short_of_float": 0.09230000000000001,
    "operating_cash_flow_ttm": 1590000000.0,
    "levered_cash_flow_ttm": 642000000.0,
    "book_value_per_share_mrq": 36.77,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Hospitals",
    "company_name": "Community Health Systems, Inc."
  },
  "CYNA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.345,
    "ebitda": -23890000.0,
    "eps_estimate_current_year": -3.81,
    "eps_estimate_next_quarter": -0.95,
    "fifty_day_moving_average": 15.3829,
    "fifty_two_week_high": 19.52,
    "fifty_two_week_low": 13.18,
    "percent_change_from_200_day_moving_average": -0.031445,
    "percent_change_from_50_day_moving_average": -0.014665999999999998,
    "shares_owned": "N/A",
    "short_ratio": 10.13,
    "two_hundred_day_moving_average": 15.6494,
    "volume": 10029.0,
    "market_cap": 184960000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.33,
    "roa_ttm": -0.31620000000000004,
    "roe_ttm": -0.3797,
    "shares_outstanding": 12200000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -18690000.0,
    "levered_cash_flow_ttm": -7140000.0,
    "book_value_per_share_mrq": 6.35,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Cynapsus Therapeutics Inc."
  },
  "CYNO": {
    "p_e_ratio": 29.6,
    "peg_ratio": 1.85,
    "earnings_per_share": 1.41,
    "ebitda": 43080000.0,
    "eps_estimate_current_year": 1.04,
    "eps_estimate_next_quarter": 0.23,
    "fifty_day_moving_average": 39.59,
    "fifty_two_week_high": 42.97,
    "fifty_two_week_low": 27.02,
    "percent_change_from_200_day_moving_average": 0.1414,
    "percent_change_from_50_day_moving_average": 0.0557,
    "shares_owned": "N/A",
    "short_ratio": 5.03,
    "two_hundred_day_moving_average": 36.62,
    "volume": 403704.0,
    "market_cap": 949930000.0,
    "price_to_sales_ttm": 2.97,
    "price_to_book_mrq": 2.45,
    "roa_ttm": 0.0325,
    "roe_ttm": 0.087,
    "shares_outstanding": 22730000.0,
    "pcnt_held_by_insiders": 0.003,
    "pcnt_held_by_institutions": 0.9179999999999999,
    "pcnt_short_of_float": 0.043,
    "operating_cash_flow_ttm": 34270000.0,
    "levered_cash_flow_ttm": 15910000.0,
    "book_value_per_share_mrq": 17.26,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Cynosure, Inc."
  },
  "CYTK": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.79,
    "earnings_per_share": -0.52,
    "ebitda": -19390000.0,
    "eps_estimate_current_year": -0.97,
    "eps_estimate_next_quarter": -0.21,
    "fifty_day_moving_average": 11.31,
    "fifty_two_week_high": 13.18,
    "fifty_two_week_low": 4.84,
    "percent_change_from_200_day_moving_average": 0.37829999999999997,
    "percent_change_from_50_day_moving_average": -0.0352,
    "shares_owned": "N/A",
    "short_ratio": 5.63,
    "two_hundred_day_moving_average": 7.92,
    "volume": 1496649.0,
    "market_cap": 423820000.0,
    "price_to_sales_ttm": 10.98,
    "price_to_book_mrq": 6.62,
    "roa_ttm": -0.1318,
    "roe_ttm": -0.2814,
    "shares_outstanding": 38850000.0,
    "pcnt_held_by_insiders": 0.18100000000000002,
    "pcnt_held_by_institutions": 0.541,
    "pcnt_short_of_float": 0.1072,
    "operating_cash_flow_ttm": 6700000.0,
    "levered_cash_flow_ttm": 9220000.0,
    "book_value_per_share_mrq": 1.74,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cytokinetics, Incorporated"
  },
  "CYTR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.86,
    "ebitda": -53320000.0,
    "eps_estimate_current_year": -0.82,
    "eps_estimate_next_quarter": -0.21,
    "fifty_day_moving_average": 2.95,
    "fifty_two_week_high": 5.42,
    "fifty_two_week_low": 1.98,
    "percent_change_from_200_day_moving_average": -0.09570000000000001,
    "percent_change_from_50_day_moving_average": -0.0783,
    "shares_owned": "N/A",
    "short_ratio": 17.96,
    "two_hundred_day_moving_average": 3.01,
    "volume": 678042.0,
    "market_cap": 180830000.0,
    "price_to_sales_ttm": 1808.26,
    "price_to_book_mrq": 2.85,
    "roa_ttm": -0.3864,
    "roe_ttm": -0.7018000000000001,
    "shares_outstanding": 66480000.00000001,
    "pcnt_held_by_insiders": 0.14550000000000002,
    "pcnt_held_by_institutions": 0.297,
    "pcnt_short_of_float": 0.1585,
    "operating_cash_flow_ttm": -45870000.0,
    "levered_cash_flow_ttm": -29060000.0,
    "book_value_per_share_mrq": 0.96,
    "next_earnings_announcement_date": [
      "2016-03-08",
      "2016-03-14"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "CytRx Corporation"
  },
  "CYTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.19,
    "ebitda": -21730000.0,
    "eps_estimate_current_year": -0.21,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 0.34,
    "fifty_two_week_high": 1.47,
    "fifty_two_week_low": 0.16,
    "percent_change_from_200_day_moving_average": -0.5057,
    "percent_change_from_50_day_moving_average": -0.38079999999999997,
    "shares_owned": "N/A",
    "short_ratio": 9.59,
    "two_hundred_day_moving_average": 0.42,
    "volume": 12734135.0,
    "market_cap": 33280000.0,
    "price_to_sales_ttm": 3.58,
    "price_to_book_mrq": 8.5,
    "roa_ttm": -0.3803,
    "roe_ttm": "-2,546.81%",
    "shares_outstanding": 158480000.0,
    "pcnt_held_by_insiders": 0.14150000000000001,
    "pcnt_held_by_institutions": 0.136,
    "pcnt_short_of_float": 0.0603,
    "operating_cash_flow_ttm": -20900000.0,
    "levered_cash_flow_ttm": -14220000.0,
    "book_value_per_share_mrq": 0.03,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cytori Therapeutics, Inc."
  },
  "DBVT": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.86,
    "earnings_per_share": -0.8,
    "ebitda": -28690000.0,
    "eps_estimate_current_year": -1.54,
    "eps_estimate_next_quarter": -0.52,
    "fifty_day_moving_average": 35.08,
    "fifty_two_week_high": 44.76,
    "fifty_two_week_low": 20.26,
    "percent_change_from_200_day_moving_average": -0.0356,
    "percent_change_from_50_day_moving_average": -0.018000000000000002,
    "shares_owned": "N/A",
    "short_ratio": 3.84,
    "two_hundred_day_moving_average": 35.72,
    "volume": 669021.0,
    "market_cap": 1580000000.0,
    "price_to_sales_ttm": 281.97,
    "price_to_book_mrq": 12.02,
    "roa_ttm": -0.21760000000000002,
    "roe_ttm": -0.3895,
    "shares_outstanding": 46000000.0,
    "pcnt_held_by_insiders": 0.0378,
    "pcnt_held_by_institutions": 0.257,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -24430000.0,
    "levered_cash_flow_ttm": -16329999.999999998,
    "book_value_per_share_mrq": 2.91,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "DBV Technologies S.A."
  },
  "DCTH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.96,
    "ebitda": -14650000.0,
    "eps_estimate_current_year": -2.22,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.46,
    "fifty_two_week_high": 1.92,
    "fifty_two_week_low": 0.36,
    "percent_change_from_200_day_moving_average": -0.1484,
    "percent_change_from_50_day_moving_average": 0.1404,
    "shares_owned": "N/A",
    "short_ratio": 7.55,
    "two_hundred_day_moving_average": 0.61,
    "volume": 124162.0,
    "market_cap": 11320000.0,
    "price_to_sales_ttm": 7.46,
    "price_to_book_mrq": 0.88,
    "roa_ttm": -0.41369999999999996,
    "roe_ttm": -0.7343000000000001,
    "shares_outstanding": 21760000.0,
    "pcnt_held_by_insiders": 0.09970000000000001,
    "pcnt_held_by_institutions": 0.165,
    "pcnt_short_of_float": 0.0816,
    "operating_cash_flow_ttm": -15310000.0,
    "levered_cash_flow_ttm": -8530000.0,
    "book_value_per_share_mrq": 0.62,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Delivery",
    "company_name": "Delcath Systems, Inc."
  },
  "DEPO": {
    "p_e_ratio": 23.23,
    "peg_ratio": 0.79,
    "earnings_per_share": 0.82,
    "ebitda": 213160000.0,
    "eps_estimate_current_year": 0.8,
    "eps_estimate_next_quarter": 0.3,
    "fifty_day_moving_average": 19.0,
    "fifty_two_week_high": 33.74,
    "fifty_two_week_low": 15.03,
    "percent_change_from_200_day_moving_average": -0.1948,
    "percent_change_from_50_day_moving_average": 0.0,
    "shares_owned": "N/A",
    "short_ratio": 4.15,
    "two_hundred_day_moving_average": 23.6,
    "volume": 2409499.0,
    "market_cap": 1150000000.0,
    "price_to_sales_ttm": 2.68,
    "price_to_book_mrq": 3.34,
    "roa_ttm": 0.0904,
    "roe_ttm": 0.1638,
    "shares_outstanding": 60480000.0,
    "pcnt_held_by_insiders": 0.0108,
    "pcnt_held_by_institutions": 1.094,
    "pcnt_short_of_float": 0.17670000000000002,
    "operating_cash_flow_ttm": 89000000.0,
    "levered_cash_flow_ttm": 159470000.0,
    "book_value_per_share_mrq": 5.65,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "DepoMed Inc."
  },
  "DERM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.16,
    "ebitda": -54580000.0,
    "eps_estimate_current_year": -2.79,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 29.13,
    "fifty_two_week_high": 34.75,
    "fifty_two_week_low": 14.2,
    "percent_change_from_200_day_moving_average": 0.3775,
    "percent_change_from_50_day_moving_average": 0.1591,
    "shares_owned": "N/A",
    "short_ratio": 4.33,
    "two_hundred_day_moving_average": 24.51,
    "volume": 1763182.0,
    "market_cap": 1010000000.0,
    "price_to_sales_ttm": 67.99,
    "price_to_book_mrq": 4.62,
    "roa_ttm": -0.22260000000000002,
    "roe_ttm": -0.4252,
    "shares_outstanding": 29920000.0,
    "pcnt_held_by_insiders": 0.0432,
    "pcnt_held_by_institutions": 0.531,
    "pcnt_short_of_float": 0.0548,
    "operating_cash_flow_ttm": -40430000.0,
    "levered_cash_flow_ttm": -26970000.0,
    "book_value_per_share_mrq": 7.18,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Dermira, Inc."
  },
  "DGX": {
    "p_e_ratio": 14.23,
    "peg_ratio": 1.58,
    "earnings_per_share": 4.88,
    "ebitda": 1490000000.0,
    "eps_estimate_current_year": 4.76,
    "eps_estimate_next_quarter": 1.13,
    "fifty_day_moving_average": 68.25,
    "fifty_two_week_high": 89.0,
    "fifty_two_week_low": 60.07,
    "percent_change_from_200_day_moving_average": 0.0058,
    "percent_change_from_50_day_moving_average": 0.0181,
    "shares_owned": "N/A",
    "short_ratio": 7.78,
    "two_hundred_day_moving_average": 69.08,
    "volume": 1803510.0,
    "market_cap": 9960000000.0,
    "price_to_sales_ttm": 1.31,
    "price_to_book_mrq": 2.16,
    "roa_ttm": 0.0742,
    "roe_ttm": 0.1681,
    "shares_outstanding": 143350000.0,
    "pcnt_held_by_insiders": 0.0034000000000000002,
    "pcnt_held_by_institutions": 0.9690000000000001,
    "pcnt_short_of_float": 0.0608,
    "operating_cash_flow_ttm": 842000000.0,
    "levered_cash_flow_ttm": 522880000.0,
    "book_value_per_share_mrq": 31.87,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Quest Diagnostics Inc."
  },
  "DHRM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.98,
    "ebitda": -5370000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.96,
    "fifty_two_week_high": 4.29,
    "fifty_two_week_low": 1.22,
    "percent_change_from_200_day_moving_average": 0.22469999999999998,
    "percent_change_from_50_day_moving_average": 0.2236,
    "shares_owned": "N/A",
    "short_ratio": 0.52,
    "two_hundred_day_moving_average": 1.96,
    "volume": 14740.0,
    "market_cap": 14030000.0,
    "price_to_sales_ttm": 2.2,
    "price_to_book_mrq": 0.4,
    "roa_ttm": -0.08529999999999999,
    "roe_ttm": -0.1631,
    "shares_outstanding": 5850000.0,
    "pcnt_held_by_insiders": 0.24359999999999998,
    "pcnt_held_by_institutions": 0.001,
    "pcnt_short_of_float": 0.0015,
    "operating_cash_flow_ttm": 3090000.0,
    "levered_cash_flow_ttm": -801460.0,
    "book_value_per_share_mrq": 6.24,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Dehaier Medical Systems Limited"
  },
  "DMTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -8.0,
    "ebitda": -29960000.0,
    "eps_estimate_current_year": -1.94,
    "eps_estimate_next_quarter": -0.53,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 12.66,
    "fifty_two_week_low": 11.1,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 5.5,
    "two_hundred_day_moving_average": 0.0,
    "volume": 709104.0,
    "market_cap": 303460000.0,
    "price_to_sales_ttm": 46.11,
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 25000000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.024399999999999998,
    "operating_cash_flow_ttm": -25850000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -9.59,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Dimension Therapeutics, Inc."
  },
  "DNAI": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.06,
    "earnings_per_share": -62.38,
    "ebitda": -38570000.0,
    "eps_estimate_current_year": -11.03,
    "eps_estimate_next_quarter": -0.6,
    "fifty_day_moving_average": 17.12,
    "fifty_two_week_high": 33.75,
    "fifty_two_week_low": 13.5,
    "percent_change_from_200_day_moving_average": -0.3554,
    "percent_change_from_50_day_moving_average": -0.1483,
    "shares_owned": "N/A",
    "short_ratio": 7.48,
    "two_hundred_day_moving_average": 22.62,
    "volume": 906860.0,
    "market_cap": 438250000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.84,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 30060000.0,
    "pcnt_held_by_insiders": 0.13419999999999999,
    "pcnt_held_by_institutions": 0.019,
    "pcnt_short_of_float": 0.0338,
    "operating_cash_flow_ttm": -24550000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 5.18,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ProNAi Therapeutics, Inc."
  },
  "DPLO": {
    "p_e_ratio": 83.57,
    "peg_ratio": 1.24,
    "earnings_per_share": 0.37,
    "ebitda": 64730000.00000001,
    "eps_estimate_current_year": 0.73,
    "eps_estimate_next_quarter": 0.2,
    "fifty_day_moving_average": 33.32,
    "fifty_two_week_high": 52.33,
    "fifty_two_week_low": 22.1,
    "percent_change_from_200_day_moving_average": -0.18350000000000002,
    "percent_change_from_50_day_moving_average": -0.0719,
    "shares_owned": "N/A",
    "short_ratio": 12.01,
    "two_hundred_day_moving_average": 37.87,
    "volume": 913848.0,
    "market_cap": 1990000000.0,
    "price_to_sales_ttm": 0.67,
    "price_to_book_mrq": 4.02,
    "roa_ttm": 0.0418,
    "roe_ttm": 0.0809,
    "shares_outstanding": 64349999.99999999,
    "pcnt_held_by_insiders": 0.4413,
    "pcnt_held_by_institutions": 0.5820000000000001,
    "pcnt_short_of_float": 0.28550000000000003,
    "operating_cash_flow_ttm": -26340000.0,
    "levered_cash_flow_ttm": -29470000.0,
    "book_value_per_share_mrq": 7.8,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Diplomat Pharmacy, Inc."
  },
  "DPRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.14,
    "earnings_per_share": -1.84,
    "ebitda": 0.0,
    "eps_estimate_current_year": -1.94,
    "eps_estimate_next_quarter": -0.6,
    "fifty_day_moving_average": 11.73,
    "fifty_two_week_high": 17.1,
    "fifty_two_week_low": 10.12,
    "percent_change_from_200_day_moving_average": -0.17420000000000002,
    "percent_change_from_50_day_moving_average": -0.054000000000000006,
    "shares_owned": "N/A",
    "short_ratio": 4.33,
    "two_hundred_day_moving_average": 13.44,
    "volume": 13397.0,
    "market_cap": 114340000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.17,
    "roa_ttm": -0.31079999999999997,
    "roe_ttm": -0.5132,
    "shares_outstanding": 10300000.0,
    "pcnt_held_by_insiders": 0.3934,
    "pcnt_held_by_institutions": 0.29,
    "pcnt_short_of_float": 0.026000000000000002,
    "operating_cash_flow_ttm": -13470000.0,
    "levered_cash_flow_ttm": -7280000.0,
    "book_value_per_share_mrq": 3.45,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Dipexium Pharmaceuticals, Inc."
  },
  "DRAD": {
    "p_e_ratio": 5.15,
    "peg_ratio": 1.78,
    "earnings_per_share": 1.12,
    "ebitda": 6250000.0,
    "eps_estimate_current_year": 0.2,
    "eps_estimate_next_quarter": 0.04,
    "fifty_day_moving_average": 5.9,
    "fifty_two_week_high": 6.92,
    "fifty_two_week_low": 3.5,
    "percent_change_from_200_day_moving_average": 0.25329999999999997,
    "percent_change_from_50_day_moving_average": -0.0239,
    "shares_owned": "N/A",
    "short_ratio": 0.18,
    "two_hundred_day_moving_average": 4.6,
    "volume": 199212.0,
    "market_cap": 111840000.0,
    "price_to_sales_ttm": 1.86,
    "price_to_book_mrq": 2.03,
    "roa_ttm": 0.0464,
    "roe_ttm": 0.4997,
    "shares_outstanding": 19420000.0,
    "pcnt_held_by_insiders": 0.022400000000000003,
    "pcnt_held_by_institutions": 0.591,
    "pcnt_short_of_float": 0.0012,
    "operating_cash_flow_ttm": 4270000.0,
    "levered_cash_flow_ttm": 1790000.0,
    "book_value_per_share_mrq": 2.81,
    "next_earnings_announcement_date": [
      "2016-03-04",
      "2016-03-08"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Digirad Corporation"
  },
  "DRNA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.28,
    "ebitda": -61130000.0,
    "eps_estimate_current_year": -3.31,
    "eps_estimate_next_quarter": -0.93,
    "fifty_day_moving_average": 12.29,
    "fifty_two_week_high": 27.33,
    "fifty_two_week_low": 7.61,
    "percent_change_from_200_day_moving_average": 0.2086,
    "percent_change_from_50_day_moving_average": 0.18230000000000002,
    "shares_owned": "N/A",
    "short_ratio": 8.76,
    "two_hundred_day_moving_average": 12.02,
    "volume": 649005.0,
    "market_cap": 299220000.0,
    "price_to_sales_ttm": 1630.65,
    "price_to_book_mrq": 2.88,
    "roa_ttm": -0.3372,
    "roe_ttm": -0.5746,
    "shares_outstanding": 20590000.0,
    "pcnt_held_by_insiders": 0.1825,
    "pcnt_held_by_institutions": 0.746,
    "pcnt_short_of_float": 0.115,
    "operating_cash_flow_ttm": -47850000.0,
    "levered_cash_flow_ttm": -26940000.0,
    "book_value_per_share_mrq": 5.06,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Dicerna Pharmaceuticals, Inc."
  },
  "DRRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.57,
    "earnings_per_share": -0.19,
    "ebitda": -20210000.0,
    "eps_estimate_current_year": -0.2,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 2.24,
    "fifty_two_week_high": 3.42,
    "fifty_two_week_low": 0.73,
    "percent_change_from_200_day_moving_average": -0.0078000000000000005,
    "percent_change_from_50_day_moving_average": 0.0148,
    "shares_owned": "N/A",
    "short_ratio": 13.88,
    "two_hundred_day_moving_average": 2.29,
    "volume": 3632609.0,
    "market_cap": 273590000.0,
    "price_to_sales_ttm": 15.01,
    "price_to_book_mrq": 15.87,
    "roa_ttm": -0.2555,
    "roe_ttm": -1.1157,
    "shares_outstanding": 120520000.0,
    "pcnt_held_by_insiders": 0.1043,
    "pcnt_held_by_institutions": 0.49700000000000005,
    "pcnt_short_of_float": 0.0302,
    "operating_cash_flow_ttm": -17230000.0,
    "levered_cash_flow_ttm": -11740000.0,
    "book_value_per_share_mrq": 0.14,
    "next_earnings_announcement_date": [
      "2016-02-29",
      "2016-03-04"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "DURECT Corporation"
  },
  "DSCI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.5,
    "ebitda": -35950000.0,
    "eps_estimate_current_year": -1.45,
    "eps_estimate_next_quarter": -0.1,
    "fifty_day_moving_average": 4.6,
    "fifty_two_week_high": 9.89,
    "fifty_two_week_low": 3.85,
    "percent_change_from_200_day_moving_average": -0.2421,
    "percent_change_from_50_day_moving_average": -0.0265,
    "shares_owned": "N/A",
    "short_ratio": 1.67,
    "two_hundred_day_moving_average": 5.91,
    "volume": 252379.0,
    "market_cap": 115610000.0,
    "price_to_sales_ttm": 1.29,
    "price_to_book_mrq": 1.08,
    "roa_ttm": -0.1832,
    "roe_ttm": -0.32159999999999994,
    "shares_outstanding": 25810000.0,
    "pcnt_held_by_insiders": 0.0626,
    "pcnt_held_by_institutions": 0.8690000000000001,
    "pcnt_short_of_float": 0.0354,
    "operating_cash_flow_ttm": -34390000.0,
    "levered_cash_flow_ttm": -20660000.0,
    "book_value_per_share_mrq": 4.05,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Derma Sciences Inc."
  },
  "DSCO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.641,
    "ebitda": -39910000.0,
    "eps_estimate_current_year": -0.44,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.2846,
    "fifty_two_week_high": 1.82,
    "fifty_two_week_low": 0.19,
    "percent_change_from_200_day_moving_average": -0.535526,
    "percent_change_from_50_day_moving_average": -0.261696,
    "shares_owned": "N/A",
    "short_ratio": 1.62,
    "two_hundred_day_moving_average": 0.4523,
    "volume": 795998.0,
    "market_cap": 23970000.0,
    "price_to_sales_ttm": 15.97,
    "price_to_book_mrq": 1.35,
    "roa_ttm": -0.45909999999999995,
    "roe_ttm": -2.3774,
    "shares_outstanding": 114060000.0,
    "pcnt_held_by_insiders": 0.027999999999999997,
    "pcnt_held_by_institutions": 0.41,
    "pcnt_short_of_float": 0.0341,
    "operating_cash_flow_ttm": -35940000.0,
    "levered_cash_flow_ttm": -24490000.0,
    "book_value_per_share_mrq": 0.16,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Discovery Laboratories Inc."
  },
  "DVAX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.27,
    "ebitda": -99190000.0,
    "eps_estimate_current_year": -3.29,
    "eps_estimate_next_quarter": -0.72,
    "fifty_day_moving_average": 25.68,
    "fifty_two_week_high": 32.49,
    "fifty_two_week_low": 14.57,
    "percent_change_from_200_day_moving_average": 0.0415,
    "percent_change_from_50_day_moving_average": 0.0546,
    "shares_owned": "N/A",
    "short_ratio": 6.56,
    "two_hundred_day_moving_average": 26.0,
    "volume": 1371597.0,
    "market_cap": 1040000000.0,
    "price_to_sales_ttm": 185.72,
    "price_to_book_mrq": 4.96,
    "roa_ttm": -0.3258,
    "roe_ttm": -0.6144,
    "shares_outstanding": 38420000.0,
    "pcnt_held_by_insiders": 0.0036,
    "pcnt_held_by_institutions": 0.727,
    "pcnt_short_of_float": 0.1358,
    "operating_cash_flow_ttm": -87580000.0,
    "levered_cash_flow_ttm": -60570000.0,
    "book_value_per_share_mrq": 5.5,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Dynavax Technologies Corporation"
  },
  "DVCR": {
    "p_e_ratio": 37.29,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.19,
    "ebitda": 22570000.0,
    "eps_estimate_current_year": 0.19,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 8.67,
    "fifty_two_week_high": 17.15,
    "fifty_two_week_low": 6.45,
    "percent_change_from_200_day_moving_average": -0.33509999999999995,
    "percent_change_from_50_day_moving_average": -0.174,
    "shares_owned": "N/A",
    "short_ratio": 0.49,
    "two_hundred_day_moving_average": 10.77,
    "volume": 6805.0,
    "market_cap": 44820000.0,
    "price_to_sales_ttm": 0.13,
    "price_to_book_mrq": 4.01,
    "roa_ttm": 0.0709,
    "roe_ttm": 0.1845,
    "shares_outstanding": 6260000.0,
    "pcnt_held_by_insiders": 0.5146000000000001,
    "pcnt_held_by_institutions": 0.19399999999999998,
    "pcnt_short_of_float": 0.0007000000000000001,
    "operating_cash_flow_ttm": 4680000.0,
    "levered_cash_flow_ttm": 9880000.0,
    "book_value_per_share_mrq": 1.92,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "Diversicare Healthcare Services Inc."
  },
  "DXCM": {
    "p_e_ratio": "N/A",
    "peg_ratio": -8.67,
    "earnings_per_share": -0.74,
    "ebitda": -47000000.0,
    "eps_estimate_current_year": -0.29,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 84.9,
    "fifty_two_week_high": 103.29,
    "fifty_two_week_low": 53.3,
    "percent_change_from_200_day_moving_average": -0.0317,
    "percent_change_from_50_day_moving_average": -0.032799999999999996,
    "shares_owned": "N/A",
    "short_ratio": 2.72,
    "two_hundred_day_moving_average": 84.8,
    "volume": 675979.0,
    "market_cap": 6680000000.0,
    "price_to_sales_ttm": 18.69,
    "price_to_book_mrq": 34.37,
    "roa_ttm": -0.17149999999999999,
    "roe_ttm": -0.375,
    "shares_outstanding": 81300000.0,
    "pcnt_held_by_insiders": 0.0195,
    "pcnt_held_by_institutions": 0.9540000000000001,
    "pcnt_short_of_float": 0.0235,
    "operating_cash_flow_ttm": 46100000.0,
    "levered_cash_flow_ttm": -2460000.0,
    "book_value_per_share_mrq": 2.38,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "DexCom, Inc."
  },
  "DXR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.279,
    "ebitda": 0.0,
    "eps_estimate_current_year": "nan",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 8.343,
    "fifty_two_week_high": 9.18,
    "fifty_two_week_low": 5.4,
    "percent_change_from_200_day_moving_average": 0.042409999999999996,
    "percent_change_from_50_day_moving_average": -0.059640000000000006,
    "shares_owned": "N/A",
    "short_ratio": 14.62,
    "two_hundred_day_moving_average": 7.526,
    "volume": 223.0,
    "market_cap": 30640000.0,
    "price_to_sales_ttm": 19.77,
    "price_to_book_mrq": 1.51,
    "roa_ttm": 0.0176,
    "roe_ttm": -0.2214,
    "shares_outstanding": 3910000.0,
    "pcnt_held_by_insiders": 0.8151,
    "pcnt_held_by_institutions": 0.043,
    "pcnt_short_of_float": 0.0067,
    "operating_cash_flow_ttm": 10210000.0,
    "levered_cash_flow_ttm": -5180000.0,
    "book_value_per_share_mrq": 5.01,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Daxor Corp."
  },
  "DYAX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -4.52,
    "earnings_per_share": -0.21,
    "ebitda": -17730000.0,
    "eps_estimate_current_year": -0.27,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 35.27,
    "fifty_two_week_high": 37.77,
    "fifty_two_week_low": 13.25,
    "percent_change_from_200_day_moving_average": 0.379,
    "percent_change_from_50_day_moving_average": 0.0604,
    "shares_owned": "N/A",
    "short_ratio": 1.27,
    "two_hundred_day_moving_average": 27.12,
    "volume": 6507181.0,
    "market_cap": 5500000000.0,
    "price_to_sales_ttm": 56.48,
    "price_to_book_mrq": 17.52,
    "roa_ttm": -0.0417,
    "roe_ttm": -0.1414,
    "shares_outstanding": 147180000.0,
    "pcnt_held_by_insiders": 0.019299999999999998,
    "pcnt_held_by_institutions": 1.004,
    "pcnt_short_of_float": 0.032,
    "operating_cash_flow_ttm": -24630000.0,
    "levered_cash_flow_ttm": -2490000.0,
    "book_value_per_share_mrq": 2.14,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Dyax Corp."
  },
  "DYNT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.13,
    "ebitda": 616677.0,
    "eps_estimate_current_year": "nan",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.04,
    "fifty_two_week_high": 4.44,
    "fifty_two_week_low": 2.7,
    "percent_change_from_200_day_moving_average": -0.0785,
    "percent_change_from_50_day_moving_average": -0.0588,
    "shares_owned": "N/A",
    "short_ratio": 1.48,
    "two_hundred_day_moving_average": 3.1,
    "volume": 2607.0,
    "market_cap": 7640000.0,
    "price_to_sales_ttm": 0.27,
    "price_to_book_mrq": 1.94,
    "roa_ttm": -0.0016,
    "roe_ttm": -0.37450000000000006,
    "shares_outstanding": 2670000.0,
    "pcnt_held_by_insiders": 0.2716,
    "pcnt_held_by_institutions": 0.048,
    "pcnt_short_of_float": 0.0026,
    "operating_cash_flow_ttm": -1260000.0,
    "levered_cash_flow_ttm": -335450.0,
    "book_value_per_share_mrq": 1.53,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Dynatronics Corp."
  },
  "EARS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.78,
    "ebitda": -29770000.0,
    "eps_estimate_current_year": -1.14,
    "eps_estimate_next_quarter": -0.29,
    "fifty_day_moving_average": 3.46,
    "fifty_two_week_high": 7.15,
    "fifty_two_week_low": 3.02,
    "percent_change_from_200_day_moving_average": -0.2568,
    "percent_change_from_50_day_moving_average": -0.0814,
    "shares_owned": "N/A",
    "short_ratio": 0.8,
    "two_hundred_day_moving_average": 4.28,
    "volume": 37004.0,
    "market_cap": 109050000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.26,
    "roa_ttm": -0.30269999999999997,
    "roe_ttm": -0.5226,
    "shares_outstanding": 34290000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0021,
    "operating_cash_flow_ttm": -27310000.0,
    "levered_cash_flow_ttm": -19170000.0,
    "book_value_per_share_mrq": 1.46,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Auris Medical Holding AG"
  },
  "EBIO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.71,
    "ebitda": -32060000.000000004,
    "eps_estimate_current_year": -1.63,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.85,
    "fifty_two_week_high": 13.77,
    "fifty_two_week_low": 2.24,
    "percent_change_from_200_day_moving_average": -0.0379,
    "percent_change_from_50_day_moving_average": -0.0086,
    "shares_owned": "N/A",
    "short_ratio": 11.48,
    "two_hundred_day_moving_average": 2.94,
    "volume": 35336.0,
    "market_cap": 55430000.0,
    "price_to_sales_ttm": 53.78,
    "price_to_book_mrq": 1.91,
    "roa_ttm": -0.4796,
    "roe_ttm": -1.0885,
    "shares_outstanding": 19590000.0,
    "pcnt_held_by_insiders": 0.1273,
    "pcnt_held_by_institutions": 0.736,
    "pcnt_short_of_float": 0.1052,
    "operating_cash_flow_ttm": -32290000.0,
    "levered_cash_flow_ttm": -19760000.0,
    "book_value_per_share_mrq": 1.47,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Eleven Biotherapeutics, Inc."
  },
  "EBS": {
    "p_e_ratio": 32.13,
    "peg_ratio": 2.49,
    "earnings_per_share": 1.19,
    "ebitda": 128430000.0,
    "eps_estimate_current_year": 1.51,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 36.5,
    "fifty_two_week_high": 38.98,
    "fifty_two_week_low": 25.86,
    "percent_change_from_200_day_moving_average": 0.14800000000000002,
    "percent_change_from_50_day_moving_average": 0.0493,
    "shares_owned": "N/A",
    "short_ratio": 8.86,
    "two_hundred_day_moving_average": 33.36,
    "volume": 1951298.0,
    "market_cap": 1490000000.0,
    "price_to_sales_ttm": 2.91,
    "price_to_book_mrq": 2.41,
    "roa_ttm": 0.0639,
    "roe_ttm": 0.1067,
    "shares_outstanding": 38940000.0,
    "pcnt_held_by_insiders": 0.203,
    "pcnt_held_by_institutions": 0.841,
    "pcnt_short_of_float": 0.11130000000000001,
    "operating_cash_flow_ttm": 93210000.0,
    "levered_cash_flow_ttm": 38630000.0,
    "book_value_per_share_mrq": 15.57,
    "next_earnings_announcement_date": [
      "2016-03-03",
      "2016-03-07"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Emergent BioSolutions, Inc."
  },
  "ECTE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.33,
    "ebitda": -8580000.0,
    "eps_estimate_current_year": -1.19,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.56,
    "fifty_two_week_high": 3.0,
    "fifty_two_week_low": 1.16,
    "percent_change_from_200_day_moving_average": -0.1065,
    "percent_change_from_50_day_moving_average": -0.0732,
    "shares_owned": "N/A",
    "short_ratio": 20.87,
    "two_hundred_day_moving_average": 1.62,
    "volume": 1967.0,
    "market_cap": 16129999.999999998,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.7062,
    "roe_ttm": -4.5571,
    "shares_outstanding": 11130000.0,
    "pcnt_held_by_insiders": 0.0076,
    "pcnt_held_by_institutions": 0.157,
    "pcnt_short_of_float": 0.0369,
    "operating_cash_flow_ttm": -5730000.0,
    "levered_cash_flow_ttm": 497120.0,
    "book_value_per_share_mrq": -0.18,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Echo Therapeutics, Inc."
  },
  "ECYT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.95,
    "ebitda": -33960000.0,
    "eps_estimate_current_year": -1.02,
    "eps_estimate_next_quarter": -0.27,
    "fifty_day_moving_average": 4.64,
    "fifty_two_week_high": 6.76,
    "fifty_two_week_low": 3.83,
    "percent_change_from_200_day_moving_average": -0.18719999999999998,
    "percent_change_from_50_day_moving_average": -0.10800000000000001,
    "shares_owned": "N/A",
    "short_ratio": 16.75,
    "two_hundred_day_moving_average": 5.09,
    "volume": 469026.0,
    "market_cap": 173780000.0,
    "price_to_sales_ttm": 2452.54,
    "price_to_book_mrq": 0.96,
    "roa_ttm": -0.1072,
    "roe_ttm": -0.2028,
    "shares_outstanding": 41980000.0,
    "pcnt_held_by_insiders": 0.1886,
    "pcnt_held_by_institutions": 0.395,
    "pcnt_short_of_float": 0.12050000000000001,
    "operating_cash_flow_ttm": -30280000.0,
    "levered_cash_flow_ttm": -14040000.0,
    "book_value_per_share_mrq": 4.27,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Endocyte, Inc."
  },
  "EDAP": {
    "p_e_ratio": "N/A",
    "peg_ratio": -4.81,
    "earnings_per_share": -0.41,
    "ebitda": -1580000.0,
    "eps_estimate_current_year": -0.27,
    "eps_estimate_next_quarter": -0.01,
    "fifty_day_moving_average": 5.0,
    "fifty_two_week_high": 6.57,
    "fifty_two_week_low": 1.9,
    "percent_change_from_200_day_moving_average": 0.0132,
    "percent_change_from_50_day_moving_average": -0.1537,
    "shares_owned": "N/A",
    "short_ratio": 3.55,
    "two_hundred_day_moving_average": 4.18,
    "volume": 80029.0,
    "market_cap": 105570000.0,
    "price_to_sales_ttm": 3.61,
    "price_to_book_mrq": 7.26,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 24960000.0,
    "pcnt_held_by_insiders": 0.0451,
    "pcnt_held_by_institutions": 0.114,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.58,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "EDAP TMS SA"
  },
  "EDGE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -16.61,
    "ebitda": -21600000.0,
    "eps_estimate_current_year": -8.93,
    "eps_estimate_next_quarter": -0.31,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 13.75,
    "fifty_two_week_low": 12.0,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 3.87,
    "two_hundred_day_moving_average": 0.0,
    "volume": 1247946.0,
    "market_cap": 361860000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.4225,
    "roe_ttm": -1.1658,
    "shares_outstanding": 28810000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0146,
    "operating_cash_flow_ttm": -17850000.0,
    "levered_cash_flow_ttm": -11890000.0,
    "book_value_per_share_mrq": -29.99,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Edge Therapeutics, Inc."
  },
  "EGLT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.36,
    "ebitda": -53960000.0,
    "eps_estimate_current_year": -3.72,
    "eps_estimate_next_quarter": -1.01,
    "fifty_day_moving_average": 9.37,
    "fifty_two_week_high": 17.03,
    "fifty_two_week_low": 4.81,
    "percent_change_from_200_day_moving_average": -0.0359,
    "percent_change_from_50_day_moving_average": 0.18739999999999998,
    "shares_owned": "N/A",
    "short_ratio": 18.07,
    "two_hundred_day_moving_average": 11.54,
    "volume": 761776.0,
    "market_cap": 271190000.0,
    "price_to_sales_ttm": 64.24,
    "price_to_book_mrq": 2.83,
    "roa_ttm": -0.27140000000000003,
    "roe_ttm": -0.8020999999999999,
    "shares_outstanding": 24370000.0,
    "pcnt_held_by_insiders": 0.5791,
    "pcnt_held_by_institutions": 0.23600000000000002,
    "pcnt_short_of_float": 0.297,
    "operating_cash_flow_ttm": -26850000.0,
    "levered_cash_flow_ttm": -23150000.0,
    "book_value_per_share_mrq": 3.97,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Egalet Corporation"
  },
  "EGRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.34,
    "ebitda": -9190000.0,
    "eps_estimate_current_year": 0.64,
    "eps_estimate_next_quarter": 0.99,
    "fifty_day_moving_average": 83.74,
    "fifty_two_week_high": 104.17,
    "fifty_two_week_low": 13.0,
    "percent_change_from_200_day_moving_average": 0.21030000000000001,
    "percent_change_from_50_day_moving_average": 0.1604,
    "shares_owned": "N/A",
    "short_ratio": 6.66,
    "two_hundred_day_moving_average": 80.29,
    "volume": 838591.0,
    "market_cap": 1510000000.0,
    "price_to_sales_ttm": 26.55,
    "price_to_book_mrq": 17.22,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 15590000.0,
    "pcnt_held_by_insiders": 0.09789999999999999,
    "pcnt_held_by_institutions": 0.861,
    "pcnt_short_of_float": 0.20670000000000002,
    "operating_cash_flow_ttm": -10550000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 5.62,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Eagle Pharmaceuticals Inc."
  },
  "ELGX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.43,
    "earnings_per_share": -0.73,
    "ebitda": -36370000.0,
    "eps_estimate_current_year": -0.6,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 9.73,
    "fifty_two_week_high": 18.07,
    "fifty_two_week_low": 8.39,
    "percent_change_from_200_day_moving_average": -0.25370000000000004,
    "percent_change_from_50_day_moving_average": -0.011000000000000001,
    "shares_owned": "N/A",
    "short_ratio": 7.73,
    "two_hundred_day_moving_average": 12.89,
    "volume": 901612.0,
    "market_cap": 652130000.0,
    "price_to_sales_ttm": 4.21,
    "price_to_book_mrq": 6.51,
    "roa_ttm": -0.10890000000000001,
    "roe_ttm": -0.4275,
    "shares_outstanding": 67790000.0,
    "pcnt_held_by_insiders": 0.014499999999999999,
    "pcnt_held_by_institutions": 1.0490000000000002,
    "pcnt_short_of_float": 0.1643,
    "operating_cash_flow_ttm": -29400000.0,
    "levered_cash_flow_ttm": -23540000.0,
    "book_value_per_share_mrq": 1.46,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Endologix Inc."
  },
  "ELMD": {
    "p_e_ratio": 16.67,
    "peg_ratio": 1.04,
    "earnings_per_share": 0.12,
    "ebitda": 2360000.0,
    "eps_estimate_current_year": 0.18,
    "eps_estimate_next_quarter": 0.05,
    "fifty_day_moving_average": 2.03,
    "fifty_two_week_high": 2.84,
    "fifty_two_week_low": 1.55,
    "percent_change_from_200_day_moving_average": 0.06480000000000001,
    "percent_change_from_50_day_moving_average": -0.0134,
    "shares_owned": "N/A",
    "short_ratio": 1.04,
    "two_hundred_day_moving_average": 1.88,
    "volume": 10388.0,
    "market_cap": 16329999.999999998,
    "price_to_sales_ttm": 0.79,
    "price_to_book_mrq": 1.07,
    "roa_ttm": 0.0594,
    "roe_ttm": 0.077,
    "shares_outstanding": 8160000.0,
    "pcnt_held_by_insiders": 0.3214,
    "pcnt_held_by_institutions": 0.10099999999999999,
    "pcnt_short_of_float": 0.0024,
    "operating_cash_flow_ttm": 2140000.0,
    "levered_cash_flow_ttm": 1220000.0,
    "book_value_per_share_mrq": 1.75,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Electromed, Inc."
  },
  "ELOS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 1.23,
    "earnings_per_share": -0.27,
    "ebitda": 4310000.0,
    "eps_estimate_current_year": 0.18,
    "eps_estimate_next_quarter": 0.05,
    "fifty_day_moving_average": 7.44,
    "fifty_two_week_high": 12.9,
    "fifty_two_week_low": 6.1,
    "percent_change_from_200_day_moving_average": -0.14859999999999998,
    "percent_change_from_50_day_moving_average": 0.0327,
    "shares_owned": "N/A",
    "short_ratio": 1.8,
    "two_hundred_day_moving_average": 9.02,
    "volume": 140085.0,
    "market_cap": 280530000.0,
    "price_to_sales_ttm": 1.03,
    "price_to_book_mrq": 1.31,
    "roa_ttm": -0.0089,
    "roe_ttm": -0.0435,
    "shares_outstanding": 36530000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": 0.737,
    "pcnt_short_of_float": 0.024399999999999998,
    "operating_cash_flow_ttm": -7460000.0,
    "levered_cash_flow_ttm": -12380000.0,
    "book_value_per_share_mrq": 5.89,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Syneron Medical Ltd."
  },
  "ENSG": {
    "p_e_ratio": 21.19,
    "peg_ratio": 1.17,
    "earnings_per_share": 2.11,
    "ebitda": 104790000.0,
    "eps_estimate_current_year": 2.55,
    "eps_estimate_next_quarter": 0.75,
    "fifty_day_moving_average": 46.99,
    "fifty_two_week_high": 54.08,
    "fifty_two_week_low": 38.44,
    "percent_change_from_200_day_moving_average": -0.0613,
    "percent_change_from_50_day_moving_average": -0.0481,
    "shares_owned": "N/A",
    "short_ratio": 5.58,
    "two_hundred_day_moving_average": 47.65,
    "volume": 478239.0,
    "market_cap": 1150000000.0,
    "price_to_sales_ttm": 0.96,
    "price_to_book_mrq": 2.9,
    "roa_ttm": 0.0916,
    "roe_ttm": 0.1595,
    "shares_outstanding": 25650000.0,
    "pcnt_held_by_insiders": 0.1771,
    "pcnt_held_by_institutions": 0.725,
    "pcnt_short_of_float": 0.034300000000000004,
    "operating_cash_flow_ttm": 31490000.0,
    "levered_cash_flow_ttm": -23130000.0,
    "book_value_per_share_mrq": 16.11,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "The Ensign Group, Inc."
  },
  "ENTA": {
    "p_e_ratio": 7.76,
    "peg_ratio": 0.0,
    "earnings_per_share": 4.09,
    "ebitda": 124790000.0,
    "eps_estimate_current_year": 1.37,
    "eps_estimate_next_quarter": 0.1,
    "fifty_day_moving_average": 31.34,
    "fifty_two_week_high": 52.58,
    "fifty_two_week_low": 16.75,
    "percent_change_from_200_day_moving_average": -0.1843,
    "percent_change_from_50_day_moving_average": 0.0125,
    "shares_owned": "N/A",
    "short_ratio": 17.72,
    "two_hundred_day_moving_average": 38.9,
    "volume": 1254789.0,
    "market_cap": 596370000.0,
    "price_to_sales_ttm": 3.64,
    "price_to_book_mrq": 2.47,
    "roa_ttm": 0.38659999999999994,
    "roe_ttm": 0.4075,
    "shares_outstanding": 18800000.0,
    "pcnt_held_by_insiders": 0.247,
    "pcnt_held_by_institutions": 0.784,
    "pcnt_short_of_float": 0.2691,
    "operating_cash_flow_ttm": 76670000.0,
    "levered_cash_flow_ttm": 75390000.0,
    "book_value_per_share_mrq": 12.62,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Enanta Pharmaceuticals, Inc."
  },
  "ENTL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.45,
    "earnings_per_share": -1.12,
    "ebitda": -11280000.0,
    "eps_estimate_current_year": -1.04,
    "eps_estimate_next_quarter": -0.16,
    "fifty_day_moving_average": 16.47,
    "fifty_two_week_high": 28.81,
    "fifty_two_week_low": 14.72,
    "percent_change_from_200_day_moving_average": -0.2275,
    "percent_change_from_50_day_moving_average": -0.0322,
    "shares_owned": "N/A",
    "short_ratio": 4.51,
    "two_hundred_day_moving_average": 20.64,
    "volume": 33766.0,
    "market_cap": 299480000.0,
    "price_to_sales_ttm": 5.16,
    "price_to_book_mrq": 4.85,
    "roa_ttm": -0.1418,
    "roe_ttm": -0.5372,
    "shares_outstanding": 18790000.0,
    "pcnt_held_by_insiders": 0.2571,
    "pcnt_held_by_institutions": 0.633,
    "pcnt_short_of_float": 0.0458,
    "operating_cash_flow_ttm": -10420000.0,
    "levered_cash_flow_ttm": -9460000.0,
    "book_value_per_share_mrq": 3.28,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Entellus Medical, Inc."
  },
  "ENZ": {
    "p_e_ratio": 37.67,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.13,
    "ebitda": -7940000.0,
    "eps_estimate_current_year": -0.21,
    "eps_estimate_next_quarter": -0.05,
    "fifty_day_moving_average": 4.41,
    "fifty_two_week_high": 5.04,
    "fifty_two_week_low": 2.26,
    "percent_change_from_200_day_moving_average": 0.3993,
    "percent_change_from_50_day_moving_average": 0.1015,
    "shares_owned": "N/A",
    "short_ratio": 2.8,
    "two_hundred_day_moving_average": 3.47,
    "volume": 157916.0,
    "market_cap": 223900000.0,
    "price_to_sales_ttm": 2.31,
    "price_to_book_mrq": 4.8,
    "roa_ttm": -0.10710000000000001,
    "roe_ttm": 0.1411,
    "shares_outstanding": 46070000.0,
    "pcnt_held_by_insiders": 0.15460000000000002,
    "pcnt_held_by_institutions": 0.501,
    "pcnt_short_of_float": 0.0116,
    "operating_cash_flow_ttm": 12210000.0,
    "levered_cash_flow_ttm": -2450000.0,
    "book_value_per_share_mrq": 1.02,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Enzo Biochem Inc."
  },
  "ENZN": {
    "p_e_ratio": 2.237,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.338,
    "ebitda": 0.0,
    "eps_estimate_current_year": 0.03,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.754,
    "fifty_two_week_high": 1.88,
    "fifty_two_week_low": 0.62,
    "percent_change_from_200_day_moving_average": -0.28955,
    "percent_change_from_50_day_moving_average": 0.00227,
    "shares_owned": "N/A",
    "short_ratio": 0.96,
    "two_hundred_day_moving_average": 1.064,
    "volume": 90528.0,
    "market_cap": 33400000.0,
    "price_to_sales_ttm": 1.64,
    "price_to_book_mrq": 2.0,
    "roa_ttm": 0.4507,
    "roe_ttm": 0.6659999999999999,
    "shares_outstanding": 44180000.0,
    "pcnt_held_by_insiders": 0.0784,
    "pcnt_held_by_institutions": 0.46299999999999997,
    "pcnt_short_of_float": 0.0067,
    "operating_cash_flow_ttm": 22190000.0,
    "levered_cash_flow_ttm": 15550000.0,
    "book_value_per_share_mrq": 0.38,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Enzon Pharmaceuticals Inc."
  },
  "ENZY": {
    "p_e_ratio": 34.6,
    "peg_ratio": 0.8,
    "earnings_per_share": 0.29,
    "ebitda": 8310000.000000001,
    "eps_estimate_current_year": 0.37,
    "eps_estimate_next_quarter": 0.1,
    "fifty_day_moving_average": 9.67,
    "fifty_two_week_high": 10.83,
    "fifty_two_week_low": 5.38,
    "percent_change_from_200_day_moving_average": 0.08810000000000001,
    "percent_change_from_50_day_moving_average": 0.034300000000000004,
    "shares_owned": "N/A",
    "short_ratio": 1.47,
    "two_hundred_day_moving_average": 9.19,
    "volume": 35506.0,
    "market_cap": 224830000.0,
    "price_to_sales_ttm": 4.7,
    "price_to_book_mrq": 1.66,
    "roa_ttm": 0.0269,
    "roe_ttm": 0.051,
    "shares_outstanding": 22480000.0,
    "pcnt_held_by_insiders": 0.205,
    "pcnt_held_by_institutions": 0.37200000000000005,
    "pcnt_short_of_float": 0.0040999999999999995,
    "operating_cash_flow_ttm": 11040000.0,
    "levered_cash_flow_ttm": 4820000.0,
    "book_value_per_share_mrq": 6.01,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Enzymotec Ltd."
  },
  "EPRS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.01,
    "earnings_per_share": -2.37,
    "ebitda": -34480000.0,
    "eps_estimate_current_year": -2.21,
    "eps_estimate_next_quarter": -0.52,
    "fifty_day_moving_average": 4.49,
    "fifty_two_week_high": 11.75,
    "fifty_two_week_low": 2.62,
    "percent_change_from_200_day_moving_average": -0.3191,
    "percent_change_from_50_day_moving_average": -0.1788,
    "shares_owned": "N/A",
    "short_ratio": 13.85,
    "two_hundred_day_moving_average": 5.42,
    "volume": 594698.0,
    "market_cap": 89950000.0,
    "price_to_sales_ttm": 229.72,
    "price_to_book_mrq": 1.34,
    "roa_ttm": -0.3094,
    "roe_ttm": -1.0139,
    "shares_outstanding": 24380000.0,
    "pcnt_held_by_insiders": 0.1998,
    "pcnt_held_by_institutions": 0.603,
    "pcnt_short_of_float": 0.0575,
    "operating_cash_flow_ttm": -38230000.0,
    "levered_cash_flow_ttm": -13020000.0,
    "book_value_per_share_mrq": 2.08,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "EPIRUS Biopharmaceuticals, Inc."
  },
  "EPZM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.3,
    "ebitda": -124110000.0,
    "eps_estimate_current_year": -3.66,
    "eps_estimate_next_quarter": -0.72,
    "fifty_day_moving_average": 15.36,
    "fifty_two_week_high": 28.48,
    "fifty_two_week_low": 11.26,
    "percent_change_from_200_day_moving_average": -0.0808,
    "percent_change_from_50_day_moving_average": 0.08039999999999999,
    "shares_owned": "N/A",
    "short_ratio": 13.56,
    "two_hundred_day_moving_average": 18.06,
    "volume": 2274658.0,
    "market_cap": 692270000.0,
    "price_to_sales_ttm": 52.73,
    "price_to_book_mrq": 3.44,
    "roa_ttm": -0.3418,
    "roe_ttm": -0.691,
    "shares_outstanding": 41700000.0,
    "pcnt_held_by_insiders": 0.2647,
    "pcnt_held_by_institutions": 0.848,
    "pcnt_short_of_float": 0.5347,
    "operating_cash_flow_ttm": -72280000.0,
    "levered_cash_flow_ttm": -112450000.0,
    "book_value_per_share_mrq": 4.55,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Epizyme, Inc."
  },
  "ERB": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.04,
    "ebitda": 58614.0,
    "eps_estimate_current_year": -0.06,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.57,
    "fifty_two_week_high": 4.01,
    "fifty_two_week_low": 1.01,
    "percent_change_from_200_day_moving_average": -0.2213,
    "percent_change_from_50_day_moving_average": -0.0138,
    "shares_owned": "N/A",
    "short_ratio": 8.31,
    "two_hundred_day_moving_average": 1.99,
    "volume": 3896.0,
    "market_cap": 68330000.0,
    "price_to_sales_ttm": 2.56,
    "price_to_book_mrq": 3.61,
    "roa_ttm": -0.024300000000000002,
    "roe_ttm": -0.09939999999999999,
    "shares_outstanding": 44090000.0,
    "pcnt_held_by_insiders": 0.8179000000000001,
    "pcnt_held_by_institutions": 0.022000000000000002,
    "pcnt_short_of_float": 0.0137,
    "operating_cash_flow_ttm": -1730000.0,
    "levered_cash_flow_ttm": -1780000.0,
    "book_value_per_share_mrq": 0.37,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "ERBA Diagnostics, Inc."
  },
  "ESMC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.05,
    "ebitda": -889321.0,
    "eps_estimate_current_year": "nan",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.1,
    "fifty_two_week_high": 1.8,
    "fifty_two_week_low": 1.01,
    "percent_change_from_200_day_moving_average": -0.1026,
    "percent_change_from_50_day_moving_average": 0.0054,
    "shares_owned": "N/A",
    "short_ratio": 0.75,
    "two_hundred_day_moving_average": 1.24,
    "volume": 10524.0,
    "market_cap": 8350000.0,
    "price_to_sales_ttm": 0.66,
    "price_to_book_mrq": 3.25,
    "roa_ttm": -0.08779999999999999,
    "roe_ttm": -0.3159,
    "shares_outstanding": 7530000.0,
    "pcnt_held_by_insiders": 0.0192,
    "pcnt_held_by_institutions": 0.195,
    "pcnt_short_of_float": 0.0005,
    "operating_cash_flow_ttm": -42760.0,
    "levered_cash_flow_ttm": -314030.0,
    "book_value_per_share_mrq": 0.36,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Escalon Medical Corp."
  },
  "ESPR": {
    "p_e_ratio": "N/A",
    "peg_ratio": -2.24,
    "earnings_per_share": -2.17,
    "ebitda": -45960000.0,
    "eps_estimate_current_year": -2.31,
    "eps_estimate_next_quarter": -0.74,
    "fifty_day_moving_average": 26.66,
    "fifty_two_week_high": 120.96,
    "fifty_two_week_low": 18.07,
    "percent_change_from_200_day_moving_average": -0.5618,
    "percent_change_from_50_day_moving_average": -0.153,
    "shares_owned": "N/A",
    "short_ratio": 6.58,
    "two_hundred_day_moving_average": 51.53,
    "volume": 1975504.0,
    "market_cap": 508480000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.82,
    "roa_ttm": -0.1573,
    "roe_ttm": -0.266,
    "shares_outstanding": 22520000.0,
    "pcnt_held_by_insiders": 0.31620000000000004,
    "pcnt_held_by_institutions": 0.764,
    "pcnt_short_of_float": 0.3261,
    "operating_cash_flow_ttm": -37920000.0,
    "levered_cash_flow_ttm": -21400000.0,
    "book_value_per_share_mrq": 13.18,
    "next_earnings_announcement_date": [
      "2016-03-03",
      "2016-03-07"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Esperion Therapeutics, Inc."
  },
  "ETRM": {
    "p_e_ratio": "N/A",
    "peg_ratio": -2.0,
    "earnings_per_share": -0.311,
    "ebitda": -26210000.0,
    "eps_estimate_current_year": -0.31,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 0.1834,
    "fifty_two_week_high": 2.05,
    "fifty_two_week_low": 0.14,
    "percent_change_from_200_day_moving_average": -0.613517,
    "percent_change_from_50_day_moving_average": -0.189332,
    "shares_owned": "N/A",
    "short_ratio": 4.98,
    "two_hundred_day_moving_average": 0.3848,
    "volume": 1551701.0,
    "market_cap": 15820000.0,
    "price_to_sales_ttm": 114.14,
    "price_to_book_mrq": 2.1,
    "roa_ttm": -0.9737,
    "roe_ttm": -2.7358999999999996,
    "shares_outstanding": 106400000.0,
    "pcnt_held_by_insiders": 0.1292,
    "pcnt_held_by_institutions": 0.163,
    "pcnt_short_of_float": 0.0943,
    "operating_cash_flow_ttm": -21670000.0,
    "levered_cash_flow_ttm": -11580000.0,
    "book_value_per_share_mrq": 0.07,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "EnteroMedics Inc."
  },
  "EVAR": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.02,
    "earnings_per_share": -2.05,
    "ebitda": -34740000.0,
    "eps_estimate_current_year": -1.97,
    "eps_estimate_next_quarter": -0.49,
    "fifty_day_moving_average": 1.88,
    "fifty_two_week_high": 6.58,
    "fifty_two_week_low": 1.25,
    "percent_change_from_200_day_moving_average": -0.5936,
    "percent_change_from_50_day_moving_average": -0.2588,
    "shares_owned": "N/A",
    "short_ratio": 0.07,
    "two_hundred_day_moving_average": 3.42,
    "volume": 40363.0,
    "market_cap": 27710000.0,
    "price_to_sales_ttm": 1.53,
    "price_to_book_mrq": 0.48,
    "roa_ttm": -0.2623,
    "roe_ttm": -0.5459,
    "shares_outstanding": 19940000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0004,
    "operating_cash_flow_ttm": -35700000.0,
    "levered_cash_flow_ttm": -22290000.0,
    "book_value_per_share_mrq": 2.9,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Lombard Medical, Inc."
  },
  "EVGN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.65,
    "ebitda": -14860000.0,
    "eps_estimate_current_year": -0.89,
    "eps_estimate_next_quarter": -0.14,
    "fifty_day_moving_average": 6.87,
    "fifty_two_week_high": 10.54,
    "fifty_two_week_low": 6.26,
    "percent_change_from_200_day_moving_average": -0.2167,
    "percent_change_from_50_day_moving_average": -0.0545,
    "shares_owned": "N/A",
    "short_ratio": 6.84,
    "two_hundred_day_moving_average": 8.3,
    "volume": 12843.0,
    "market_cap": 165060000.0,
    "price_to_sales_ttm": 13.74,
    "price_to_book_mrq": 1.54,
    "roa_ttm": -0.08810000000000001,
    "roe_ttm": -0.1451,
    "shares_outstanding": 25390000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0017000000000000001,
    "operating_cash_flow_ttm": -9570000.0,
    "levered_cash_flow_ttm": -8320000.0,
    "book_value_per_share_mrq": 4.26,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Evogene Ltd."
  },
  "EVHC": {
    "p_e_ratio": 29.34,
    "peg_ratio": 1.14,
    "earnings_per_share": 0.8,
    "ebitda": 577940000.0,
    "eps_estimate_current_year": 1.28,
    "eps_estimate_next_quarter": 0.31,
    "fifty_day_moving_average": 26.99,
    "fifty_two_week_high": 45.95,
    "fifty_two_week_low": 20.33,
    "percent_change_from_200_day_moving_average": -0.3508,
    "percent_change_from_50_day_moving_average": -0.1316,
    "shares_owned": "N/A",
    "short_ratio": 1.3,
    "two_hundred_day_moving_average": 36.1,
    "volume": 2628369.0,
    "market_cap": 4380000000.0,
    "price_to_sales_ttm": 0.87,
    "price_to_book_mrq": 2.32,
    "roa_ttm": 0.0509,
    "roe_ttm": 0.084,
    "shares_outstanding": 186730000.0,
    "pcnt_held_by_insiders": 0.0087,
    "pcnt_held_by_institutions": 1.057,
    "pcnt_short_of_float": 0.0252,
    "operating_cash_flow_ttm": 274990000.0,
    "levered_cash_flow_ttm": 223860000.0,
    "book_value_per_share_mrq": 10.27,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "Envision Healthcare Holdings, Inc."
  },
  "EVOK": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.04,
    "earnings_per_share": -2.0,
    "ebitda": 0.0,
    "eps_estimate_current_year": -1.95,
    "eps_estimate_next_quarter": -0.44,
    "fifty_day_moving_average": 3.45,
    "fifty_two_week_high": 8.32,
    "fifty_two_week_low": 2.54,
    "percent_change_from_200_day_moving_average": -0.2324,
    "percent_change_from_50_day_moving_average": -0.0737,
    "shares_owned": "N/A",
    "short_ratio": 4.49,
    "two_hundred_day_moving_average": 4.17,
    "volume": 54383.0,
    "market_cap": 22870000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.35,
    "roa_ttm": -0.6073,
    "roe_ttm": -1.4609999999999999,
    "shares_outstanding": 7150000.0,
    "pcnt_held_by_insiders": 0.3237,
    "pcnt_held_by_institutions": 0.078,
    "pcnt_short_of_float": 0.0904,
    "operating_cash_flow_ttm": -10560000.0,
    "levered_cash_flow_ttm": -5810000.0,
    "book_value_per_share_mrq": 0.75,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Evoke Pharma, Inc."
  },
  "EXAC": {
    "p_e_ratio": 15.82,
    "peg_ratio": 1.91,
    "earnings_per_share": 1.12,
    "ebitda": 42550000.0,
    "eps_estimate_current_year": 1.04,
    "eps_estimate_next_quarter": 0.28,
    "fifty_day_moving_average": 17.51,
    "fifty_two_week_high": 26.2,
    "fifty_two_week_low": 16.11,
    "percent_change_from_200_day_moving_average": -0.0653,
    "percent_change_from_50_day_moving_average": 0.011000000000000001,
    "shares_owned": "N/A",
    "short_ratio": 6.47,
    "two_hundred_day_moving_average": 18.94,
    "volume": 71125.0,
    "market_cap": 249180000.0,
    "price_to_sales_ttm": 1.01,
    "price_to_book_mrq": 1.1,
    "roa_ttm": 0.0562,
    "roe_ttm": 0.07339999999999999,
    "shares_outstanding": 14080000.0,
    "pcnt_held_by_insiders": 0.27149999999999996,
    "pcnt_held_by_institutions": 0.631,
    "pcnt_short_of_float": 0.027999999999999997,
    "operating_cash_flow_ttm": 29200000.0,
    "levered_cash_flow_ttm": 13210000.0,
    "book_value_per_share_mrq": 15.88,
    "next_earnings_announcement_date": [
      "2016-02-15",
      "2016-02-19"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Exactech Inc."
  },
  "EXAS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.23,
    "earnings_per_share": -1.68,
    "ebitda": -144370000.0,
    "eps_estimate_current_year": -1.77,
    "eps_estimate_next_quarter": -0.46,
    "fifty_day_moving_average": 9.08,
    "fifty_two_week_high": 32.85,
    "fifty_two_week_low": 6.79,
    "percent_change_from_200_day_moving_average": -0.5112,
    "percent_change_from_50_day_moving_average": -0.0118,
    "shares_owned": "N/A",
    "short_ratio": 9.09,
    "two_hundred_day_moving_average": 18.35,
    "volume": 8642827.0,
    "market_cap": 864150000.0,
    "price_to_sales_ttm": 32.47,
    "price_to_book_mrq": 2.38,
    "roa_ttm": -0.3007,
    "roe_ttm": -0.5214,
    "shares_outstanding": 96340000.0,
    "pcnt_held_by_insiders": 0.0147,
    "pcnt_held_by_institutions": 0.945,
    "pcnt_short_of_float": 0.3207,
    "operating_cash_flow_ttm": -131130000.0,
    "levered_cash_flow_ttm": -95980000.0,
    "book_value_per_share_mrq": 3.75,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Exact Sciences Corporation"
  },
  "EXEL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.25,
    "earnings_per_share": -0.91,
    "ebitda": -130990000.00000001,
    "eps_estimate_current_year": -0.85,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 5.53,
    "fifty_two_week_high": 6.81,
    "fifty_two_week_low": 1.26,
    "percent_change_from_200_day_moving_average": -0.047,
    "percent_change_from_50_day_moving_average": -0.0977,
    "shares_owned": "N/A",
    "short_ratio": 13.5,
    "two_hundred_day_moving_average": 5.24,
    "volume": 7029450.0,
    "market_cap": 1130000000.0,
    "price_to_sales_ttm": 33.04,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.22,
    "roe_ttm": "N/A",
    "shares_outstanding": 227220000.0,
    "pcnt_held_by_insiders": 0.1732,
    "pcnt_held_by_institutions": 0.48100000000000004,
    "pcnt_short_of_float": 0.2762,
    "operating_cash_flow_ttm": -156130000.0,
    "levered_cash_flow_ttm": -69590000.0,
    "book_value_per_share_mrq": -0.33,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Exelixis, Inc."
  },
  "EYEG": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.338,
    "ebitda": -4190000.0000000005,
    "eps_estimate_current_year": -1.55,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 2.9574,
    "fifty_two_week_high": 27.0,
    "fifty_two_week_low": 2.39,
    "percent_change_from_200_day_moving_average": -0.47273499999999996,
    "percent_change_from_50_day_moving_average": -0.134409,
    "shares_owned": "N/A",
    "short_ratio": 0.15,
    "two_hundred_day_moving_average": 4.8551,
    "volume": 11733.0,
    "market_cap": 19600000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.33,
    "roa_ttm": -0.4483,
    "roe_ttm": -2.2232,
    "shares_outstanding": 7660000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.027200000000000002,
    "operating_cash_flow_ttm": -3350000.0,
    "levered_cash_flow_ttm": -1650000.0,
    "book_value_per_share_mrq": 1.13,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Eyegate Pharmaceuticals, Inc."
  },
  "EYES": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.83,
    "ebitda": -19410000.0,
    "eps_estimate_current_year": -0.55,
    "eps_estimate_next_quarter": -0.14,
    "fifty_day_moving_average": 5.71,
    "fifty_two_week_high": 19.63,
    "fifty_two_week_low": 4.57,
    "percent_change_from_200_day_moving_average": -0.3041,
    "percent_change_from_50_day_moving_average": 0.1984,
    "shares_owned": "N/A",
    "short_ratio": 9.33,
    "two_hundred_day_moving_average": 9.83,
    "volume": 1269482.0,
    "market_cap": 245220000.0,
    "price_to_sales_ttm": 31.66,
    "price_to_book_mrq": 10.48,
    "roa_ttm": -0.575,
    "roe_ttm": "-1,128.84%",
    "shares_outstanding": 35850000.0,
    "pcnt_held_by_insiders": 0.4782,
    "pcnt_held_by_institutions": 0.064,
    "pcnt_short_of_float": 0.3182,
    "operating_cash_flow_ttm": -15750000.0,
    "levered_cash_flow_ttm": -6130000.0,
    "book_value_per_share_mrq": 0.68,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Second Sight Medical Products, Inc."
  },
  "FATE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.23,
    "ebitda": -26210000.0,
    "eps_estimate_current_year": -1.19,
    "eps_estimate_next_quarter": -0.27,
    "fifty_day_moving_average": 4.09,
    "fifty_two_week_high": 8.78,
    "fifty_two_week_low": 3.12,
    "percent_change_from_200_day_moving_average": -0.3796,
    "percent_change_from_50_day_moving_average": -0.133,
    "shares_owned": "N/A",
    "short_ratio": 2.23,
    "two_hundred_day_moving_average": 5.72,
    "volume": 63407.0,
    "market_cap": 101950000.0,
    "price_to_sales_ttm": 75.23,
    "price_to_book_mrq": 2.27,
    "roa_ttm": -0.2716,
    "roe_ttm": -0.7326,
    "shares_outstanding": 28720000.0,
    "pcnt_held_by_insiders": 0.2477,
    "pcnt_held_by_institutions": 0.634,
    "pcnt_short_of_float": 0.0337,
    "operating_cash_flow_ttm": -17580000.0,
    "levered_cash_flow_ttm": -15140000.0,
    "book_value_per_share_mrq": 1.57,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Fate Therapeutics, Inc."
  },
  "FBIO": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.16,
    "earnings_per_share": -1.04,
    "ebitda": -41950000.0,
    "eps_estimate_current_year": -0.58,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.9,
    "fifty_two_week_high": 5.35,
    "fifty_two_week_low": 1.96,
    "percent_change_from_200_day_moving_average": -0.1747,
    "percent_change_from_50_day_moving_average": -0.1421,
    "shares_owned": "N/A",
    "short_ratio": 32.45,
    "two_hundred_day_moving_average": 3.02,
    "volume": 90287.0,
    "market_cap": 117360000.0,
    "price_to_sales_ttm": 221.75,
    "price_to_book_mrq": 2.17,
    "roa_ttm": -0.30010000000000003,
    "roe_ttm": -0.6848000000000001,
    "shares_outstanding": 47130000.0,
    "pcnt_held_by_insiders": 0.4571,
    "pcnt_held_by_institutions": 0.10099999999999999,
    "pcnt_short_of_float": 0.1032,
    "operating_cash_flow_ttm": -26770000.0,
    "levered_cash_flow_ttm": -11030000.0,
    "book_value_per_share_mrq": 1.14,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Fortress Biotech, Inc."
  },
  "FCSC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.54,
    "ebitda": -32250000.0,
    "eps_estimate_current_year": -0.54,
    "eps_estimate_next_quarter": -0.16,
    "fifty_day_moving_average": 5.17,
    "fifty_two_week_high": 7.6,
    "fifty_two_week_low": 2.31,
    "percent_change_from_200_day_moving_average": -0.0424,
    "percent_change_from_50_day_moving_average": 0.0019,
    "shares_owned": "N/A",
    "short_ratio": 19.91,
    "two_hundred_day_moving_average": 5.41,
    "volume": 119155.0,
    "market_cap": 227400000.0,
    "price_to_sales_ttm": 485.14,
    "price_to_book_mrq": 7.2,
    "roa_ttm": -0.4229,
    "roe_ttm": -0.6215999999999999,
    "shares_outstanding": 43900000.0,
    "pcnt_held_by_insiders": 0.002,
    "pcnt_held_by_institutions": 0.65,
    "pcnt_short_of_float": 0.12390000000000001,
    "operating_cash_flow_ttm": -23260000.0,
    "levered_cash_flow_ttm": -16040000.0,
    "book_value_per_share_mrq": 0.72,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Fibrocell Science, Inc."
  },
  "FGEN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.58,
    "ebitda": -71790000.0,
    "eps_estimate_current_year": -1.02,
    "eps_estimate_next_quarter": -0.42,
    "fifty_day_moving_average": 28.11,
    "fifty_two_week_high": 40.59,
    "fifty_two_week_low": 16.95,
    "percent_change_from_200_day_moving_average": 0.19579999999999997,
    "percent_change_from_50_day_moving_average": 0.0369,
    "shares_owned": "N/A",
    "short_ratio": 6.17,
    "two_hundred_day_moving_average": 24.38,
    "volume": 2999775.0,
    "market_cap": 1790000000.0,
    "price_to_sales_ttm": 10.89,
    "price_to_book_mrq": 8.63,
    "roa_ttm": -0.1143,
    "roe_ttm": -0.49090000000000006,
    "shares_outstanding": 61340000.0,
    "pcnt_held_by_insiders": 0.1893,
    "pcnt_held_by_institutions": 0.423,
    "pcnt_short_of_float": 0.0553,
    "operating_cash_flow_ttm": -3030000.0,
    "levered_cash_flow_ttm": -5530000.0,
    "book_value_per_share_mrq": 3.55,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "FibroGen, Inc."
  },
  "FLDM": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.16,
    "earnings_per_share": -1.8,
    "ebitda": -43760000.0,
    "eps_estimate_current_year": -1.93,
    "eps_estimate_next_quarter": -0.48,
    "fifty_day_moving_average": 10.35,
    "fifty_two_week_high": 46.38,
    "fifty_two_week_low": 7.2,
    "percent_change_from_200_day_moving_average": -0.2686,
    "percent_change_from_50_day_moving_average": 0.035699999999999996,
    "shares_owned": "N/A",
    "short_ratio": 4.83,
    "two_hundred_day_moving_average": 14.66,
    "volume": 436422.0,
    "market_cap": 308650000.0,
    "price_to_sales_ttm": 2.55,
    "price_to_book_mrq": 2.42,
    "roa_ttm": -0.0775,
    "roe_ttm": -0.36869999999999997,
    "shares_outstanding": 28790000.0,
    "pcnt_held_by_insiders": 0.09789999999999999,
    "pcnt_held_by_institutions": 1.002,
    "pcnt_short_of_float": 0.2147,
    "operating_cash_flow_ttm": -33850000.0,
    "levered_cash_flow_ttm": -14170000.0,
    "book_value_per_share_mrq": 4.31,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Fluidigm Corporation"
  },
  "FLKS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.49,
    "ebitda": -26600000.0,
    "eps_estimate_current_year": -2.15,
    "eps_estimate_next_quarter": -0.75,
    "fifty_day_moving_average": 11.7,
    "fifty_two_week_high": 24.82,
    "fifty_two_week_low": 9.23,
    "percent_change_from_200_day_moving_average": -0.1497,
    "percent_change_from_50_day_moving_average": 0.0138,
    "shares_owned": "N/A",
    "short_ratio": 14.36,
    "two_hundred_day_moving_average": 13.95,
    "volume": 700433.0,
    "market_cap": 212820000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.94,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 17940000.0,
    "pcnt_held_by_insiders": 0.488,
    "pcnt_held_by_institutions": 0.324,
    "pcnt_short_of_float": 0.061500000000000006,
    "operating_cash_flow_ttm": -19920000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 6.33,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Flex Pharma, Inc."
  },
  "FLML": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.82,
    "earnings_per_share": -1.56,
    "ebitda": 67860000.0,
    "eps_estimate_current_year": -0.44,
    "eps_estimate_next_quarter": 0.27,
    "fifty_day_moving_average": 14.68,
    "fifty_two_week_high": 26.09,
    "fifty_two_week_low": 9.3,
    "percent_change_from_200_day_moving_average": -0.2959,
    "percent_change_from_50_day_moving_average": -0.0737,
    "shares_owned": "N/A",
    "short_ratio": 2.13,
    "two_hundred_day_moving_average": 19.31,
    "volume": 186668.0,
    "market_cap": 552500000.0,
    "price_to_sales_ttm": 4.07,
    "price_to_book_mrq": 21.47,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 40620000.0,
    "pcnt_held_by_insiders": 0.1079,
    "pcnt_held_by_institutions": 0.6920000000000001,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.62,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Delivery",
    "company_name": "Flamel Technologies SA"
  },
  "FLXN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.0,
    "ebitda": -40160000.0,
    "eps_estimate_current_year": -2.15,
    "eps_estimate_next_quarter": -0.54,
    "fifty_day_moving_average": 18.23,
    "fifty_two_week_high": 30.37,
    "fifty_two_week_low": 13.08,
    "percent_change_from_200_day_moving_average": -0.076,
    "percent_change_from_50_day_moving_average": 0.0436,
    "shares_owned": "N/A",
    "short_ratio": 8.96,
    "two_hundred_day_moving_average": 20.6,
    "volume": 917096.0,
    "market_cap": 409890000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.59,
    "roa_ttm": -0.24539999999999998,
    "roe_ttm": -0.4621,
    "shares_outstanding": 21540000.0,
    "pcnt_held_by_insiders": 0.5632,
    "pcnt_held_by_institutions": 0.41200000000000003,
    "pcnt_short_of_float": 0.0975,
    "operating_cash_flow_ttm": -34290000.0,
    "levered_cash_flow_ttm": -22190000.0,
    "book_value_per_share_mrq": 5.37,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Flexion Therapeutics, Inc."
  },
  "FMI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.68,
    "ebitda": -75910000.0,
    "eps_estimate_current_year": -2.39,
    "eps_estimate_next_quarter": -0.53,
    "fifty_day_moving_average": 17.61,
    "fifty_two_week_high": 54.28,
    "fifty_two_week_low": 15.58,
    "percent_change_from_200_day_moving_average": -0.125,
    "percent_change_from_50_day_moving_average": 0.1868,
    "shares_owned": "N/A",
    "short_ratio": 7.91,
    "two_hundred_day_moving_average": 23.89,
    "volume": 840182.0,
    "market_cap": 720030000.0,
    "price_to_sales_ttm": 7.97,
    "price_to_book_mrq": 2.5,
    "roa_ttm": -0.24350000000000002,
    "roe_ttm": -0.4534,
    "shares_outstanding": 34450000.0,
    "pcnt_held_by_insiders": 0.7048000000000001,
    "pcnt_held_by_institutions": 0.35,
    "pcnt_short_of_float": 0.2483,
    "operating_cash_flow_ttm": -65930000.00000001,
    "levered_cash_flow_ttm": -52090000.0,
    "book_value_per_share_mrq": 7.95,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Foundation Medicine, Inc."
  },
  "FOLD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.1,
    "ebitda": -104520000.0,
    "eps_estimate_current_year": -1.12,
    "eps_estimate_next_quarter": -0.29,
    "fifty_day_moving_average": 9.98,
    "fifty_two_week_high": 18.83,
    "fifty_two_week_low": 5.69,
    "percent_change_from_200_day_moving_average": -0.27940000000000004,
    "percent_change_from_50_day_moving_average": -0.0863,
    "shares_owned": "N/A",
    "short_ratio": 7.1,
    "two_hundred_day_moving_average": 12.66,
    "volume": 8104945.0,
    "market_cap": 1140000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.97,
    "roa_ttm": -0.1193,
    "roe_ttm": -0.5234000000000001,
    "shares_outstanding": 124900000.0,
    "pcnt_held_by_insiders": 0.0404,
    "pcnt_held_by_institutions": 0.976,
    "pcnt_short_of_float": 0.2712,
    "operating_cash_flow_ttm": -79140000.0,
    "levered_cash_flow_ttm": -36110000.0,
    "book_value_per_share_mrq": 3.04,
    "next_earnings_announcement_date": [
      "2016-03-01",
      "2016-03-07"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Amicus Therapeutics, Inc."
  },
  "FOMX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.43,
    "ebitda": -11490000.0,
    "eps_estimate_current_year": -0.63,
    "eps_estimate_next_quarter": -0.37,
    "fifty_day_moving_average": 7.58,
    "fifty_two_week_high": 14.0,
    "fifty_two_week_low": 6.0,
    "percent_change_from_200_day_moving_average": -0.1215,
    "percent_change_from_50_day_moving_average": 0.07980000000000001,
    "shares_owned": "N/A",
    "short_ratio": 11.04,
    "two_hundred_day_moving_average": 9.32,
    "volume": 925460.0,
    "market_cap": 250250000.0,
    "price_to_sales_ttm": 70.92,
    "price_to_book_mrq": 2.4,
    "roa_ttm": -0.0928,
    "roe_ttm": -0.1515,
    "shares_outstanding": 30560000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0975,
    "operating_cash_flow_ttm": -9760000.0,
    "levered_cash_flow_ttm": -6210000.0,
    "book_value_per_share_mrq": 3.46,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Foamix Pharmaceuticals Ltd."
  },
  "FONR": {
    "p_e_ratio": 8.73,
    "peg_ratio": 0.0,
    "earnings_per_share": 2.04,
    "ebitda": 16239999.999999998,
    "eps_estimate_current_year": "nan",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 16.58,
    "fifty_two_week_high": 18.48,
    "fifty_two_week_low": 9.1,
    "percent_change_from_200_day_moving_average": 0.3824,
    "percent_change_from_50_day_moving_average": 0.07400000000000001,
    "shares_owned": "N/A",
    "short_ratio": 0.46,
    "two_hundred_day_moving_average": 12.88,
    "volume": 35173.0,
    "market_cap": 108520000.0,
    "price_to_sales_ttm": 1.34,
    "price_to_book_mrq": 2.66,
    "roa_ttm": 0.1036,
    "roe_ttm": 0.3094,
    "shares_outstanding": 6050000.0,
    "pcnt_held_by_insiders": 0.0184,
    "pcnt_held_by_institutions": 0.20199999999999999,
    "pcnt_short_of_float": 0.005600000000000001,
    "operating_cash_flow_ttm": 13840000.0,
    "levered_cash_flow_ttm": 8130000.000000001,
    "book_value_per_share_mrq": 6.68,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Fonar Corp."
  },
  "FPRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.38,
    "ebitda": -57030000.0,
    "eps_estimate_current_year": 8.38,
    "eps_estimate_next_quarter": -0.63,
    "fifty_day_moving_average": 37.46,
    "fifty_two_week_high": 45.72,
    "fifty_two_week_low": 14.7,
    "percent_change_from_200_day_moving_average": 0.7155,
    "percent_change_from_50_day_moving_average": 0.1938,
    "shares_owned": "N/A",
    "short_ratio": 5.89,
    "two_hundred_day_moving_average": 26.07,
    "volume": 2977036.0,
    "market_cap": 1230000000.0,
    "price_to_sales_ttm": 57.01,
    "price_to_book_mrq": 9.58,
    "roa_ttm": -0.22149999999999997,
    "roe_ttm": -0.5289,
    "shares_outstanding": 27500000.0,
    "pcnt_held_by_insiders": 0.1689,
    "pcnt_held_by_institutions": 0.726,
    "pcnt_short_of_float": 0.13140000000000002,
    "operating_cash_flow_ttm": -25790000.0,
    "levered_cash_flow_ttm": -31310000.0,
    "book_value_per_share_mrq": 4.57,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Five Prime Therapeutics, Inc."
  },
  "FVE": {
    "p_e_ratio": "N/A",
    "peg_ratio": -6.25,
    "earnings_per_share": -2.29,
    "ebitda": 19530000.0,
    "eps_estimate_current_year": -0.04,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.45,
    "fifty_two_week_high": 5.07,
    "fifty_two_week_low": 2.74,
    "percent_change_from_200_day_moving_average": -0.0942,
    "percent_change_from_50_day_moving_average": -0.0066,
    "shares_owned": "N/A",
    "short_ratio": 5.18,
    "two_hundred_day_moving_average": 3.79,
    "volume": 258534.0,
    "market_cap": 168190000.0,
    "price_to_sales_ttm": 0.16,
    "price_to_book_mrq": 0.92,
    "roa_ttm": -0.0165,
    "roe_ttm": -0.4266,
    "shares_outstanding": 49040000.0,
    "pcnt_held_by_insiders": 0.177,
    "pcnt_held_by_institutions": 0.609,
    "pcnt_short_of_float": 0.024900000000000002,
    "operating_cash_flow_ttm": 26750000.0,
    "levered_cash_flow_ttm": 3800000.0,
    "book_value_per_share_mrq": 3.88,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "Five Star Quality Care Inc."
  },
  "FWP": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.97,
    "earnings_per_share": -1.57,
    "ebitda": -45280000.0,
    "eps_estimate_current_year": -0.97,
    "eps_estimate_next_quarter": -0.46,
    "fifty_day_moving_average": 21.86,
    "fifty_two_week_high": 43.34,
    "fifty_two_week_low": 18.48,
    "percent_change_from_200_day_moving_average": -0.3563,
    "percent_change_from_50_day_moving_average": -0.15460000000000002,
    "shares_owned": "N/A",
    "short_ratio": 5.16,
    "two_hundred_day_moving_average": 28.71,
    "volume": 55774.0,
    "market_cap": 866190000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.92,
    "roa_ttm": -0.2622,
    "roe_ttm": -0.3267,
    "shares_outstanding": 46870000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -25820000.0,
    "levered_cash_flow_ttm": -13810000.0,
    "book_value_per_share_mrq": 4.01,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Forward Pharma A/S"
  },
  "GALE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.36,
    "ebitda": -41790000.0,
    "eps_estimate_current_year": -0.3,
    "eps_estimate_next_quarter": -0.05,
    "fifty_day_moving_average": 1.54,
    "fifty_two_week_high": 2.39,
    "fifty_two_week_low": 1.1,
    "percent_change_from_200_day_moving_average": -0.0946,
    "percent_change_from_50_day_moving_average": -0.027200000000000002,
    "shares_owned": "N/A",
    "short_ratio": 21.04,
    "two_hundred_day_moving_average": 1.66,
    "volume": 1040216.0,
    "market_cap": 242860000.0,
    "price_to_sales_ttm": 25.71,
    "price_to_book_mrq": 7.4,
    "roa_ttm": -0.3287,
    "roe_ttm": -1.3509,
    "shares_outstanding": 161910000.0,
    "pcnt_held_by_insiders": 0.0043,
    "pcnt_held_by_institutions": 0.17600000000000002,
    "pcnt_short_of_float": 0.1426,
    "operating_cash_flow_ttm": -43610000.0,
    "levered_cash_flow_ttm": -36690000.0,
    "book_value_per_share_mrq": 0.2,
    "next_earnings_announcement_date": [
      "2016-03-03",
      "2016-03-07"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Galena Biopharma, Inc."
  },
  "GALT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.87,
    "ebitda": -18970000.0,
    "eps_estimate_current_year": -0.84,
    "eps_estimate_next_quarter": -0.21,
    "fifty_day_moving_average": 2.21,
    "fifty_two_week_high": 4.5,
    "fifty_two_week_low": 1.66,
    "percent_change_from_200_day_moving_average": -0.3086,
    "percent_change_from_50_day_moving_average": -0.2296,
    "shares_owned": "N/A",
    "short_ratio": 7.59,
    "two_hundred_day_moving_average": 2.46,
    "volume": 116276.0,
    "market_cap": 48770000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.37,
    "roa_ttm": -0.44909999999999994,
    "roe_ttm": -0.7676999999999999,
    "shares_outstanding": 28690000.0,
    "pcnt_held_by_insiders": 0.2114,
    "pcnt_held_by_institutions": 0.149,
    "pcnt_short_of_float": 0.0596,
    "operating_cash_flow_ttm": -15490000.0,
    "levered_cash_flow_ttm": -8279999.999999999,
    "book_value_per_share_mrq": 0.51,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Galectin Therapeutics, Inc."
  },
  "GB": {
    "p_e_ratio": 44.78,
    "peg_ratio": 1.98,
    "earnings_per_share": 1.2,
    "ebitda": 114370000.0,
    "eps_estimate_current_year": 2.82,
    "eps_estimate_next_quarter": 0.63,
    "fifty_day_moving_average": 56.59,
    "fifty_two_week_high": 63.19,
    "fifty_two_week_low": 47.36,
    "percent_change_from_200_day_moving_average": -0.0169,
    "percent_change_from_50_day_moving_average": -0.0504,
    "shares_owned": "N/A",
    "short_ratio": 4.19,
    "two_hundred_day_moving_average": 54.67,
    "volume": 579782.0,
    "market_cap": 1640000000.0,
    "price_to_sales_ttm": 2.61,
    "price_to_book_mrq": 2.21,
    "roa_ttm": 0.051,
    "roe_ttm": 0.0507,
    "shares_outstanding": 30560000.0,
    "pcnt_held_by_insiders": 0.018500000000000003,
    "pcnt_held_by_institutions": 0.992,
    "pcnt_short_of_float": 0.0302,
    "operating_cash_flow_ttm": 57580000.0,
    "levered_cash_flow_ttm": 35840000.0,
    "book_value_per_share_mrq": 25.25,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Greatbatch, Inc."
  },
  "GBIM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.64,
    "ebitda": -3370000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.25,
    "fifty_two_week_high": 10.95,
    "fifty_two_week_low": 1.43,
    "percent_change_from_200_day_moving_average": 0.5211,
    "percent_change_from_50_day_moving_average": 0.3056,
    "shares_owned": "N/A",
    "short_ratio": 0.12,
    "two_hundred_day_moving_average": 2.79,
    "volume": 21464.0,
    "market_cap": 24390000.0,
    "price_to_sales_ttm": 3.47,
    "price_to_book_mrq": 6.4,
    "roa_ttm": -0.1333,
    "roe_ttm": -0.6705,
    "shares_outstanding": 5750000.0,
    "pcnt_held_by_insiders": 0.4089,
    "pcnt_held_by_institutions": 0.13,
    "pcnt_short_of_float": 0.0021,
    "operating_cash_flow_ttm": -7760000.0,
    "levered_cash_flow_ttm": -2990000.0,
    "book_value_per_share_mrq": 0.65,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "GlobeImmune Inc."
  },
  "GBSN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -166.65,
    "ebitda": -17720000.0,
    "eps_estimate_current_year": -567.0,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 5.37,
    "fifty_two_week_high": 366.0,
    "fifty_two_week_low": 2.12,
    "percent_change_from_200_day_moving_average": -0.97,
    "percent_change_from_50_day_moving_average": -0.5771999999999999,
    "shares_owned": "N/A",
    "short_ratio": 0.26,
    "two_hundred_day_moving_average": 75.62,
    "volume": 2069203.0,
    "market_cap": 7210000.0,
    "price_to_sales_ttm": 4.39,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -1.0476,
    "roe_ttm": "N/A",
    "shares_outstanding": 3180000.0,
    "pcnt_held_by_insiders": 0.0412,
    "pcnt_held_by_institutions": 0.004,
    "pcnt_short_of_float": 0.0316,
    "operating_cash_flow_ttm": -18310000.0,
    "levered_cash_flow_ttm": -16170000.000000002,
    "book_value_per_share_mrq": -6.07,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Great Basin Scientific, Inc."
  },
  "GBT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -6.97,
    "ebitda": -35330000.0,
    "eps_estimate_current_year": -6.59,
    "eps_estimate_next_quarter": -0.54,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 34.33,
    "fifty_two_week_low": 30.38,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 6.82,
    "two_hundred_day_moving_average": 0.0,
    "volume": 1000391.0,
    "market_cap": 925290000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 6.37,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 30460000.0,
    "pcnt_held_by_insiders": 0.1826,
    "pcnt_held_by_institutions": 0.03,
    "pcnt_short_of_float": 0.2162,
    "operating_cash_flow_ttm": -26610000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 5.29,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Global Blood Therapeutics, Inc."
  },
  "GEN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 1.13,
    "earnings_per_share": -3.87,
    "ebitda": 469730000.0,
    "eps_estimate_current_year": 0.36,
    "eps_estimate_next_quarter": 0.07,
    "fifty_day_moving_average": 4.62,
    "fifty_two_week_high": 9.32,
    "fifty_two_week_low": 3.82,
    "percent_change_from_200_day_moving_average": -0.3592,
    "percent_change_from_50_day_moving_average": -0.1696,
    "shares_owned": "N/A",
    "short_ratio": 5.34,
    "two_hundred_day_moving_average": 5.99,
    "volume": 293816.0,
    "market_cap": 589640000.0,
    "price_to_sales_ttm": 0.12,
    "price_to_book_mrq": "N/A",
    "roa_ttm": 0.0271,
    "roe_ttm": "N/A",
    "shares_outstanding": 73590000.0,
    "pcnt_held_by_insiders": 0.4385,
    "pcnt_held_by_institutions": 0.292,
    "pcnt_short_of_float": 0.0462,
    "operating_cash_flow_ttm": 17340000.0,
    "levered_cash_flow_ttm": 53350000.0,
    "book_value_per_share_mrq": -1.12,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "Genesis Healthcare, Inc."
  },
  "GENE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.9,
    "ebitda": -6860000.0,
    "eps_estimate_current_year": -1.72,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.8,
    "fifty_two_week_high": 11.0,
    "fifty_two_week_low": 1.04,
    "percent_change_from_200_day_moving_average": -0.016,
    "percent_change_from_50_day_moving_average": -0.0274,
    "shares_owned": "N/A",
    "short_ratio": 0.3,
    "two_hundred_day_moving_average": 2.76,
    "volume": 484365.0,
    "market_cap": 31100000.0,
    "price_to_sales_ttm": 22.18,
    "price_to_book_mrq": 2.32,
    "roa_ttm": -0.4493,
    "roe_ttm": -0.8477,
    "shares_outstanding": 11440000.0,
    "pcnt_held_by_insiders": 0.2915,
    "pcnt_held_by_institutions": 0.087,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -6900000.0,
    "levered_cash_flow_ttm": -4480000.0,
    "book_value_per_share_mrq": 1.2,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Genetic Technologies Limited"
  },
  "GERN": {
    "p_e_ratio": "N/A",
    "peg_ratio": -31.53,
    "earnings_per_share": -0.0,
    "ebitda": 428000.0,
    "eps_estimate_current_year": -0.03,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 4.32,
    "fifty_two_week_high": 5.3,
    "fifty_two_week_low": 2.6,
    "percent_change_from_200_day_moving_average": 0.29760000000000003,
    "percent_change_from_50_day_moving_average": 0.1374,
    "shares_owned": "N/A",
    "short_ratio": 12.92,
    "two_hundred_day_moving_average": 3.78,
    "volume": 15074732.0,
    "market_cap": 776870000.0,
    "price_to_sales_ttm": 20.6,
    "price_to_book_mrq": 5.06,
    "roa_ttm": 0.0016,
    "roe_ttm": -0.003,
    "shares_outstanding": 158220000.0,
    "pcnt_held_by_insiders": 0.005,
    "pcnt_held_by_institutions": 0.46,
    "pcnt_short_of_float": 0.23170000000000002,
    "operating_cash_flow_ttm": 9530000.0,
    "levered_cash_flow_ttm": 7660000.0,
    "book_value_per_share_mrq": 0.94,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Geron Corporation"
  },
  "GHDX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.14,
    "earnings_per_share": -1.14,
    "ebitda": -24680000.0,
    "eps_estimate_current_year": -0.96,
    "eps_estimate_next_quarter": -0.07,
    "fifty_day_moving_average": 28.07,
    "fifty_two_week_high": 34.5,
    "fifty_two_week_low": 20.05,
    "percent_change_from_200_day_moving_average": 0.2593,
    "percent_change_from_50_day_moving_average": 0.16140000000000002,
    "shares_owned": "N/A",
    "short_ratio": 9.92,
    "two_hundred_day_moving_average": 25.89,
    "volume": 2402847.0,
    "market_cap": 1060000000.0,
    "price_to_sales_ttm": 3.48,
    "price_to_book_mrq": 7.4,
    "roa_ttm": -0.10980000000000001,
    "roe_ttm": -0.2668,
    "shares_outstanding": 32540000.0,
    "pcnt_held_by_insiders": 0.0274,
    "pcnt_held_by_institutions": 0.9390000000000001,
    "pcnt_short_of_float": 0.1378,
    "operating_cash_flow_ttm": -9960000.0,
    "levered_cash_flow_ttm": -11150000.0,
    "book_value_per_share_mrq": 4.07,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Genomic Health Inc."
  },
  "GI": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.15,
    "earnings_per_share": -3.36,
    "ebitda": -41320000.0,
    "eps_estimate_current_year": -2.88,
    "eps_estimate_next_quarter": -0.6,
    "fifty_day_moving_average": 8.92,
    "fifty_two_week_high": 19.69,
    "fifty_two_week_low": 7.37,
    "percent_change_from_200_day_moving_average": -0.38299999999999995,
    "percent_change_from_50_day_moving_average": -0.0733,
    "shares_owned": "N/A",
    "short_ratio": 15.25,
    "two_hundred_day_moving_average": 13.4,
    "volume": 134271.0,
    "market_cap": 205060000.0,
    "price_to_sales_ttm": 2.93,
    "price_to_book_mrq": 1.92,
    "roa_ttm": -0.2437,
    "roe_ttm": -4.3450999999999995,
    "shares_outstanding": 24800000.0,
    "pcnt_held_by_insiders": 0.1373,
    "pcnt_held_by_institutions": 0.46299999999999997,
    "pcnt_short_of_float": 0.3044,
    "operating_cash_flow_ttm": -41540000.0,
    "levered_cash_flow_ttm": -28950000.0,
    "book_value_per_share_mrq": 4.44,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "EndoChoice Holdings, Inc."
  },
  "GKOS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.25,
    "ebitda": -9040000.0,
    "eps_estimate_current_year": -1.41,
    "eps_estimate_next_quarter": -0.16,
    "fifty_day_moving_average": 23.27,
    "fifty_two_week_high": 33.92,
    "fifty_two_week_low": 18.53,
    "percent_change_from_200_day_moving_average": -0.08710000000000001,
    "percent_change_from_50_day_moving_average": 0.0466,
    "shares_owned": "N/A",
    "short_ratio": 4.88,
    "two_hundred_day_moving_average": 26.68,
    "volume": 163325.0,
    "market_cap": 781980000.0,
    "price_to_sales_ttm": 12.16,
    "price_to_book_mrq": 8.41,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 32100000.0,
    "pcnt_held_by_insiders": 0.1361,
    "pcnt_held_by_institutions": 0.39,
    "pcnt_short_of_float": 0.0717,
    "operating_cash_flow_ttm": -3110000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 2.95,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Glaukos Corporation"
  },
  "GLMD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.85,
    "ebitda": -9550000.0,
    "eps_estimate_current_year": -0.96,
    "eps_estimate_next_quarter": -0.55,
    "fifty_day_moving_average": 8.88,
    "fifty_two_week_high": 13.5,
    "fifty_two_week_low": 5.41,
    "percent_change_from_200_day_moving_average": -0.0669,
    "percent_change_from_50_day_moving_average": -0.026099999999999998,
    "shares_owned": "N/A",
    "short_ratio": 4.4,
    "two_hundred_day_moving_average": 9.27,
    "volume": 5787.0,
    "market_cap": 96020000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.74,
    "roa_ttm": -0.1909,
    "roe_ttm": -0.3223,
    "shares_outstanding": 11100000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0063,
    "operating_cash_flow_ttm": -8860000.0,
    "levered_cash_flow_ttm": -7120000.0,
    "book_value_per_share_mrq": 2.26,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Galmed Pharmaceuticals Ltd."
  },
  "GLPG": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.34,
    "ebitda": -77140000.0,
    "eps_estimate_current_year": -0.78,
    "eps_estimate_next_quarter": 4.17,
    "fifty_day_moving_average": 51.52,
    "fifty_two_week_high": 65.7,
    "fifty_two_week_low": 38.04,
    "percent_change_from_200_day_moving_average": 0.0603,
    "percent_change_from_50_day_moving_average": 0.1085,
    "shares_owned": "N/A",
    "short_ratio": 0.85,
    "two_hundred_day_moving_average": 53.86,
    "volume": 217395.0,
    "market_cap": 2230000000.0,
    "price_to_sales_ttm": 27.1,
    "price_to_book_mrq": 4.83,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 39010000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -116600000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 11.64,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Galapagos NV"
  },
  "GLYC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.6,
    "ebitda": -11110000.0,
    "eps_estimate_current_year": -0.64,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 6.77,
    "fifty_two_week_high": 9.22,
    "fifty_two_week_low": 4.88,
    "percent_change_from_200_day_moving_average": -0.1264,
    "percent_change_from_50_day_moving_average": -0.0823,
    "shares_owned": "N/A",
    "short_ratio": 10.24,
    "two_hundred_day_moving_average": 7.11,
    "volume": 35973.0,
    "market_cap": 118230000.0,
    "price_to_sales_ttm": 6.08,
    "price_to_book_mrq": 2.5,
    "roa_ttm": -0.1195,
    "roe_ttm": -0.212,
    "shares_outstanding": 19040000.0,
    "pcnt_held_by_insiders": 0.034300000000000004,
    "pcnt_held_by_institutions": 0.737,
    "pcnt_short_of_float": 0.0159,
    "operating_cash_flow_ttm": -7440000.0,
    "levered_cash_flow_ttm": -2980000.0,
    "book_value_per_share_mrq": 2.56,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "GlycoMimetics, Inc."
  },
  "GMED": {
    "p_e_ratio": 25.25,
    "peg_ratio": 1.96,
    "earnings_per_share": 1.07,
    "ebitda": 181440000.0,
    "eps_estimate_current_year": 1.08,
    "eps_estimate_next_quarter": 0.28,
    "fifty_day_moving_average": 26.2,
    "fifty_two_week_high": 28.99,
    "fifty_two_week_low": 20.48,
    "percent_change_from_200_day_moving_average": 0.07440000000000001,
    "percent_change_from_50_day_moving_average": 0.031200000000000002,
    "shares_owned": "N/A",
    "short_ratio": 15.66,
    "two_hundred_day_moving_average": 25.15,
    "volume": 623922.0,
    "market_cap": 2570000000.0,
    "price_to_sales_ttm": 4.93,
    "price_to_book_mrq": 3.83,
    "roa_ttm": 0.1365,
    "roe_ttm": 0.1675,
    "shares_outstanding": 71190000.0,
    "pcnt_held_by_insiders": 0.0337,
    "pcnt_held_by_institutions": 0.953,
    "pcnt_short_of_float": 0.1167,
    "operating_cash_flow_ttm": 79820000.0,
    "levered_cash_flow_ttm": 25310000.0,
    "book_value_per_share_mrq": 7.08,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Globus Medical, Inc."
  },
  "GNCA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.01,
    "ebitda": -41390000.0,
    "eps_estimate_current_year": -1.78,
    "eps_estimate_next_quarter": -0.43,
    "fifty_day_moving_average": 6.04,
    "fifty_two_week_high": 16.18,
    "fifty_two_week_low": 4.27,
    "percent_change_from_200_day_moving_average": -0.33390000000000003,
    "percent_change_from_50_day_moving_average": 0.08470000000000001,
    "shares_owned": "N/A",
    "short_ratio": 6.09,
    "two_hundred_day_moving_average": 9.83,
    "volume": 155618.0,
    "market_cap": 184150000.0,
    "price_to_sales_ttm": 251.08,
    "price_to_book_mrq": 1.92,
    "roa_ttm": -0.3039,
    "roe_ttm": -0.6267,
    "shares_outstanding": 28120000.0,
    "pcnt_held_by_insiders": 0.2576,
    "pcnt_held_by_institutions": 0.47600000000000003,
    "pcnt_short_of_float": 0.0917,
    "operating_cash_flow_ttm": -36780000.0,
    "levered_cash_flow_ttm": -21610000.0,
    "book_value_per_share_mrq": 3.52,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Genocea Biosciences, Inc."
  },
  "GNMK": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.25,
    "earnings_per_share": -1.0,
    "ebitda": -38450000.0,
    "eps_estimate_current_year": -1.07,
    "eps_estimate_next_quarter": -0.28,
    "fifty_day_moving_average": 7.4,
    "fifty_two_week_high": 14.4,
    "fifty_two_week_low": 4.63,
    "percent_change_from_200_day_moving_average": -0.0947,
    "percent_change_from_50_day_moving_average": 0.0588,
    "shares_owned": "N/A",
    "short_ratio": 11.56,
    "two_hundred_day_moving_average": 8.66,
    "volume": 250017.0,
    "market_cap": 332750000.0,
    "price_to_sales_ttm": 9.38,
    "price_to_book_mrq": 6.24,
    "roa_ttm": -0.2985,
    "roe_ttm": -0.6056,
    "shares_outstanding": 42440000.0,
    "pcnt_held_by_insiders": 0.0661,
    "pcnt_held_by_institutions": 1.0590000000000002,
    "pcnt_short_of_float": 0.18789999999999998,
    "operating_cash_flow_ttm": -31020000.0,
    "levered_cash_flow_ttm": -22290000.0,
    "book_value_per_share_mrq": 1.28,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "GenMark Diagnostics, Inc."
  },
  "GNVC": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.14,
    "earnings_per_share": -0.19,
    "ebitda": -3720000.0,
    "eps_estimate_current_year": -0.37,
    "eps_estimate_next_quarter": -0.07,
    "fifty_day_moving_average": 1.92,
    "fifty_two_week_high": 4.67,
    "fifty_two_week_low": 1.51,
    "percent_change_from_200_day_moving_average": -0.09880000000000001,
    "percent_change_from_50_day_moving_average": 0.0155,
    "shares_owned": "N/A",
    "short_ratio": 2.48,
    "two_hundred_day_moving_average": 2.16,
    "volume": 72702.0,
    "market_cap": 33670000.0,
    "price_to_sales_ttm": 7.51,
    "price_to_book_mrq": 3.52,
    "roa_ttm": -0.1966,
    "roe_ttm": -0.31079999999999997,
    "shares_outstanding": 17260000.0,
    "pcnt_held_by_insiders": 0.0397,
    "pcnt_held_by_institutions": 0.327,
    "pcnt_short_of_float": 0.0023,
    "operating_cash_flow_ttm": -2760000.0,
    "levered_cash_flow_ttm": -1990000.0,
    "book_value_per_share_mrq": 0.53,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "GenVec, Inc."
  },
  "GTXI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.227,
    "ebitda": -21290000.0,
    "eps_estimate_current_year": -0.49,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.9494,
    "fifty_two_week_high": 1.59,
    "fifty_two_week_low": 0.6,
    "percent_change_from_200_day_moving_average": -0.290715,
    "percent_change_from_50_day_moving_average": -0.207208,
    "shares_owned": "N/A",
    "short_ratio": 49.06,
    "two_hundred_day_moving_average": 1.0612,
    "volume": 122238.0,
    "market_cap": 105660000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 26.11,
    "roa_ttm": -0.5252,
    "roe_ttm": -4.0213,
    "shares_outstanding": 140370000.0,
    "pcnt_held_by_insiders": 0.736,
    "pcnt_held_by_institutions": 0.102,
    "pcnt_short_of_float": 0.048799999999999996,
    "operating_cash_flow_ttm": -19890000.0,
    "levered_cash_flow_ttm": 18550000.0,
    "book_value_per_share_mrq": 0.03,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "GTX Inc."
  },
  "GWPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.11,
    "earnings_per_share": -3.25,
    "ebitda": -91310000.0,
    "eps_estimate_current_year": -6.15,
    "eps_estimate_next_quarter": -1.37,
    "fifty_day_moving_average": 81.71,
    "fifty_two_week_high": 133.98,
    "fifty_two_week_low": 65.28,
    "percent_change_from_200_day_moving_average": -0.3448,
    "percent_change_from_50_day_moving_average": -0.1826,
    "shares_owned": "N/A",
    "short_ratio": 6.4,
    "two_hundred_day_moving_average": 101.94,
    "volume": 545461.0,
    "market_cap": 1450000000.0,
    "price_to_sales_ttm": 35.09,
    "price_to_book_mrq": 4.08,
    "roa_ttm": -0.1641,
    "roe_ttm": -0.2207,
    "shares_outstanding": 21760000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -69360000.0,
    "levered_cash_flow_ttm": -76130000.0,
    "book_value_per_share_mrq": 16.82,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "GW Pharmaceuticals plc"
  },
  "HAE": {
    "p_e_ratio": 63.47,
    "peg_ratio": 1.4,
    "earnings_per_share": 0.49,
    "ebitda": 142230000.0,
    "eps_estimate_current_year": 1.71,
    "eps_estimate_next_quarter": 0.46,
    "fifty_day_moving_average": 32.47,
    "fifty_two_week_high": 45.43,
    "fifty_two_week_low": 29.7,
    "percent_change_from_200_day_moving_average": -0.1432,
    "percent_change_from_50_day_moving_average": -0.0421,
    "shares_owned": "N/A",
    "short_ratio": 6.5,
    "two_hundred_day_moving_average": 36.3,
    "volume": 524121.0,
    "market_cap": 1580000000.0,
    "price_to_sales_ttm": 1.79,
    "price_to_book_mrq": 2.05,
    "roa_ttm": 0.025099999999999997,
    "roe_ttm": 0.0321,
    "shares_outstanding": 50720000.0,
    "pcnt_held_by_insiders": 0.0058,
    "pcnt_held_by_institutions": 1.0659999999999998,
    "pcnt_short_of_float": 0.0348,
    "operating_cash_flow_ttm": 118960000.0,
    "levered_cash_flow_ttm": 31660000.0,
    "book_value_per_share_mrq": 15.35,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Haemonetics Corporation"
  },
  "HALO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.33,
    "ebitda": -33890000.0,
    "eps_estimate_current_year": -0.44,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 16.75,
    "fifty_two_week_high": 25.25,
    "fifty_two_week_low": 8.93,
    "percent_change_from_200_day_moving_average": -0.1328,
    "percent_change_from_50_day_moving_average": -0.0443,
    "shares_owned": "N/A",
    "short_ratio": 11.18,
    "two_hundred_day_moving_average": 18.46,
    "volume": 1854823.0,
    "market_cap": 2029999999.9999998,
    "price_to_sales_ttm": 18.12,
    "price_to_book_mrq": 64.38,
    "roa_ttm": -0.1375,
    "roe_ttm": -1.166,
    "shares_outstanding": 126860000.0,
    "pcnt_held_by_insiders": 0.0368,
    "pcnt_held_by_institutions": 0.774,
    "pcnt_short_of_float": 0.1432,
    "operating_cash_flow_ttm": -22830000.0,
    "levered_cash_flow_ttm": -5620000.0,
    "book_value_per_share_mrq": 0.25,
    "next_earnings_announcement_date": [
      "2016-02-29",
      "2016-03-04"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Halozyme Therapeutics, Inc."
  },
  "HART": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.26,
    "ebitda": -9700000.0,
    "eps_estimate_current_year": -1.07,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.64,
    "fifty_two_week_high": 4.43,
    "fifty_two_week_low": 0.53,
    "percent_change_from_200_day_moving_average": 0.6547,
    "percent_change_from_50_day_moving_average": 0.2956,
    "shares_owned": "N/A",
    "short_ratio": 0.12,
    "two_hundred_day_moving_average": 1.28,
    "volume": 837822.0,
    "market_cap": 29890000.0,
    "price_to_sales_ttm": 173.57,
    "price_to_book_mrq": 3.12,
    "roa_ttm": -0.6646,
    "roe_ttm": -1.358,
    "shares_outstanding": 14100000.0,
    "pcnt_held_by_insiders": 0.1206,
    "pcnt_held_by_institutions": 0.22,
    "pcnt_short_of_float": 0.042300000000000004,
    "operating_cash_flow_ttm": -7880000.0,
    "levered_cash_flow_ttm": -2280000.0,
    "book_value_per_share_mrq": 0.64,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Harvard Apparatus Regenerative Technology, Inc."
  },
  "HBIO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 2.49,
    "earnings_per_share": -0.06,
    "ebitda": 5020000.0,
    "eps_estimate_current_year": 0.14,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.15,
    "fifty_two_week_high": 6.84,
    "fifty_two_week_low": 2.73,
    "percent_change_from_200_day_moving_average": -0.1751,
    "percent_change_from_50_day_moving_average": 0.1165,
    "shares_owned": "N/A",
    "short_ratio": 6.96,
    "two_hundred_day_moving_average": 4.27,
    "volume": 145168.0,
    "market_cap": 119480000.0,
    "price_to_sales_ttm": 1.07,
    "price_to_book_mrq": 1.26,
    "roa_ttm": 0.003,
    "roe_ttm": -0.020099999999999996,
    "shares_outstanding": 33940000.0,
    "pcnt_held_by_insiders": 0.1604,
    "pcnt_held_by_institutions": 0.6859999999999999,
    "pcnt_short_of_float": 0.0338,
    "operating_cash_flow_ttm": 204000.0,
    "levered_cash_flow_ttm": -2410000.0,
    "book_value_per_share_mrq": 2.78,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Harvard Bioscience Inc."
  },
  "HEB": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.074,
    "ebitda": -17320000.0,
    "eps_estimate_current_year": -0.11,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.1254,
    "fifty_two_week_high": 0.33,
    "fifty_two_week_low": 0.06,
    "percent_change_from_200_day_moving_average": -0.5680080000000001,
    "percent_change_from_50_day_moving_average": -0.414011,
    "shares_owned": "N/A",
    "short_ratio": 1.16,
    "two_hundred_day_moving_average": 0.1701,
    "volume": 3512730.0,
    "market_cap": 18190000.0,
    "price_to_sales_ttm": 135.63,
    "price_to_book_mrq": 0.85,
    "roa_ttm": -0.3924,
    "roe_ttm": -0.6681999999999999,
    "shares_outstanding": 247520000.0,
    "pcnt_held_by_insiders": 0.016,
    "pcnt_held_by_institutions": 0.057999999999999996,
    "pcnt_short_of_float": 0.0023,
    "operating_cash_flow_ttm": -16730000.0,
    "levered_cash_flow_ttm": -13260000.0,
    "book_value_per_share_mrq": 0.09,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Hemispherx Biopharma, Inc."
  },
  "HGR": {
    "p_e_ratio": 10.17,
    "peg_ratio": 1.08,
    "earnings_per_share": 1.65,
    "ebitda": 158860000.0,
    "eps_estimate_current_year": 1.62,
    "eps_estimate_next_quarter": 0.59,
    "fifty_day_moving_average": 15.34,
    "fifty_two_week_high": 26.79,
    "fifty_two_week_low": 13.27,
    "percent_change_from_200_day_moving_average": -0.0738,
    "percent_change_from_50_day_moving_average": 0.0929,
    "shares_owned": "N/A",
    "short_ratio": 18.05,
    "two_hundred_day_moving_average": 18.11,
    "volume": 428522.0,
    "market_cap": 575870000.0,
    "price_to_sales_ttm": 0.59,
    "price_to_book_mrq": 1.03,
    "roa_ttm": 0.0572,
    "roe_ttm": 0.10289999999999999,
    "shares_outstanding": 34340000.0,
    "pcnt_held_by_insiders": 0.035,
    "pcnt_held_by_institutions": 1.054,
    "pcnt_short_of_float": 0.0683,
    "operating_cash_flow_ttm": 51130000.0,
    "levered_cash_flow_ttm": -4200000.0,
    "book_value_per_share_mrq": 17.09,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "Hanger, Inc."
  },
  "HH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.125,
    "ebitda": -6110000.0,
    "eps_estimate_current_year": 0.01,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.1297,
    "fifty_two_week_high": 0.63,
    "fifty_two_week_low": 0.06,
    "percent_change_from_200_day_moving_average": -0.588528,
    "percent_change_from_50_day_moving_average": -0.463435,
    "shares_owned": "N/A",
    "short_ratio": 0.22,
    "two_hundred_day_moving_average": 0.1691,
    "volume": 1523865.0,
    "market_cap": 5430000.0,
    "price_to_sales_ttm": 0.16,
    "price_to_book_mrq": 1.39,
    "roa_ttm": -0.2568,
    "roe_ttm": -1.6787,
    "shares_outstanding": 78020000.0,
    "pcnt_held_by_insiders": 0.2289,
    "pcnt_held_by_institutions": 0.311,
    "pcnt_short_of_float": 0.0018,
    "operating_cash_flow_ttm": -5390000.0,
    "levered_cash_flow_ttm": -2400000.0,
    "book_value_per_share_mrq": 0.04,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "Hooper Holmes Inc."
  },
  "HIIQ": {
    "p_e_ratio": 95.24,
    "peg_ratio": 2.75,
    "earnings_per_share": 0.06,
    "ebitda": 5050000.0,
    "eps_estimate_current_year": 0.21,
    "eps_estimate_next_quarter": 0.07,
    "fifty_day_moving_average": 5.12,
    "fifty_two_week_high": 9.38,
    "fifty_two_week_low": 4.0,
    "percent_change_from_200_day_moving_average": 0.2379,
    "percent_change_from_50_day_moving_average": 0.1727,
    "shares_owned": "N/A",
    "short_ratio": 33.15,
    "two_hundred_day_moving_average": 4.85,
    "volume": 37335.0,
    "market_cap": 46560000.0,
    "price_to_sales_ttm": 0.48,
    "price_to_book_mrq": 1.18,
    "roa_ttm": 0.0161,
    "roe_ttm": 0.0256,
    "shares_outstanding": 7760000.0,
    "pcnt_held_by_insiders": 0.2122,
    "pcnt_held_by_institutions": 0.505,
    "pcnt_short_of_float": 0.2066,
    "operating_cash_flow_ttm": -5890000.0,
    "levered_cash_flow_ttm": -3620000.0,
    "book_value_per_share_mrq": 5.09,
    "next_earnings_announcement_date": [
      "2016-03-16",
      "2016-03-21"
    ],
    "sector": "Healthcare",
    "industry": "Health Care Plans",
    "company_name": "Health Insurance Innovations, Inc."
  },
  "HLS": {
    "p_e_ratio": 18.42,
    "peg_ratio": 1.26,
    "earnings_per_share": 1.85,
    "ebitda": 652600000.0,
    "eps_estimate_current_year": 2.16,
    "eps_estimate_next_quarter": 0.6,
    "fifty_day_moving_average": 34.76,
    "fifty_two_week_high": 48.37,
    "fifty_two_week_low": 32.55,
    "percent_change_from_200_day_moving_average": -0.1668,
    "percent_change_from_50_day_moving_average": -0.0191,
    "shares_owned": "N/A",
    "short_ratio": 6.67,
    "two_hundred_day_moving_average": 40.93,
    "volume": 729897.0,
    "market_cap": 3120000000.0,
    "price_to_sales_ttm": 1.1,
    "price_to_book_mrq": 4.99,
    "roa_ttm": 0.0935,
    "roe_ttm": 0.3038,
    "shares_outstanding": 91440000.0,
    "pcnt_held_by_insiders": 0.09050000000000001,
    "pcnt_held_by_institutions": 0.9159999999999999,
    "pcnt_short_of_float": 0.0507,
    "operating_cash_flow_ttm": 438400000.0,
    "levered_cash_flow_ttm": 192450000.0,
    "book_value_per_share_mrq": 6.9,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "HEALTHSOUTH Corp."
  },
  "HLTH": {
    "p_e_ratio": 43.33,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.07,
    "ebitda": 24470000.0,
    "eps_estimate_current_year": 0.25,
    "eps_estimate_next_quarter": 0.2,
    "fifty_day_moving_average": 2.88,
    "fifty_two_week_high": 9.34,
    "fifty_two_week_low": 2.15,
    "percent_change_from_200_day_moving_average": -0.3657,
    "percent_change_from_50_day_moving_average": 0.0837,
    "shares_owned": "N/A",
    "short_ratio": 9.51,
    "two_hundred_day_moving_average": 4.92,
    "volume": 1313025.0,
    "market_cap": 221190000.0,
    "price_to_sales_ttm": 1.48,
    "price_to_book_mrq": 2.62,
    "roa_ttm": 0.15130000000000002,
    "roe_ttm": 0.35969999999999996,
    "shares_outstanding": 70890000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": 7070000.0,
    "levered_cash_flow_ttm": 3530000.0,
    "book_value_per_share_mrq": 1.14,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Nobilis Health Corp."
  },
  "HNSN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -4.37,
    "ebitda": -36540000.0,
    "eps_estimate_current_year": -3.0,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.06,
    "fifty_two_week_high": 12.3,
    "fifty_two_week_low": 2.41,
    "percent_change_from_200_day_moving_average": -0.5645,
    "percent_change_from_50_day_moving_average": -0.187,
    "shares_owned": "N/A",
    "short_ratio": 26.26,
    "two_hundred_day_moving_average": 5.72,
    "volume": 32635.0,
    "market_cap": 46990000.0,
    "price_to_sales_ttm": 2.77,
    "price_to_book_mrq": 3.69,
    "roa_ttm": -0.3996,
    "roe_ttm": -2.9295,
    "shares_outstanding": 18870000.0,
    "pcnt_held_by_insiders": 0.2729,
    "pcnt_held_by_institutions": 0.337,
    "pcnt_short_of_float": 0.1417,
    "operating_cash_flow_ttm": -39860000.0,
    "levered_cash_flow_ttm": -22940000.0,
    "book_value_per_share_mrq": 0.68,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Hansen Medical, Inc."
  },
  "HNT": {
    "p_e_ratio": 34.51,
    "peg_ratio": 0.86,
    "earnings_per_share": 1.96,
    "ebitda": 427370000.0,
    "eps_estimate_current_year": 3.32,
    "eps_estimate_next_quarter": 0.84,
    "fifty_day_moving_average": 63.97,
    "fifty_two_week_high": 76.67,
    "fifty_two_week_low": 50.79,
    "percent_change_from_200_day_moving_average": 0.0443,
    "percent_change_from_50_day_moving_average": 0.0547,
    "shares_owned": "N/A",
    "short_ratio": 1.56,
    "two_hundred_day_moving_average": 64.61,
    "volume": 1941317.0,
    "market_cap": 5220000000.0,
    "price_to_sales_ttm": 0.32,
    "price_to_book_mrq": 2.84,
    "roa_ttm": 0.0464,
    "roe_ttm": 0.0864,
    "shares_outstanding": 77290000.0,
    "pcnt_held_by_insiders": 0.0212,
    "pcnt_held_by_institutions": 0.972,
    "pcnt_short_of_float": 0.016,
    "operating_cash_flow_ttm": 460000000.0,
    "levered_cash_flow_ttm": -59410000.0,
    "book_value_per_share_mrq": 23.13,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Health Care Plans",
    "company_name": "Health Net, Inc."
  },
  "HRC": {
    "p_e_ratio": 59.37,
    "peg_ratio": 0.94,
    "earnings_per_share": 0.82,
    "ebitda": 294900000.0,
    "eps_estimate_current_year": 3.11,
    "eps_estimate_next_quarter": 0.75,
    "fifty_day_moving_average": 50.72,
    "fifty_two_week_high": 58.73,
    "fifty_two_week_low": 44.69,
    "percent_change_from_200_day_moving_average": -0.08130000000000001,
    "percent_change_from_50_day_moving_average": -0.0403,
    "shares_owned": "N/A",
    "short_ratio": 9.13,
    "two_hundred_day_moving_average": 52.99,
    "volume": 1072778.0,
    "market_cap": 3170000000.0,
    "price_to_sales_ttm": 1.6,
    "price_to_book_mrq": 2.77,
    "roa_ttm": 0.037599999999999995,
    "roe_ttm": 0.04769999999999999,
    "shares_outstanding": 65170000.0,
    "pcnt_held_by_insiders": 0.1081,
    "pcnt_held_by_institutions": 0.893,
    "pcnt_short_of_float": 0.0622,
    "operating_cash_flow_ttm": 213800000.0,
    "levered_cash_flow_ttm": 64160000.0,
    "book_value_per_share_mrq": 17.6,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Hill-Rom Holdings, Inc."
  },
  "HRT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.01,
    "ebitda": 1480000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 5.8,
    "fifty_two_week_high": 7.95,
    "fifty_two_week_low": 4.2,
    "percent_change_from_200_day_moving_average": -0.114,
    "percent_change_from_50_day_moving_average": -0.0582,
    "shares_owned": "N/A",
    "short_ratio": 9.7,
    "two_hundred_day_moving_average": 6.16,
    "volume": 3551.0,
    "market_cap": 15250000.0,
    "price_to_sales_ttm": 0.68,
    "price_to_book_mrq": 2.1,
    "roa_ttm": 0.0005,
    "roe_ttm": -0.052000000000000005,
    "shares_outstanding": 2790000.0,
    "pcnt_held_by_insiders": 0.3998,
    "pcnt_held_by_institutions": 0.14400000000000002,
    "pcnt_short_of_float": 0.005699999999999999,
    "operating_cash_flow_ttm": 1170000.0,
    "levered_cash_flow_ttm": -595790.0,
    "book_value_per_share_mrq": 2.59,
    "next_earnings_announcement_date": [
      "2016-03-18",
      "2016-03-22"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Arrhythmia Research Technology Inc."
  },
  "HRTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.12,
    "earnings_per_share": -2.87,
    "ebitda": 0.0,
    "eps_estimate_current_year": -2.71,
    "eps_estimate_next_quarter": -0.7,
    "fifty_day_moving_average": 27.7,
    "fifty_two_week_high": 42.25,
    "fifty_two_week_low": 7.09,
    "percent_change_from_200_day_moving_average": -0.1446,
    "percent_change_from_50_day_moving_average": -0.0719,
    "shares_owned": "N/A",
    "short_ratio": 0.0,
    "two_hundred_day_moving_average": 30.05,
    "volume": 1288514.0,
    "market_cap": null,
    "price_to_sales_ttm": null,
    "price_to_book_mrq": null,
    "roa_ttm": null,
    "roe_ttm": null,
    "shares_outstanding": null,
    "pcnt_held_by_insiders": null,
    "pcnt_held_by_institutions": null,
    "pcnt_short_of_float": null,
    "operating_cash_flow_ttm": null,
    "levered_cash_flow_ttm": null,
    "book_value_per_share_mrq": null,
    "next_earnings_announcement_date": null,
    "sector": null,
    "industry": null
  },
  "HSGX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.63,
    "ebitda": -28560000.0,
    "eps_estimate_current_year": -2.23,
    "eps_estimate_next_quarter": -0.58,
    "fifty_day_moving_average": 3.52,
    "fifty_two_week_high": 12.47,
    "fifty_two_week_low": 2.71,
    "percent_change_from_200_day_moving_average": -0.4415,
    "percent_change_from_50_day_moving_average": -0.15710000000000002,
    "shares_owned": "N/A",
    "short_ratio": 1.52,
    "two_hundred_day_moving_average": 5.32,
    "volume": 23851.0,
    "market_cap": 39420000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.06,
    "roa_ttm": -0.6429,
    "roe_ttm": -1.1320000000000001,
    "shares_outstanding": 13270000.0,
    "pcnt_held_by_insiders": 0.4102,
    "pcnt_held_by_institutions": 0.408,
    "pcnt_short_of_float": 0.0044,
    "operating_cash_flow_ttm": -28180000.0,
    "levered_cash_flow_ttm": -19010000.0,
    "book_value_per_share_mrq": 2.73,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Histogenics Corporation"
  },
  "HSKA": {
    "p_e_ratio": 58.44,
    "peg_ratio": 2.06,
    "earnings_per_share": 0.59,
    "ebitda": 12000000.0,
    "eps_estimate_current_year": 0.62,
    "eps_estimate_next_quarter": 0.14,
    "fifty_day_moving_average": 34.31,
    "fifty_two_week_high": 37.24,
    "fifty_two_week_low": 15.58,
    "percent_change_from_200_day_moving_average": 0.069,
    "percent_change_from_50_day_moving_average": 0.0032,
    "shares_owned": "N/A",
    "short_ratio": 2.7,
    "two_hundred_day_moving_average": 32.2,
    "volume": 68913.0,
    "market_cap": 227950000.0,
    "price_to_sales_ttm": 2.3,
    "price_to_book_mrq": 3.86,
    "roa_ttm": 0.0471,
    "roe_ttm": 0.059500000000000004,
    "shares_outstanding": 6620000.0,
    "pcnt_held_by_insiders": 0.1432,
    "pcnt_held_by_institutions": 0.5489999999999999,
    "pcnt_short_of_float": 0.0285,
    "operating_cash_flow_ttm": 1250000.0,
    "levered_cash_flow_ttm": 5580000.0,
    "book_value_per_share_mrq": 8.98,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Heska Corporation"
  },
  "HTBX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.31,
    "ebitda": -17770000.0,
    "eps_estimate_current_year": -2.39,
    "eps_estimate_next_quarter": -0.42,
    "fifty_day_moving_average": 3.15,
    "fifty_two_week_high": 10.9,
    "fifty_two_week_low": 1.67,
    "percent_change_from_200_day_moving_average": -0.5661999999999999,
    "percent_change_from_50_day_moving_average": -0.32630000000000003,
    "shares_owned": "N/A",
    "short_ratio": 1.84,
    "two_hundred_day_moving_average": 4.89,
    "volume": 33101.0,
    "market_cap": 17840000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.73,
    "roa_ttm": -0.6690999999999999,
    "roe_ttm": -1.5613,
    "shares_outstanding": 8420000.0,
    "pcnt_held_by_insiders": 0.3002,
    "pcnt_held_by_institutions": 0.24600000000000002,
    "pcnt_short_of_float": 0.011399999999999999,
    "operating_cash_flow_ttm": -14860000.0,
    "levered_cash_flow_ttm": -8300000.000000001,
    "book_value_per_share_mrq": 1.19,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Heat Biologics, Inc."
  },
  "HTGM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -7.81,
    "ebitda": -16329999.999999998,
    "eps_estimate_current_year": -4.85,
    "eps_estimate_next_quarter": -0.81,
    "fifty_day_moving_average": 5.19,
    "fifty_two_week_high": 19.75,
    "fifty_two_week_low": 4.6,
    "percent_change_from_200_day_moving_average": -0.3624,
    "percent_change_from_50_day_moving_average": 0.0111,
    "shares_owned": "N/A",
    "short_ratio": 10.28,
    "two_hundred_day_moving_average": 8.23,
    "volume": 4101.0,
    "market_cap": 35910000.0,
    "price_to_sales_ttm": 8.62,
    "price_to_book_mrq": 1.59,
    "roa_ttm": -0.3736,
    "roe_ttm": -3.0046,
    "shares_outstanding": 6840000.0,
    "pcnt_held_by_insiders": 0.2687,
    "pcnt_held_by_institutions": 0.547,
    "pcnt_short_of_float": 0.0129,
    "operating_cash_flow_ttm": -17460000.0,
    "levered_cash_flow_ttm": -12130000.0,
    "book_value_per_share_mrq": 3.28,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "HTG Molecular Diagnostics, Inc."
  },
  "HTWR": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.38,
    "earnings_per_share": -4.23,
    "ebitda": -20390000.0,
    "eps_estimate_current_year": -3.02,
    "eps_estimate_next_quarter": -0.62,
    "fifty_day_moving_average": 47.27,
    "fifty_two_week_high": 95.59,
    "fifty_two_week_low": 34.7,
    "percent_change_from_200_day_moving_average": -0.2771,
    "percent_change_from_50_day_moving_average": -0.0167,
    "shares_owned": "N/A",
    "short_ratio": 8.46,
    "two_hundred_day_moving_average": 64.3,
    "volume": 458026.0,
    "market_cap": 804100000.0,
    "price_to_sales_ttm": 2.81,
    "price_to_book_mrq": 4.29,
    "roa_ttm": -0.0398,
    "roe_ttm": -0.37560000000000004,
    "shares_outstanding": 17300000.0,
    "pcnt_held_by_insiders": 0.065,
    "pcnt_held_by_institutions": 1.045,
    "pcnt_short_of_float": 0.24280000000000002,
    "operating_cash_flow_ttm": -1240000.0,
    "levered_cash_flow_ttm": 26120000.0,
    "book_value_per_share_mrq": 10.65,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Heartware International Inc."
  },
  "HWAY": {
    "p_e_ratio": "N/A",
    "peg_ratio": 7.86,
    "earnings_per_share": -0.25,
    "ebitda": 51770000.0,
    "eps_estimate_current_year": 0.11,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 12.65,
    "fifty_two_week_high": 23.3,
    "fifty_two_week_low": 9.93,
    "percent_change_from_200_day_moving_average": 0.0148,
    "percent_change_from_50_day_moving_average": -0.0017000000000000001,
    "shares_owned": "N/A",
    "short_ratio": 5.93,
    "two_hundred_day_moving_average": 12.45,
    "volume": 833842.0,
    "market_cap": 455170000.0,
    "price_to_sales_ttm": 0.6,
    "price_to_book_mrq": 1.58,
    "roa_ttm": 0.0259,
    "roe_ttm": -0.0315,
    "shares_outstanding": 36040000.0,
    "pcnt_held_by_insiders": 0.0837,
    "pcnt_held_by_institutions": 1.024,
    "pcnt_short_of_float": 0.0897,
    "operating_cash_flow_ttm": 58610000.0,
    "levered_cash_flow_ttm": 35550000.0,
    "book_value_per_share_mrq": 8.2,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "Healthways Inc."
  },
  "HYH": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.89,
    "earnings_per_share": -9.51,
    "ebitda": 215700000.0,
    "eps_estimate_current_year": 2.06,
    "eps_estimate_next_quarter": 0.47,
    "fifty_day_moving_average": 31.83,
    "fifty_two_week_high": 50.92,
    "fifty_two_week_low": 26.58,
    "percent_change_from_200_day_moving_average": -0.0166,
    "percent_change_from_50_day_moving_average": 0.0601,
    "shares_owned": "N/A",
    "short_ratio": 9.88,
    "two_hundred_day_moving_average": 34.31,
    "volume": 962391.0,
    "market_cap": 1570000000.0,
    "price_to_sales_ttm": 0.97,
    "price_to_book_mrq": 1.5,
    "roa_ttm": 0.040999999999999995,
    "roe_ttm": -0.2841,
    "shares_outstanding": 46610000.0,
    "pcnt_held_by_insiders": 0.0029,
    "pcnt_held_by_institutions": 0.7759999999999999,
    "pcnt_short_of_float": 0.071,
    "operating_cash_flow_ttm": 115200000.0,
    "levered_cash_flow_ttm": 120320000.0,
    "book_value_per_share_mrq": 22.34,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Halyard Health, Inc."
  },
  "HZNP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.91,
    "earnings_per_share": -0.12,
    "ebitda": 113700000.0,
    "eps_estimate_current_year": 1.92,
    "eps_estimate_next_quarter": 0.52,
    "fifty_day_moving_average": 19.78,
    "fifty_two_week_high": 39.49,
    "fifty_two_week_low": 12.16,
    "percent_change_from_200_day_moving_average": -0.22460000000000002,
    "percent_change_from_50_day_moving_average": 0.0512,
    "shares_owned": "N/A",
    "short_ratio": 1.97,
    "two_hundred_day_moving_average": 26.81,
    "volume": 5358213.0,
    "market_cap": 3310000000.0,
    "price_to_sales_ttm": 5.5,
    "price_to_book_mrq": 2.7,
    "roa_ttm": 0.010700000000000001,
    "roe_ttm": -0.018500000000000003,
    "shares_outstanding": 159290000.0,
    "pcnt_held_by_insiders": 0.1714,
    "pcnt_held_by_institutions": 0.792,
    "pcnt_short_of_float": 0.13019999999999998,
    "operating_cash_flow_ttm": 69310000.0,
    "levered_cash_flow_ttm": 166100000.0,
    "book_value_per_share_mrq": 7.9,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Horizon Pharma plc"
  },
  "IART": {
    "p_e_ratio": "N/A",
    "peg_ratio": 1.89,
    "earnings_per_share": -0.04,
    "ebitda": 210510000.0,
    "eps_estimate_current_year": 3.09,
    "eps_estimate_next_quarter": 0.78,
    "fifty_day_moving_average": 63.52,
    "fifty_two_week_high": 68.46,
    "fifty_two_week_low": 47.67,
    "percent_change_from_200_day_moving_average": 0.0677,
    "percent_change_from_50_day_moving_average": 0.0446,
    "shares_owned": "N/A",
    "short_ratio": 7.07,
    "two_hundred_day_moving_average": 62.15,
    "volume": 814326.0,
    "market_cap": 2450000000.0,
    "price_to_sales_ttm": 2.46,
    "price_to_book_mrq": 3.34,
    "roa_ttm": 0.0529,
    "roe_ttm": 0.0141,
    "shares_outstanding": 36980000.0,
    "pcnt_held_by_insiders": 0.2003,
    "pcnt_held_by_institutions": 0.752,
    "pcnt_short_of_float": 0.08929999999999999,
    "operating_cash_flow_ttm": 89850000.0,
    "levered_cash_flow_ttm": 123630000.0,
    "book_value_per_share_mrq": 19.77,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Integra LifeSciences Holdings Corporation"
  },
  "IBIO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.094,
    "ebitda": -6700000.0,
    "eps_estimate_current_year": -0.15,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.627,
    "fifty_two_week_high": 1.32,
    "fifty_two_week_low": 0.4,
    "percent_change_from_200_day_moving_average": -0.1868,
    "percent_change_from_50_day_moving_average": -0.04488,
    "shares_owned": "N/A",
    "short_ratio": 13.82,
    "two_hundred_day_moving_average": 0.737,
    "volume": 93047.0,
    "market_cap": 46320000.0,
    "price_to_sales_ttm": 36.98,
    "price_to_book_mrq": 4.49,
    "roa_ttm": -0.48960000000000004,
    "roe_ttm": -0.9208,
    "shares_outstanding": 77330000.0,
    "pcnt_held_by_insiders": 0.44909999999999994,
    "pcnt_held_by_institutions": 0.035,
    "pcnt_short_of_float": 0.0345,
    "operating_cash_flow_ttm": -5300000.0,
    "levered_cash_flow_ttm": -2420000.0,
    "book_value_per_share_mrq": 0.13,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "iBio, Inc."
  },
  "ICCC": {
    "p_e_ratio": 22.71,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.33,
    "ebitda": 2350000.0,
    "eps_estimate_current_year": "nan",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 7.25,
    "fifty_two_week_high": 11.4,
    "fifty_two_week_low": 4.77,
    "percent_change_from_200_day_moving_average": -0.0087,
    "percent_change_from_50_day_moving_average": 0.0407,
    "shares_owned": "N/A",
    "short_ratio": 0.59,
    "two_hundred_day_moving_average": 7.61,
    "volume": 1304.0,
    "market_cap": 23030000.0,
    "price_to_sales_ttm": 2.37,
    "price_to_book_mrq": 2.24,
    "roa_ttm": 0.0931,
    "roe_ttm": 0.10859999999999999,
    "shares_outstanding": 3060000.0,
    "pcnt_held_by_insiders": 0.2841,
    "pcnt_held_by_institutions": 0.085,
    "pcnt_short_of_float": 0.0015,
    "operating_cash_flow_ttm": 2320000.0,
    "levered_cash_flow_ttm": -1290000.0,
    "book_value_per_share_mrq": 3.37,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ImmuCell Corp."
  },
  "ICLR": {
    "p_e_ratio": 21.18,
    "peg_ratio": 0.92,
    "earnings_per_share": 3.57,
    "ebitda": 323500000.0,
    "eps_estimate_current_year": 3.97,
    "eps_estimate_next_quarter": 1.1,
    "fifty_day_moving_average": 71.25,
    "fifty_two_week_high": 84.14,
    "fifty_two_week_low": 50.87,
    "percent_change_from_200_day_moving_average": 0.0453,
    "percent_change_from_50_day_moving_average": 0.061399999999999996,
    "shares_owned": "N/A",
    "short_ratio": 4.9,
    "two_hundred_day_moving_average": 72.34,
    "volume": 447904.0,
    "market_cap": 4330000000.0,
    "price_to_sales_ttm": 2.76,
    "price_to_book_mrq": 5.0,
    "roa_ttm": 0.0984,
    "roe_ttm": 0.23600000000000002,
    "shares_outstanding": 57230000.0,
    "pcnt_held_by_insiders": 0.08220000000000001,
    "pcnt_held_by_institutions": 0.981,
    "pcnt_short_of_float": 0.04019999999999999,
    "operating_cash_flow_ttm": 238650000.0,
    "levered_cash_flow_ttm": 141100000.0,
    "book_value_per_share_mrq": 15.08,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "ICON Public Limited Company"
  },
  "ICPT": {
    "p_e_ratio": "N/A",
    "peg_ratio": -2.44,
    "earnings_per_share": -7.54,
    "ebitda": -174100000.0,
    "eps_estimate_current_year": -9.15,
    "eps_estimate_next_quarter": -3.05,
    "fifty_day_moving_average": 170.32,
    "fifty_two_week_high": 314.88,
    "fifty_two_week_low": 137.28,
    "percent_change_from_200_day_moving_average": -0.2398,
    "percent_change_from_50_day_moving_average": -0.0836,
    "shares_owned": "N/A",
    "short_ratio": 5.17,
    "two_hundred_day_moving_average": 205.33,
    "volume": 1177160.0,
    "market_cap": 3800000000.0,
    "price_to_sales_ttm": 1451.58,
    "price_to_book_mrq": 5.94,
    "roa_ttm": -0.2186,
    "roe_ttm": -0.3685,
    "shares_outstanding": 24330000.0,
    "pcnt_held_by_insiders": 0.2923,
    "pcnt_held_by_institutions": 0.754,
    "pcnt_short_of_float": 0.21530000000000002,
    "operating_cash_flow_ttm": -129360000.00000001,
    "levered_cash_flow_ttm": -73860000.0,
    "book_value_per_share_mrq": 27.95,
    "next_earnings_announcement_date": [
      "2016-02-29",
      "2016-03-04"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Intercept Pharmaceuticals, Inc."
  },
  "ICUI": {
    "p_e_ratio": 37.86,
    "peg_ratio": 2.55,
    "earnings_per_share": 2.87,
    "ebitda": 92560000.0,
    "eps_estimate_current_year": 3.93,
    "eps_estimate_next_quarter": 1.0,
    "fifty_day_moving_average": 112.39,
    "fifty_two_week_high": 124.69,
    "fifty_two_week_low": 79.44,
    "percent_change_from_200_day_moving_average": 0.020099999999999996,
    "percent_change_from_50_day_moving_average": -0.0322,
    "shares_owned": "N/A",
    "short_ratio": 2.38,
    "two_hundred_day_moving_average": 106.63,
    "volume": 184912.0,
    "market_cap": 1740000000.0,
    "price_to_sales_ttm": 5.35,
    "price_to_book_mrq": 3.1,
    "roa_ttm": 0.0818,
    "roe_ttm": 0.0886,
    "shares_outstanding": 15980000.0,
    "pcnt_held_by_insiders": 0.1045,
    "pcnt_held_by_institutions": 0.9309999999999999,
    "pcnt_short_of_float": 0.0271,
    "operating_cash_flow_ttm": 54730000.0,
    "levered_cash_flow_ttm": 49150000.0,
    "book_value_per_share_mrq": 35.56,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "ICU Medical, Inc."
  },
  "IDRA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.45,
    "ebitda": -48280000.0,
    "eps_estimate_current_year": -0.44,
    "eps_estimate_next_quarter": -0.11,
    "fifty_day_moving_average": 3.51,
    "fifty_two_week_high": 5.48,
    "fifty_two_week_low": 2.27,
    "percent_change_from_200_day_moving_average": 0.0018,
    "percent_change_from_50_day_moving_average": -0.051399999999999994,
    "shares_owned": "N/A",
    "short_ratio": 14.78,
    "two_hundred_day_moving_average": 3.32,
    "volume": 1200693.0,
    "market_cap": 394110000.0,
    "price_to_sales_ttm": 6480.15,
    "price_to_book_mrq": 4.27,
    "roa_ttm": -0.3811,
    "roe_ttm": -0.6665000000000001,
    "shares_outstanding": 118350000.0,
    "pcnt_held_by_insiders": 0.16570000000000001,
    "pcnt_held_by_institutions": 0.515,
    "pcnt_short_of_float": 0.19640000000000002,
    "operating_cash_flow_ttm": -43840000.0,
    "levered_cash_flow_ttm": -26880000.0,
    "book_value_per_share_mrq": 0.78,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Idera Pharmaceuticals, Inc."
  },
  "IDXX": {
    "p_e_ratio": 38.15,
    "peg_ratio": 2.43,
    "earnings_per_share": 1.83,
    "ebitda": 337720000.0,
    "eps_estimate_current_year": 2.05,
    "eps_estimate_next_quarter": 0.48,
    "fifty_day_moving_average": 69.59,
    "fifty_two_week_high": 84.25,
    "fifty_two_week_low": 61.37,
    "percent_change_from_200_day_moving_average": -0.0077,
    "percent_change_from_50_day_moving_average": 0.0053,
    "shares_owned": "N/A",
    "short_ratio": 15.27,
    "two_hundred_day_moving_average": 70.5,
    "volume": 1061827.0,
    "market_cap": 6550000000.0,
    "price_to_sales_ttm": 4.09,
    "price_to_book_mrq": "N/A",
    "roa_ttm": 0.1225,
    "roe_ttm": 1.8219999999999998,
    "shares_outstanding": 93600000.0,
    "pcnt_held_by_insiders": 0.0131,
    "pcnt_held_by_institutions": 1.0290000000000001,
    "pcnt_short_of_float": 0.0917,
    "operating_cash_flow_ttm": 169770000.0,
    "levered_cash_flow_ttm": 107460000.0,
    "book_value_per_share_mrq": -0.43,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "IDEXX Laboratories, Inc."
  },
  "IMDZ": {
    "p_e_ratio": "N/A",
    "peg_ratio": -2.08,
    "earnings_per_share": -2.2,
    "ebitda": -40230000.0,
    "eps_estimate_current_year": -2.0,
    "eps_estimate_next_quarter": -0.59,
    "fifty_day_moving_average": 19.05,
    "fifty_two_week_high": 40.13,
    "fifty_two_week_low": 10.17,
    "percent_change_from_200_day_moving_average": 0.1602,
    "percent_change_from_50_day_moving_average": 0.1325,
    "shares_owned": "N/A",
    "short_ratio": 9.97,
    "two_hundred_day_moving_average": 18.59,
    "volume": 690669.0,
    "market_cap": 434490000.0,
    "price_to_sales_ttm": 41.15,
    "price_to_book_mrq": 3.51,
    "roa_ttm": -0.2398,
    "roe_ttm": -0.4083,
    "shares_outstanding": 20140000.0,
    "pcnt_held_by_insiders": 0.28350000000000003,
    "pcnt_held_by_institutions": 0.669,
    "pcnt_short_of_float": 0.1543,
    "operating_cash_flow_ttm": -38140000.0,
    "levered_cash_flow_ttm": -23430000.0,
    "book_value_per_share_mrq": 5.92,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Immune Design Corp."
  },
  "IMGN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.84,
    "ebitda": -55900000.0,
    "eps_estimate_current_year": -1.44,
    "eps_estimate_next_quarter": -0.34,
    "fifty_day_moving_average": 12.86,
    "fifty_two_week_high": 19.43,
    "fifty_two_week_low": 5.34,
    "percent_change_from_200_day_moving_average": -0.0026,
    "percent_change_from_50_day_moving_average": 0.054000000000000006,
    "shares_owned": "N/A",
    "short_ratio": 9.89,
    "two_hundred_day_moving_average": 13.59,
    "volume": 2969998.0,
    "market_cap": 1180000000.0,
    "price_to_sales_ttm": 13.24,
    "price_to_book_mrq": 99.77,
    "roa_ttm": -0.1783,
    "roe_ttm": -2.0458000000000003,
    "shares_outstanding": 86980000.0,
    "pcnt_held_by_insiders": 0.0036,
    "pcnt_held_by_institutions": 0.917,
    "pcnt_short_of_float": 0.2052,
    "operating_cash_flow_ttm": -67740000.0,
    "levered_cash_flow_ttm": -44060000.0,
    "book_value_per_share_mrq": 0.13,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ImmunoGen, Inc."
  },
  "IMMU": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.54,
    "ebitda": -47280000.0,
    "eps_estimate_current_year": -0.39,
    "eps_estimate_next_quarter": -0.13,
    "fifty_day_moving_average": 3.05,
    "fifty_two_week_high": 5.48,
    "fifty_two_week_low": 1.5,
    "percent_change_from_200_day_moving_average": 0.0706,
    "percent_change_from_50_day_moving_average": 0.011899999999999999,
    "shares_owned": "N/A",
    "short_ratio": 17.46,
    "two_hundred_day_moving_average": 2.89,
    "volume": 1174574.0,
    "market_cap": 292440000.0,
    "price_to_sales_ttm": 53.98,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.4618,
    "roe_ttm": "-1,314.49%",
    "shares_outstanding": 94640000.0,
    "pcnt_held_by_insiders": 0.0684,
    "pcnt_held_by_institutions": 0.43700000000000006,
    "pcnt_short_of_float": 0.1968,
    "operating_cash_flow_ttm": -43240000.0,
    "levered_cash_flow_ttm": -26420000.0,
    "book_value_per_share_mrq": -0.19,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Immunomedics Inc."
  },
  "IMMY": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.35,
    "earnings_per_share": -1.43,
    "ebitda": -12390000.0,
    "eps_estimate_current_year": -1.36,
    "eps_estimate_next_quarter": -0.38,
    "fifty_day_moving_average": 6.66,
    "fifty_two_week_high": 8.79,
    "fifty_two_week_low": 4.94,
    "percent_change_from_200_day_moving_average": -0.0353,
    "percent_change_from_50_day_moving_average": 0.0756,
    "shares_owned": "N/A",
    "short_ratio": 2.45,
    "two_hundred_day_moving_average": 7.42,
    "volume": 32335.0,
    "market_cap": 69320000.0,
    "price_to_sales_ttm": 10.35,
    "price_to_book_mrq": 31.16,
    "roa_ttm": -0.5869,
    "roe_ttm": -2.1584,
    "shares_outstanding": 9680000.0,
    "pcnt_held_by_insiders": 0.41090000000000004,
    "pcnt_held_by_institutions": 0.17,
    "pcnt_short_of_float": 0.0365,
    "operating_cash_flow_ttm": -9890000.0,
    "levered_cash_flow_ttm": -5610000.0,
    "book_value_per_share_mrq": 0.23,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Imprimis Pharmaceuticals, Inc."
  },
  "IMNP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.82,
    "ebitda": -12950000.0,
    "eps_estimate_current_year": -0.63,
    "eps_estimate_next_quarter": -0.13,
    "fifty_day_moving_average": 0.97,
    "fifty_two_week_high": 2.32,
    "fifty_two_week_low": 0.61,
    "percent_change_from_200_day_moving_average": -0.4618,
    "percent_change_from_50_day_moving_average": -0.1968,
    "shares_owned": "N/A",
    "short_ratio": 1.38,
    "two_hundred_day_moving_average": 1.45,
    "volume": 207506.0,
    "market_cap": 23620000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.68,
    "roa_ttm": -0.22899999999999998,
    "roe_ttm": -1.0647,
    "shares_outstanding": 30280000.0,
    "pcnt_held_by_insiders": 0.3478,
    "pcnt_held_by_institutions": 0.013999999999999999,
    "pcnt_short_of_float": 0.0143,
    "operating_cash_flow_ttm": -13210000.0,
    "levered_cash_flow_ttm": -9110000.0,
    "book_value_per_share_mrq": 0.44,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Immune Pharmaceuticals, Inc."
  },
  "IMUC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.128,
    "ebitda": -12440000.0,
    "eps_estimate_current_year": -0.15,
    "eps_estimate_next_quarter": -0.04,
    "fifty_day_moving_average": 0.4197,
    "fifty_two_week_high": 0.83,
    "fifty_two_week_low": 0.35,
    "percent_change_from_200_day_moving_average": -0.152747,
    "percent_change_from_50_day_moving_average": -0.09819499999999999,
    "shares_owned": "N/A",
    "short_ratio": 8.48,
    "two_hundred_day_moving_average": 0.4467,
    "volume": 364829.0,
    "market_cap": 34180000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.3,
    "roa_ttm": -0.2773,
    "roe_ttm": -0.40659999999999996,
    "shares_outstanding": 90310000.0,
    "pcnt_held_by_insiders": 0.0060999999999999995,
    "pcnt_held_by_institutions": 0.14800000000000002,
    "pcnt_short_of_float": 0.0235,
    "operating_cash_flow_ttm": -15330000.0,
    "levered_cash_flow_ttm": -6650000.0,
    "book_value_per_share_mrq": 0.29,
    "next_earnings_announcement_date": [
      "2016-03-07",
      "2016-03-11"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ImmunoCellular Therapeutics, Ltd."
  },
  "INFI": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.04,
    "earnings_per_share": -2.64,
    "ebitda": -125190000.0,
    "eps_estimate_current_year": -2.46,
    "eps_estimate_next_quarter": -0.94,
    "fifty_day_moving_average": 8.48,
    "fifty_two_week_high": 17.88,
    "fifty_two_week_low": 7.19,
    "percent_change_from_200_day_moving_average": -0.1409,
    "percent_change_from_50_day_moving_average": -0.0529,
    "shares_owned": "N/A",
    "short_ratio": 7.9,
    "two_hundred_day_moving_average": 9.35,
    "volume": 5209486.0,
    "market_cap": 395320000.0,
    "price_to_sales_ttm": 3.77,
    "price_to_book_mrq": 2.95,
    "roa_ttm": -0.2175,
    "roe_ttm": -0.6833,
    "shares_outstanding": 49230000.0,
    "pcnt_held_by_insiders": 0.0181,
    "pcnt_held_by_institutions": 1.042,
    "pcnt_short_of_float": 0.1641,
    "operating_cash_flow_ttm": -213400000.0,
    "levered_cash_flow_ttm": -172470000.0,
    "book_value_per_share_mrq": 2.72,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Infinity Pharmaceuticals, Inc."
  },
  "INFU": {
    "p_e_ratio": 23.39,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.12,
    "ebitda": 17020000.0,
    "eps_estimate_current_year": 0.24,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.86,
    "fifty_two_week_high": 3.42,
    "fifty_two_week_low": 2.22,
    "percent_change_from_200_day_moving_average": -0.017,
    "percent_change_from_50_day_moving_average": 0.0138,
    "shares_owned": "N/A",
    "short_ratio": 32.58,
    "two_hundred_day_moving_average": 2.95,
    "volume": 11419.0,
    "market_cap": 65290000.00000001,
    "price_to_sales_ttm": 1.03,
    "price_to_book_mrq": 1.34,
    "roa_ttm": 0.0683,
    "roe_ttm": 0.0588,
    "shares_outstanding": 22510000.0,
    "pcnt_held_by_insiders": 0.4576,
    "pcnt_held_by_institutions": 0.423,
    "pcnt_short_of_float": 0.0216,
    "operating_cash_flow_ttm": 8440000.0,
    "levered_cash_flow_ttm": 464250.0,
    "book_value_per_share_mrq": 2.18,
    "next_earnings_announcement_date": [
      "2016-03-07",
      "2016-03-11"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "InfuSystem Holdings, Inc."
  },
  "INGN": {
    "p_e_ratio": 91.6,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.44,
    "ebitda": 26780000.0,
    "eps_estimate_current_year": 0.3,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 41.41,
    "fifty_two_week_high": 55.98,
    "fifty_two_week_low": 29.06,
    "percent_change_from_200_day_moving_average": -0.0883,
    "percent_change_from_50_day_moving_average": -0.015700000000000002,
    "shares_owned": "N/A",
    "short_ratio": 4.66,
    "two_hundred_day_moving_average": 44.71,
    "volume": 292118.0,
    "market_cap": 801020000.0,
    "price_to_sales_ttm": 5.48,
    "price_to_book_mrq": 6.21,
    "roa_ttm": 0.0552,
    "roe_ttm": 0.0758,
    "shares_outstanding": 19650000.0,
    "pcnt_held_by_insiders": 0.0504,
    "pcnt_held_by_institutions": 0.9329999999999999,
    "pcnt_short_of_float": 0.1045,
    "operating_cash_flow_ttm": 29930000.0,
    "levered_cash_flow_ttm": 5050000.0,
    "book_value_per_share_mrq": 6.63,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Inogen, Inc."
  },
  "INNL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.1,
    "ebitda": -39530000.0,
    "eps_estimate_current_year": -1.66,
    "eps_estimate_next_quarter": -0.6,
    "fifty_day_moving_average": 9.2,
    "fifty_two_week_high": 16.46,
    "fifty_two_week_low": 5.7,
    "percent_change_from_200_day_moving_average": -0.3862,
    "percent_change_from_50_day_moving_average": -0.1641,
    "shares_owned": "N/A",
    "short_ratio": 0.03,
    "two_hundred_day_moving_average": 12.53,
    "volume": 2301.0,
    "market_cap": 179330000.0,
    "price_to_sales_ttm": 63.64,
    "price_to_book_mrq": 10.77,
    "roa_ttm": -0.4833,
    "roe_ttm": -1.5935,
    "shares_outstanding": 23320000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -33220000.0,
    "levered_cash_flow_ttm": -19960000.0,
    "book_value_per_share_mrq": 0.7,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Innocoll AG"
  },
  "INO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.3,
    "ebitda": -29950000.0,
    "eps_estimate_current_year": -0.4,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 6.84,
    "fifty_two_week_high": 10.83,
    "fifty_two_week_low": 5.32,
    "percent_change_from_200_day_moving_average": -0.0463,
    "percent_change_from_50_day_moving_average": 0.0046,
    "shares_owned": "N/A",
    "short_ratio": 12.36,
    "two_hundred_day_moving_average": 7.2,
    "volume": 6631011.0,
    "market_cap": 495900000.0,
    "price_to_sales_ttm": 12.88,
    "price_to_book_mrq": 2.47,
    "roa_ttm": -0.10869999999999999,
    "roe_ttm": -0.11960000000000001,
    "shares_outstanding": 72180000.0,
    "pcnt_held_by_insiders": 0.0567,
    "pcnt_held_by_institutions": 0.331,
    "pcnt_short_of_float": 0.2621,
    "operating_cash_flow_ttm": -13740000.0,
    "levered_cash_flow_ttm": -13610000.0,
    "book_value_per_share_mrq": 2.68,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Inovio Pharmaceuticals, Inc."
  },
  "INSM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.89,
    "ebitda": -106250000.0,
    "eps_estimate_current_year": -2.0,
    "eps_estimate_next_quarter": -0.57,
    "fifty_day_moving_average": 17.1,
    "fifty_two_week_high": 28.66,
    "fifty_two_week_low": 13.93,
    "percent_change_from_200_day_moving_average": -0.1801,
    "percent_change_from_50_day_moving_average": 0.04650000000000001,
    "shares_owned": "N/A",
    "short_ratio": 8.68,
    "two_hundred_day_moving_average": 21.83,
    "volume": 1808526.0,
    "market_cap": 1110000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.27,
    "roa_ttm": -0.2173,
    "roe_ttm": -0.3886,
    "shares_outstanding": 61800000.0,
    "pcnt_held_by_insiders": 0.0437,
    "pcnt_held_by_institutions": 0.8959999999999999,
    "pcnt_short_of_float": 0.1056,
    "operating_cash_flow_ttm": -86080000.0,
    "levered_cash_flow_ttm": -56510000.0,
    "book_value_per_share_mrq": 5.49,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Insmed Incorporated"
  },
  "INSY": {
    "p_e_ratio": 41.54,
    "peg_ratio": 0.83,
    "earnings_per_share": 0.68,
    "ebitda": 92990000.0,
    "eps_estimate_current_year": 1.23,
    "eps_estimate_next_quarter": 0.24,
    "fifty_day_moving_average": 28.8,
    "fifty_two_week_high": 46.17,
    "fifty_two_week_low": 20.15,
    "percent_change_from_200_day_moving_average": -0.1411,
    "percent_change_from_50_day_moving_average": -0.0178,
    "shares_owned": "N/A",
    "short_ratio": 18.56,
    "two_hundred_day_moving_average": 32.94,
    "volume": 1041124.0,
    "market_cap": 2020000000.0,
    "price_to_sales_ttm": 6.74,
    "price_to_book_mrq": 8.72,
    "roa_ttm": 0.22,
    "roe_ttm": 0.2664,
    "shares_outstanding": 71420000.0,
    "pcnt_held_by_insiders": 0.6629999999999999,
    "pcnt_held_by_institutions": 0.457,
    "pcnt_short_of_float": 0.8687,
    "operating_cash_flow_ttm": 90610000.0,
    "levered_cash_flow_ttm": 69950000.0,
    "book_value_per_share_mrq": 3.29,
    "next_earnings_announcement_date": [
      "2016-03-01",
      "2016-03-07"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "INSYS Therapeutics, Inc."
  },
  "IPCI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.24,
    "ebitda": -4710000.0,
    "eps_estimate_current_year": -0.26,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 1.98,
    "fifty_two_week_high": 3.92,
    "fifty_two_week_low": 1.73,
    "percent_change_from_200_day_moving_average": -0.16219999999999998,
    "percent_change_from_50_day_moving_average": 0.0355,
    "shares_owned": "N/A",
    "short_ratio": 14.77,
    "two_hundred_day_moving_average": 2.45,
    "volume": 28385.0,
    "market_cap": 49350000.0,
    "price_to_sales_ttm": 10.21,
    "price_to_book_mrq": 20.93,
    "roa_ttm": -0.41869999999999996,
    "roe_ttm": -1.4003999999999999,
    "shares_outstanding": 24070000.0,
    "pcnt_held_by_insiders": 0.2194,
    "pcnt_held_by_institutions": 0.006,
    "pcnt_short_of_float": 0.0658,
    "operating_cash_flow_ttm": -3900000.0,
    "levered_cash_flow_ttm": -2490000.0,
    "book_value_per_share_mrq": 0.1,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Delivery",
    "company_name": "IntelliPharmaCeutics International Inc."
  },
  "IPXL": {
    "p_e_ratio": 108.59,
    "peg_ratio": 1.24,
    "earnings_per_share": 0.38,
    "ebitda": 115730000.0,
    "eps_estimate_current_year": 1.29,
    "eps_estimate_next_quarter": 0.51,
    "fifty_day_moving_average": 40.97,
    "fifty_two_week_high": 52.1,
    "fifty_two_week_low": 29.76,
    "percent_change_from_200_day_moving_average": -0.0352,
    "percent_change_from_50_day_moving_average": 0.0177,
    "shares_owned": "N/A",
    "short_ratio": 7.49,
    "two_hundred_day_moving_average": 43.22,
    "volume": 1207736.0,
    "market_cap": 2940000000.0,
    "price_to_sales_ttm": 4.16,
    "price_to_book_mrq": 2.87,
    "roa_ttm": 0.0245,
    "roe_ttm": 0.028900000000000002,
    "shares_outstanding": 70510000.0,
    "pcnt_held_by_insiders": 0.0592,
    "pcnt_held_by_institutions": 0.98,
    "pcnt_short_of_float": 0.1131,
    "operating_cash_flow_ttm": 13950000.0,
    "levered_cash_flow_ttm": -25210000.0,
    "book_value_per_share_mrq": 14.66,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Impax Laboratories Inc."
  },
  "IRIX": {
    "p_e_ratio": 10.91,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.87,
    "ebitda": 1280000.0,
    "eps_estimate_current_year": 0.18,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 9.38,
    "fifty_two_week_high": 11.28,
    "fifty_two_week_low": 6.42,
    "percent_change_from_200_day_moving_average": 0.1741,
    "percent_change_from_50_day_moving_average": 0.0105,
    "shares_owned": "N/A",
    "short_ratio": 0.69,
    "two_hundred_day_moving_average": 8.07,
    "volume": 15749.0,
    "market_cap": 94290000.0,
    "price_to_sales_ttm": 2.3,
    "price_to_book_mrq": 2.89,
    "roa_ttm": 0.0134,
    "roe_ttm": 0.3012,
    "shares_outstanding": 9950000.0,
    "pcnt_held_by_insiders": 0.42619999999999997,
    "pcnt_held_by_institutions": 0.193,
    "pcnt_short_of_float": 0.0017000000000000001,
    "operating_cash_flow_ttm": "1,000.00K",
    "levered_cash_flow_ttm": -1710000.0,
    "book_value_per_share_mrq": 3.3,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "IRIDEX Corporation"
  },
  "IRMD": {
    "p_e_ratio": 57.8,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.45,
    "ebitda": 8660000.0,
    "eps_estimate_current_year": 0.68,
    "eps_estimate_next_quarter": 0.19,
    "fifty_day_moving_average": 29.68,
    "fifty_two_week_high": 33.25,
    "fifty_two_week_low": 10.85,
    "percent_change_from_200_day_moving_average": 0.0256,
    "percent_change_from_50_day_moving_average": -0.12560000000000002,
    "shares_owned": "N/A",
    "short_ratio": 2.61,
    "two_hundred_day_moving_average": 25.3,
    "volume": 463946.0,
    "market_cap": 289550000.0,
    "price_to_sales_ttm": 10.44,
    "price_to_book_mrq": 9.72,
    "roa_ttm": 0.1974,
    "roe_ttm": 0.2236,
    "shares_outstanding": 11160000.0,
    "pcnt_held_by_insiders": 0.6724,
    "pcnt_held_by_institutions": 0.121,
    "pcnt_short_of_float": 0.0678,
    "operating_cash_flow_ttm": 4179999.9999999995,
    "levered_cash_flow_ttm": 3590000.0,
    "book_value_per_share_mrq": 2.54,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "IRadimed Corporation"
  },
  "IRWD": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.39,
    "earnings_per_share": -1.18,
    "ebitda": -117700000.0,
    "eps_estimate_current_year": -1.07,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 11.7,
    "fifty_two_week_high": 17.11,
    "fifty_two_week_low": 9.77,
    "percent_change_from_200_day_moving_average": 0.0227,
    "percent_change_from_50_day_moving_average": 0.0055000000000000005,
    "shares_owned": "N/A",
    "short_ratio": 16.77,
    "two_hundred_day_moving_average": 11.5,
    "volume": 4257785.0,
    "market_cap": 1680000000.0,
    "price_to_sales_ttm": 12.05,
    "price_to_book_mrq": 16.11,
    "roa_ttm": -0.16870000000000002,
    "roe_ttm": -1.5941999999999998,
    "shares_outstanding": 126990000.0,
    "pcnt_held_by_insiders": 0.0722,
    "pcnt_held_by_institutions": 1.135,
    "pcnt_short_of_float": 0.2518,
    "operating_cash_flow_ttm": -110350000.0,
    "levered_cash_flow_ttm": -65000000.0,
    "book_value_per_share_mrq": 0.7,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Ironwood Pharmaceuticals, Inc."
  },
  "ISIS": {
    "p_e_ratio": 486.05,
    "peg_ratio": -3.99,
    "earnings_per_share": 0.12,
    "ebitda": 8530000.0,
    "eps_estimate_current_year": -0.63,
    "eps_estimate_next_quarter": -0.43,
    "fifty_day_moving_average": 58.66,
    "fifty_two_week_high": 77.8,
    "fifty_two_week_low": 37.38,
    "percent_change_from_200_day_moving_average": 0.0703,
    "percent_change_from_50_day_moving_average": -0.013999999999999999,
    "shares_owned": "N/A",
    "short_ratio": 7.08,
    "two_hundred_day_moving_average": 54.04,
    "volume": 1769960.0,
    "market_cap": 6950000000.0,
    "price_to_sales_ttm": 22.05,
    "price_to_book_mrq": 28.46,
    "roa_ttm": -0.001,
    "roe_ttm": 0.0481,
    "shares_outstanding": 120120000.0,
    "pcnt_held_by_insiders": 0.0073,
    "pcnt_held_by_institutions": 0.8320000000000001,
    "pcnt_short_of_float": 0.1246,
    "operating_cash_flow_ttm": 129280000.0,
    "levered_cash_flow_ttm": 66790000.00000001,
    "book_value_per_share_mrq": 2.05,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Isis Pharmaceuticals, Inc."
  },
  "ISR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.07,
    "ebitda": -3590000.0,
    "eps_estimate_current_year": 0.08,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.21,
    "fifty_two_week_high": 3.79,
    "fifty_two_week_low": 0.96,
    "percent_change_from_200_day_moving_average": -0.2552,
    "percent_change_from_50_day_moving_average": -0.14150000000000001,
    "shares_owned": "N/A",
    "short_ratio": 11.0,
    "two_hundred_day_moving_average": 1.4,
    "volume": 206813.0,
    "market_cap": 57210000.0,
    "price_to_sales_ttm": 12.45,
    "price_to_book_mrq": 2.96,
    "roa_ttm": -0.1124,
    "roe_ttm": -0.1809,
    "shares_outstanding": 55010000.0,
    "pcnt_held_by_insiders": 0.0074,
    "pcnt_held_by_institutions": 0.077,
    "pcnt_short_of_float": 0.1025,
    "operating_cash_flow_ttm": -3490000.0,
    "levered_cash_flow_ttm": -2220000.0,
    "book_value_per_share_mrq": 0.36,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "IsoRay, Inc."
  },
  "ITCI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.79,
    "ebitda": -91640000.0,
    "eps_estimate_current_year": -3.13,
    "eps_estimate_next_quarter": -0.8,
    "fifty_day_moving_average": 53.23,
    "fifty_two_week_high": 60.79,
    "fifty_two_week_low": 16.29,
    "percent_change_from_200_day_moving_average": 0.3848,
    "percent_change_from_50_day_moving_average": 0.0128,
    "shares_owned": "N/A",
    "short_ratio": 7.39,
    "two_hundred_day_moving_average": 38.93,
    "volume": 1172715.0,
    "market_cap": 2320000000.0,
    "price_to_sales_ttm": 18559.35,
    "price_to_book_mrq": 4.68,
    "roa_ttm": -0.17620000000000002,
    "roe_ttm": -0.2867,
    "shares_outstanding": 43020000.0,
    "pcnt_held_by_insiders": 0.2756,
    "pcnt_held_by_institutions": 0.441,
    "pcnt_short_of_float": 0.2066,
    "operating_cash_flow_ttm": -73430000.0,
    "levered_cash_flow_ttm": -41990000.0,
    "book_value_per_share_mrq": 11.67,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Intra-Cellular Therapies, Inc."
  },
  "ITEK": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -5.3,
    "ebitda": 0.0,
    "eps_estimate_current_year": -3.49,
    "eps_estimate_next_quarter": -0.22,
    "fifty_day_moving_average": 11.3,
    "fifty_two_week_high": 19.45,
    "fifty_two_week_low": 4.68,
    "percent_change_from_200_day_moving_average": 0.1081,
    "percent_change_from_50_day_moving_average": 0.0141,
    "shares_owned": "N/A",
    "short_ratio": 5.56,
    "two_hundred_day_moving_average": 10.34,
    "volume": 891527.0,
    "market_cap": 302660000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.65,
    "roa_ttm": -0.1349,
    "roe_ttm": -1.0668,
    "shares_outstanding": 26410000.0,
    "pcnt_held_by_insiders": 0.051699999999999996,
    "pcnt_held_by_institutions": 0.205,
    "pcnt_short_of_float": 0.1499,
    "operating_cash_flow_ttm": -13370000.0,
    "levered_cash_flow_ttm": -8029999.999999999,
    "book_value_per_share_mrq": 4.41,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Inotek Pharmaceuticals Corporation"
  },
  "IVC": {
    "p_e_ratio": "N/A",
    "peg_ratio": -2.66,
    "earnings_per_share": -1.02,
    "ebitda": 10880000.0,
    "eps_estimate_current_year": -0.67,
    "eps_estimate_next_quarter": -0.07,
    "fifty_day_moving_average": 18.7,
    "fifty_two_week_high": 23.59,
    "fifty_two_week_low": 14.0,
    "percent_change_from_200_day_moving_average": -0.0547,
    "percent_change_from_50_day_moving_average": -0.0653,
    "shares_owned": "N/A",
    "short_ratio": 7.63,
    "two_hundred_day_moving_average": 18.49,
    "volume": 325569.0,
    "market_cap": 587930000.0,
    "price_to_sales_ttm": 0.49,
    "price_to_book_mrq": 1.18,
    "roa_ttm": -0.0063,
    "roe_ttm": -0.055,
    "shares_outstanding": 32549999.999999996,
    "pcnt_held_by_insiders": 0.061200000000000004,
    "pcnt_held_by_institutions": 0.9159999999999999,
    "pcnt_short_of_float": 0.0473,
    "operating_cash_flow_ttm": -26800000.0,
    "levered_cash_flow_ttm": 18370000.0,
    "book_value_per_share_mrq": 15.08,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Invacare Corporation"
  },
  "IVTY": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.11,
    "earnings_per_share": -7.38,
    "ebitda": -29610000.0,
    "eps_estimate_current_year": -4.46,
    "eps_estimate_next_quarter": -0.6,
    "fifty_day_moving_average": 12.09,
    "fifty_two_week_high": 18.18,
    "fifty_two_week_low": 8.97,
    "percent_change_from_200_day_moving_average": -0.2354,
    "percent_change_from_50_day_moving_average": -0.1858,
    "shares_owned": "N/A",
    "short_ratio": 9.5,
    "two_hundred_day_moving_average": 12.87,
    "volume": 90940.0,
    "market_cap": 130940000.0,
    "price_to_sales_ttm": 6.73,
    "price_to_book_mrq": 2.49,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 13310000.0,
    "pcnt_held_by_insiders": 0.1043,
    "pcnt_held_by_institutions": 0.48,
    "pcnt_short_of_float": 0.027200000000000002,
    "operating_cash_flow_ttm": -27790000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 3.91,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Invuity, Inc."
  },
  "JAGX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.02,
    "earnings_per_share": -2.23,
    "ebitda": 0.0,
    "eps_estimate_current_year": -3.27,
    "eps_estimate_next_quarter": -0.56,
    "fifty_day_moving_average": 2.39,
    "fifty_two_week_high": 7.06,
    "fifty_two_week_low": 1.69,
    "percent_change_from_200_day_moving_average": -0.4183,
    "percent_change_from_50_day_moving_average": -0.1381,
    "shares_owned": "N/A",
    "short_ratio": 0.7,
    "two_hundred_day_moving_average": 3.54,
    "volume": 27345.0,
    "market_cap": 16739999.999999998,
    "price_to_sales_ttm": 89.56,
    "price_to_book_mrq": 2.17,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 8119999.999999999,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0049,
    "operating_cash_flow_ttm": -12230000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 1.03,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Jaguar Animal Health, Inc."
  },
  "JAZZ": {
    "p_e_ratio": 27.87,
    "peg_ratio": 0.83,
    "earnings_per_share": 5.02,
    "ebitda": 662320000.0,
    "eps_estimate_current_year": 9.52,
    "eps_estimate_next_quarter": 2.56,
    "fifty_day_moving_average": 141.65,
    "fifty_two_week_high": 194.73,
    "fifty_two_week_low": 117.26,
    "percent_change_from_200_day_moving_average": -0.12279999999999999,
    "percent_change_from_50_day_moving_average": -0.012,
    "shares_owned": "N/A",
    "short_ratio": 2.33,
    "two_hundred_day_moving_average": 159.55,
    "volume": 1032811.0,
    "market_cap": 8610000000.0,
    "price_to_sales_ttm": 6.51,
    "price_to_book_mrq": 5.46,
    "roa_ttm": 0.1003,
    "roe_ttm": 0.2262,
    "shares_outstanding": 61500000.0,
    "pcnt_held_by_insiders": 0.0326,
    "pcnt_held_by_institutions": 0.956,
    "pcnt_short_of_float": 0.0409,
    "operating_cash_flow_ttm": 544620000.0,
    "levered_cash_flow_ttm": 463890000.0,
    "book_value_per_share_mrq": 25.42,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Jazz Pharmaceuticals Public Limited Company"
  },
  "JNP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.06,
    "ebitda": 1990000.0,
    "eps_estimate_current_year": 0.0,
    "eps_estimate_next_quarter": 0.11,
    "fifty_day_moving_average": 11.57,
    "fifty_two_week_high": 15.44,
    "fifty_two_week_low": 5.09,
    "percent_change_from_200_day_moving_average": -0.011000000000000001,
    "percent_change_from_50_day_moving_average": -0.0658,
    "shares_owned": "N/A",
    "short_ratio": 2.99,
    "two_hundred_day_moving_average": 10.93,
    "volume": 33103.0,
    "market_cap": 116770000.0,
    "price_to_sales_ttm": 3.15,
    "price_to_book_mrq": 2.82,
    "roa_ttm": -0.0004,
    "roe_ttm": -0.0131,
    "shares_outstanding": 10800000.0,
    "pcnt_held_by_insiders": 0.0334,
    "pcnt_held_by_institutions": 0.29,
    "pcnt_short_of_float": 0.014199999999999999,
    "operating_cash_flow_ttm": 3060000.0,
    "levered_cash_flow_ttm": 2210000.0,
    "book_value_per_share_mrq": 3.86,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Juniper Pharmaceuticals, Inc."
  },
  "JUNO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -5.12,
    "ebitda": -329160000.0,
    "eps_estimate_current_year": -1.65,
    "eps_estimate_next_quarter": -0.58,
    "fifty_day_moving_average": 51.49,
    "fifty_two_week_high": 69.28,
    "fifty_two_week_low": 33.0,
    "percent_change_from_200_day_moving_average": -0.0754,
    "percent_change_from_50_day_moving_average": -0.1332,
    "shares_owned": "N/A",
    "short_ratio": 6.63,
    "two_hundred_day_moving_average": 48.27,
    "volume": 3546261.0,
    "market_cap": 4490000000.0,
    "price_to_sales_ttm": 321.32,
    "price_to_book_mrq": 3.94,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 100620000.0,
    "pcnt_held_by_insiders": 0.2662,
    "pcnt_held_by_institutions": 0.485,
    "pcnt_short_of_float": 0.1353,
    "operating_cash_flow_ttm": 6730000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 11.4,
    "next_earnings_announcement_date": [
      "2016-03-16",
      "2016-03-21"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Juno Therapeutics Inc."
  },
  "JYNT": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.18,
    "earnings_per_share": -0.87,
    "ebitda": -5500000.0,
    "eps_estimate_current_year": -0.9,
    "eps_estimate_next_quarter": -0.18,
    "fifty_day_moving_average": 5.84,
    "fifty_two_week_high": 12.99,
    "fifty_two_week_low": 4.95,
    "percent_change_from_200_day_moving_average": -0.311,
    "percent_change_from_50_day_moving_average": -0.0546,
    "shares_owned": "N/A",
    "short_ratio": 2.96,
    "two_hundred_day_moving_average": 8.01,
    "volume": 11843.0,
    "market_cap": 67230000.0,
    "price_to_sales_ttm": 4.21,
    "price_to_book_mrq": 4.68,
    "roa_ttm": -0.2475,
    "roe_ttm": -1.7328999999999999,
    "shares_outstanding": 12180000.0,
    "pcnt_held_by_insiders": 0.4179,
    "pcnt_held_by_institutions": 0.212,
    "pcnt_short_of_float": 0.0178,
    "operating_cash_flow_ttm": -4330000.0,
    "levered_cash_flow_ttm": -3060000.0,
    "book_value_per_share_mrq": 1.1,
    "next_earnings_announcement_date": [
      "2015-12-21",
      "2015-12-28"
    ],
    "sector": "Healthcare",
    "industry": "Hospitals",
    "company_name": "The Joint Corp."
  },
  "KANG": {
    "p_e_ratio": 44.85,
    "peg_ratio": 0.69,
    "earnings_per_share": 0.45,
    "ebitda": 69230000.0,
    "eps_estimate_current_year": 0.65,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 17.59,
    "fifty_two_week_high": 22.67,
    "fifty_two_week_low": 10.2,
    "percent_change_from_200_day_moving_average": 0.1977,
    "percent_change_from_50_day_moving_average": 0.1577,
    "shares_owned": "N/A",
    "short_ratio": 1.2,
    "two_hundred_day_moving_average": 17.0,
    "volume": 428027.0,
    "market_cap": 1310000000.0,
    "price_to_sales_ttm": 3.86,
    "price_to_book_mrq": 3.95,
    "roa_ttm": 0.0538,
    "roe_ttm": 0.0928,
    "shares_outstanding": 64550000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 5.08,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "iKang Healthcare Group, Inc."
  },
  "KBIO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -8.11,
    "ebitda": -30190000.0,
    "eps_estimate_current_year": -6.49,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 17.16,
    "fifty_two_week_high": 45.82,
    "fifty_two_week_low": 0.44,
    "percent_change_from_200_day_moving_average": 2.679,
    "percent_change_from_50_day_moving_average": 0.3747,
    "shares_owned": "N/A",
    "short_ratio": 0.14,
    "two_hundred_day_moving_average": 6.41,
    "volume": 0.0,
    "market_cap": 97280000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 9.31,
    "roa_ttm": -0.4409,
    "roe_ttm": -1.29,
    "shares_outstanding": 4120000.0,
    "pcnt_held_by_insiders": 0.001,
    "pcnt_held_by_institutions": 0.278,
    "pcnt_short_of_float": 0.15789999999999998,
    "operating_cash_flow_ttm": -30110000.0,
    "levered_cash_flow_ttm": -17430000.0,
    "book_value_per_share_mrq": 2.53,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "KaloBios Pharmaceuticals, Inc."
  },
  "KERX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.04,
    "earnings_per_share": -1.25,
    "ebitda": -119700000.0,
    "eps_estimate_current_year": -1.07,
    "eps_estimate_next_quarter": -0.17,
    "fifty_day_moving_average": 5.06,
    "fifty_two_week_high": 15.13,
    "fifty_two_week_low": 3.04,
    "percent_change_from_200_day_moving_average": -0.158,
    "percent_change_from_50_day_moving_average": 0.0642,
    "shares_owned": "N/A",
    "short_ratio": 16.48,
    "two_hundred_day_moving_average": 6.39,
    "volume": 11125256.0,
    "market_cap": 565940000.0,
    "price_to_sales_ttm": 60.26,
    "price_to_book_mrq": 4.21,
    "roa_ttm": -0.5339,
    "roe_ttm": -1.1434,
    "shares_outstanding": 105190000.0,
    "pcnt_held_by_insiders": 0.2659,
    "pcnt_held_by_institutions": 0.615,
    "pcnt_short_of_float": 0.30820000000000003,
    "operating_cash_flow_ttm": -136470000.0,
    "levered_cash_flow_ttm": -88060000.0,
    "book_value_per_share_mrq": 1.15,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Keryx Biopharmaceuticals Inc."
  },
  "KIN": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.17,
    "earnings_per_share": -1.39,
    "ebitda": -27480000.0,
    "eps_estimate_current_year": -1.49,
    "eps_estimate_next_quarter": -0.34,
    "fifty_day_moving_average": 4.38,
    "fifty_two_week_high": 7.91,
    "fifty_two_week_low": 3.15,
    "percent_change_from_200_day_moving_average": -0.3236,
    "percent_change_from_50_day_moving_average": -0.1081,
    "shares_owned": "N/A",
    "short_ratio": 1.55,
    "two_hundred_day_moving_average": 5.78,
    "volume": 68436.0,
    "market_cap": 77450000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 0.93,
    "roa_ttm": -0.17980000000000002,
    "roe_ttm": -0.2948,
    "shares_outstanding": 19810000.0,
    "pcnt_held_by_insiders": 0.1597,
    "pcnt_held_by_institutions": 0.609,
    "pcnt_short_of_float": 0.0166,
    "operating_cash_flow_ttm": -22360000.0,
    "levered_cash_flow_ttm": -12840000.0,
    "book_value_per_share_mrq": 4.13,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Kindred Biosciences, Inc."
  },
  "KITE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.81,
    "ebitda": -75530000.0,
    "eps_estimate_current_year": -2.16,
    "eps_estimate_next_quarter": -0.9,
    "fifty_day_moving_average": 75.34,
    "fifty_two_week_high": 89.84,
    "fifty_two_week_low": 44.01,
    "percent_change_from_200_day_moving_average": -0.0424,
    "percent_change_from_50_day_moving_average": -0.1634,
    "shares_owned": "N/A",
    "short_ratio": 5.52,
    "two_hundred_day_moving_average": 65.82,
    "volume": 1293806.0,
    "market_cap": 3000000000.0,
    "price_to_sales_ttm": 228.1,
    "price_to_book_mrq": 7.75,
    "roa_ttm": -0.1512,
    "roe_ttm": -0.2752,
    "shares_outstanding": 47610000.0,
    "pcnt_held_by_insiders": 0.3086,
    "pcnt_held_by_institutions": 0.684,
    "pcnt_short_of_float": 0.2071,
    "operating_cash_flow_ttm": 2240000.0,
    "levered_cash_flow_ttm": -18730000.0,
    "book_value_per_share_mrq": 8.24,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Kite Pharma, Inc."
  },
  "KMDA": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.66,
    "earnings_per_share": -0.31,
    "ebitda": -4420000.0,
    "eps_estimate_current_year": -0.42,
    "eps_estimate_next_quarter": -0.05,
    "fifty_day_moving_average": 4.09,
    "fifty_two_week_high": 5.15,
    "fifty_two_week_low": 3.19,
    "percent_change_from_200_day_moving_average": 0.08460000000000001,
    "percent_change_from_50_day_moving_average": 0.0216,
    "shares_owned": "N/A",
    "short_ratio": 0.69,
    "two_hundred_day_moving_average": 3.85,
    "volume": 0.0,
    "market_cap": 148610000.0,
    "price_to_sales_ttm": 2.15,
    "price_to_book_mrq": 2.09,
    "roa_ttm": -0.0405,
    "roe_ttm": -0.1482,
    "shares_outstanding": 35550000.0,
    "pcnt_held_by_insiders": 0.049699999999999994,
    "pcnt_held_by_institutions": 0.065,
    "pcnt_short_of_float": 0.0002,
    "operating_cash_flow_ttm": -7860000.0,
    "levered_cash_flow_ttm": -4190000.0000000005,
    "book_value_per_share_mrq": 2.0,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Kamada Ltd."
  },
  "KMPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -4.32,
    "ebitda": -22940000.0,
    "eps_estimate_current_year": -3.97,
    "eps_estimate_next_quarter": -0.45,
    "fifty_day_moving_average": 16.48,
    "fifty_two_week_high": 26.15,
    "fifty_two_week_low": 10.9,
    "percent_change_from_200_day_moving_average": 0.08449999999999999,
    "percent_change_from_50_day_moving_average": 0.1718,
    "shares_owned": "N/A",
    "short_ratio": 4.33,
    "two_hundred_day_moving_average": 17.81,
    "volume": 452140.0,
    "market_cap": 279010000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.3469,
    "roe_ttm": -4.6132,
    "shares_outstanding": 14450000.0,
    "pcnt_held_by_insiders": 0.17670000000000002,
    "pcnt_held_by_institutions": 0.414,
    "pcnt_short_of_float": 0.0176,
    "operating_cash_flow_ttm": -20830000.0,
    "levered_cash_flow_ttm": -13880000.0,
    "book_value_per_share_mrq": -0.4,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "KemPharm, Inc."
  },
  "KND": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.75,
    "earnings_per_share": -2.36,
    "ebitda": 504000000.0,
    "eps_estimate_current_year": 1.21,
    "eps_estimate_next_quarter": 0.3,
    "fifty_day_moving_average": 12.74,
    "fifty_two_week_high": 24.66,
    "fifty_two_week_low": 11.12,
    "percent_change_from_200_day_moving_average": -0.3333,
    "percent_change_from_50_day_moving_average": -0.0788,
    "shares_owned": "N/A",
    "short_ratio": 3.22,
    "two_hundred_day_moving_average": 17.61,
    "volume": 3181314.0,
    "market_cap": 983780000.0,
    "price_to_sales_ttm": 0.16,
    "price_to_book_mrq": 0.73,
    "roa_ttm": 0.0414,
    "roe_ttm": -0.07629999999999999,
    "shares_outstanding": 83800000.0,
    "pcnt_held_by_insiders": 0.020099999999999996,
    "pcnt_held_by_institutions": 0.978,
    "pcnt_short_of_float": 0.0623,
    "operating_cash_flow_ttm": 174220000.0,
    "levered_cash_flow_ttm": 235210000.0,
    "book_value_per_share_mrq": 17.39,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "Kindred Healthcare Inc."
  },
  "KOOL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.37,
    "ebitda": -13740000.0,
    "eps_estimate_current_year": -0.31,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 0.43,
    "fifty_two_week_high": 1.14,
    "fifty_two_week_low": 0.22,
    "percent_change_from_200_day_moving_average": -0.634,
    "percent_change_from_50_day_moving_average": -0.4619,
    "shares_owned": "N/A",
    "short_ratio": 1.72,
    "two_hundred_day_moving_average": 0.63,
    "volume": 235496.0,
    "market_cap": 9350000.0,
    "price_to_sales_ttm": 0.64,
    "price_to_book_mrq": 0.3,
    "roa_ttm": -0.1703,
    "roe_ttm": -0.38409999999999994,
    "shares_outstanding": 40670000.0,
    "pcnt_held_by_insiders": 0.2939,
    "pcnt_held_by_institutions": 0.139,
    "pcnt_short_of_float": 0.0109,
    "operating_cash_flow_ttm": -8270000.0,
    "levered_cash_flow_ttm": -967250.0,
    "book_value_per_share_mrq": 0.79,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Cesca Therapeutics Inc."
  },
  "KPTI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.3,
    "earnings_per_share": -3.3,
    "ebitda": -115130000.0,
    "eps_estimate_current_year": -3.35,
    "eps_estimate_next_quarter": -0.87,
    "fifty_day_moving_average": 15.85,
    "fifty_two_week_high": 39.68,
    "fifty_two_week_low": 10.0,
    "percent_change_from_200_day_moving_average": -0.2484,
    "percent_change_from_50_day_moving_average": -0.15,
    "shares_owned": "N/A",
    "short_ratio": 14.43,
    "two_hundred_day_moving_average": 17.92,
    "volume": 442819.0,
    "market_cap": 481310000.0,
    "price_to_sales_ttm": 2042.69,
    "price_to_book_mrq": 2.22,
    "roa_ttm": -0.3064,
    "roe_ttm": -0.5132,
    "shares_outstanding": 35730000.0,
    "pcnt_held_by_insiders": 0.4289,
    "pcnt_held_by_institutions": 0.638,
    "pcnt_short_of_float": 0.3147,
    "operating_cash_flow_ttm": -86420000.0,
    "levered_cash_flow_ttm": -47130000.0,
    "book_value_per_share_mrq": 6.18,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Karyopharm Therapeutics, Inc."
  },
  "KTOV": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -7.94,
    "ebitda": 0.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 3.85,
    "fifty_two_week_low": 3.38,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 0.03,
    "two_hundred_day_moving_average": 0.0,
    "volume": 445986.0,
    "market_cap": 2410000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 18.75,
    "roa_ttm": -1.0473000000000001,
    "roe_ttm": -3.9925,
    "shares_outstanding": 647000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -3380000.0,
    "levered_cash_flow_ttm": -2330000.0,
    "book_value_per_share_mrq": 0.2,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Kitov Pharmaceuticals Holdings LTD"
  },
  "KTWO": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.98,
    "earnings_per_share": -1.07,
    "ebitda": -12860000.0,
    "eps_estimate_current_year": -0.99,
    "eps_estimate_next_quarter": -0.19,
    "fifty_day_moving_average": 19.82,
    "fifty_two_week_high": 26.29,
    "fifty_two_week_low": 16.4,
    "percent_change_from_200_day_moving_average": -0.0904,
    "percent_change_from_50_day_moving_average": -0.0239,
    "shares_owned": "N/A",
    "short_ratio": 4.65,
    "two_hundred_day_moving_average": 21.27,
    "volume": 154404.0,
    "market_cap": 797780000.0,
    "price_to_sales_ttm": 3.83,
    "price_to_book_mrq": 2.74,
    "roa_ttm": -0.0712,
    "roe_ttm": -0.1501,
    "shares_outstanding": 41230000.0,
    "pcnt_held_by_insiders": 0.5039,
    "pcnt_held_by_institutions": 0.47,
    "pcnt_short_of_float": 0.04,
    "operating_cash_flow_ttm": -14830000.0,
    "levered_cash_flow_ttm": -5610000.0,
    "book_value_per_share_mrq": 7.09,
    "next_earnings_announcement_date": [
      "2016-03-16",
      "2016-03-21"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "K2M Group Holdings, Inc."
  },
  "KURA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -77.94,
    "ebitda": -11800000.0,
    "eps_estimate_current_year": -2.6,
    "eps_estimate_next_quarter": -0.69,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 8.39,
    "fifty_two_week_low": 7.14,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 0.43,
    "two_hundred_day_moving_average": 0.0,
    "volume": 219913.0,
    "market_cap": 164980000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.32,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 21370000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -2550000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 3.46,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Kura Oncology, Inc."
  },
  "LAKE": {
    "p_e_ratio": 5.0,
    "peg_ratio": 0.87,
    "earnings_per_share": 2.28,
    "ebitda": 15540000.0,
    "eps_estimate_current_year": 1.31,
    "eps_estimate_next_quarter": 0.24,
    "fifty_day_moving_average": 13.32,
    "fifty_two_week_high": 15.78,
    "fifty_two_week_low": 7.78,
    "percent_change_from_200_day_moving_average": -0.0466,
    "percent_change_from_50_day_moving_average": -0.1454,
    "shares_owned": "N/A",
    "short_ratio": 5.61,
    "two_hundred_day_moving_average": 11.94,
    "volume": 205372.0,
    "market_cap": 82400000.0,
    "price_to_sales_ttm": 0.74,
    "price_to_book_mrq": 1.19,
    "roa_ttm": 0.1005,
    "roe_ttm": 0.2751,
    "shares_outstanding": 7240000.0,
    "pcnt_held_by_insiders": 0.1018,
    "pcnt_held_by_institutions": 0.35,
    "pcnt_short_of_float": 0.0687,
    "operating_cash_flow_ttm": -3610000.0,
    "levered_cash_flow_ttm": 909880.0,
    "book_value_per_share_mrq": 9.58,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Lakeland Industries Inc."
  },
  "LBIO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.61,
    "ebitda": -23520000.0,
    "eps_estimate_current_year": -0.62,
    "eps_estimate_next_quarter": -0.1,
    "fifty_day_moving_average": 7.2,
    "fifty_two_week_high": 15.03,
    "fifty_two_week_low": 5.27,
    "percent_change_from_200_day_moving_average": -0.013000000000000001,
    "percent_change_from_50_day_moving_average": 0.06570000000000001,
    "shares_owned": "N/A",
    "short_ratio": 13.11,
    "two_hundred_day_moving_average": 7.77,
    "volume": 1805167.0,
    "market_cap": 366890000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.45,
    "roa_ttm": -0.23399999999999999,
    "roe_ttm": -0.3848,
    "shares_outstanding": 47830000.0,
    "pcnt_held_by_insiders": 0.12960000000000002,
    "pcnt_held_by_institutions": 0.778,
    "pcnt_short_of_float": 0.15810000000000002,
    "operating_cash_flow_ttm": -15120000.0,
    "levered_cash_flow_ttm": -8570000.0,
    "book_value_per_share_mrq": 2.29,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Lion Biotechnologies, Inc."
  },
  "LBMH": {
    "p_e_ratio": 24.23,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.14,
    "ebitda": 13070000.0,
    "eps_estimate_current_year": 0.17,
    "eps_estimate_next_quarter": 0.04,
    "fifty_day_moving_average": 3.01,
    "fifty_two_week_high": 3.9,
    "fifty_two_week_low": 1.96,
    "percent_change_from_200_day_moving_average": 0.2789,
    "percent_change_from_50_day_moving_average": 0.1038,
    "shares_owned": "N/A",
    "short_ratio": 0.67,
    "two_hundred_day_moving_average": 2.6,
    "volume": 173788.0,
    "market_cap": 178900000.0,
    "price_to_sales_ttm": 2.21,
    "price_to_book_mrq": 5.31,
    "roa_ttm": 0.13419999999999999,
    "roe_ttm": 0.221,
    "shares_outstanding": 53890000.0,
    "pcnt_held_by_insiders": 0.3981,
    "pcnt_held_by_institutions": 0.281,
    "pcnt_short_of_float": 0.0143,
    "operating_cash_flow_ttm": 3700000.0,
    "levered_cash_flow_ttm": 17690000.0,
    "book_value_per_share_mrq": 0.63,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Liberator Medical Holdings, Inc."
  },
  "LCI": {
    "p_e_ratio": 10.31,
    "peg_ratio": 0.74,
    "earnings_per_share": 3.99,
    "ebitda": 237320000.0,
    "eps_estimate_current_year": 3.94,
    "eps_estimate_next_quarter": 1.01,
    "fifty_day_moving_average": 38.77,
    "fifty_two_week_high": 72.44,
    "fifty_two_week_low": 33.13,
    "percent_change_from_200_day_moving_average": -0.1746,
    "percent_change_from_50_day_moving_average": 0.061200000000000004,
    "shares_owned": "N/A",
    "short_ratio": 8.72,
    "two_hundred_day_moving_average": 49.84,
    "volume": 1698724.0,
    "market_cap": 1500000000.0,
    "price_to_sales_ttm": 3.54,
    "price_to_book_mrq": 2.95,
    "roa_ttm": 0.3151,
    "roe_ttm": 0.3553,
    "shares_outstanding": 36540000.0,
    "pcnt_held_by_insiders": 0.2591,
    "pcnt_held_by_institutions": 0.674,
    "pcnt_short_of_float": 0.3799,
    "operating_cash_flow_ttm": 129979999.99999999,
    "levered_cash_flow_ttm": 89090000.0,
    "book_value_per_share_mrq": 13.79,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Lannett Company, Inc."
  },
  "LDRH": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.99,
    "earnings_per_share": -0.53,
    "ebitda": -13290000.0,
    "eps_estimate_current_year": -0.58,
    "eps_estimate_next_quarter": -0.14,
    "fifty_day_moving_average": 25.16,
    "fifty_two_week_high": 47.12,
    "fifty_two_week_low": 20.95,
    "percent_change_from_200_day_moving_average": -0.3218,
    "percent_change_from_50_day_moving_average": -0.0455,
    "shares_owned": "N/A",
    "short_ratio": 5.66,
    "two_hundred_day_moving_average": 35.42,
    "volume": 896278.0,
    "market_cap": 697660000.0,
    "price_to_sales_ttm": 4.23,
    "price_to_book_mrq": 3.5,
    "roa_ttm": -0.0623,
    "roe_ttm": -0.0949,
    "shares_outstanding": 29040000.0,
    "pcnt_held_by_insiders": 0.10769999999999999,
    "pcnt_held_by_institutions": 0.8909999999999999,
    "pcnt_short_of_float": 0.07490000000000001,
    "operating_cash_flow_ttm": -15630000.0,
    "levered_cash_flow_ttm": -18710000.0,
    "book_value_per_share_mrq": 6.59,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "LDR Holding Corporation"
  },
  "LENS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.49,
    "ebitda": -20420000.0,
    "eps_estimate_current_year": -1.59,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 5.06,
    "fifty_two_week_high": 9.38,
    "fifty_two_week_low": 3.62,
    "percent_change_from_200_day_moving_average": -0.0275,
    "percent_change_from_50_day_moving_average": 0.2181,
    "shares_owned": "N/A",
    "short_ratio": 2.79,
    "two_hundred_day_moving_average": 6.33,
    "volume": 337161.0,
    "market_cap": 82270000.0,
    "price_to_sales_ttm": 472.94,
    "price_to_book_mrq": 3.06,
    "roa_ttm": -0.9027,
    "roe_ttm": -9.687899999999999,
    "shares_outstanding": 13360000.0,
    "pcnt_held_by_insiders": 0.6873,
    "pcnt_held_by_institutions": 0.256,
    "pcnt_short_of_float": 0.027200000000000002,
    "operating_cash_flow_ttm": -14230000.0,
    "levered_cash_flow_ttm": -11660000.0,
    "book_value_per_share_mrq": 1.87,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Presbia PLC"
  },
  "LGND": {
    "p_e_ratio": 9.05,
    "peg_ratio": 0.71,
    "earnings_per_share": 12.15,
    "ebitda": 29900000.0,
    "eps_estimate_current_year": 3.36,
    "eps_estimate_next_quarter": 0.53,
    "fifty_day_moving_average": 102.63,
    "fifty_two_week_high": 114.0,
    "fifty_two_week_low": 49.65,
    "percent_change_from_200_day_moving_average": 0.1338,
    "percent_change_from_50_day_moving_average": 0.0722,
    "shares_owned": "N/A",
    "short_ratio": 10.74,
    "two_hundred_day_moving_average": 97.05,
    "volume": 684713.0,
    "market_cap": 2190000000.0,
    "price_to_sales_ttm": 30.23,
    "price_to_book_mrq": 7.62,
    "roa_ttm": 0.043,
    "roe_ttm": 1.5119,
    "shares_outstanding": 19930000.0,
    "pcnt_held_by_insiders": 0.0062,
    "pcnt_held_by_institutions": 1.053,
    "pcnt_short_of_float": 0.245,
    "operating_cash_flow_ttm": 38310000.0,
    "levered_cash_flow_ttm": 16399999.999999998,
    "book_value_per_share_mrq": 14.67,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ligand Pharmaceuticals Incorporated"
  },
  "LHCG": {
    "p_e_ratio": 26.58,
    "peg_ratio": 1.67,
    "earnings_per_share": 1.72,
    "ebitda": 77530000.0,
    "eps_estimate_current_year": 1.86,
    "eps_estimate_next_quarter": 0.5,
    "fifty_day_moving_average": 46.08,
    "fifty_two_week_high": 51.83,
    "fifty_two_week_low": 27.51,
    "percent_change_from_200_day_moving_average": 0.0479,
    "percent_change_from_50_day_moving_average": -0.0075,
    "shares_owned": "N/A",
    "short_ratio": 3.39,
    "two_hundred_day_moving_average": 43.65,
    "volume": 528069.0,
    "market_cap": 821950000.0,
    "price_to_sales_ttm": 1.08,
    "price_to_book_mrq": 2.34,
    "roa_ttm": 0.07769999999999999,
    "roe_ttm": 0.1142,
    "shares_outstanding": 17970000.0,
    "pcnt_held_by_insiders": 0.23800000000000002,
    "pcnt_held_by_institutions": 0.6970000000000001,
    "pcnt_short_of_float": 0.036000000000000004,
    "operating_cash_flow_ttm": 56830000.0,
    "levered_cash_flow_ttm": 31690000.0,
    "book_value_per_share_mrq": 19.85,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Home Health Care",
    "company_name": "LHC Group, Inc."
  },
  "LIFE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.7,
    "ebitda": -36310000.0,
    "eps_estimate_current_year": -5.58,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 9.61,
    "fifty_two_week_high": 28.29,
    "fifty_two_week_low": 7.37,
    "percent_change_from_200_day_moving_average": -0.3191,
    "percent_change_from_50_day_moving_average": 0.047400000000000005,
    "shares_owned": "N/A",
    "short_ratio": 9.66,
    "two_hundred_day_moving_average": 14.79,
    "volume": 786040.0,
    "market_cap": 238140000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.86,
    "roa_ttm": -0.2763,
    "roe_ttm": -0.5407,
    "shares_outstanding": 23650000.0,
    "pcnt_held_by_insiders": 0.0943,
    "pcnt_held_by_institutions": 0.608,
    "pcnt_short_of_float": 0.049100000000000005,
    "operating_cash_flow_ttm": -32759999.999999996,
    "levered_cash_flow_ttm": -21400000.0,
    "book_value_per_share_mrq": 5.46,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "aTyr Pharma Inc."
  },
  "LJPC": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.77,
    "earnings_per_share": -2.43,
    "ebitda": -36510000.0,
    "eps_estimate_current_year": -2.72,
    "eps_estimate_next_quarter": -0.72,
    "fifty_day_moving_average": 29.02,
    "fifty_two_week_high": 44.99,
    "fifty_two_week_low": 14.12,
    "percent_change_from_200_day_moving_average": -0.045,
    "percent_change_from_50_day_moving_average": -0.0626,
    "shares_owned": "N/A",
    "short_ratio": 6.48,
    "two_hundred_day_moving_average": 28.48,
    "volume": 823443.0,
    "market_cap": 496170000.0,
    "price_to_sales_ttm": 782.64,
    "price_to_book_mrq": 3.99,
    "roa_ttm": -0.2386,
    "roe_ttm": -0.3962,
    "shares_outstanding": 18240000.0,
    "pcnt_held_by_insiders": 0.2418,
    "pcnt_held_by_institutions": 0.5,
    "pcnt_short_of_float": 0.121,
    "operating_cash_flow_ttm": -22110000.0,
    "levered_cash_flow_ttm": -9930000.0,
    "book_value_per_share_mrq": 6.96,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "La Jolla Pharmaceutical Co."
  },
  "LMAT": {
    "p_e_ratio": 41.69,
    "peg_ratio": 2.7,
    "earnings_per_share": 0.4,
    "ebitda": 14010000.0,
    "eps_estimate_current_year": 0.37,
    "eps_estimate_next_quarter": 0.1,
    "fifty_day_moving_average": 14.91,
    "fifty_two_week_high": 16.86,
    "fifty_two_week_low": 7.17,
    "percent_change_from_200_day_moving_average": 0.2668,
    "percent_change_from_50_day_moving_average": 0.10980000000000001,
    "shares_owned": "N/A",
    "short_ratio": 3.27,
    "two_hundred_day_moving_average": 13.06,
    "volume": 324785.0,
    "market_cap": 299820000.0,
    "price_to_sales_ttm": 3.82,
    "price_to_book_mrq": 3.89,
    "roa_ttm": 0.0779,
    "roe_ttm": 0.1011,
    "shares_outstanding": 18120000.0,
    "pcnt_held_by_insiders": 0.34119999999999995,
    "pcnt_held_by_institutions": 0.539,
    "pcnt_short_of_float": 0.0405,
    "operating_cash_flow_ttm": 10190000.0,
    "levered_cash_flow_ttm": 6450000.0,
    "book_value_per_share_mrq": 4.11,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "LeMaitre Vascular, Inc."
  },
  "LMNX": {
    "p_e_ratio": 23.16,
    "peg_ratio": 0.89,
    "earnings_per_share": 0.93,
    "ebitda": 52990000.0,
    "eps_estimate_current_year": 0.55,
    "eps_estimate_next_quarter": 0.14,
    "fifty_day_moving_average": 21.22,
    "fifty_two_week_high": 22.85,
    "fifty_two_week_low": 15.05,
    "percent_change_from_200_day_moving_average": 0.1482,
    "percent_change_from_50_day_moving_average": 0.0129,
    "shares_owned": "N/A",
    "short_ratio": 15.47,
    "two_hundred_day_moving_average": 18.72,
    "volume": 1027883.0,
    "market_cap": 925400000.0,
    "price_to_sales_ttm": 4.02,
    "price_to_book_mrq": 2.7,
    "roa_ttm": 0.0707,
    "roe_ttm": 0.1233,
    "shares_outstanding": 43060000.0,
    "pcnt_held_by_insiders": 0.08310000000000001,
    "pcnt_held_by_institutions": 0.768,
    "pcnt_short_of_float": 0.13419999999999999,
    "operating_cash_flow_ttm": 58450000.0,
    "levered_cash_flow_ttm": 28850000.0,
    "book_value_per_share_mrq": 8.12,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Luminex Corporation"
  },
  "LNTH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.15,
    "earnings_per_share": -0.86,
    "ebitda": 62030000.0,
    "eps_estimate_current_year": 0.44,
    "eps_estimate_next_quarter": 0.14,
    "fifty_day_moving_average": 3.63,
    "fifty_two_week_high": 8.58,
    "fifty_two_week_low": 2.56,
    "percent_change_from_200_day_moving_average": -0.3362,
    "percent_change_from_50_day_moving_average": -0.027999999999999997,
    "shares_owned": "N/A",
    "short_ratio": 3.53,
    "two_hundred_day_moving_average": 5.32,
    "volume": 225414.0,
    "market_cap": 111100000.0,
    "price_to_sales_ttm": 0.37,
    "price_to_book_mrq": "N/A",
    "roa_ttm": 0.10550000000000001,
    "roe_ttm": "N/A",
    "shares_outstanding": 31470000.0,
    "pcnt_held_by_insiders": 0.0273,
    "pcnt_held_by_institutions": 0.385,
    "pcnt_short_of_float": 0.0242,
    "operating_cash_flow_ttm": 5260000.0,
    "levered_cash_flow_ttm": -6240000.0,
    "book_value_per_share_mrq": -6.26,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Lantheus Holdings, Inc."
  },
  "LOXO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.82,
    "ebitda": -30230000.0,
    "eps_estimate_current_year": -1.96,
    "eps_estimate_next_quarter": -0.48,
    "fifty_day_moving_average": 29.04,
    "fifty_two_week_high": 35.0,
    "fifty_two_week_low": 9.9,
    "percent_change_from_200_day_moving_average": 0.4628,
    "percent_change_from_50_day_moving_average": 0.0998,
    "shares_owned": "N/A",
    "short_ratio": 3.03,
    "two_hundred_day_moving_average": 21.83,
    "volume": 455336.0,
    "market_cap": 612850000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 5.59,
    "roa_ttm": -0.1746,
    "roe_ttm": -0.2826,
    "shares_outstanding": 19190000.0,
    "pcnt_held_by_insiders": 0.1709,
    "pcnt_held_by_institutions": 0.879,
    "pcnt_short_of_float": 0.0904,
    "operating_cash_flow_ttm": -25100000.0,
    "levered_cash_flow_ttm": -14100000.0,
    "book_value_per_share_mrq": 5.63,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Loxo Oncology, Inc."
  },
  "LPCN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.17,
    "ebitda": -15160000.0,
    "eps_estimate_current_year": -1.12,
    "eps_estimate_next_quarter": -0.25,
    "fifty_day_moving_average": 12.38,
    "fifty_two_week_high": 19.23,
    "fifty_two_week_low": 4.93,
    "percent_change_from_200_day_moving_average": 0.066,
    "percent_change_from_50_day_moving_average": 0.0504,
    "shares_owned": "N/A",
    "short_ratio": 3.0,
    "two_hundred_day_moving_average": 12.19,
    "volume": 116934.0,
    "market_cap": 237300000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.94,
    "roa_ttm": -0.23600000000000002,
    "roe_ttm": -0.4623,
    "shares_outstanding": 18250000.0,
    "pcnt_held_by_insiders": 0.1594,
    "pcnt_held_by_institutions": 0.49200000000000005,
    "pcnt_short_of_float": 0.0839,
    "operating_cash_flow_ttm": -16410000.0,
    "levered_cash_flow_ttm": -8440000.0,
    "book_value_per_share_mrq": 2.54,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Lipocine Inc."
  },
  "LPNT": {
    "p_e_ratio": 21.18,
    "peg_ratio": 1.86,
    "earnings_per_share": 3.28,
    "ebitda": 649900000.0,
    "eps_estimate_current_year": 4.02,
    "eps_estimate_next_quarter": 1.07,
    "fifty_day_moving_average": 70.76,
    "fifty_two_week_high": 88.18,
    "fifty_two_week_low": 58.61,
    "percent_change_from_200_day_moving_average": -0.09210000000000002,
    "percent_change_from_50_day_moving_average": -0.0191,
    "shares_owned": "N/A",
    "short_ratio": 4.38,
    "two_hundred_day_moving_average": 76.45,
    "volume": 775530.0,
    "market_cap": 3020000000.0,
    "price_to_sales_ttm": 0.59,
    "price_to_book_mrq": 1.36,
    "roa_ttm": 0.0417,
    "roe_ttm": 0.0703,
    "shares_outstanding": 43530000.0,
    "pcnt_held_by_insiders": 0.0189,
    "pcnt_held_by_institutions": 0.9490000000000001,
    "pcnt_short_of_float": 0.047400000000000005,
    "operating_cash_flow_ttm": 646700000.0,
    "levered_cash_flow_ttm": 377880000.0,
    "book_value_per_share_mrq": 51.4,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Hospitals",
    "company_name": "LifePoint Health, Inc."
  },
  "LPTN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.63,
    "ebitda": -15020000.0,
    "eps_estimate_current_year": 2.03,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.22,
    "fifty_two_week_high": 3.75,
    "fifty_two_week_low": 0.16,
    "percent_change_from_200_day_moving_average": -0.08839999999999999,
    "percent_change_from_50_day_moving_average": -0.0204,
    "shares_owned": "N/A",
    "short_ratio": 0.38,
    "two_hundred_day_moving_average": 0.24,
    "volume": 187491.0,
    "market_cap": 7130000.0,
    "price_to_sales_ttm": 2.9,
    "price_to_book_mrq": 0.57,
    "roa_ttm": -0.4675,
    "roe_ttm": -0.8222,
    "shares_outstanding": 32409999.999999996,
    "pcnt_held_by_insiders": 0.1452,
    "pcnt_held_by_institutions": 0.026000000000000002,
    "pcnt_short_of_float": 0.0175,
    "operating_cash_flow_ttm": -11860000.0,
    "levered_cash_flow_ttm": -6480000.0,
    "book_value_per_share_mrq": 0.39,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Lpath Inc."
  },
  "LXRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.18,
    "earnings_per_share": -0.95,
    "ebitda": -75470000.0,
    "eps_estimate_current_year": -0.78,
    "eps_estimate_next_quarter": 0.07,
    "fifty_day_moving_average": 12.77,
    "fifty_two_week_high": 15.79,
    "fifty_two_week_low": 6.02,
    "percent_change_from_200_day_moving_average": 0.2155,
    "percent_change_from_50_day_moving_average": 0.0426,
    "shares_owned": "N/A",
    "short_ratio": 13.74,
    "two_hundred_day_moving_average": 10.95,
    "volume": 3542075.0,
    "market_cap": 1380000000.0,
    "price_to_sales_ttm": 55.59,
    "price_to_book_mrq": 6.8,
    "roa_ttm": -0.1649,
    "roe_ttm": -0.6844,
    "shares_outstanding": 103620000.0,
    "pcnt_held_by_insiders": 0.0629,
    "pcnt_held_by_institutions": 0.9520000000000001,
    "pcnt_short_of_float": 0.5328,
    "operating_cash_flow_ttm": -85610000.0,
    "levered_cash_flow_ttm": -37120000.0,
    "book_value_per_share_mrq": 1.91,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Lexicon Pharmaceuticals, Inc."
  },
  "MACK": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.24,
    "earnings_per_share": -1.01,
    "ebitda": -87250000.0,
    "eps_estimate_current_year": -1.14,
    "eps_estimate_next_quarter": -0.4,
    "fifty_day_moving_average": 8.85,
    "fifty_two_week_high": 13.84,
    "fifty_two_week_low": 7.21,
    "percent_change_from_200_day_moving_average": -0.20920000000000002,
    "percent_change_from_50_day_moving_average": -0.1018,
    "shares_owned": "N/A",
    "short_ratio": 16.96,
    "two_hundred_day_moving_average": 10.05,
    "volume": 3604230.0,
    "market_cap": 918810000.0,
    "price_to_sales_ttm": 9.19,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.3947,
    "roe_ttm": "N/A",
    "shares_outstanding": 115570000.0,
    "pcnt_held_by_insiders": 0.1051,
    "pcnt_held_by_institutions": 0.6970000000000001,
    "pcnt_short_of_float": 0.2484,
    "operating_cash_flow_ttm": -133729999.99999999,
    "levered_cash_flow_ttm": -69080000.0,
    "book_value_per_share_mrq": -1.23,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Merrimack Pharmaceuticals, Inc."
  },
  "MASI": {
    "p_e_ratio": 27.73,
    "peg_ratio": 1.68,
    "earnings_per_share": 1.49,
    "ebitda": 130750000.0,
    "eps_estimate_current_year": 1.49,
    "eps_estimate_next_quarter": 0.4,
    "fifty_day_moving_average": 41.53,
    "fifty_two_week_high": 46.0,
    "fifty_two_week_low": 25.12,
    "percent_change_from_200_day_moving_average": 0.025099999999999997,
    "percent_change_from_50_day_moving_average": -0.0025,
    "shares_owned": "N/A",
    "short_ratio": 4.72,
    "two_hundred_day_moving_average": 40.41,
    "volume": 1176063.0,
    "market_cap": 2080000000.0,
    "price_to_sales_ttm": 3.4,
    "price_to_book_mrq": 7.81,
    "roa_ttm": 0.1306,
    "roe_ttm": 0.2833,
    "shares_outstanding": 50290000.0,
    "pcnt_held_by_insiders": 0.1016,
    "pcnt_held_by_institutions": 0.838,
    "pcnt_short_of_float": 0.0347,
    "operating_cash_flow_ttm": 82130000.0,
    "levered_cash_flow_ttm": 28790000.0,
    "book_value_per_share_mrq": 5.35,
    "next_earnings_announcement_date": [
      "2016-02-15",
      "2016-02-19"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Masimo Corporation"
  },
  "MCRB": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.38,
    "earnings_per_share": -2.83,
    "ebitda": -41810000.0,
    "eps_estimate_current_year": -2.2,
    "eps_estimate_next_quarter": -0.44,
    "fifty_day_moving_average": 34.21,
    "fifty_two_week_high": 52.0,
    "fifty_two_week_low": 25.0,
    "percent_change_from_200_day_moving_average": 0.1094,
    "percent_change_from_50_day_moving_average": 0.2009,
    "shares_owned": "N/A",
    "short_ratio": 21.58,
    "two_hundred_day_moving_average": 37.04,
    "volume": 1324551.0,
    "market_cap": 1600000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 7.47,
    "roa_ttm": -0.2243,
    "roe_ttm": -0.38280000000000003,
    "shares_outstanding": 39060000.0,
    "pcnt_held_by_insiders": 0.18719999999999998,
    "pcnt_held_by_institutions": 0.298,
    "pcnt_short_of_float": 0.2299,
    "operating_cash_flow_ttm": -33390000.0,
    "levered_cash_flow_ttm": -20720000.0,
    "book_value_per_share_mrq": 5.69,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Seres Therapeutics, Inc."
  },
  "MCUR": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.03,
    "earnings_per_share": -1.48,
    "ebitda": -26400000.0,
    "eps_estimate_current_year": -1.32,
    "eps_estimate_next_quarter": -0.22,
    "fifty_day_moving_average": 1.39,
    "fifty_two_week_high": 16.1,
    "fifty_two_week_low": 0.85,
    "percent_change_from_200_day_moving_average": -0.8258,
    "percent_change_from_50_day_moving_average": -0.1367,
    "shares_owned": "N/A",
    "short_ratio": 0.09,
    "two_hundred_day_moving_average": 6.89,
    "volume": 166801.0,
    "market_cap": 20470000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 0.74,
    "roa_ttm": -0.3876,
    "roe_ttm": -0.6578,
    "shares_outstanding": 17060000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.028399999999999998,
    "operating_cash_flow_ttm": -22300000.0,
    "levered_cash_flow_ttm": -12850000.0,
    "book_value_per_share_mrq": 1.72,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Macrocure Ltd."
  },
  "MD": {
    "p_e_ratio": 20.44,
    "peg_ratio": 1.19,
    "earnings_per_share": 3.49,
    "ebitda": 607970000.0,
    "eps_estimate_current_year": 4.07,
    "eps_estimate_next_quarter": 0.93,
    "fifty_day_moving_average": 72.05,
    "fifty_two_week_high": 86.09,
    "fifty_two_week_low": 64.12,
    "percent_change_from_200_day_moving_average": -0.0711,
    "percent_change_from_50_day_moving_average": -0.009000000000000001,
    "shares_owned": "N/A",
    "short_ratio": 5.86,
    "two_hundred_day_moving_average": 76.87,
    "volume": 877868.0,
    "market_cap": 6710000000.0,
    "price_to_sales_ttm": 2.52,
    "price_to_book_mrq": 2.9,
    "roa_ttm": 0.08539999999999999,
    "roe_ttm": 0.13699999999999998,
    "shares_outstanding": 94040000.0,
    "pcnt_held_by_insiders": 0.0191,
    "pcnt_held_by_institutions": 1.043,
    "pcnt_short_of_float": 0.0666,
    "operating_cash_flow_ttm": 443370000.0,
    "levered_cash_flow_ttm": 358040000.0,
    "book_value_per_share_mrq": 25.1,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "MEDNAX, Inc."
  },
  "MDCO": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.98,
    "earnings_per_share": -2.31,
    "ebitda": -197380000.0,
    "eps_estimate_current_year": -3.9,
    "eps_estimate_next_quarter": -1.17,
    "fifty_day_moving_average": 39.86,
    "fifty_two_week_high": 43.79,
    "fifty_two_week_low": 23.32,
    "percent_change_from_200_day_moving_average": 0.1197,
    "percent_change_from_50_day_moving_average": -0.0070999999999999995,
    "shares_owned": "N/A",
    "short_ratio": 10.52,
    "two_hundred_day_moving_average": 35.35,
    "volume": 2072293.0,
    "market_cap": 2750000000.0,
    "price_to_sales_ttm": 5.38,
    "price_to_book_mrq": 2.8,
    "roa_ttm": -0.0736,
    "roe_ttm": -0.1659,
    "shares_outstanding": 69440000.0,
    "pcnt_held_by_insiders": 0.1561,
    "pcnt_held_by_institutions": 1.109,
    "pcnt_short_of_float": 0.2762,
    "operating_cash_flow_ttm": -65390000.0,
    "levered_cash_flow_ttm": -14460000.0,
    "book_value_per_share_mrq": 13.75,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "The Medicines Company"
  },
  "MDGN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.63,
    "ebitda": -27920000.0,
    "eps_estimate_current_year": -1.21,
    "eps_estimate_next_quarter": -0.28,
    "fifty_day_moving_average": 6.79,
    "fifty_two_week_high": 10.25,
    "fifty_two_week_low": 4.81,
    "percent_change_from_200_day_moving_average": -0.1496,
    "percent_change_from_50_day_moving_average": -0.08460000000000001,
    "shares_owned": "N/A",
    "short_ratio": 9.22,
    "two_hundred_day_moving_average": 7.31,
    "volume": 274626.0,
    "market_cap": 204390000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 17.05,
    "roa_ttm": -0.9926,
    "roe_ttm": -3.5104,
    "shares_outstanding": 32860000.0,
    "pcnt_held_by_insiders": 0.18510000000000001,
    "pcnt_held_by_institutions": 0.16,
    "pcnt_short_of_float": 0.0766,
    "operating_cash_flow_ttm": -20480000.0,
    "levered_cash_flow_ttm": -1470000.0,
    "book_value_per_share_mrq": 0.36,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Medgenics, Inc."
  },
  "MDVN": {
    "p_e_ratio": 27.0,
    "peg_ratio": 0.38,
    "earnings_per_share": 1.62,
    "ebitda": 350080000.0,
    "eps_estimate_current_year": 1.03,
    "eps_estimate_next_quarter": 0.37,
    "fifty_day_moving_average": 42.01,
    "fifty_two_week_high": 70.79,
    "fifty_two_week_low": 37.63,
    "percent_change_from_200_day_moving_average": -0.0861,
    "percent_change_from_50_day_moving_average": 0.0424,
    "shares_owned": "N/A",
    "short_ratio": 2.22,
    "two_hundred_day_moving_average": 47.91,
    "volume": 2394692.0,
    "market_cap": 7170000000.0,
    "price_to_sales_ttm": 8.51,
    "price_to_book_mrq": 10.63,
    "roa_ttm": 0.262,
    "roe_ttm": 0.5786,
    "shares_outstanding": 163710000.0,
    "pcnt_held_by_insiders": 0.011699999999999999,
    "pcnt_held_by_institutions": 0.955,
    "pcnt_short_of_float": 0.027000000000000003,
    "operating_cash_flow_ttm": 274250000.0,
    "levered_cash_flow_ttm": 202480000.0,
    "book_value_per_share_mrq": 4.11,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Medivation, Inc."
  },
  "MDVX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.6,
    "ebitda": -5470000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.42,
    "fifty_two_week_high": 5.8,
    "fifty_two_week_low": 0.87,
    "percent_change_from_200_day_moving_average": -0.49479999999999996,
    "percent_change_from_50_day_moving_average": -0.0915,
    "shares_owned": "N/A",
    "short_ratio": 1.08,
    "two_hundred_day_moving_average": 2.55,
    "volume": 6383.0,
    "market_cap": 14510000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.24,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 11250000.0,
    "pcnt_held_by_insiders": 0.3825,
    "pcnt_held_by_institutions": 0.001,
    "pcnt_short_of_float": 0.0022,
    "operating_cash_flow_ttm": -5870000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 1.04,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Medovex Corp."
  },
  "MDWD": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.21,
    "earnings_per_share": -0.99,
    "ebitda": -19950000.0,
    "eps_estimate_current_year": -0.88,
    "eps_estimate_next_quarter": -0.14,
    "fifty_day_moving_average": 9.56,
    "fifty_two_week_high": 10.47,
    "fifty_two_week_low": 5.0,
    "percent_change_from_200_day_moving_average": 0.1973,
    "percent_change_from_50_day_moving_average": -0.0322,
    "shares_owned": "N/A",
    "short_ratio": 4.47,
    "two_hundred_day_moving_average": 7.73,
    "volume": 5455.0,
    "market_cap": 197000000.0,
    "price_to_sales_ttm": 441.29,
    "price_to_book_mrq": 6.62,
    "roa_ttm": -0.19390000000000002,
    "roe_ttm": -0.5297,
    "shares_outstanding": 21300000.0,
    "pcnt_held_by_insiders": 0.4489,
    "pcnt_held_by_institutions": 0.115,
    "pcnt_short_of_float": 0.0101,
    "operating_cash_flow_ttm": -19090000.0,
    "levered_cash_flow_ttm": -8810000.0,
    "book_value_per_share_mrq": 1.4,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "MediWound Ltd."
  },
  "MDXG": {
    "p_e_ratio": 56.45,
    "peg_ratio": 3.03,
    "earnings_per_share": 0.17,
    "ebitda": 23780000.0,
    "eps_estimate_current_year": 0.21,
    "eps_estimate_next_quarter": 0.05,
    "fifty_day_moving_average": 8.28,
    "fifty_two_week_high": 13.2,
    "fifty_two_week_low": 6.71,
    "percent_change_from_200_day_moving_average": -0.0246,
    "percent_change_from_50_day_moving_average": 0.1521,
    "shares_owned": "N/A",
    "short_ratio": 16.55,
    "two_hundred_day_moving_average": 9.78,
    "volume": 5329289.0,
    "market_cap": 1040000000.0,
    "price_to_sales_ttm": 5.55,
    "price_to_book_mrq": 9.67,
    "roa_ttm": 0.1191,
    "roe_ttm": 0.21899999999999997,
    "shares_outstanding": 108960000.0,
    "pcnt_held_by_insiders": 0.08839999999999999,
    "pcnt_held_by_institutions": 0.527,
    "pcnt_short_of_float": 0.1862,
    "operating_cash_flow_ttm": 22740000.0,
    "levered_cash_flow_ttm": 10770000.0,
    "book_value_per_share_mrq": 0.92,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "MiMedx Group, Inc."
  },
  "MEIP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 25.8,
    "earnings_per_share": -0.9,
    "ebitda": -28350000.0,
    "eps_estimate_current_year": -0.64,
    "eps_estimate_next_quarter": -0.17,
    "fifty_day_moving_average": 1.71,
    "fifty_two_week_high": 6.59,
    "fifty_two_week_low": 1.47,
    "percent_change_from_200_day_moving_average": -0.0034000000000000002,
    "percent_change_from_50_day_moving_average": 0.0095,
    "shares_owned": "N/A",
    "short_ratio": 0.79,
    "two_hundred_day_moving_average": 1.74,
    "volume": 550706.0,
    "market_cap": 59090000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.01,
    "roa_ttm": -0.3482,
    "roe_ttm": -0.6054999999999999,
    "shares_outstanding": 34160000.0,
    "pcnt_held_by_insiders": 0.1612,
    "pcnt_held_by_institutions": 0.162,
    "pcnt_short_of_float": 0.0175,
    "operating_cash_flow_ttm": -27100000.0,
    "levered_cash_flow_ttm": -16550000.0,
    "book_value_per_share_mrq": 1.64,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "MEI Pharma, Inc."
  },
  "MELA": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.02,
    "earnings_per_share": -4.52,
    "ebitda": -14900000.0,
    "eps_estimate_current_year": -2.95,
    "eps_estimate_next_quarter": -0.13,
    "fifty_day_moving_average": 1.15,
    "fifty_two_week_high": 4.05,
    "fifty_two_week_low": 1.0,
    "percent_change_from_200_day_moving_average": -0.0594,
    "percent_change_from_50_day_moving_average": -0.0167,
    "shares_owned": "N/A",
    "short_ratio": 20.38,
    "two_hundred_day_moving_average": 1.2,
    "volume": 24730.0,
    "market_cap": 11510000.0,
    "price_to_sales_ttm": 1.24,
    "price_to_book_mrq": 0.71,
    "roa_ttm": -0.2889,
    "roe_ttm": -1.8558000000000001,
    "shares_outstanding": 10180000.0,
    "pcnt_held_by_insiders": 0.1316,
    "pcnt_held_by_institutions": 0.099,
    "pcnt_short_of_float": 0.0981,
    "operating_cash_flow_ttm": -10090000.0,
    "levered_cash_flow_ttm": -5170000.0,
    "book_value_per_share_mrq": 1.61,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "MELA Sciences, Inc."
  },
  "MGCD": {
    "p_e_ratio": 10.2,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.64,
    "ebitda": 2220000.0,
    "eps_estimate_current_year": 0.06,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 6.69,
    "fifty_two_week_high": 7.7,
    "fifty_two_week_low": 5.0,
    "percent_change_from_200_day_moving_average": 0.073,
    "percent_change_from_50_day_moving_average": -0.028399999999999998,
    "shares_owned": "N/A",
    "short_ratio": 0.19,
    "two_hundred_day_moving_average": 6.06,
    "volume": 3500.0,
    "market_cap": 27690000.0,
    "price_to_sales_ttm": 0.76,
    "price_to_book_mrq": 1.49,
    "roa_ttm": 0.028999999999999998,
    "roe_ttm": 0.1577,
    "shares_outstanding": 4260000.0,
    "pcnt_held_by_insiders": 0.091,
    "pcnt_held_by_institutions": 0.203,
    "pcnt_short_of_float": 0.0001,
    "operating_cash_flow_ttm": -982000.0,
    "levered_cash_flow_ttm": -2990000.0,
    "book_value_per_share_mrq": 4.45,
    "next_earnings_announcement_date": [
      "2016-01-05",
      "2016-01-11"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "MGC Diagnostics Corporation"
  },
  "MGLN": {
    "p_e_ratio": 62.73,
    "peg_ratio": -4.16,
    "earnings_per_share": 0.97,
    "ebitda": 208110000.0,
    "eps_estimate_current_year": 0.87,
    "eps_estimate_next_quarter": 0.49,
    "fifty_day_moving_average": 53.45,
    "fifty_two_week_high": 73.0,
    "fifty_two_week_low": 45.4,
    "percent_change_from_200_day_moving_average": 0.0432,
    "percent_change_from_50_day_moving_average": 0.1432,
    "shares_owned": "N/A",
    "short_ratio": 3.97,
    "two_hundred_day_moving_average": 58.57,
    "volume": 740185.0,
    "market_cap": 1500000000.0,
    "price_to_sales_ttm": 0.36,
    "price_to_book_mrq": 1.44,
    "roa_ttm": 0.0443,
    "roe_ttm": 0.021,
    "shares_outstanding": 24610000.0,
    "pcnt_held_by_insiders": 0.011399999999999999,
    "pcnt_held_by_institutions": 0.9620000000000001,
    "pcnt_short_of_float": 0.027000000000000003,
    "operating_cash_flow_ttm": 194930000.0,
    "levered_cash_flow_ttm": 153440000.0,
    "book_value_per_share_mrq": 42.04,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Health Care Plans",
    "company_name": "Magellan Health, Inc."
  },
  "MGNX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.29,
    "earnings_per_share": -0.36,
    "ebitda": -8440000.0,
    "eps_estimate_current_year": -0.38,
    "eps_estimate_next_quarter": -0.54,
    "fifty_day_moving_average": 32.71,
    "fifty_two_week_high": 39.9,
    "fifty_two_week_low": 19.67,
    "percent_change_from_200_day_moving_average": -0.001,
    "percent_change_from_50_day_moving_average": -0.0391,
    "shares_owned": "N/A",
    "short_ratio": 14.0,
    "two_hundred_day_moving_average": 31.46,
    "volume": 2086811.0,
    "market_cap": 1080000000.0,
    "price_to_sales_ttm": 10.93,
    "price_to_book_mrq": 3.16,
    "roa_ttm": -0.023,
    "roe_ttm": -0.044800000000000006,
    "shares_outstanding": 34310000.0,
    "pcnt_held_by_insiders": 0.2145,
    "pcnt_held_by_institutions": 0.6459999999999999,
    "pcnt_short_of_float": 0.1315,
    "operating_cash_flow_ttm": -9670000.0,
    "levered_cash_flow_ttm": -6470000.0,
    "book_value_per_share_mrq": 9.91,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "MacroGenics, Inc."
  },
  "MIRN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -256.64,
    "ebitda": -20530000.0,
    "eps_estimate_current_year": -3.12,
    "eps_estimate_next_quarter": -0.4,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 11.01,
    "fifty_two_week_low": 7.21,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 1.89,
    "two_hundred_day_moving_average": 0.0,
    "volume": 226804.0,
    "market_cap": 150190000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 20830000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0029,
    "operating_cash_flow_ttm": -17900000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -605.71,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Mirna Therapeutics, Inc."
  },
  "MLAB": {
    "p_e_ratio": 41.09,
    "peg_ratio": 0.0,
    "earnings_per_share": 2.37,
    "ebitda": 22640000.0,
    "eps_estimate_current_year": 3.34,
    "eps_estimate_next_quarter": 1.01,
    "fifty_day_moving_average": 107.22,
    "fifty_two_week_high": 126.05,
    "fifty_two_week_low": 67.7,
    "percent_change_from_200_day_moving_average": -0.0696,
    "percent_change_from_50_day_moving_average": -0.0925,
    "shares_owned": "N/A",
    "short_ratio": 6.44,
    "two_hundred_day_moving_average": 104.58,
    "volume": 29543.0,
    "market_cap": 350670000.0,
    "price_to_sales_ttm": 4.65,
    "price_to_book_mrq": 4.5,
    "roa_ttm": 0.0759,
    "roe_ttm": 0.11710000000000001,
    "shares_outstanding": 3600000.0,
    "pcnt_held_by_insiders": 0.2045,
    "pcnt_held_by_institutions": 0.581,
    "pcnt_short_of_float": 0.042300000000000004,
    "operating_cash_flow_ttm": 16030000.000000002,
    "levered_cash_flow_ttm": 18870000.0,
    "book_value_per_share_mrq": 21.92,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Mesa Laboratories Inc."
  },
  "MLSS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.25,
    "ebitda": -3230000.0,
    "eps_estimate_current_year": 0.08,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.49,
    "fifty_two_week_high": 4.0,
    "fifty_two_week_low": 2.0,
    "percent_change_from_200_day_moving_average": -0.2561,
    "percent_change_from_50_day_moving_average": -0.1148,
    "shares_owned": "N/A",
    "short_ratio": 1.93,
    "two_hundred_day_moving_average": 2.96,
    "volume": 30494.0,
    "market_cap": 47250000.0,
    "price_to_sales_ttm": 4.9,
    "price_to_book_mrq": 4.27,
    "roa_ttm": -0.1326,
    "roe_ttm": -0.40409999999999996,
    "shares_outstanding": 21480000.0,
    "pcnt_held_by_insiders": 0.4777,
    "pcnt_held_by_institutions": 0.019,
    "pcnt_short_of_float": 0.0023,
    "operating_cash_flow_ttm": -3380000.0,
    "levered_cash_flow_ttm": -4280000.0,
    "book_value_per_share_mrq": 0.52,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Milestone Scientific Inc."
  },
  "MMSI": {
    "p_e_ratio": 32.14,
    "peg_ratio": 1.44,
    "earnings_per_share": 0.59,
    "ebitda": 85820000.0,
    "eps_estimate_current_year": 0.86,
    "eps_estimate_next_quarter": 0.21,
    "fifty_day_moving_average": 18.72,
    "fifty_two_week_high": 26.42,
    "fifty_two_week_low": 15.2,
    "percent_change_from_200_day_moving_average": -0.1355,
    "percent_change_from_50_day_moving_average": 0.0115,
    "shares_owned": "N/A",
    "short_ratio": 3.84,
    "two_hundred_day_moving_average": 21.9,
    "volume": 1402344.0,
    "market_cap": 836740000.0,
    "price_to_sales_ttm": 1.54,
    "price_to_book_mrq": 1.79,
    "roa_ttm": 0.0403,
    "roe_ttm": 0.0591,
    "shares_outstanding": 44200000.0,
    "pcnt_held_by_insiders": 0.10039999999999999,
    "pcnt_held_by_institutions": 0.8490000000000001,
    "pcnt_short_of_float": 0.0542,
    "operating_cash_flow_ttm": 78750000.0,
    "levered_cash_flow_ttm": 18130000.0,
    "book_value_per_share_mrq": 10.38,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Merit Medical Systems, Inc."
  },
  "MNK": {
    "p_e_ratio": 25.9,
    "peg_ratio": 0.59,
    "earnings_per_share": 2.75,
    "ebitda": 1320000000.0,
    "eps_estimate_current_year": 7.83,
    "eps_estimate_next_quarter": 1.77,
    "fifty_day_moving_average": 66.69,
    "fifty_two_week_high": 134.26,
    "fifty_two_week_low": 52.01,
    "percent_change_from_200_day_moving_average": -0.20440000000000003,
    "percent_change_from_50_day_moving_average": 0.0683,
    "shares_owned": "N/A",
    "short_ratio": 2.89,
    "two_hundred_day_moving_average": 89.54,
    "volume": 1950809.0,
    "market_cap": 8260000000.0,
    "price_to_sales_ttm": 2.48,
    "price_to_book_mrq": 1.57,
    "roa_ttm": 0.0287,
    "roe_ttm": 0.06,
    "shares_outstanding": 115950000.0,
    "pcnt_held_by_insiders": 0.0546,
    "pcnt_held_by_institutions": 0.9259999999999999,
    "pcnt_short_of_float": 0.1,
    "operating_cash_flow_ttm": 896400000.0,
    "levered_cash_flow_ttm": 788590000.0,
    "book_value_per_share_mrq": 45.67,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Mallinckrodt Public Limited Company"
  },
  "MNKD": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.21,
    "earnings_per_share": -0.32,
    "ebitda": -91200000.0,
    "eps_estimate_current_year": -0.28,
    "eps_estimate_next_quarter": -0.04,
    "fifty_day_moving_average": 2.2,
    "fifty_two_week_high": 7.88,
    "fifty_two_week_low": 1.38,
    "percent_change_from_200_day_moving_average": -0.615,
    "percent_change_from_50_day_moving_average": -0.3274,
    "shares_owned": "N/A",
    "short_ratio": 12.06,
    "two_hundred_day_moving_average": 3.84,
    "volume": 15126880.0,
    "market_cap": 634420000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.1916,
    "roe_ttm": "N/A",
    "shares_outstanding": 428660000.0,
    "pcnt_held_by_insiders": 0.36920000000000003,
    "pcnt_held_by_institutions": 0.276,
    "pcnt_short_of_float": 0.43200000000000005,
    "operating_cash_flow_ttm": -70430000.0,
    "levered_cash_flow_ttm": -101790000.0,
    "book_value_per_share_mrq": -0.3,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "MannKind Corp."
  },
  "MNOV": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.55,
    "earnings_per_share": -0.34,
    "ebitda": -8440000.0,
    "eps_estimate_current_year": -0.32,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 3.29,
    "fifty_two_week_high": 5.9,
    "fifty_two_week_low": 2.62,
    "percent_change_from_200_day_moving_average": 0.0467,
    "percent_change_from_50_day_moving_average": 0.0808,
    "shares_owned": "N/A",
    "short_ratio": 9.56,
    "two_hundred_day_moving_average": 3.4,
    "volume": 33757.0,
    "market_cap": 92410000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.07,
    "roa_ttm": -0.15710000000000002,
    "roe_ttm": -0.2948,
    "shares_outstanding": 25960000.0,
    "pcnt_held_by_insiders": 0.225,
    "pcnt_held_by_institutions": 0.085,
    "pcnt_short_of_float": 0.015300000000000001,
    "operating_cash_flow_ttm": -6670000.0,
    "levered_cash_flow_ttm": -3340000.0,
    "book_value_per_share_mrq": 1.16,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "MediciNova Inc."
  },
  "MNTA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.19,
    "ebitda": -62190000.0,
    "eps_estimate_current_year": -0.88,
    "eps_estimate_next_quarter": -0.01,
    "fifty_day_moving_average": 17.2,
    "fifty_two_week_high": 25.56,
    "fifty_two_week_low": 10.22,
    "percent_change_from_200_day_moving_average": -0.1533,
    "percent_change_from_50_day_moving_average": -0.0446,
    "shares_owned": "N/A",
    "short_ratio": 6.14,
    "two_hundred_day_moving_average": 19.41,
    "volume": 2603670.0,
    "market_cap": 1130000000.0,
    "price_to_sales_ttm": 12.32,
    "price_to_book_mrq": 2.77,
    "roa_ttm": -0.1306,
    "roe_ttm": -0.23629999999999998,
    "shares_outstanding": 68880000.0,
    "pcnt_held_by_insiders": 0.09050000000000001,
    "pcnt_held_by_institutions": 0.894,
    "pcnt_short_of_float": 0.1106,
    "operating_cash_flow_ttm": -48260000.0,
    "levered_cash_flow_ttm": -21300000.0,
    "book_value_per_share_mrq": 5.78,
    "next_earnings_announcement_date": [
      "2016-02-15",
      "2016-02-19"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Momenta Pharmaceuticals Inc."
  },
  "MOH": {
    "p_e_ratio": 21.86,
    "peg_ratio": 0.61,
    "earnings_per_share": 2.76,
    "ebitda": 489890000.0,
    "eps_estimate_current_year": 2.69,
    "eps_estimate_next_quarter": 0.81,
    "fifty_day_moving_average": 61.2,
    "fifty_two_week_high": 82.37,
    "fifty_two_week_low": 49.37,
    "percent_change_from_200_day_moving_average": -0.1264,
    "percent_change_from_50_day_moving_average": -0.014199999999999999,
    "shares_owned": "N/A",
    "short_ratio": 7.74,
    "two_hundred_day_moving_average": 69.06,
    "volume": 2313855.0,
    "market_cap": 3380000000.0,
    "price_to_sales_ttm": 0.26,
    "price_to_book_mrq": 2.18,
    "roa_ttm": 0.051,
    "roe_ttm": 0.11869999999999999,
    "shares_outstanding": 56080000.0,
    "pcnt_held_by_insiders": 0.2615,
    "pcnt_held_by_institutions": 0.85,
    "pcnt_short_of_float": 0.23800000000000002,
    "operating_cash_flow_ttm": 1120000000.0,
    "levered_cash_flow_ttm": 381360000.0,
    "book_value_per_share_mrq": 27.07,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Health Care Plans",
    "company_name": "Molina Healthcare, Inc."
  },
  "MR": {
    "p_e_ratio": 17.95,
    "peg_ratio": 17.88,
    "earnings_per_share": 1.49,
    "ebitda": 245960000.0,
    "eps_estimate_current_year": 1.42,
    "eps_estimate_next_quarter": 0.35,
    "fifty_day_moving_average": 26.55,
    "fifty_two_week_high": 33.83,
    "fifty_two_week_low": 21.8,
    "percent_change_from_200_day_moving_average": 0.0277,
    "percent_change_from_50_day_moving_average": 0.0077,
    "shares_owned": "N/A",
    "short_ratio": 2.44,
    "two_hundred_day_moving_average": 26.03,
    "volume": 680177.0,
    "market_cap": 3150000000.0,
    "price_to_sales_ttm": 2.35,
    "price_to_book_mrq": 1.99,
    "roa_ttm": 0.0504,
    "roe_ttm": 0.113,
    "shares_outstanding": 117850000.0,
    "pcnt_held_by_insiders": 0.0229,
    "pcnt_held_by_institutions": 0.9890000000000001,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": 348590000.0,
    "levered_cash_flow_ttm": -196800000.0,
    "book_value_per_share_mrq": 13.4,
    "next_earnings_announcement_date": [
      "2016-03-07",
      "2016-03-11"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Mindray Medical International Limited"
  },
  "MRNS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.47,
    "ebitda": -20480000.0,
    "eps_estimate_current_year": -1.57,
    "eps_estimate_next_quarter": -0.31,
    "fifty_day_moving_average": 6.35,
    "fifty_two_week_high": 20.72,
    "fifty_two_week_low": 4.52,
    "percent_change_from_200_day_moving_average": -0.3015,
    "percent_change_from_50_day_moving_average": 0.20370000000000002,
    "shares_owned": "N/A",
    "short_ratio": 0.29,
    "two_hundred_day_moving_average": 10.94,
    "volume": 286280.0,
    "market_cap": 147720000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.79,
    "roa_ttm": -0.3037,
    "roe_ttm": -0.5965,
    "shares_outstanding": 19330000.0,
    "pcnt_held_by_insiders": 0.44310000000000005,
    "pcnt_held_by_institutions": 0.449,
    "pcnt_short_of_float": 0.0158,
    "operating_cash_flow_ttm": -17050000.0,
    "levered_cash_flow_ttm": -10850000.0,
    "book_value_per_share_mrq": 1.79,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Marinus Pharmaceuticals, Inc."
  },
  "MRTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.66,
    "ebitda": -56470000.0,
    "eps_estimate_current_year": -3.84,
    "eps_estimate_next_quarter": -0.88,
    "fifty_day_moving_average": 37.15,
    "fifty_two_week_high": 52.0,
    "fifty_two_week_low": 18.23,
    "percent_change_from_200_day_moving_average": -0.0217,
    "percent_change_from_50_day_moving_average": -0.1417,
    "shares_owned": "N/A",
    "short_ratio": 4.36,
    "two_hundred_day_moving_average": 32.6,
    "volume": 816761.0,
    "market_cap": 614390000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.68,
    "roa_ttm": -0.3829,
    "roe_ttm": -0.6665000000000001,
    "shares_outstanding": 19270000.0,
    "pcnt_held_by_insiders": 0.1624,
    "pcnt_held_by_institutions": 0.469,
    "pcnt_short_of_float": 0.0964,
    "operating_cash_flow_ttm": -43270000.0,
    "levered_cash_flow_ttm": -21630000.0,
    "book_value_per_share_mrq": 6.95,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Mirati Therapeutics, Inc."
  },
  "MSLI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.0,
    "ebitda": 21610000.0,
    "eps_estimate_current_year": 0.01,
    "eps_estimate_next_quarter": 0.01,
    "fifty_day_moving_average": 1.32,
    "fifty_two_week_high": 2.85,
    "fifty_two_week_low": 1.1,
    "percent_change_from_200_day_moving_average": -0.2534,
    "percent_change_from_50_day_moving_average": 0.0281,
    "shares_owned": "N/A",
    "short_ratio": 73.32,
    "two_hundred_day_moving_average": 1.82,
    "volume": 36815.0,
    "market_cap": 139130000.0,
    "price_to_sales_ttm": 4.05,
    "price_to_book_mrq": 1.1,
    "roa_ttm": 0.013300000000000001,
    "roe_ttm": -0.0017000000000000001,
    "shares_outstanding": 102300000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.002,
    "operating_cash_flow_ttm": 14610000.0,
    "levered_cash_flow_ttm": -14670000.0,
    "book_value_per_share_mrq": 1.27,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Merus Labs International Inc."
  },
  "MSON": {
    "p_e_ratio": 15.41,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.61,
    "ebitda": -761849.0,
    "eps_estimate_current_year": 0.35,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 9.43,
    "fifty_two_week_high": 14.5,
    "fifty_two_week_low": 8.2,
    "percent_change_from_200_day_moving_average": -0.0559,
    "percent_change_from_50_day_moving_average": 0.0028000000000000004,
    "shares_owned": "N/A",
    "short_ratio": 0.53,
    "two_hundred_day_moving_average": 10.02,
    "volume": 29955.0,
    "market_cap": 73670000.0,
    "price_to_sales_ttm": 3.33,
    "price_to_book_mrq": 3.17,
    "roa_ttm": -0.0632,
    "roe_ttm": 0.2296,
    "shares_outstanding": 7790000.0,
    "pcnt_held_by_insiders": 0.2391,
    "pcnt_held_by_institutions": 0.156,
    "pcnt_short_of_float": 0.0017000000000000001,
    "operating_cash_flow_ttm": 1930000.0,
    "levered_cash_flow_ttm": -2880000.0,
    "book_value_per_share_mrq": 3.09,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Misonix, Inc."
  },
  "MSTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.23,
    "ebitda": -35880000.0,
    "eps_estimate_current_year": -0.25,
    "eps_estimate_next_quarter": -0.07,
    "fifty_day_moving_average": 0.42,
    "fifty_two_week_high": 0.63,
    "fifty_two_week_low": 0.33,
    "percent_change_from_200_day_moving_average": -0.131,
    "percent_change_from_50_day_moving_average": -0.041100000000000005,
    "shares_owned": "N/A",
    "short_ratio": 3.77,
    "two_hundred_day_moving_average": 0.46,
    "volume": 515491.0,
    "market_cap": 65450000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.9,
    "roa_ttm": -0.3764,
    "roe_ttm": -0.9390000000000001,
    "shares_outstanding": 163610000.0,
    "pcnt_held_by_insiders": 0.0026,
    "pcnt_held_by_institutions": 0.22899999999999998,
    "pcnt_short_of_float": 0.038599999999999995,
    "operating_cash_flow_ttm": -30150000.0,
    "levered_cash_flow_ttm": -15980000.0,
    "book_value_per_share_mrq": 0.21,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Mast Therapeutics, Inc."
  },
  "MTD": {
    "p_e_ratio": 26.99,
    "peg_ratio": 2.23,
    "earnings_per_share": 12.26,
    "ebitda": 535480000.0,
    "eps_estimate_current_year": 12.88,
    "eps_estimate_next_quarter": 2.43,
    "fifty_day_moving_average": 332.33,
    "fifty_two_week_high": 350.11,
    "fifty_two_week_low": 275.3,
    "percent_change_from_200_day_moving_average": 0.0345,
    "percent_change_from_50_day_moving_average": -0.0038,
    "shares_owned": "N/A",
    "short_ratio": 5.25,
    "two_hundred_day_moving_average": 320.03,
    "volume": 332431.0,
    "market_cap": 9060000000.0,
    "price_to_sales_ttm": 3.75,
    "price_to_book_mrq": 15.49,
    "roa_ttm": 0.1489,
    "roe_ttm": 0.4886,
    "shares_outstanding": 27360000.0,
    "pcnt_held_by_insiders": 0.0229,
    "pcnt_held_by_institutions": 0.9590000000000001,
    "pcnt_short_of_float": 0.0461,
    "operating_cash_flow_ttm": 430500000.0,
    "levered_cash_flow_ttm": 328680000.0,
    "book_value_per_share_mrq": 21.43,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Mettler-Toledo International Inc."
  },
  "MYOK": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -9.68,
    "ebitda": -17640000.0,
    "eps_estimate_current_year": -2.66,
    "eps_estimate_next_quarter": -0.39,
    "fifty_day_moving_average": 11.64,
    "fifty_two_week_high": 14.82,
    "fifty_two_week_low": 8.98,
    "percent_change_from_200_day_moving_average": 0.1648,
    "percent_change_from_50_day_moving_average": 0.1617,
    "shares_owned": "N/A",
    "short_ratio": 1.26,
    "two_hundred_day_moving_average": 11.61,
    "volume": 911659.0,
    "market_cap": 365760000.0,
    "price_to_sales_ttm": 24.03,
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 27050000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.005699999999999999,
    "operating_cash_flow_ttm": -29320000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -14.27,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "MyoKardia, Inc."
  },
  "MYOS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.55,
    "ebitda": -5110000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.17,
    "fifty_two_week_high": 8.25,
    "fifty_two_week_low": 1.36,
    "percent_change_from_200_day_moving_average": -0.1747,
    "percent_change_from_50_day_moving_average": 0.0594,
    "shares_owned": "N/A",
    "short_ratio": 2.43,
    "two_hundred_day_moving_average": 2.79,
    "volume": 165576.0,
    "market_cap": 7640000.0,
    "price_to_sales_ttm": 65.95,
    "price_to_book_mrq": 1.93,
    "roa_ttm": -0.5485,
    "roe_ttm": -0.9131,
    "shares_outstanding": 3320000.0,
    "pcnt_held_by_insiders": 0.1577,
    "pcnt_held_by_institutions": 0.027000000000000003,
    "pcnt_short_of_float": 0.0319,
    "operating_cash_flow_ttm": -2390000.0,
    "levered_cash_flow_ttm": -1160000.0,
    "book_value_per_share_mrq": 1.39,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "MYOS Corporation"
  },
  "MZOR": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.51,
    "earnings_per_share": -0.76,
    "ebitda": -15470000.0,
    "eps_estimate_current_year": -0.75,
    "eps_estimate_next_quarter": -0.23,
    "fifty_day_moving_average": 9.84,
    "fifty_two_week_high": 14.99,
    "fifty_two_week_low": 8.5,
    "percent_change_from_200_day_moving_average": -0.2184,
    "percent_change_from_50_day_moving_average": -0.0437,
    "shares_owned": "N/A",
    "short_ratio": 16.15,
    "two_hundred_day_moving_average": 12.04,
    "volume": 70327.0,
    "market_cap": 199140000.0,
    "price_to_sales_ttm": 8.85,
    "price_to_book_mrq": 4.54,
    "roa_ttm": -0.17120000000000002,
    "roe_ttm": -0.3188,
    "shares_outstanding": 21160000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -9110000.0,
    "levered_cash_flow_ttm": -3640000.0,
    "book_value_per_share_mrq": 2.1,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Mazor Robotics Ltd."
  },
  "NAII": {
    "p_e_ratio": 14.42,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.6,
    "ebitda": 9370000.0,
    "eps_estimate_current_year": "nan",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 7.29,
    "fifty_two_week_high": 8.75,
    "fifty_two_week_low": 5.02,
    "percent_change_from_200_day_moving_average": 0.3751,
    "percent_change_from_50_day_moving_average": 0.1859,
    "shares_owned": "N/A",
    "short_ratio": 0.4,
    "two_hundred_day_moving_average": 6.29,
    "volume": 29957.0,
    "market_cap": 58700000.0,
    "price_to_sales_ttm": 0.69,
    "price_to_book_mrq": 1.27,
    "roa_ttm": 0.08130000000000001,
    "roe_ttm": 0.0917,
    "shares_outstanding": 6790000.0,
    "pcnt_held_by_insiders": 0.5489,
    "pcnt_held_by_institutions": 0.134,
    "pcnt_short_of_float": 0.0031,
    "operating_cash_flow_ttm": 3050000.0,
    "levered_cash_flow_ttm": 2250000.0,
    "book_value_per_share_mrq": 6.91,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Related Products",
    "company_name": "Natural Alternatives International Inc."
  },
  "NATR": {
    "p_e_ratio": 29.64,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.36,
    "ebitda": 16309999.999999998,
    "eps_estimate_current_year": 0.8,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 11.46,
    "fifty_two_week_high": 15.4,
    "fifty_two_week_low": 10.3,
    "percent_change_from_200_day_moving_average": -0.1355,
    "percent_change_from_50_day_moving_average": -0.0768,
    "shares_owned": "N/A",
    "short_ratio": 10.58,
    "two_hundred_day_moving_average": 12.24,
    "volume": 38998.0,
    "market_cap": 196660000.0,
    "price_to_sales_ttm": 0.61,
    "price_to_book_mrq": 1.53,
    "roa_ttm": 0.037200000000000004,
    "roe_ttm": 0.067,
    "shares_outstanding": 18590000.0,
    "pcnt_held_by_insiders": 0.055,
    "pcnt_held_by_institutions": 0.745,
    "pcnt_short_of_float": 0.0222,
    "operating_cash_flow_ttm": 8820000.0,
    "levered_cash_flow_ttm": -9300000.0,
    "book_value_per_share_mrq": 7.06,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Nature's Sunshine Products Inc."
  },
  "NAVB": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.21,
    "ebitda": -19850000.0,
    "eps_estimate_current_year": -0.2,
    "eps_estimate_next_quarter": -0.03,
    "fifty_day_moving_average": 1.58,
    "fifty_two_week_high": 2.5,
    "fifty_two_week_low": 1.22,
    "percent_change_from_200_day_moving_average": -0.2249,
    "percent_change_from_50_day_moving_average": -0.12119999999999999,
    "shares_owned": "N/A",
    "short_ratio": 66.59,
    "two_hundred_day_moving_average": 1.79,
    "volume": 834164.0,
    "market_cap": 216420000.0,
    "price_to_sales_ttm": 18.04,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.7269,
    "roe_ttm": "N/A",
    "shares_outstanding": 155700000.0,
    "pcnt_held_by_insiders": 0.011399999999999999,
    "pcnt_held_by_institutions": 0.35,
    "pcnt_short_of_float": 0.1981,
    "operating_cash_flow_ttm": -19710000.0,
    "levered_cash_flow_ttm": -12090000.0,
    "book_value_per_share_mrq": -0.35,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Navidea Biopharmaceuticals, Inc"
  },
  "NBIX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 5.56,
    "earnings_per_share": -0.96,
    "ebitda": -82960000.0,
    "eps_estimate_current_year": -1.03,
    "eps_estimate_next_quarter": -0.24,
    "fifty_day_moving_average": 53.12,
    "fifty_two_week_high": 58.46,
    "fifty_two_week_low": 19.68,
    "percent_change_from_200_day_moving_average": 0.06509999999999999,
    "percent_change_from_50_day_moving_average": -0.0236,
    "shares_owned": "N/A",
    "short_ratio": 6.27,
    "two_hundred_day_moving_average": 48.7,
    "volume": 1476214.0,
    "market_cap": 4470000000.0,
    "price_to_sales_ttm": 229.3,
    "price_to_book_mrq": 10.11,
    "roa_ttm": -0.1398,
    "roe_ttm": -0.2357,
    "shares_outstanding": 86200000.0,
    "pcnt_held_by_insiders": 0.0089,
    "pcnt_held_by_institutions": 0.981,
    "pcnt_short_of_float": 0.0721,
    "operating_cash_flow_ttm": -38100000.0,
    "levered_cash_flow_ttm": -24360000.0,
    "book_value_per_share_mrq": 5.2,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Neurocrine Biosciences Inc."
  },
  "NBRV": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -4.78,
    "ebitda": -19230000.0,
    "eps_estimate_current_year": -6.5,
    "eps_estimate_next_quarter": -0.37,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 9.4,
    "fifty_two_week_low": 8.61,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 2.31,
    "two_hundred_day_moving_average": 0.0,
    "volume": 45294.0,
    "market_cap": 185120000.0,
    "price_to_sales_ttm": 55.13,
    "price_to_book_mrq": 1.6,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 20990000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -20120000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 5.42,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Nabriva Therapeutics AG"
  },
  "NBY": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.317,
    "ebitda": -19600000.0,
    "eps_estimate_current_year": -4.95,
    "eps_estimate_next_quarter": -1.19,
    "fifty_day_moving_average": 3.8957,
    "fifty_two_week_high": 26.25,
    "fifty_two_week_low": 0.09,
    "percent_change_from_200_day_moving_average": -0.99021,
    "percent_change_from_50_day_moving_average": -0.9737659999999999,
    "shares_owned": "N/A",
    "short_ratio": 1.37,
    "two_hundred_day_moving_average": 10.4387,
    "volume": 820083.0,
    "market_cap": 8910000.0,
    "price_to_sales_ttm": 2.46,
    "price_to_book_mrq": 30.47,
    "roa_ttm": -1.3935,
    "roe_ttm": -6.5023,
    "shares_outstanding": 87140000.0,
    "pcnt_held_by_insiders": 0.1917,
    "pcnt_held_by_institutions": 0.049,
    "pcnt_short_of_float": 0.005699999999999999,
    "operating_cash_flow_ttm": -18210000.0,
    "levered_cash_flow_ttm": -10570000.0,
    "book_value_per_share_mrq": 0.0,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "NovaBay Pharmaceuticals, Inc."
  },
  "NDRM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.87,
    "ebitda": -17940000.0,
    "eps_estimate_current_year": -0.95,
    "eps_estimate_next_quarter": -0.41,
    "fifty_day_moving_average": 18.91,
    "fifty_two_week_high": 26.5,
    "fifty_two_week_low": 5.81,
    "percent_change_from_200_day_moving_average": -0.1005,
    "percent_change_from_50_day_moving_average": -0.0706,
    "shares_owned": "N/A",
    "short_ratio": 3.7,
    "two_hundred_day_moving_average": 19.53,
    "volume": 665638.0,
    "market_cap": 378400000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.81,
    "roa_ttm": -0.20329999999999998,
    "roe_ttm": -0.6520999999999999,
    "shares_outstanding": 21540000.0,
    "pcnt_held_by_insiders": 0.5273,
    "pcnt_held_by_institutions": 0.11,
    "pcnt_short_of_float": 0.1283,
    "operating_cash_flow_ttm": -13390000.0,
    "levered_cash_flow_ttm": -5810000.0,
    "book_value_per_share_mrq": 4.74,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "NeuroDerm Ltd."
  },
  "NEO": {
    "p_e_ratio": "N/A",
    "peg_ratio": -40.35,
    "earnings_per_share": -0.0,
    "ebitda": 8020000.0,
    "eps_estimate_current_year": -0.01,
    "eps_estimate_next_quarter": 0.01,
    "fifty_day_moving_average": 7.8,
    "fifty_two_week_high": 8.3,
    "fifty_two_week_low": 3.33,
    "percent_change_from_200_day_moving_average": 0.245,
    "percent_change_from_50_day_moving_average": 0.039,
    "shares_owned": "N/A",
    "short_ratio": 4.22,
    "two_hundred_day_moving_average": 6.51,
    "volume": 521022.0,
    "market_cap": 491010000.0,
    "price_to_sales_ttm": 4.99,
    "price_to_book_mrq": 7.9,
    "roa_ttm": 0.0097,
    "roe_ttm": -0.0003,
    "shares_outstanding": 60620000.0,
    "pcnt_held_by_insiders": 0.1747,
    "pcnt_held_by_institutions": 0.609,
    "pcnt_short_of_float": 0.0441,
    "operating_cash_flow_ttm": 5260000.0,
    "levered_cash_flow_ttm": 2650000.0,
    "book_value_per_share_mrq": 1.02,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Neogenomics Inc."
  },
  "NEOG": {
    "p_e_ratio": 63.71,
    "peg_ratio": 3.47,
    "earnings_per_share": 0.91,
    "ebitda": 65410000.0,
    "eps_estimate_current_year": 1.07,
    "eps_estimate_next_quarter": 0.26,
    "fifty_day_moving_average": 57.15,
    "fifty_two_week_high": 62.7,
    "fifty_two_week_low": 41.51,
    "percent_change_from_200_day_moving_average": 0.10830000000000001,
    "percent_change_from_50_day_moving_average": 0.0146,
    "shares_owned": "N/A",
    "short_ratio": 10.47,
    "two_hundred_day_moving_average": 52.31,
    "volume": 666662.0,
    "market_cap": 2170000000.0,
    "price_to_sales_ttm": 7.48,
    "price_to_book_mrq": 5.93,
    "roa_ttm": 0.0889,
    "roe_ttm": 0.0992,
    "shares_outstanding": 37370000.0,
    "pcnt_held_by_insiders": 0.0407,
    "pcnt_held_by_institutions": 0.868,
    "pcnt_short_of_float": 0.0513,
    "operating_cash_flow_ttm": 39970000.0,
    "levered_cash_flow_ttm": 30950000.0,
    "book_value_per_share_mrq": 9.79,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Neogen Corp."
  },
  "NEOS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -7.84,
    "ebitda": -19770000.0,
    "eps_estimate_current_year": -7.28,
    "eps_estimate_next_quarter": -0.87,
    "fifty_day_moving_average": 14.36,
    "fifty_two_week_high": 28.99,
    "fifty_two_week_low": 11.53,
    "percent_change_from_200_day_moving_average": -0.3272,
    "percent_change_from_50_day_moving_average": -0.1359,
    "shares_owned": "N/A",
    "short_ratio": 6.24,
    "two_hundred_day_moving_average": 18.44,
    "volume": 524438.0,
    "market_cap": 197850000.0,
    "price_to_sales_ttm": 81.11,
    "price_to_book_mrq": 2.38,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 15940000.0,
    "pcnt_held_by_insiders": 0.0962,
    "pcnt_held_by_institutions": 0.021,
    "pcnt_short_of_float": 0.0382,
    "operating_cash_flow_ttm": -18840000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 5.49,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Neos Therapeutics, Inc."
  },
  "NEOT": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.01,
    "earnings_per_share": -3.08,
    "ebitda": -36030000.0,
    "eps_estimate_current_year": -3.7,
    "eps_estimate_next_quarter": -0.22,
    "fifty_day_moving_average": 7.89,
    "fifty_two_week_high": 15.05,
    "fifty_two_week_low": 1.24,
    "percent_change_from_200_day_moving_average": -0.8675,
    "percent_change_from_50_day_moving_average": -0.8364,
    "shares_owned": "N/A",
    "short_ratio": 3.36,
    "two_hundred_day_moving_average": 9.73,
    "volume": 759837.0,
    "market_cap": 17710000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 0.53,
    "roa_ttm": -0.6548999999999999,
    "roe_ttm": -1.6894,
    "shares_outstanding": 13730000.0,
    "pcnt_held_by_insiders": 0.5408,
    "pcnt_held_by_institutions": 0.209,
    "pcnt_short_of_float": 0.018000000000000002,
    "operating_cash_flow_ttm": -27480000.0,
    "levered_cash_flow_ttm": -13310000.0,
    "book_value_per_share_mrq": 2.39,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Neothetics, Inc."
  },
  "NEPT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.163,
    "ebitda": -17920000.0,
    "eps_estimate_current_year": -0.1,
    "eps_estimate_next_quarter": -0.01,
    "fifty_day_moving_average": 1.1346,
    "fifty_two_week_high": 2.11,
    "fifty_two_week_low": 0.97,
    "percent_change_from_200_day_moving_average": -0.18341200000000002,
    "percent_change_from_50_day_moving_average": -0.099571,
    "shares_owned": "N/A",
    "short_ratio": 19.15,
    "two_hundred_day_moving_average": 1.2511,
    "volume": 112745.0,
    "market_cap": 76990000.0,
    "price_to_sales_ttm": 6.96,
    "price_to_book_mrq": 2.2,
    "roa_ttm": -0.1654,
    "roe_ttm": -0.24480000000000002,
    "shares_outstanding": 75370000.0,
    "pcnt_held_by_insiders": 0.1501,
    "pcnt_held_by_institutions": 0.015,
    "pcnt_short_of_float": 0.0002,
    "operating_cash_flow_ttm": -17150000.0,
    "levered_cash_flow_ttm": -15250000.0,
    "book_value_per_share_mrq": 0.48,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Neptune Technologies & Bioressources, Inc."
  },
  "NERV": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.19,
    "ebitda": -25340000.0,
    "eps_estimate_current_year": -1.18,
    "eps_estimate_next_quarter": -0.39,
    "fifty_day_moving_average": 5.08,
    "fifty_two_week_high": 10.0,
    "fifty_two_week_low": 4.25,
    "percent_change_from_200_day_moving_average": 0.0252,
    "percent_change_from_50_day_moving_average": 0.10189999999999999,
    "shares_owned": "N/A",
    "short_ratio": 3.96,
    "two_hundred_day_moving_average": 5.46,
    "volume": 68236.0,
    "market_cap": 138440000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.11,
    "roa_ttm": -0.1949,
    "roe_ttm": -0.4355,
    "shares_outstanding": 24720000.0,
    "pcnt_held_by_insiders": 0.4623,
    "pcnt_held_by_institutions": 0.358,
    "pcnt_short_of_float": 0.0064,
    "operating_cash_flow_ttm": -22680000.0,
    "levered_cash_flow_ttm": -23800000.0,
    "book_value_per_share_mrq": 2.55,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Minerva Neurosciences, Inc."
  },
  "NHC": {
    "p_e_ratio": 20.38,
    "peg_ratio": 0.0,
    "earnings_per_share": 3.1,
    "ebitda": 106170000.0,
    "eps_estimate_current_year": 2.54,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 65.61,
    "fifty_two_week_high": 69.4,
    "fifty_two_week_low": 58.98,
    "percent_change_from_200_day_moving_average": -0.0105,
    "percent_change_from_50_day_moving_average": -0.0375,
    "shares_owned": "N/A",
    "short_ratio": 10.9,
    "two_hundred_day_moving_average": 63.82,
    "volume": 99379.0,
    "market_cap": 941310000.0,
    "price_to_sales_ttm": 1.06,
    "price_to_book_mrq": 1.59,
    "roa_ttm": 0.0409,
    "roe_ttm": 0.0727,
    "shares_outstanding": 14910000.0,
    "pcnt_held_by_insiders": 0.342,
    "pcnt_held_by_institutions": 0.368,
    "pcnt_short_of_float": 0.023399999999999997,
    "operating_cash_flow_ttm": 81080000.0,
    "levered_cash_flow_ttm": 28430000.0,
    "book_value_per_share_mrq": 40.34,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "National HealthCare Corporation"
  },
  "NK": {
    "p_e_ratio": "N/A",
    "peg_ratio": 3.59,
    "earnings_per_share": -2.97,
    "ebitda": -160540000.0,
    "eps_estimate_current_year": -2.57,
    "eps_estimate_next_quarter": -0.14,
    "fifty_day_moving_average": 16.04,
    "fifty_two_week_high": 38.48,
    "fifty_two_week_low": 10.1,
    "percent_change_from_200_day_moving_average": -0.12050000000000001,
    "percent_change_from_50_day_moving_average": -0.0229,
    "shares_owned": "N/A",
    "short_ratio": 6.38,
    "two_hundred_day_moving_average": 17.82,
    "volume": 3208021.0,
    "market_cap": 1270000000.0,
    "price_to_sales_ttm": 3977.25,
    "price_to_book_mrq": 3.51,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 81220000.0,
    "pcnt_held_by_insiders": 0.5454,
    "pcnt_held_by_institutions": 0.048,
    "pcnt_short_of_float": 0.1099,
    "operating_cash_flow_ttm": -16780000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 4.47,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "NantKwest, Inc."
  },
  "NKTR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 3.76,
    "earnings_per_share": -0.56,
    "ebitda": -25190000.0,
    "eps_estimate_current_year": -0.58,
    "eps_estimate_next_quarter": -0.29,
    "fifty_day_moving_average": 14.53,
    "fifty_two_week_high": 16.4,
    "fifty_two_week_low": 9.16,
    "percent_change_from_200_day_moving_average": 0.2798,
    "percent_change_from_50_day_moving_average": 0.0924,
    "shares_owned": "N/A",
    "short_ratio": 13.79,
    "two_hundred_day_moving_average": 12.4,
    "volume": 3921104.0,
    "market_cap": 2120000000.0,
    "price_to_sales_ttm": 10.06,
    "price_to_book_mrq": 54.3,
    "roa_ttm": -0.0506,
    "roe_ttm": -1.6859,
    "shares_outstanding": 133449999.99999999,
    "pcnt_held_by_insiders": 0.0044,
    "pcnt_held_by_institutions": 1.057,
    "pcnt_short_of_float": 0.21760000000000002,
    "operating_cash_flow_ttm": -22600000.0,
    "levered_cash_flow_ttm": 37280000.0,
    "book_value_per_share_mrq": 0.29,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Nektar Therapeutics"
  },
  "NLNK": {
    "p_e_ratio": 10.31,
    "peg_ratio": 0.0,
    "earnings_per_share": 3.43,
    "ebitda": 131610000.00000001,
    "eps_estimate_current_year": -1.6,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 36.45,
    "fifty_two_week_high": 58.73,
    "fifty_two_week_low": 31.56,
    "percent_change_from_200_day_moving_average": -0.18239999999999998,
    "percent_change_from_50_day_moving_average": -0.0308,
    "shares_owned": "N/A",
    "short_ratio": 8.44,
    "two_hundred_day_moving_average": 43.21,
    "volume": 737743.0,
    "market_cap": 1020000000.0,
    "price_to_sales_ttm": 4.43,
    "price_to_book_mrq": 4.91,
    "roa_ttm": 0.5207,
    "roe_ttm": 0.7779,
    "shares_outstanding": 28780000.0,
    "pcnt_held_by_insiders": 0.3231,
    "pcnt_held_by_institutions": 0.504,
    "pcnt_short_of_float": 0.25370000000000004,
    "operating_cash_flow_ttm": 114940000.0,
    "levered_cash_flow_ttm": 90810000.0,
    "book_value_per_share_mrq": 7.21,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "NewLink Genetics Corporation"
  },
  "NNVC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.13,
    "ebitda": -7340000.0,
    "eps_estimate_current_year": -0.2,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.16,
    "fifty_two_week_high": 3.15,
    "fifty_two_week_low": 0.89,
    "percent_change_from_200_day_moving_average": -0.2273,
    "percent_change_from_50_day_moving_average": -0.0837,
    "shares_owned": "N/A",
    "short_ratio": 20.5,
    "two_hundred_day_moving_average": 1.37,
    "volume": 84286.0,
    "market_cap": 61040000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.01,
    "roa_ttm": -0.1061,
    "roe_ttm": -0.13849999999999998,
    "shares_outstanding": 57590000.0,
    "pcnt_held_by_insiders": 0.24989999999999998,
    "pcnt_held_by_institutions": 0.07200000000000001,
    "pcnt_short_of_float": 0.0341,
    "operating_cash_flow_ttm": -6170000.0,
    "levered_cash_flow_ttm": -10290000.0,
    "book_value_per_share_mrq": 0.53,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "NanoViricides, Inc."
  },
  "NRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.41,
    "ebitda": -21710000.0,
    "eps_estimate_current_year": -2.32,
    "eps_estimate_next_quarter": -0.48,
    "fifty_day_moving_average": 2.06,
    "fifty_two_week_high": 17.98,
    "fifty_two_week_low": 1.44,
    "percent_change_from_200_day_moving_average": -0.6142,
    "percent_change_from_50_day_moving_average": -0.23800000000000002,
    "shares_owned": "N/A",
    "short_ratio": 2.89,
    "two_hundred_day_moving_average": 4.07,
    "volume": 155177.0,
    "market_cap": 20330000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.56,
    "roa_ttm": -0.5509000000000001,
    "roe_ttm": -1.2453,
    "shares_outstanding": 12950000.0,
    "pcnt_held_by_insiders": 0.5586,
    "pcnt_held_by_institutions": 0.215,
    "pcnt_short_of_float": 0.09210000000000002,
    "operating_cash_flow_ttm": -20460000.0,
    "levered_cash_flow_ttm": -12470000.0,
    "book_value_per_share_mrq": 1.06,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "NephroGenex, Inc."
  },
  "NSPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.01,
    "earnings_per_share": -6.572,
    "ebitda": -29700000.0,
    "eps_estimate_current_year": -2.25,
    "eps_estimate_next_quarter": -0.63,
    "fifty_day_moving_average": 1.2349,
    "fifty_two_week_high": 9.0,
    "fifty_two_week_low": 0.48,
    "percent_change_from_200_day_moving_average": -0.665526,
    "percent_change_from_50_day_moving_average": -0.38276400000000005,
    "shares_owned": "N/A",
    "short_ratio": 3.49,
    "two_hundred_day_moving_average": 2.2788,
    "volume": 2174715.0,
    "market_cap": 22490000.0,
    "price_to_sales_ttm": 0.21,
    "price_to_book_mrq": 0.28,
    "roa_ttm": -0.5550999999999999,
    "roe_ttm": -2.2011000000000003,
    "shares_outstanding": 29510000.0,
    "pcnt_held_by_insiders": 0.1038,
    "pcnt_held_by_institutions": 0.162,
    "pcnt_short_of_float": 0.059000000000000004,
    "operating_cash_flow_ttm": -29270000.0,
    "levered_cash_flow_ttm": -20360000.0,
    "book_value_per_share_mrq": 1.75,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Nanosphere, Inc."
  },
  "NSPR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.9,
    "ebitda": -15230000.0,
    "eps_estimate_current_year": -2.55,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.85,
    "fifty_two_week_high": 10.1,
    "fifty_two_week_low": 0.63,
    "percent_change_from_200_day_moving_average": -0.6031,
    "percent_change_from_50_day_moving_average": -0.16219999999999998,
    "shares_owned": "N/A",
    "short_ratio": 1.13,
    "two_hundred_day_moving_average": 1.79,
    "volume": 16125.0,
    "market_cap": 5530000.0,
    "price_to_sales_ttm": 2.35,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.9864,
    "roe_ttm": "N/A",
    "shares_outstanding": 7790000.0,
    "pcnt_held_by_insiders": 0.17550000000000002,
    "pcnt_held_by_institutions": 0.152,
    "pcnt_short_of_float": 0.0231,
    "operating_cash_flow_ttm": -14470000.0,
    "levered_cash_flow_ttm": -8320000.0,
    "book_value_per_share_mrq": -0.08,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "InspireMD, Inc."
  },
  "NSTG": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.63,
    "ebitda": -43320000.0,
    "eps_estimate_current_year": -1.79,
    "eps_estimate_next_quarter": -0.42,
    "fifty_day_moving_average": 14.4,
    "fifty_two_week_high": 19.81,
    "fifty_two_week_low": 9.95,
    "percent_change_from_200_day_moving_average": -0.045599999999999995,
    "percent_change_from_50_day_moving_average": 0.008,
    "shares_owned": "N/A",
    "short_ratio": 11.96,
    "two_hundred_day_moving_average": 15.21,
    "volume": 629027.0,
    "market_cap": 283240000.0,
    "price_to_sales_ttm": 5.1,
    "price_to_book_mrq": 10.49,
    "roa_ttm": -0.3093,
    "roe_ttm": -1.1861,
    "shares_outstanding": 19510000.0,
    "pcnt_held_by_insiders": 0.1766,
    "pcnt_held_by_institutions": 0.772,
    "pcnt_short_of_float": 0.1264,
    "operating_cash_flow_ttm": -43640000.0,
    "levered_cash_flow_ttm": -28410000.0,
    "book_value_per_share_mrq": 1.39,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "NanoString Technologies, Inc."
  },
  "NTEC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.03,
    "ebitda": -5580000.0,
    "eps_estimate_current_year": -0.96,
    "eps_estimate_next_quarter": -0.16,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 5.7,
    "fifty_two_week_low": 5.44,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 0.15,
    "two_hundred_day_moving_average": 0.0,
    "volume": 9707.0,
    "market_cap": 47720000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.23,
    "roa_ttm": -0.1518,
    "roe_ttm": -0.2929,
    "shares_outstanding": 8680000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -4960000.0,
    "levered_cash_flow_ttm": -3770000.0,
    "book_value_per_share_mrq": 4.44,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Intec Pharma Ltd."
  },
  "NTRA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.02,
    "ebitda": -31680000.0,
    "eps_estimate_current_year": -2.15,
    "eps_estimate_next_quarter": -0.49,
    "fifty_day_moving_average": 9.46,
    "fifty_two_week_high": 23.24,
    "fifty_two_week_low": 7.74,
    "percent_change_from_200_day_moving_average": -0.125,
    "percent_change_from_50_day_moving_average": 0.2302,
    "shares_owned": "N/A",
    "short_ratio": 17.31,
    "two_hundred_day_moving_average": 13.3,
    "volume": 347010.0,
    "market_cap": 581950000.0,
    "price_to_sales_ttm": 2.91,
    "price_to_book_mrq": 2.64,
    "roa_ttm": -0.147,
    "roe_ttm": -0.4235,
    "shares_outstanding": 50000000.0,
    "pcnt_held_by_insiders": 0.1637,
    "pcnt_held_by_institutions": 0.064,
    "pcnt_short_of_float": 0.0843,
    "operating_cash_flow_ttm": -23010000.0,
    "levered_cash_flow_ttm": -16780000.0,
    "book_value_per_share_mrq": 4.13,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Natera, Inc."
  },
  "NURO": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.04,
    "earnings_per_share": -5.49,
    "ebitda": -12160000.0,
    "eps_estimate_current_year": -3.8,
    "eps_estimate_next_quarter": -0.68,
    "fifty_day_moving_average": 2.61,
    "fifty_two_week_high": 8.2,
    "fifty_two_week_low": 2.17,
    "percent_change_from_200_day_moving_average": -0.2697,
    "percent_change_from_50_day_moving_average": -0.07519999999999999,
    "shares_owned": "N/A",
    "short_ratio": 5.38,
    "two_hundred_day_moving_average": 3.3,
    "volume": 60374.0,
    "market_cap": 8310000.000000001,
    "price_to_sales_ttm": 1.45,
    "price_to_book_mrq": 1.02,
    "roa_ttm": -0.5832,
    "roe_ttm": -1.278,
    "shares_outstanding": 3450000.0,
    "pcnt_held_by_insiders": 0.024399999999999998,
    "pcnt_held_by_institutions": 0.053,
    "pcnt_short_of_float": 0.0342,
    "operating_cash_flow_ttm": -11940000.0,
    "levered_cash_flow_ttm": -8130000.000000001,
    "book_value_per_share_mrq": 2.46,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "NeuroMetrix Inc."
  },
  "NUVA": {
    "p_e_ratio": 42.39,
    "peg_ratio": 2.6,
    "earnings_per_share": 1.22,
    "ebitda": 162430000.0,
    "eps_estimate_current_year": 1.26,
    "eps_estimate_next_quarter": 0.31,
    "fifty_day_moving_average": 51.25,
    "fifty_two_week_high": 56.61,
    "fifty_two_week_low": 41.52,
    "percent_change_from_200_day_moving_average": 0.0171,
    "percent_change_from_50_day_moving_average": 0.009899999999999999,
    "shares_owned": "N/A",
    "short_ratio": 7.37,
    "two_hundred_day_moving_average": 50.89,
    "volume": 926127.0,
    "market_cap": 2540000000.0,
    "price_to_sales_ttm": 3.18,
    "price_to_book_mrq": 3.72,
    "roa_ttm": 0.0521,
    "roe_ttm": 0.0929,
    "shares_outstanding": 49100000.0,
    "pcnt_held_by_insiders": 0.0173,
    "pcnt_held_by_institutions": 1.041,
    "pcnt_short_of_float": 0.06280000000000001,
    "operating_cash_flow_ttm": 67069999.99999999,
    "levered_cash_flow_ttm": -43780000.0,
    "book_value_per_share_mrq": 13.94,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "NuVasive, Inc."
  },
  "NVAX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.43,
    "ebitda": -103120000.0,
    "eps_estimate_current_year": -0.44,
    "eps_estimate_next_quarter": -0.13,
    "fifty_day_moving_average": 7.8,
    "fifty_two_week_high": 15.01,
    "fifty_two_week_low": 5.61,
    "percent_change_from_200_day_moving_average": -0.1056,
    "percent_change_from_50_day_moving_average": 0.0941,
    "shares_owned": "N/A",
    "short_ratio": 7.55,
    "two_hundred_day_moving_average": 9.54,
    "volume": 9833191.0,
    "market_cap": 2300000000.0,
    "price_to_sales_ttm": 63.03,
    "price_to_book_mrq": 6.37,
    "roa_ttm": -0.1972,
    "roe_ttm": -0.3489,
    "shares_outstanding": 269860000.0,
    "pcnt_held_by_insiders": 0.0336,
    "pcnt_held_by_institutions": 0.695,
    "pcnt_short_of_float": 0.1777,
    "operating_cash_flow_ttm": -91110000.0,
    "levered_cash_flow_ttm": -66610000.0,
    "book_value_per_share_mrq": 1.36,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Novavax, Inc."
  },
  "NVCN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.37,
    "ebitda": -19580000.0,
    "eps_estimate_current_year": -0.55,
    "eps_estimate_next_quarter": -0.13,
    "fifty_day_moving_average": 4.55,
    "fifty_two_week_high": 10.12,
    "fifty_two_week_low": 3.49,
    "percent_change_from_200_day_moving_average": -0.3556,
    "percent_change_from_50_day_moving_average": -0.21960000000000002,
    "shares_owned": "N/A",
    "short_ratio": 3.44,
    "two_hundred_day_moving_average": 5.51,
    "volume": 20988.0,
    "market_cap": 236310000.0,
    "price_to_sales_ttm": 25.58,
    "price_to_book_mrq": 3.77,
    "roa_ttm": -0.2901,
    "roe_ttm": -0.5614,
    "shares_outstanding": 66569999.99999999,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -16370000.000000002,
    "levered_cash_flow_ttm": -7610000.0,
    "book_value_per_share_mrq": 0.96,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Neovasc Inc."
  },
  "NVCR": {
    "p_e_ratio": "N/A",
    "peg_ratio": -6.33,
    "earnings_per_share": -7.99,
    "ebitda": -93860000.0,
    "eps_estimate_current_year": -0.81,
    "eps_estimate_next_quarter": -0.26,
    "fifty_day_moving_average": 24.84,
    "fifty_two_week_high": 30.89,
    "fifty_two_week_low": 15.01,
    "percent_change_from_200_day_moving_average": 0.1698,
    "percent_change_from_50_day_moving_average": 0.1158,
    "shares_owned": "N/A",
    "short_ratio": 5.05,
    "two_hundred_day_moving_average": 23.7,
    "volume": 1094538.0,
    "market_cap": 2320000000.0,
    "price_to_sales_ttm": 93.84,
    "price_to_book_mrq": 2.82,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 83620000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0265,
    "operating_cash_flow_ttm": -91380000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 9.75,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "NovoCure Limited"
  },
  "NVDQ": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.59,
    "earnings_per_share": -0.75,
    "ebitda": -32200000.000000004,
    "eps_estimate_current_year": -0.66,
    "eps_estimate_next_quarter": -0.18,
    "fifty_day_moving_average": 12.26,
    "fifty_two_week_high": 17.29,
    "fifty_two_week_low": 9.4,
    "percent_change_from_200_day_moving_average": 0.0758,
    "percent_change_from_50_day_moving_average": 0.0288,
    "shares_owned": "N/A",
    "short_ratio": 20.71,
    "two_hundred_day_moving_average": 11.72,
    "volume": 406376.0,
    "market_cap": 708670000.0,
    "price_to_sales_ttm": 13.2,
    "price_to_book_mrq": 4.67,
    "roa_ttm": -0.1252,
    "roe_ttm": -0.2339,
    "shares_outstanding": 56200000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -32170000.0,
    "levered_cash_flow_ttm": -28310000.0,
    "book_value_per_share_mrq": 2.69,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Novadaq Technologies Inc."
  },
  "NVET": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.73,
    "ebitda": -16570000.0,
    "eps_estimate_current_year": -1.89,
    "eps_estimate_next_quarter": -0.52,
    "fifty_day_moving_average": 4.03,
    "fifty_two_week_high": 11.3,
    "fifty_two_week_low": 2.85,
    "percent_change_from_200_day_moving_average": -0.1748,
    "percent_change_from_50_day_moving_average": -0.09570000000000001,
    "shares_owned": "N/A",
    "short_ratio": 1.33,
    "two_hundred_day_moving_average": 4.41,
    "volume": 854148.0,
    "market_cap": 41710000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 0.7,
    "roa_ttm": -0.2585,
    "roe_ttm": -0.36210000000000003,
    "shares_outstanding": 11460000.0,
    "pcnt_held_by_insiders": 0.4853,
    "pcnt_held_by_institutions": 0.314,
    "pcnt_short_of_float": 0.0176,
    "operating_cash_flow_ttm": -10480000.0,
    "levered_cash_flow_ttm": -9220000.0,
    "book_value_per_share_mrq": 4.25,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Nexvet Biopharma Public Limited Company"
  },
  "NVGN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.55,
    "ebitda": -5330000.0,
    "eps_estimate_current_year": -0.02,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.4,
    "fifty_two_week_high": 9.5,
    "fifty_two_week_low": 2.03,
    "percent_change_from_200_day_moving_average": -0.27149999999999996,
    "percent_change_from_50_day_moving_average": -0.0381,
    "shares_owned": "N/A",
    "short_ratio": 0.73,
    "two_hundred_day_moving_average": 3.17,
    "volume": 23816.0,
    "market_cap": 39090000.0,
    "price_to_sales_ttm": 32.35,
    "price_to_book_mrq": 1.25,
    "roa_ttm": -0.19820000000000002,
    "roe_ttm": -0.31920000000000004,
    "shares_outstanding": 16920000.0,
    "pcnt_held_by_insiders": 0.0479,
    "pcnt_held_by_institutions": 0.025,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -4099999.9999999995,
    "levered_cash_flow_ttm": -2490000.0,
    "book_value_per_share_mrq": 1.88,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Novogen Limited"
  },
  "NVIV": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.46,
    "ebitda": -20900000.0,
    "eps_estimate_current_year": -0.63,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 7.96,
    "fifty_two_week_high": 19.68,
    "fifty_two_week_low": 4.88,
    "percent_change_from_200_day_moving_average": -0.225,
    "percent_change_from_50_day_moving_average": 0.0874,
    "shares_owned": "N/A",
    "short_ratio": 14.89,
    "two_hundred_day_moving_average": 11.17,
    "volume": 614538.0,
    "market_cap": 236920000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 12.08,
    "roa_ttm": -0.61,
    "roe_ttm": -2.4148,
    "shares_outstanding": 27360000.0,
    "pcnt_held_by_insiders": 0.1819,
    "pcnt_held_by_institutions": 0.16399999999999998,
    "pcnt_short_of_float": 0.11960000000000001,
    "operating_cash_flow_ttm": -15190000.0,
    "levered_cash_flow_ttm": -7970000.0,
    "book_value_per_share_mrq": 0.63,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "InVivo Therapeutics Holdings Corp."
  },
  "NVLS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.26,
    "ebitda": -19690000.0,
    "eps_estimate_current_year": -1.76,
    "eps_estimate_next_quarter": -0.34,
    "fifty_day_moving_average": 8.18,
    "fifty_two_week_high": 20.43,
    "fifty_two_week_low": 7.05,
    "percent_change_from_200_day_moving_average": -0.34409999999999996,
    "percent_change_from_50_day_moving_average": 0.0348,
    "shares_owned": "N/A",
    "short_ratio": 4.1,
    "two_hundred_day_moving_average": 12.91,
    "volume": 117215.0,
    "market_cap": 130880000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.39,
    "roa_ttm": -0.25920000000000004,
    "roe_ttm": -0.4432,
    "shares_outstanding": 15450000.0,
    "pcnt_held_by_insiders": 0.1008,
    "pcnt_held_by_institutions": 0.7759999999999999,
    "pcnt_short_of_float": 0.026000000000000002,
    "operating_cash_flow_ttm": -16970000.0,
    "levered_cash_flow_ttm": -9710000.0,
    "book_value_per_share_mrq": 5.78,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Nivalis Therapeutics, Inc."
  },
  "NVRO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 25.03,
    "earnings_per_share": -2.66,
    "ebitda": -56010000.0,
    "eps_estimate_current_year": -2.68,
    "eps_estimate_next_quarter": -0.7,
    "fifty_day_moving_average": 56.25,
    "fifty_two_week_high": 69.0,
    "fifty_two_week_low": 35.11,
    "percent_change_from_200_day_moving_average": 0.3071,
    "percent_change_from_50_day_moving_average": 0.1677,
    "shares_owned": "N/A",
    "short_ratio": 5.64,
    "two_hundred_day_moving_average": 50.26,
    "volume": 626887.0,
    "market_cap": 1840000000.0,
    "price_to_sales_ttm": 40.56,
    "price_to_book_mrq": 7.67,
    "roa_ttm": -0.2048,
    "roe_ttm": -0.42200000000000004,
    "shares_outstanding": 27940000.0,
    "pcnt_held_by_insiders": 0.6684,
    "pcnt_held_by_institutions": 0.5379999999999999,
    "pcnt_short_of_float": 0.2192,
    "operating_cash_flow_ttm": -79160000.0,
    "levered_cash_flow_ttm": -57100000.0,
    "book_value_per_share_mrq": 8.75,
    "next_earnings_announcement_date": [
      "2016-03-16",
      "2016-03-21"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Nevro Corp."
  },
  "NVTA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.95,
    "ebitda": -76010000.0,
    "eps_estimate_current_year": -3.19,
    "eps_estimate_next_quarter": -0.74,
    "fifty_day_moving_average": 7.45,
    "fifty_two_week_high": 22.35,
    "fifty_two_week_low": 6.46,
    "percent_change_from_200_day_moving_average": -0.19329999999999997,
    "percent_change_from_50_day_moving_average": 0.0895,
    "shares_owned": "N/A",
    "short_ratio": 5.88,
    "two_hundred_day_moving_average": 10.07,
    "volume": 117648.0,
    "market_cap": 259240000.0,
    "price_to_sales_ttm": 43.08,
    "price_to_book_mrq": 1.63,
    "roa_ttm": -0.4042,
    "roe_ttm": -0.7136,
    "shares_outstanding": 31930000.0,
    "pcnt_held_by_insiders": 0.5091,
    "pcnt_held_by_institutions": 0.38799999999999996,
    "pcnt_short_of_float": 0.0735,
    "operating_cash_flow_ttm": -74220000.0,
    "levered_cash_flow_ttm": -55270000.0,
    "book_value_per_share_mrq": 5.05,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Invitae Corporation"
  },
  "NWBO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.84,
    "ebitda": -100620000.0,
    "eps_estimate_current_year": -1.85,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 4.62,
    "fifty_two_week_high": 12.55,
    "fifty_two_week_low": 3.45,
    "percent_change_from_200_day_moving_average": -0.4289,
    "percent_change_from_50_day_moving_average": -0.0507,
    "shares_owned": "N/A",
    "short_ratio": 36.12,
    "two_hundred_day_moving_average": 7.69,
    "volume": 581436.0,
    "market_cap": 405450000.0,
    "price_to_sales_ttm": 222.44,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -1.5475999999999999,
    "roe_ttm": "N/A",
    "shares_outstanding": 92360000.0,
    "pcnt_held_by_insiders": 0.30219999999999997,
    "pcnt_held_by_institutions": 0.426,
    "pcnt_short_of_float": 0.3875,
    "operating_cash_flow_ttm": -75080000.0,
    "levered_cash_flow_ttm": -20160000.0,
    "book_value_per_share_mrq": -0.73,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Northwest Biotherapeutics, Inc."
  },
  "NXTM": {
    "p_e_ratio": "N/A",
    "peg_ratio": -4.23,
    "earnings_per_share": -0.28,
    "ebitda": 338999.0,
    "eps_estimate_current_year": -0.24,
    "eps_estimate_next_quarter": -0.05,
    "fifty_day_moving_average": 19.62,
    "fifty_two_week_high": 21.1,
    "fifty_two_week_low": 13.47,
    "percent_change_from_200_day_moving_average": 0.2095,
    "percent_change_from_50_day_moving_average": 0.0356,
    "shares_owned": "N/A",
    "short_ratio": 5.73,
    "two_hundred_day_moving_average": 16.8,
    "volume": 722410.0,
    "market_cap": 1300000000.0,
    "price_to_sales_ttm": 3.94,
    "price_to_book_mrq": 6.79,
    "roa_ttm": -0.0341,
    "roe_ttm": -0.098,
    "shares_outstanding": 63730000.0,
    "pcnt_held_by_insiders": 0.0655,
    "pcnt_held_by_institutions": 0.9740000000000001,
    "pcnt_short_of_float": 0.0593,
    "operating_cash_flow_ttm": -1460000.0,
    "levered_cash_flow_ttm": 15980000.0,
    "book_value_per_share_mrq": 2.97,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Nxstage Medical, Inc."
  },
  "NYMX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.63,
    "ebitda": -22940000.0,
    "eps_estimate_current_year": -0.2,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.43,
    "fifty_two_week_high": 4.37,
    "fifty_two_week_low": 0.35,
    "percent_change_from_200_day_moving_average": 0.4057,
    "percent_change_from_50_day_moving_average": 0.060899999999999996,
    "shares_owned": "N/A",
    "short_ratio": 8.25,
    "two_hundred_day_moving_average": 2.59,
    "volume": 291902.0,
    "market_cap": 155160000.0,
    "price_to_sales_ttm": 34.52,
    "price_to_book_mrq": "N/A",
    "roa_ttm": "-1,382.64%",
    "roe_ttm": "N/A",
    "shares_outstanding": 42630000.0,
    "pcnt_held_by_insiders": 0.061,
    "pcnt_held_by_institutions": 0.027999999999999997,
    "pcnt_short_of_float": 0.0593,
    "operating_cash_flow_ttm": -4040000.0,
    "levered_cash_flow_ttm": 5690000.0,
    "book_value_per_share_mrq": -0.06,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Nymox Pharmaceutical Corporation"
  },
  "OASM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.51,
    "ebitda": -14800000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 3.59,
    "fifty_two_week_low": 3.52,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 0.0,
    "two_hundred_day_moving_average": 0.0,
    "volume": 2650.0,
    "market_cap": 125500000.0,
    "price_to_sales_ttm": 61.67,
    "price_to_book_mrq": 3.05,
    "roa_ttm": -0.1648,
    "roe_ttm": -0.44780000000000003,
    "shares_outstanding": 34960000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -10870000.0,
    "levered_cash_flow_ttm": -11930000.0,
    "book_value_per_share_mrq": 1.21,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Oasmia Pharmaceutical AB (publ)"
  },
  "OCAT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.67,
    "ebitda": -27700000.0,
    "eps_estimate_current_year": -0.62,
    "eps_estimate_next_quarter": -0.18,
    "fifty_day_moving_average": 7.71,
    "fifty_two_week_high": 8.71,
    "fifty_two_week_low": 3.06,
    "percent_change_from_200_day_moving_average": 0.5706,
    "percent_change_from_50_day_moving_average": 0.1009,
    "shares_owned": "N/A",
    "short_ratio": 1.44,
    "two_hundred_day_moving_average": 5.41,
    "volume": 2312415.0,
    "market_cap": 359130000.0,
    "price_to_sales_ttm": 1772.08,
    "price_to_book_mrq": 26.12,
    "roa_ttm": -0.8184999999999999,
    "roe_ttm": -3.4454000000000002,
    "shares_outstanding": 42300000.0,
    "pcnt_held_by_insiders": 0.08109999999999999,
    "pcnt_held_by_institutions": 0.141,
    "pcnt_short_of_float": 0.052300000000000006,
    "operating_cash_flow_ttm": -24140000.0,
    "levered_cash_flow_ttm": -37100000.0,
    "book_value_per_share_mrq": 0.33,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ocata Therapeutics, Inc."
  },
  "OCLS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.87,
    "ebitda": -7500000.0,
    "eps_estimate_current_year": -0.45,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 1.17,
    "fifty_two_week_high": 1.97,
    "fifty_two_week_low": 0.65,
    "percent_change_from_200_day_moving_average": -0.1322,
    "percent_change_from_50_day_moving_average": -0.04650000000000001,
    "shares_owned": "N/A",
    "short_ratio": 5.24,
    "two_hundred_day_moving_average": 1.29,
    "volume": 145681.0,
    "market_cap": 18490000.0,
    "price_to_sales_ttm": 1.25,
    "price_to_book_mrq": 1.74,
    "roa_ttm": -0.3037,
    "roe_ttm": -0.9551000000000001,
    "shares_outstanding": 16510000.000000002,
    "pcnt_held_by_insiders": 0.030899999999999997,
    "pcnt_held_by_institutions": 0.063,
    "pcnt_short_of_float": 0.0535,
    "operating_cash_flow_ttm": -8020000.0,
    "levered_cash_flow_ttm": -5820000.0,
    "book_value_per_share_mrq": 0.66,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Oculus Innovative Sciences, Inc."
  },
  "OCRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.26,
    "ebitda": -24880000.0,
    "eps_estimate_current_year": -1.31,
    "eps_estimate_next_quarter": -0.34,
    "fifty_day_moving_average": 3.33,
    "fifty_two_week_high": 7.5,
    "fifty_two_week_low": 2.82,
    "percent_change_from_200_day_moving_average": -0.18170000000000003,
    "percent_change_from_50_day_moving_average": -0.1001,
    "shares_owned": "N/A",
    "short_ratio": 0.5,
    "two_hundred_day_moving_average": 3.67,
    "volume": 33955.0,
    "market_cap": 61510000.0,
    "price_to_sales_ttm": 436.61,
    "price_to_book_mrq": 1.66,
    "roa_ttm": -0.2928,
    "roe_ttm": -0.5535,
    "shares_outstanding": 20500000.0,
    "pcnt_held_by_insiders": 0.41359999999999997,
    "pcnt_held_by_institutions": 0.299,
    "pcnt_short_of_float": 0.0096,
    "operating_cash_flow_ttm": -19330000.0,
    "levered_cash_flow_ttm": -10790000.0,
    "book_value_per_share_mrq": 1.78,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ocera Therapeutics, Inc."
  },
  "OCUL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.65,
    "ebitda": -34750000.0,
    "eps_estimate_current_year": -1.56,
    "eps_estimate_next_quarter": -0.48,
    "fifty_day_moving_average": 9.3,
    "fifty_two_week_high": 44.19,
    "fifty_two_week_low": 6.74,
    "percent_change_from_200_day_moving_average": -0.375,
    "percent_change_from_50_day_moving_average": 0.129,
    "shares_owned": "N/A",
    "short_ratio": 7.69,
    "two_hundred_day_moving_average": 16.8,
    "volume": 1079497.0,
    "market_cap": 259709999.99999997,
    "price_to_sales_ttm": 131.51,
    "price_to_book_mrq": 2.42,
    "roa_ttm": -0.2182,
    "roe_ttm": -0.4509,
    "shares_outstanding": 24730000.0,
    "pcnt_held_by_insiders": 0.3209,
    "pcnt_held_by_institutions": 0.73,
    "pcnt_short_of_float": 0.1902,
    "operating_cash_flow_ttm": -30730000.0,
    "levered_cash_flow_ttm": -18250000.0,
    "book_value_per_share_mrq": 4.0,
    "next_earnings_announcement_date": [
      "2016-03-08",
      "2016-03-14"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ocular Therapeutix, Inc."
  },
  "OFIX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 2.82,
    "earnings_per_share": -0.64,
    "ebitda": 26200000.0,
    "eps_estimate_current_year": 0.75,
    "eps_estimate_next_quarter": 0.19,
    "fifty_day_moving_average": 39.11,
    "fifty_two_week_high": 42.61,
    "fifty_two_week_low": 28.05,
    "percent_change_from_200_day_moving_average": 0.07200000000000001,
    "percent_change_from_50_day_moving_average": -0.016200000000000003,
    "shares_owned": "N/A",
    "short_ratio": 3.07,
    "two_hundred_day_moving_average": 35.89,
    "volume": 113107.0,
    "market_cap": 726880000.0,
    "price_to_sales_ttm": 1.87,
    "price_to_book_mrq": 2.47,
    "roa_ttm": 0.0105,
    "roe_ttm": -0.0317,
    "shares_outstanding": 18890000.0,
    "pcnt_held_by_insiders": 0.032400000000000005,
    "pcnt_held_by_institutions": 0.995,
    "pcnt_short_of_float": 0.0208,
    "operating_cash_flow_ttm": 41230000.0,
    "levered_cash_flow_ttm": 63710000.0,
    "book_value_per_share_mrq": 15.74,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Orthofix International N.V."
  },
  "OGEN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.29,
    "ebitda": -10630000.0,
    "eps_estimate_current_year": -0.37,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.28,
    "fifty_two_week_high": 3.87,
    "fifty_two_week_low": 0.66,
    "percent_change_from_200_day_moving_average": -0.13849999999999998,
    "percent_change_from_50_day_moving_average": 0.1886,
    "shares_owned": "N/A",
    "short_ratio": 4.59,
    "two_hundred_day_moving_average": 1.76,
    "volume": 55518.0,
    "market_cap": 55450000.0,
    "price_to_sales_ttm": 38.49,
    "price_to_book_mrq": 29.76,
    "roa_ttm": -0.6786,
    "roe_ttm": -1.6401,
    "shares_outstanding": 36480000.0,
    "pcnt_held_by_insiders": 0.3386,
    "pcnt_held_by_institutions": 0.405,
    "pcnt_short_of_float": 0.0259,
    "operating_cash_flow_ttm": -4680000.0,
    "levered_cash_flow_ttm": -6020000.0,
    "book_value_per_share_mrq": 0.04,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Oragenics Inc."
  },
  "OGXI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.86,
    "ebitda": -21970000.0,
    "eps_estimate_current_year": -0.78,
    "eps_estimate_next_quarter": -0.21,
    "fifty_day_moving_average": 1.92,
    "fifty_two_week_high": 4.1,
    "fifty_two_week_low": 1.11,
    "percent_change_from_200_day_moving_average": -0.5152,
    "percent_change_from_50_day_moving_average": -0.3861,
    "shares_owned": "N/A",
    "short_ratio": 7.71,
    "two_hundred_day_moving_average": 2.43,
    "volume": 378145.0,
    "market_cap": 35170000.0,
    "price_to_sales_ttm": 1.99,
    "price_to_book_mrq": 0.91,
    "roa_ttm": -0.2121,
    "roe_ttm": -0.5347999999999999,
    "shares_outstanding": 29800000.0,
    "pcnt_held_by_insiders": 0.0079,
    "pcnt_held_by_institutions": 0.27,
    "pcnt_short_of_float": 0.1158,
    "operating_cash_flow_ttm": -5360000.0,
    "levered_cash_flow_ttm": 5160000.0,
    "book_value_per_share_mrq": 1.3,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "OncoGenex Pharmaceuticals, Inc."
  },
  "OHRP": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.05,
    "earnings_per_share": -0.54,
    "ebitda": -16290000.0,
    "eps_estimate_current_year": -0.98,
    "eps_estimate_next_quarter": -0.23,
    "fifty_day_moving_average": 3.84,
    "fifty_two_week_high": 12.31,
    "fifty_two_week_low": 2.02,
    "percent_change_from_200_day_moving_average": 0.6344,
    "percent_change_from_50_day_moving_average": 0.32020000000000004,
    "shares_owned": "N/A",
    "short_ratio": 4.6,
    "two_hundred_day_moving_average": 3.1,
    "volume": 674907.0,
    "market_cap": 153780000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.38,
    "roa_ttm": -0.2785,
    "roe_ttm": -0.439,
    "shares_outstanding": 30330000.0,
    "pcnt_held_by_insiders": 0.2441,
    "pcnt_held_by_institutions": 0.203,
    "pcnt_short_of_float": 0.1235,
    "operating_cash_flow_ttm": -10690000.0,
    "levered_cash_flow_ttm": -7300000.0,
    "book_value_per_share_mrq": 1.4,
    "next_earnings_announcement_date": [
      "2015-12-21",
      "2015-12-28"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ohr Pharmaceutical, Inc."
  },
  "OMED": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.53,
    "ebitda": -74770000.0,
    "eps_estimate_current_year": -2.74,
    "eps_estimate_next_quarter": 0.85,
    "fifty_day_moving_average": 21.11,
    "fifty_two_week_high": 29.83,
    "fifty_two_week_low": 13.33,
    "percent_change_from_200_day_moving_average": -0.012199999999999999,
    "percent_change_from_50_day_moving_average": -0.0248,
    "shares_owned": "N/A",
    "short_ratio": 15.27,
    "two_hundred_day_moving_average": 20.84,
    "volume": 243303.0,
    "market_cap": 619940000.0,
    "price_to_sales_ttm": 22.58,
    "price_to_book_mrq": 25.01,
    "roa_ttm": -0.21050000000000002,
    "roe_ttm": -1.3241999999999998,
    "shares_outstanding": 30110000.0,
    "pcnt_held_by_insiders": 0.6174000000000001,
    "pcnt_held_by_institutions": 0.37200000000000005,
    "pcnt_short_of_float": 0.09390000000000001,
    "operating_cash_flow_ttm": -73010000.0,
    "levered_cash_flow_ttm": -35540000.0,
    "book_value_per_share_mrq": 0.83,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "OncoMed Pharmaceuticals, Inc."
  },
  "OMER": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.08,
    "earnings_per_share": -2.08,
    "ebitda": -72930000.0,
    "eps_estimate_current_year": -2.01,
    "eps_estimate_next_quarter": -0.39,
    "fifty_day_moving_average": 14.35,
    "fifty_two_week_high": 30.23,
    "fifty_two_week_low": 10.48,
    "percent_change_from_200_day_moving_average": -0.052000000000000005,
    "percent_change_from_50_day_moving_average": 0.023,
    "shares_owned": "N/A",
    "short_ratio": 29.31,
    "two_hundred_day_moving_average": 15.49,
    "volume": 2618708.0,
    "market_cap": 557390000.0,
    "price_to_sales_ttm": 73.46,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -1.3711000000000002,
    "roe_ttm": "N/A",
    "shares_outstanding": 37970000.0,
    "pcnt_held_by_insiders": 0.1157,
    "pcnt_held_by_institutions": 0.513,
    "pcnt_short_of_float": 0.2763,
    "operating_cash_flow_ttm": -64300000.0,
    "levered_cash_flow_ttm": -36060000.0,
    "book_value_per_share_mrq": -0.24,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Omeros Corporation"
  },
  "ONCE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.86,
    "ebitda": -47960000.0,
    "eps_estimate_current_year": -2.58,
    "eps_estimate_next_quarter": -0.72,
    "fifty_day_moving_average": 54.22,
    "fifty_two_week_high": 79.5,
    "fifty_two_week_low": 36.96,
    "percent_change_from_200_day_moving_average": -0.19920000000000002,
    "percent_change_from_50_day_moving_average": -0.1862,
    "shares_owned": "N/A",
    "short_ratio": 10.39,
    "two_hundred_day_moving_average": 55.11,
    "volume": 1140585.0,
    "market_cap": 1180000000.0,
    "price_to_sales_ttm": 205.28,
    "price_to_book_mrq": 5.83,
    "roa_ttm": -0.1991,
    "roe_ttm": -0.39289999999999997,
    "shares_outstanding": 26800000.0,
    "pcnt_held_by_insiders": 0.4514,
    "pcnt_held_by_institutions": 0.598,
    "pcnt_short_of_float": 0.2316,
    "operating_cash_flow_ttm": -14560000.0,
    "levered_cash_flow_ttm": -18520000.0,
    "book_value_per_share_mrq": 7.8,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Spark Therapeutics, Inc."
  },
  "ONCS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.81,
    "ebitda": -23700000.0,
    "eps_estimate_current_year": -1.83,
    "eps_estimate_next_quarter": -0.47,
    "fifty_day_moving_average": 3.16,
    "fifty_two_week_high": 10.0,
    "fifty_two_week_low": 2.23,
    "percent_change_from_200_day_moving_average": -0.5637,
    "percent_change_from_50_day_moving_average": -0.2933,
    "shares_owned": "N/A",
    "short_ratio": 2.18,
    "two_hundred_day_moving_average": 5.11,
    "volume": 192077.0,
    "market_cap": 37850000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.24,
    "roa_ttm": -0.4578,
    "roe_ttm": -0.7833,
    "shares_outstanding": 16970000.0,
    "pcnt_held_by_insiders": 0.1478,
    "pcnt_held_by_institutions": 0.062,
    "pcnt_short_of_float": 0.0217,
    "operating_cash_flow_ttm": -18880000.0,
    "levered_cash_flow_ttm": -11060000.0,
    "book_value_per_share_mrq": 1.84,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "OncoSec Medical Incorporated"
  },
  "ONTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.849,
    "ebitda": -40320000.0,
    "eps_estimate_current_year": -1.49,
    "eps_estimate_next_quarter": -0.21,
    "fifty_day_moving_average": 1.3077,
    "fifty_two_week_high": 4.43,
    "fifty_two_week_low": 0.94,
    "percent_change_from_200_day_moving_average": -0.477467,
    "percent_change_from_50_day_moving_average": -0.279963,
    "shares_owned": "N/A",
    "short_ratio": 4.12,
    "two_hundred_day_moving_average": 1.802,
    "volume": 384758.0,
    "market_cap": 23420000.0,
    "price_to_sales_ttm": 12.98,
    "price_to_book_mrq": 7.25,
    "roa_ttm": -0.5743,
    "roe_ttm": -2.0374,
    "shares_outstanding": 24870000.0,
    "pcnt_held_by_insiders": 0.41479999999999995,
    "pcnt_held_by_institutions": 0.049,
    "pcnt_short_of_float": 0.024,
    "operating_cash_flow_ttm": -40470000.0,
    "levered_cash_flow_ttm": -24900000.0,
    "book_value_per_share_mrq": 0.14,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Onconova Therapeutics, Inc."
  },
  "ONTY": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.53,
    "ebitda": -50400000.0,
    "eps_estimate_current_year": -0.33,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 3.06,
    "fifty_two_week_high": 4.69,
    "fifty_two_week_low": 1.41,
    "percent_change_from_200_day_moving_average": -0.33409999999999995,
    "percent_change_from_50_day_moving_average": -0.2812,
    "shares_owned": "N/A",
    "short_ratio": 5.85,
    "two_hundred_day_moving_average": 3.3,
    "volume": 3324139.0,
    "market_cap": 208840000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.24,
    "roa_ttm": -0.2722,
    "roe_ttm": -0.485,
    "shares_outstanding": 94930000.0,
    "pcnt_held_by_insiders": 0.1975,
    "pcnt_held_by_institutions": 0.524,
    "pcnt_short_of_float": 0.0584,
    "operating_cash_flow_ttm": -48970000.0,
    "levered_cash_flow_ttm": -30280000.0,
    "book_value_per_share_mrq": 0.97,
    "next_earnings_announcement_date": [
      "2016-03-08",
      "2016-03-14"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Oncothyreon Inc"
  },
  "ONVO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.41,
    "ebitda": -34090000.0,
    "eps_estimate_current_year": -0.44,
    "eps_estimate_next_quarter": -0.11,
    "fifty_day_moving_average": 3.08,
    "fifty_two_week_high": 7.68,
    "fifty_two_week_low": 1.9,
    "percent_change_from_200_day_moving_average": -0.147,
    "percent_change_from_50_day_moving_average": -0.06849999999999999,
    "shares_owned": "N/A",
    "short_ratio": 22.56,
    "two_hundred_day_moving_average": 3.36,
    "volume": 1451039.0,
    "market_cap": 265230000.00000003,
    "price_to_sales_ttm": 251.46,
    "price_to_book_mrq": 3.39,
    "roa_ttm": -0.3136,
    "roe_ttm": -0.5331,
    "shares_outstanding": 92410000.0,
    "pcnt_held_by_insiders": 0.0836,
    "pcnt_held_by_institutions": 0.27899999999999997,
    "pcnt_short_of_float": 0.2139,
    "operating_cash_flow_ttm": -24840000.0,
    "levered_cash_flow_ttm": -14120000.0,
    "book_value_per_share_mrq": 0.83,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Organovo Holdings, Inc."
  },
  "OPGN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.49,
    "ebitda": -10550000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.74,
    "fifty_two_week_high": 5.44,
    "fifty_two_week_low": 1.45,
    "percent_change_from_200_day_moving_average": -0.4535,
    "percent_change_from_50_day_moving_average": -0.11960000000000001,
    "shares_owned": "N/A",
    "short_ratio": 2.8,
    "two_hundred_day_moving_average": 2.8,
    "volume": 21875.0,
    "market_cap": 19190000.0,
    "price_to_sales_ttm": 6.63,
    "price_to_book_mrq": 1.64,
    "roa_ttm": -0.7193999999999999,
    "roe_ttm": -2.8442000000000003,
    "shares_outstanding": 12540000.0,
    "pcnt_held_by_insiders": 0.6789000000000001,
    "pcnt_held_by_institutions": 0.018000000000000002,
    "pcnt_short_of_float": 0.018000000000000002,
    "operating_cash_flow_ttm": -12550000.0,
    "levered_cash_flow_ttm": -7060000.0,
    "book_value_per_share_mrq": 0.95,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "OpGen, Inc."
  },
  "OPHT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.97,
    "ebitda": -112910000.0,
    "eps_estimate_current_year": -3.41,
    "eps_estimate_next_quarter": -1.46,
    "fifty_day_moving_average": 61.51,
    "fifty_two_week_high": 77.55,
    "fifty_two_week_low": 35.72,
    "percent_change_from_200_day_moving_average": 0.4396,
    "percent_change_from_50_day_moving_average": 0.2475,
    "shares_owned": "N/A",
    "short_ratio": 5.0,
    "two_hundred_day_moving_average": 53.3,
    "volume": 1422006.0,
    "market_cap": 2680000000.0,
    "price_to_sales_ttm": 52.61,
    "price_to_book_mrq": 30.6,
    "roa_ttm": -0.1507,
    "roe_ttm": -0.7855,
    "shares_outstanding": 34960000.0,
    "pcnt_held_by_insiders": 0.0548,
    "pcnt_held_by_institutions": 0.8759999999999999,
    "pcnt_short_of_float": 0.1027,
    "operating_cash_flow_ttm": -28730000.0,
    "levered_cash_flow_ttm": 7210000.0,
    "book_value_per_share_mrq": 2.38,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ophthotech Corporation"
  },
  "OPK": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.19,
    "ebitda": -57840000.0,
    "eps_estimate_current_year": -0.09,
    "eps_estimate_next_quarter": -0.01,
    "fifty_day_moving_average": 10.54,
    "fifty_two_week_high": 19.2,
    "fifty_two_week_low": 8.2,
    "percent_change_from_200_day_moving_average": -0.1932,
    "percent_change_from_50_day_moving_average": -0.053399999999999996,
    "shares_owned": "N/A",
    "short_ratio": 13.97,
    "two_hundred_day_moving_average": 12.37,
    "volume": 4963919.0,
    "market_cap": 5440000000.0,
    "price_to_sales_ttm": 22.7,
    "price_to_book_mrq": 2.78,
    "roa_ttm": -0.023700000000000002,
    "roe_ttm": -0.060599999999999994,
    "shares_outstanding": 545010000.0,
    "pcnt_held_by_insiders": 0.0001,
    "pcnt_held_by_institutions": 0.16899999999999998,
    "pcnt_short_of_float": 0.3015,
    "operating_cash_flow_ttm": 148610000.0,
    "levered_cash_flow_ttm": -75190000.0,
    "book_value_per_share_mrq": 3.62,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Opko Health, Inc."
  },
  "OPXA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.6,
    "ebitda": -13570000.0,
    "eps_estimate_current_year": -1.86,
    "eps_estimate_next_quarter": -0.44,
    "fifty_day_moving_average": 3.25,
    "fifty_two_week_high": 8.64,
    "fifty_two_week_low": 2.33,
    "percent_change_from_200_day_moving_average": -0.1208,
    "percent_change_from_50_day_moving_average": -0.0722,
    "shares_owned": "N/A",
    "short_ratio": 0.66,
    "two_hundred_day_moving_average": 3.43,
    "volume": 87917.0,
    "market_cap": 21080000.0,
    "price_to_sales_ttm": 17.57,
    "price_to_book_mrq": 1.9,
    "roa_ttm": -0.5344,
    "roe_ttm": -1.1853,
    "shares_outstanding": 6980000.0,
    "pcnt_held_by_insiders": 0.0933,
    "pcnt_held_by_institutions": 0.049,
    "pcnt_short_of_float": 0.0579,
    "operating_cash_flow_ttm": -10540000.0,
    "levered_cash_flow_ttm": -5830000.0,
    "book_value_per_share_mrq": 1.66,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Opexa Therapeutics, Inc."
  },
  "OREX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.04,
    "earnings_per_share": -0.4,
    "ebitda": -44550000.0,
    "eps_estimate_current_year": -0.5,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 2.36,
    "fifty_two_week_high": 9.37,
    "fifty_two_week_low": 1.39,
    "percent_change_from_200_day_moving_average": -0.43579999999999997,
    "percent_change_from_50_day_moving_average": -0.2257,
    "shares_owned": "N/A",
    "short_ratio": 15.71,
    "two_hundred_day_moving_average": 3.24,
    "volume": 28269474.0,
    "market_cap": 266160000.00000003,
    "price_to_sales_ttm": 5.89,
    "price_to_book_mrq": 5.41,
    "roa_ttm": -0.1369,
    "roe_ttm": -1.5927,
    "shares_outstanding": 145440000.0,
    "pcnt_held_by_insiders": 0.3403,
    "pcnt_held_by_institutions": 0.8809999999999999,
    "pcnt_short_of_float": 0.3496,
    "operating_cash_flow_ttm": 50250000.0,
    "levered_cash_flow_ttm": 17600000.0,
    "book_value_per_share_mrq": 0.32,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Orexigen Therapeutics, Inc."
  },
  "ORMP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.67,
    "ebitda": -7380000.0,
    "eps_estimate_current_year": -0.79,
    "eps_estimate_next_quarter": -0.21,
    "fifty_day_moving_average": 7.92,
    "fifty_two_week_high": 10.74,
    "fifty_two_week_low": 3.71,
    "percent_change_from_200_day_moving_average": 0.2704,
    "percent_change_from_50_day_moving_average": 0.08560000000000001,
    "shares_owned": "N/A",
    "short_ratio": 2.97,
    "two_hundred_day_moving_average": 6.77,
    "volume": 40552.0,
    "market_cap": 99760000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.96,
    "roa_ttm": -0.1916,
    "roe_ttm": -0.3171,
    "shares_outstanding": 11600000.0,
    "pcnt_held_by_insiders": 0.2113,
    "pcnt_held_by_institutions": 0.028999999999999998,
    "pcnt_short_of_float": 0.061900000000000004,
    "operating_cash_flow_ttm": -4950000.0,
    "levered_cash_flow_ttm": -2310000.0,
    "book_value_per_share_mrq": 2.15,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Oramed Pharmaceuticals Inc."
  },
  "ORPN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.96,
    "ebitda": -13830000.0,
    "eps_estimate_current_year": -0.99,
    "eps_estimate_next_quarter": -0.26,
    "fifty_day_moving_average": 4.49,
    "fifty_two_week_high": 8.85,
    "fifty_two_week_low": 3.45,
    "percent_change_from_200_day_moving_average": -0.2253,
    "percent_change_from_50_day_moving_average": -0.028900000000000002,
    "shares_owned": "N/A",
    "short_ratio": 1.96,
    "two_hundred_day_moving_average": 5.63,
    "volume": 33323.0,
    "market_cap": 62040000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.51,
    "roa_ttm": -0.2959,
    "roe_ttm": -0.4932,
    "shares_outstanding": 14230000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0077,
    "operating_cash_flow_ttm": -11070000.0,
    "levered_cash_flow_ttm": -6050000.0,
    "book_value_per_share_mrq": 1.55,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Bio Blast Pharma Ltd."
  },
  "OSIR": {
    "p_e_ratio": 242.976,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.042,
    "ebitda": 4410000.0,
    "eps_estimate_current_year": 0.08,
    "eps_estimate_next_quarter": 0.01,
    "fifty_day_moving_average": 12.217,
    "fifty_two_week_high": 23.67,
    "fifty_two_week_low": 9.76,
    "percent_change_from_200_day_moving_average": -0.40592,
    "percent_change_from_50_day_moving_average": -0.16472,
    "shares_owned": "N/A",
    "short_ratio": 9.56,
    "two_hundred_day_moving_average": 17.178,
    "volume": 1421718.0,
    "market_cap": 351590000.0,
    "price_to_sales_ttm": 4.34,
    "price_to_book_mrq": 4.7,
    "roa_ttm": 0.0215,
    "roe_ttm": 0.021,
    "shares_outstanding": 34450000.0,
    "pcnt_held_by_insiders": 0.5244,
    "pcnt_held_by_institutions": 0.3,
    "pcnt_short_of_float": 0.19079999999999997,
    "operating_cash_flow_ttm": 2250000.0,
    "levered_cash_flow_ttm": 1060000.0,
    "book_value_per_share_mrq": 2.32,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Osiris Therapeutics, Inc."
  },
  "OSUR": {
    "p_e_ratio": 418.75,
    "peg_ratio": 3.82,
    "earnings_per_share": 0.02,
    "ebitda": 7240000.0,
    "eps_estimate_current_year": 0.09,
    "eps_estimate_next_quarter": 0.01,
    "fifty_day_moving_average": 6.07,
    "fifty_two_week_high": 10.93,
    "fifty_two_week_low": 4.39,
    "percent_change_from_200_day_moving_average": 0.2311,
    "percent_change_from_50_day_moving_average": 0.1039,
    "shares_owned": "N/A",
    "short_ratio": 3.44,
    "two_hundred_day_moving_average": 5.44,
    "volume": 807629.0,
    "market_cap": 378430000.0,
    "price_to_sales_ttm": 3.34,
    "price_to_book_mrq": 2.42,
    "roa_ttm": 0.0046,
    "roe_ttm": 0.005600000000000001,
    "shares_outstanding": 56480000.0,
    "pcnt_held_by_insiders": 0.0318,
    "pcnt_held_by_institutions": 0.71,
    "pcnt_short_of_float": 0.0342,
    "operating_cash_flow_ttm": 14250000.0,
    "levered_cash_flow_ttm": 12160000.0,
    "book_value_per_share_mrq": 2.83,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "OraSure Technologies, Inc."
  },
  "OTIC": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.63,
    "earnings_per_share": -2.17,
    "ebitda": -50410000.0,
    "eps_estimate_current_year": -2.75,
    "eps_estimate_next_quarter": -1.15,
    "fifty_day_moving_average": 26.74,
    "fifty_two_week_high": 41.99,
    "fifty_two_week_low": 16.5,
    "percent_change_from_200_day_moving_average": 0.2256,
    "percent_change_from_50_day_moving_average": 0.0969,
    "shares_owned": "N/A",
    "short_ratio": 10.3,
    "two_hundred_day_moving_average": 23.93,
    "volume": 1899440.0,
    "market_cap": 710910000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.62,
    "roa_ttm": -0.1681,
    "roe_ttm": -0.2779,
    "shares_outstanding": 24240000.0,
    "pcnt_held_by_insiders": 0.2741,
    "pcnt_held_by_institutions": 0.778,
    "pcnt_short_of_float": 0.1399,
    "operating_cash_flow_ttm": -44220000.0,
    "levered_cash_flow_ttm": -26490000.0,
    "book_value_per_share_mrq": 8.24,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Otonomy, Inc."
  },
  "OVAS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.72,
    "ebitda": -69110000.0,
    "eps_estimate_current_year": -2.64,
    "eps_estimate_next_quarter": -0.72,
    "fifty_day_moving_average": 10.77,
    "fifty_two_week_high": 55.69,
    "fifty_two_week_low": 7.9,
    "percent_change_from_200_day_moving_average": -0.4817,
    "percent_change_from_50_day_moving_average": -0.029900000000000003,
    "shares_owned": "N/A",
    "short_ratio": 21.6,
    "two_hundred_day_moving_average": 20.16,
    "volume": 4498374.0,
    "market_cap": 285060000.0,
    "price_to_sales_ttm": 2348.2,
    "price_to_book_mrq": 1.98,
    "roa_ttm": -0.38020000000000004,
    "roe_ttm": -0.6770999999999999,
    "shares_outstanding": 27280000.0,
    "pcnt_held_by_insiders": 0.1149,
    "pcnt_held_by_institutions": 0.973,
    "pcnt_short_of_float": 0.5374,
    "operating_cash_flow_ttm": -49490000.0,
    "levered_cash_flow_ttm": -26850000.0,
    "book_value_per_share_mrq": 5.23,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "OvaScience, Inc."
  },
  "OXFD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.21,
    "ebitda": -22260000.0,
    "eps_estimate_current_year": -1.11,
    "eps_estimate_next_quarter": -0.25,
    "fifty_day_moving_average": 12.69,
    "fifty_two_week_high": 15.04,
    "fifty_two_week_low": 10.41,
    "percent_change_from_200_day_moving_average": -0.09789999999999999,
    "percent_change_from_50_day_moving_average": -0.061,
    "shares_owned": "N/A",
    "short_ratio": 9.79,
    "two_hundred_day_moving_average": 13.21,
    "volume": 110874.0,
    "market_cap": 268650000.0,
    "price_to_sales_ttm": 4.74,
    "price_to_book_mrq": 2.8,
    "roa_ttm": -0.1575,
    "roe_ttm": -0.2995,
    "shares_outstanding": 22540000.0,
    "pcnt_held_by_insiders": 0.0277,
    "pcnt_held_by_institutions": 0.8140000000000001,
    "pcnt_short_of_float": 0.0242,
    "operating_cash_flow_ttm": -19480000.0,
    "levered_cash_flow_ttm": -13660000.0,
    "book_value_per_share_mrq": 4.37,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Oxford Immunotec Global PLC"
  },
  "OXGN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.519,
    "ebitda": -12310000.0,
    "eps_estimate_current_year": -0.53,
    "eps_estimate_next_quarter": -0.17,
    "fifty_day_moving_average": 0.8771,
    "fifty_two_week_high": 1.97,
    "fifty_two_week_low": 0.77,
    "percent_change_from_200_day_moving_average": -0.290466,
    "percent_change_from_50_day_moving_average": -0.053974,
    "shares_owned": "N/A",
    "short_ratio": 9.43,
    "two_hundred_day_moving_average": 1.1695,
    "volume": 149997.0,
    "market_cap": 22030000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 0.76,
    "roa_ttm": -0.2412,
    "roe_ttm": -0.4067,
    "shares_outstanding": 26540000.0,
    "pcnt_held_by_insiders": 0.0564,
    "pcnt_held_by_institutions": 0.075,
    "pcnt_short_of_float": 0.0572,
    "operating_cash_flow_ttm": -11810000.0,
    "levered_cash_flow_ttm": -7220000.0,
    "book_value_per_share_mrq": 1.09,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "OXiGENE, Inc."
  },
  "PACB": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.85,
    "earnings_per_share": -0.67,
    "ebitda": -65410000.0,
    "eps_estimate_current_year": -0.42,
    "eps_estimate_next_quarter": -0.23,
    "fifty_day_moving_average": 9.12,
    "fifty_two_week_high": 12.32,
    "fifty_two_week_low": 3.58,
    "percent_change_from_200_day_moving_average": 0.9087999999999999,
    "percent_change_from_50_day_moving_average": 0.3371,
    "shares_owned": "N/A",
    "short_ratio": 7.62,
    "two_hundred_day_moving_average": 6.39,
    "volume": 4517926.0,
    "market_cap": 939900000.0,
    "price_to_sales_ttm": 11.3,
    "price_to_book_mrq": 19.73,
    "roa_ttm": -0.3896,
    "roe_ttm": -1.0436,
    "shares_outstanding": 77040000.0,
    "pcnt_held_by_insiders": 0.11230000000000001,
    "pcnt_held_by_institutions": 0.642,
    "pcnt_short_of_float": 0.2802,
    "operating_cash_flow_ttm": -62530000.0,
    "levered_cash_flow_ttm": -33070000.0,
    "book_value_per_share_mrq": 0.55,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Pacific Biosciences of California, Inc."
  },
  "PAHC": {
    "p_e_ratio": 20.77,
    "peg_ratio": 2.32,
    "earnings_per_share": 1.5,
    "ebitda": 104360000.0,
    "eps_estimate_current_year": 1.73,
    "eps_estimate_next_quarter": 0.43,
    "fifty_day_moving_average": 32.34,
    "fifty_two_week_high": 40.54,
    "fifty_two_week_low": 26.95,
    "percent_change_from_200_day_moving_average": -0.0971,
    "percent_change_from_50_day_moving_average": -0.0358,
    "shares_owned": "N/A",
    "short_ratio": 2.47,
    "two_hundred_day_moving_average": 34.53,
    "volume": 591217.0,
    "market_cap": 1220000000.0,
    "price_to_sales_ttm": 1.65,
    "price_to_book_mrq": 54.6,
    "roa_ttm": 0.1109,
    "roe_ttm": 2.7188,
    "shares_outstanding": 18100000.0,
    "pcnt_held_by_insiders": 0.004,
    "pcnt_held_by_institutions": 1.0290000000000001,
    "pcnt_short_of_float": 0.0368,
    "operating_cash_flow_ttm": 48950000.0,
    "levered_cash_flow_ttm": 43270000.0,
    "book_value_per_share_mrq": 0.58,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "Phibro Animal Health Corporation"
  },
  "PARN": {
    "p_e_ratio": 14.8069,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.28,
    "ebitda": -5570000.0,
    "eps_estimate_current_year": -1.07,
    "eps_estimate_next_quarter": -0.33,
    "fifty_day_moving_average": 3.7792,
    "fifty_two_week_high": 6.0,
    "fifty_two_week_low": 3.2,
    "percent_change_from_200_day_moving_average": -0.00499,
    "percent_change_from_50_day_moving_average": 0.085283,
    "shares_owned": "N/A",
    "short_ratio": 0.71,
    "two_hundred_day_moving_average": 4.1221,
    "volume": 3985.0,
    "market_cap": 54480000.0,
    "price_to_sales_ttm": 7.3,
    "price_to_book_mrq": 2.77,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 13280000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.001,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 1.52,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Parnell Pharmaceuticals Holdings Ltd."
  },
  "PBMD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.45,
    "ebitda": -9260000.0,
    "eps_estimate_current_year": -0.14,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.15,
    "fifty_two_week_high": 6.48,
    "fifty_two_week_low": 0.42,
    "percent_change_from_200_day_moving_average": -0.1531,
    "percent_change_from_50_day_moving_average": -0.030899999999999997,
    "shares_owned": "N/A",
    "short_ratio": 1.32,
    "two_hundred_day_moving_average": 1.31,
    "volume": 512077.0,
    "market_cap": 73050000.0,
    "price_to_sales_ttm": 76.78,
    "price_to_book_mrq": 3.7,
    "roa_ttm": -0.3179,
    "roe_ttm": -1.36,
    "shares_outstanding": 65810000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -5550000.0,
    "levered_cash_flow_ttm": -4720000.0,
    "book_value_per_share_mrq": 0.3,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Prima Biomed Ltd."
  },
  "PBYI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.27,
    "earnings_per_share": -7.13,
    "ebitda": -225080000.0,
    "eps_estimate_current_year": -7.49,
    "eps_estimate_next_quarter": -2.04,
    "fifty_day_moving_average": 77.23,
    "fifty_two_week_high": 252.92,
    "fifty_two_week_low": 56.11,
    "percent_change_from_200_day_moving_average": -0.2193,
    "percent_change_from_50_day_moving_average": -0.055099999999999996,
    "shares_owned": "N/A",
    "short_ratio": 7.14,
    "two_hundred_day_moving_average": 93.46,
    "volume": 1092549.0,
    "market_cap": 2370000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 9.95,
    "roa_ttm": -0.6363,
    "roe_ttm": -1.1647,
    "shares_outstanding": 32439999.999999996,
    "pcnt_held_by_insiders": 0.12990000000000002,
    "pcnt_held_by_institutions": 0.953,
    "pcnt_short_of_float": 0.2697,
    "operating_cash_flow_ttm": -139900000.0,
    "levered_cash_flow_ttm": -57200000.0,
    "book_value_per_share_mrq": 7.55,
    "next_earnings_announcement_date": [
      "2016-02-29",
      "2016-03-04"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Puma Biotechnology, Inc."
  },
  "PCRX": {
    "p_e_ratio": 291.61,
    "peg_ratio": 1.19,
    "earnings_per_share": 0.26,
    "ebitda": 29120000.0,
    "eps_estimate_current_year": 1.0,
    "eps_estimate_next_quarter": 0.15,
    "fifty_day_moving_average": 61.1,
    "fifty_two_week_high": 121.95,
    "fifty_two_week_low": 35.78,
    "percent_change_from_200_day_moving_average": 0.2593,
    "percent_change_from_50_day_moving_average": 0.2457,
    "shares_owned": "N/A",
    "short_ratio": 10.41,
    "two_hundred_day_moving_average": 60.44,
    "volume": 1658292.0,
    "market_cap": 2800000000.0,
    "price_to_sales_ttm": 11.21,
    "price_to_book_mrq": 12.94,
    "roa_ttm": 0.0337,
    "roe_ttm": 0.0558,
    "shares_outstanding": 36760000.0,
    "pcnt_held_by_insiders": 0.0836,
    "pcnt_held_by_institutions": 1.172,
    "pcnt_short_of_float": 0.2413,
    "operating_cash_flow_ttm": 25590000.0,
    "levered_cash_flow_ttm": -15760000.0,
    "book_value_per_share_mrq": 5.69,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Pacira Pharmaceuticals, Inc."
  },
  "PDEX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.08,
    "ebitda": -231000.0,
    "eps_estimate_current_year": "nan",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.51,
    "fifty_two_week_high": 3.07,
    "fifty_two_week_low": 1.99,
    "percent_change_from_200_day_moving_average": 0.014199999999999999,
    "percent_change_from_50_day_moving_average": -0.0245,
    "shares_owned": "N/A",
    "short_ratio": 0.48,
    "two_hundred_day_moving_average": 2.42,
    "volume": 7873.0,
    "market_cap": 10150000.0,
    "price_to_sales_ttm": 0.7,
    "price_to_book_mrq": 1.24,
    "roa_ttm": -0.0436,
    "roe_ttm": -0.0397,
    "shares_outstanding": 4139999.9999999995,
    "pcnt_held_by_insiders": 0.3914,
    "pcnt_held_by_institutions": 0.001,
    "pcnt_short_of_float": 0.0011,
    "operating_cash_flow_ttm": -1930000.0,
    "levered_cash_flow_ttm": -1790000.0,
    "book_value_per_share_mrq": 2.02,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Pro-Dex Inc."
  },
  "PDLI": {
    "p_e_ratio": 2.27,
    "peg_ratio": 0.14,
    "earnings_per_share": 1.67,
    "ebitda": 456440000.0,
    "eps_estimate_current_year": 1.94,
    "eps_estimate_next_quarter": 0.52,
    "fifty_day_moving_average": 3.89,
    "fifty_two_week_high": 7.97,
    "fifty_two_week_low": 3.29,
    "percent_change_from_200_day_moving_average": -0.2782,
    "percent_change_from_50_day_moving_average": -0.0252,
    "shares_owned": "N/A",
    "short_ratio": 10.49,
    "two_hundred_day_moving_average": 5.25,
    "volume": 4438552.0,
    "market_cap": 619950000.0,
    "price_to_sales_ttm": 1.26,
    "price_to_book_mrq": 1.05,
    "roa_ttm": 0.2844,
    "roe_ttm": 0.5758,
    "shares_outstanding": 163580000.0,
    "pcnt_held_by_insiders": 0.0062,
    "pcnt_held_by_institutions": 0.925,
    "pcnt_short_of_float": 0.25670000000000004,
    "operating_cash_flow_ttm": 300430000.0,
    "levered_cash_flow_ttm": 112380000.0,
    "book_value_per_share_mrq": 3.64,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "PDL BioPharma, Inc."
  },
  "PEN": {
    "p_e_ratio": 1617.06,
    "peg_ratio": -34.36,
    "earnings_per_share": 0.03,
    "ebitda": 4139999.9999999995,
    "eps_estimate_current_year": -0.08,
    "eps_estimate_next_quarter": -0.1,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 57.98,
    "fifty_two_week_low": 52.73,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 6.25,
    "two_hundred_day_moving_average": 0.0,
    "volume": 831872.0,
    "market_cap": 1640000000.0,
    "price_to_sales_ttm": 9.83,
    "price_to_book_mrq": 7.19,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 29890000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0264,
    "operating_cash_flow_ttm": -18030000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 7.65,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Penumbra, Inc."
  },
  "PETS": {
    "p_e_ratio": 16.68,
    "peg_ratio": 3.35,
    "earnings_per_share": 1.0,
    "ebitda": 32380000.000000004,
    "eps_estimate_current_year": 1.0,
    "eps_estimate_next_quarter": 0.25,
    "fifty_day_moving_average": 16.85,
    "fifty_two_week_high": 18.42,
    "fifty_two_week_low": 13.91,
    "percent_change_from_200_day_moving_average": -0.0113,
    "percent_change_from_50_day_moving_average": -0.0131,
    "shares_owned": "N/A",
    "short_ratio": 36.8,
    "two_hundred_day_moving_average": 16.82,
    "volume": 533365.0,
    "market_cap": 335010000.0,
    "price_to_sales_ttm": 1.48,
    "price_to_book_mrq": 4.26,
    "roa_ttm": 0.2359,
    "roe_ttm": 0.2648,
    "shares_outstanding": 20140000.0,
    "pcnt_held_by_insiders": 0.0426,
    "pcnt_held_by_institutions": 0.84,
    "pcnt_short_of_float": 0.30870000000000003,
    "operating_cash_flow_ttm": 22490000.0,
    "levered_cash_flow_ttm": 21550000.0,
    "book_value_per_share_mrq": 3.93,
    "next_earnings_announcement_date": [
      "2016-01-18",
      "2016-01-22"
    ],
    "sector": "Healthcare",
    "industry": "Drug Delivery",
    "company_name": "PetMed Express, Inc."
  },
  "PETX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.23,
    "earnings_per_share": -2.38,
    "ebitda": -44800000.0,
    "eps_estimate_current_year": -1.71,
    "eps_estimate_next_quarter": -0.37,
    "fifty_day_moving_average": 6.24,
    "fifty_two_week_high": 20.63,
    "fifty_two_week_low": 5.2,
    "percent_change_from_200_day_moving_average": -0.5351,
    "percent_change_from_50_day_moving_average": -0.0717,
    "shares_owned": "N/A",
    "short_ratio": 9.69,
    "two_hundred_day_moving_average": 12.45,
    "volume": 1691027.0,
    "market_cap": 202680000.0,
    "price_to_sales_ttm": 224.31,
    "price_to_book_mrq": 1.69,
    "roa_ttm": -0.16399999999999998,
    "roe_ttm": -0.5324,
    "shares_outstanding": 35010000.0,
    "pcnt_held_by_insiders": 0.2237,
    "pcnt_held_by_institutions": 0.7,
    "pcnt_short_of_float": 0.1741,
    "operating_cash_flow_ttm": -37530000.0,
    "levered_cash_flow_ttm": -27020000.0,
    "book_value_per_share_mrq": 3.28,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Aratana Therapeutics, Inc."
  },
  "PFNX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.07,
    "ebitda": -22060000.0,
    "eps_estimate_current_year": -1.48,
    "eps_estimate_next_quarter": -0.55,
    "fifty_day_moving_average": 14.37,
    "fifty_two_week_high": 24.41,
    "fifty_two_week_low": 6.4,
    "percent_change_from_200_day_moving_average": -0.3417,
    "percent_change_from_50_day_moving_average": -0.17370000000000002,
    "shares_owned": "N/A",
    "short_ratio": 9.1,
    "two_hundred_day_moving_average": 18.03,
    "volume": 178545.0,
    "market_cap": 276030000.0,
    "price_to_sales_ttm": 33.42,
    "price_to_book_mrq": 3.51,
    "roa_ttm": -0.1326,
    "roe_ttm": -0.3246,
    "shares_outstanding": 23250000.0,
    "pcnt_held_by_insiders": 0.3005,
    "pcnt_held_by_institutions": 0.7979999999999999,
    "pcnt_short_of_float": 0.061200000000000004,
    "operating_cash_flow_ttm": 28350000.0,
    "levered_cash_flow_ttm": -8560000.0,
    "book_value_per_share_mrq": 3.41,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Pfenex Inc."
  },
  "PGND": {
    "p_e_ratio": "N/A",
    "peg_ratio": 2.32,
    "earnings_per_share": -0.76,
    "ebitda": 28450000.0,
    "eps_estimate_current_year": 0.92,
    "eps_estimate_next_quarter": 0.25,
    "fifty_day_moving_average": 32.84,
    "fifty_two_week_high": 36.15,
    "fifty_two_week_low": 25.0,
    "percent_change_from_200_day_moving_average": -0.0015,
    "percent_change_from_50_day_moving_average": -0.0712,
    "shares_owned": "N/A",
    "short_ratio": 7.9,
    "two_hundred_day_moving_average": 30.55,
    "volume": 950807.0,
    "market_cap": 1610000000.0,
    "price_to_sales_ttm": 5.33,
    "price_to_book_mrq": 2.97,
    "roa_ttm": -0.0079,
    "roe_ttm": -0.0852,
    "shares_outstanding": 52700000.0,
    "pcnt_held_by_insiders": 0.0499,
    "pcnt_held_by_institutions": 0.8320000000000001,
    "pcnt_short_of_float": 0.0706,
    "operating_cash_flow_ttm": 81550000.0,
    "levered_cash_flow_ttm": 80630000.0,
    "book_value_per_share_mrq": 10.53,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "Press Ganey Holdings, Inc."
  },
  "PGNX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.07,
    "earnings_per_share": -0.63,
    "ebitda": -41330000.0,
    "eps_estimate_current_year": -0.6,
    "eps_estimate_next_quarter": -0.14,
    "fifty_day_moving_average": 6.71,
    "fifty_two_week_high": 11.15,
    "fifty_two_week_low": 4.86,
    "percent_change_from_200_day_moving_average": -0.1442,
    "percent_change_from_50_day_moving_average": -0.09390000000000001,
    "shares_owned": "N/A",
    "short_ratio": 13.68,
    "two_hundred_day_moving_average": 7.1,
    "volume": 6442607.0,
    "market_cap": 424420000.0,
    "price_to_sales_ttm": 136.36,
    "price_to_book_mrq": 4.25,
    "roa_ttm": -0.1693,
    "roe_ttm": -0.37979999999999997,
    "shares_outstanding": 69810000.0,
    "pcnt_held_by_insiders": 0.0159,
    "pcnt_held_by_institutions": 0.977,
    "pcnt_short_of_float": 0.2579,
    "operating_cash_flow_ttm": 1970000.0,
    "levered_cash_flow_ttm": 17020000.0,
    "book_value_per_share_mrq": 1.39,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Progenics Pharmaceuticals, Inc."
  },
  "PHMD": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.04,
    "earnings_per_share": -5.43,
    "ebitda": -13580000.0,
    "eps_estimate_current_year": -0.73,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.41,
    "fifty_two_week_high": 2.95,
    "fifty_two_week_low": 0.27,
    "percent_change_from_200_day_moving_average": -0.5776,
    "percent_change_from_50_day_moving_average": -0.1286,
    "shares_owned": "N/A",
    "short_ratio": 29.59,
    "two_hundred_day_moving_average": 0.85,
    "volume": 376313.0,
    "market_cap": 7950000.0,
    "price_to_sales_ttm": 0.06,
    "price_to_book_mrq": 0.19,
    "roa_ttm": -0.0751,
    "roe_ttm": -0.6365999999999999,
    "shares_outstanding": 22080000.0,
    "pcnt_held_by_insiders": 0.3657,
    "pcnt_held_by_institutions": 0.33899999999999997,
    "pcnt_short_of_float": 0.09390000000000001,
    "operating_cash_flow_ttm": 12610000.0,
    "levered_cash_flow_ttm": 24580000.0,
    "book_value_per_share_mrq": 1.79,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "PhotoMedex, Inc."
  },
  "PIP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.08,
    "ebitda": -2420000.0,
    "eps_estimate_current_year": -0.1,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.66,
    "fifty_two_week_high": 2.1,
    "fifty_two_week_low": 1.2,
    "percent_change_from_200_day_moving_average": -0.0599,
    "percent_change_from_50_day_moving_average": -0.0786,
    "shares_owned": "N/A",
    "short_ratio": 32.7,
    "two_hundred_day_moving_average": 1.63,
    "volume": 50259.0,
    "market_cap": 98610000.0,
    "price_to_sales_ttm": 9.26,
    "price_to_book_mrq": 5.85,
    "roa_ttm": -0.0725,
    "roe_ttm": -0.2701,
    "shares_outstanding": 64450000.0,
    "pcnt_held_by_insiders": 0.024399999999999998,
    "pcnt_held_by_institutions": 0.11900000000000001,
    "pcnt_short_of_float": 0.037599999999999995,
    "operating_cash_flow_ttm": -4910000.0,
    "levered_cash_flow_ttm": -1070000.0,
    "book_value_per_share_mrq": 0.28,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "PharmAthene, Inc."
  },
  "PIRS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.52,
    "ebitda": -12710000.0,
    "eps_estimate_current_year": -0.47,
    "eps_estimate_next_quarter": -0.13,
    "fifty_day_moving_average": 2.22,
    "fifty_two_week_high": 4.4,
    "fifty_two_week_low": 1.54,
    "percent_change_from_200_day_moving_average": -0.0758,
    "percent_change_from_50_day_moving_average": 0.0785,
    "shares_owned": "N/A",
    "short_ratio": 0.7,
    "two_hundred_day_moving_average": 2.59,
    "volume": 205335.0,
    "market_cap": 95030000.0,
    "price_to_sales_ttm": 22.77,
    "price_to_book_mrq": 2.75,
    "roa_ttm": -0.4089,
    "roe_ttm": -1.0167,
    "shares_outstanding": 39760000.0,
    "pcnt_held_by_insiders": 0.3,
    "pcnt_held_by_institutions": 0.244,
    "pcnt_short_of_float": 0.0102,
    "operating_cash_flow_ttm": -10190000.0,
    "levered_cash_flow_ttm": -7890000.0,
    "book_value_per_share_mrq": 0.85,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Pieris Pharmaceuticals, Inc."
  },
  "PKI": {
    "p_e_ratio": 32.93,
    "peg_ratio": 2.2,
    "earnings_per_share": 1.54,
    "ebitda": 355200000.0,
    "eps_estimate_current_year": 2.57,
    "eps_estimate_next_quarter": 0.56,
    "fifty_day_moving_average": 51.93,
    "fifty_two_week_high": 54.45,
    "fifty_two_week_low": 41.7,
    "percent_change_from_200_day_moving_average": 0.0068000000000000005,
    "percent_change_from_50_day_moving_average": -0.020499999999999997,
    "shares_owned": "N/A",
    "short_ratio": 3.86,
    "two_hundred_day_moving_average": 50.53,
    "volume": 2081399.0,
    "market_cap": 5690000000.0,
    "price_to_sales_ttm": 2.57,
    "price_to_book_mrq": 2.83,
    "roa_ttm": 0.0381,
    "roe_ttm": 0.08529999999999999,
    "shares_outstanding": 111930000.0,
    "pcnt_held_by_insiders": 0.0092,
    "pcnt_held_by_institutions": 0.963,
    "pcnt_short_of_float": 0.029500000000000002,
    "operating_cash_flow_ttm": 258420000.00000003,
    "levered_cash_flow_ttm": 211870000.0,
    "book_value_per_share_mrq": 18.36,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "PerkinElmer Inc."
  },
  "PLX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.07,
    "earnings_per_share": -0.25,
    "ebitda": -16670000.000000002,
    "eps_estimate_current_year": 0.5,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.99,
    "fifty_two_week_high": 2.4,
    "fifty_two_week_low": 0.74,
    "percent_change_from_200_day_moving_average": -0.267,
    "percent_change_from_50_day_moving_average": 0.064,
    "shares_owned": "N/A",
    "short_ratio": 3.06,
    "two_hundred_day_moving_average": 1.43,
    "volume": 2446006.0,
    "market_cap": 104390000.0,
    "price_to_sales_ttm": 4.82,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.1664,
    "roe_ttm": "N/A",
    "shares_outstanding": 99410000.0,
    "pcnt_held_by_insiders": 0.139,
    "pcnt_held_by_institutions": 0.313,
    "pcnt_short_of_float": 0.0158,
    "operating_cash_flow_ttm": -25300000.0,
    "levered_cash_flow_ttm": -14160000.0,
    "book_value_per_share_mrq": -0.73,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Protalix BioTherapeutics, Inc."
  },
  "PMD": {
    "p_e_ratio": 29.35,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.37,
    "ebitda": 3470000.0,
    "eps_estimate_current_year": 0.93,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 11.16,
    "fifty_two_week_high": 17.83,
    "fifty_two_week_low": 9.5,
    "percent_change_from_200_day_moving_average": -0.08199999999999999,
    "percent_change_from_50_day_moving_average": -0.023799999999999998,
    "shares_owned": "N/A",
    "short_ratio": 3.06,
    "two_hundred_day_moving_average": 11.86,
    "volume": 19654.0,
    "market_cap": 59050000.0,
    "price_to_sales_ttm": 2.15,
    "price_to_book_mrq": 4.86,
    "roa_ttm": 0.061900000000000004,
    "roe_ttm": 0.1598,
    "shares_outstanding": 5420000.0,
    "pcnt_held_by_insiders": 0.0731,
    "pcnt_held_by_institutions": 0.5870000000000001,
    "pcnt_short_of_float": 0.0075,
    "operating_cash_flow_ttm": 4470000.0,
    "levered_cash_flow_ttm": 464610.0,
    "book_value_per_share_mrq": 2.25,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Psychemedics Corp."
  },
  "PODD": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.41,
    "earnings_per_share": -0.91,
    "ebitda": -8320000.0,
    "eps_estimate_current_year": -1.03,
    "eps_estimate_next_quarter": -0.22,
    "fifty_day_moving_average": 35.18,
    "fifty_two_week_high": 46.96,
    "fifty_two_week_low": 24.95,
    "percent_change_from_200_day_moving_average": 0.151,
    "percent_change_from_50_day_moving_average": 0.027999999999999997,
    "shares_owned": "N/A",
    "short_ratio": 5.77,
    "two_hundred_day_moving_average": 31.42,
    "volume": 439696.0,
    "market_cap": 2060000000.0,
    "price_to_sales_ttm": 6.95,
    "price_to_book_mrq": 37.37,
    "roa_ttm": -0.0479,
    "roe_ttm": -0.7617,
    "shares_outstanding": 56930000.0,
    "pcnt_held_by_insiders": 0.0134,
    "pcnt_held_by_institutions": 1.148,
    "pcnt_short_of_float": 0.0708,
    "operating_cash_flow_ttm": 10650000.0,
    "levered_cash_flow_ttm": 20390000.0,
    "book_value_per_share_mrq": 0.97,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Insulet Corporation"
  },
  "POZN": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.65,
    "earnings_per_share": -0.54,
    "ebitda": -937408.0,
    "eps_estimate_current_year": -0.14,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 6.95,
    "fifty_two_week_high": 12.69,
    "fifty_two_week_low": 5.49,
    "percent_change_from_200_day_moving_average": -0.2003,
    "percent_change_from_50_day_moving_average": -0.0174,
    "shares_owned": "N/A",
    "short_ratio": 4.59,
    "two_hundred_day_moving_average": 8.54,
    "volume": 1444592.0,
    "market_cap": 226760000.0,
    "price_to_sales_ttm": 8.96,
    "price_to_book_mrq": 7.81,
    "roa_ttm": -0.013500000000000002,
    "roe_ttm": -0.5218,
    "shares_outstanding": 33200000.000000004,
    "pcnt_held_by_insiders": 0.1757,
    "pcnt_held_by_institutions": 0.578,
    "pcnt_short_of_float": 0.11230000000000001,
    "operating_cash_flow_ttm": -4470000.0,
    "levered_cash_flow_ttm": 11280000.0,
    "book_value_per_share_mrq": 0.89,
    "next_earnings_announcement_date": [
      "2016-03-07",
      "2016-03-11"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "POZEN Inc."
  },
  "PPHM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.29,
    "ebitda": -51810000.0,
    "eps_estimate_current_year": -0.29,
    "eps_estimate_next_quarter": -0.07,
    "fifty_day_moving_average": 1.19,
    "fifty_two_week_high": 1.66,
    "fifty_two_week_low": 0.91,
    "percent_change_from_200_day_moving_average": -0.0113,
    "percent_change_from_50_day_moving_average": 0.0034000000000000002,
    "shares_owned": "N/A",
    "short_ratio": 7.07,
    "two_hundred_day_moving_average": 1.2,
    "volume": 1155579.0,
    "market_cap": 273350000.0,
    "price_to_sales_ttm": 7.93,
    "price_to_book_mrq": 3.84,
    "roa_ttm": -0.3398,
    "roe_ttm": -0.8133,
    "shares_outstanding": 229700000.0,
    "pcnt_held_by_insiders": 0.044500000000000005,
    "pcnt_held_by_institutions": 0.17600000000000002,
    "pcnt_short_of_float": 0.0394,
    "operating_cash_flow_ttm": -38440000.0,
    "levered_cash_flow_ttm": -24190000.0,
    "book_value_per_share_mrq": 0.31,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Peregrine Pharmaceuticals, Inc."
  },
  "PRAH": {
    "p_e_ratio": 94.5,
    "peg_ratio": 1.22,
    "earnings_per_share": 0.5,
    "ebitda": 215130000.0,
    "eps_estimate_current_year": 1.9,
    "eps_estimate_next_quarter": 0.51,
    "fifty_day_moving_average": 43.22,
    "fifty_two_week_high": 49.0,
    "fifty_two_week_low": 22.4,
    "percent_change_from_200_day_moving_average": 0.1967,
    "percent_change_from_50_day_moving_average": 0.102,
    "shares_owned": "N/A",
    "short_ratio": 12.97,
    "two_hundred_day_moving_average": 39.8,
    "volume": 1846032.0,
    "market_cap": 2870000000.0,
    "price_to_sales_ttm": 2.16,
    "price_to_book_mrq": 4.17,
    "roa_ttm": 0.036699999999999997,
    "roe_ttm": 0.0548,
    "shares_outstanding": 60230000.0,
    "pcnt_held_by_insiders": 0.0002,
    "pcnt_held_by_institutions": 1.022,
    "pcnt_short_of_float": 0.1454,
    "operating_cash_flow_ttm": 93490000.0,
    "levered_cash_flow_ttm": 74830000.0,
    "book_value_per_share_mrq": 11.51,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "PRA Health Sciences, Inc."
  },
  "PRAN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.08,
    "ebitda": -7600000.0,
    "eps_estimate_current_year": -0.31,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.849,
    "fifty_two_week_high": 1.87,
    "fifty_two_week_low": 0.68,
    "percent_change_from_200_day_moving_average": -0.29,
    "percent_change_from_50_day_moving_average": -0.14562,
    "shares_owned": "N/A",
    "short_ratio": 2.52,
    "two_hundred_day_moving_average": 1.021,
    "volume": 133026.0,
    "market_cap": 38710000.0,
    "price_to_sales_ttm": 8.19,
    "price_to_book_mrq": 1.37,
    "roa_ttm": -0.16010000000000002,
    "roe_ttm": -0.1533,
    "shares_outstanding": 53390000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -7740000.0,
    "levered_cash_flow_ttm": -4910000.0,
    "book_value_per_share_mrq": 0.52,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Prana Biotechnology Limited"
  },
  "PRPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.19,
    "ebitda": -2680000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.37,
    "fifty_two_week_high": 1.75,
    "fifty_two_week_low": 1.05,
    "percent_change_from_200_day_moving_average": -0.0124,
    "percent_change_from_50_day_moving_average": 0.0507,
    "shares_owned": "N/A",
    "short_ratio": 1.35,
    "two_hundred_day_moving_average": 1.46,
    "volume": 15956.0,
    "market_cap": 24600000.0,
    "price_to_sales_ttm": 1.13,
    "price_to_book_mrq": 2.41,
    "roa_ttm": -0.1186,
    "roe_ttm": -0.29359999999999997,
    "shares_outstanding": 17080000.0,
    "pcnt_held_by_insiders": 0.40740000000000004,
    "pcnt_held_by_institutions": 0.11,
    "pcnt_short_of_float": 0.0019,
    "operating_cash_flow_ttm": -4220000.0,
    "levered_cash_flow_ttm": -3950000.0,
    "book_value_per_share_mrq": 0.59,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Related Products",
    "company_name": "ProPhase Labs, Inc."
  },
  "PRQR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.78,
    "ebitda": -26050000.0,
    "eps_estimate_current_year": -1.1,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 10.67,
    "fifty_two_week_high": 27.6,
    "fifty_two_week_low": 6.95,
    "percent_change_from_200_day_moving_average": -0.5107,
    "percent_change_from_50_day_moving_average": -0.3141,
    "shares_owned": "N/A",
    "short_ratio": 6.42,
    "two_hundred_day_moving_average": 14.96,
    "volume": 36874.0,
    "market_cap": 170830000.0,
    "price_to_sales_ttm": 59.78,
    "price_to_book_mrq": 1.62,
    "roa_ttm": -0.1379,
    "roe_ttm": -0.16190000000000002,
    "shares_outstanding": 23340000.0,
    "pcnt_held_by_insiders": 0.1232,
    "pcnt_held_by_institutions": 0.47100000000000003,
    "pcnt_short_of_float": 0.0231,
    "operating_cash_flow_ttm": -24330000.0,
    "levered_cash_flow_ttm": -16800000.0,
    "book_value_per_share_mrq": 4.44,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ProQR Therapeutics N.V."
  },
  "PRSC": {
    "p_e_ratio": 75.28,
    "peg_ratio": 1.69,
    "earnings_per_share": 0.63,
    "ebitda": 111650000.0,
    "eps_estimate_current_year": 1.87,
    "eps_estimate_next_quarter": 0.78,
    "fifty_day_moving_average": 48.51,
    "fifty_two_week_high": 56.92,
    "fifty_two_week_low": 35.54,
    "percent_change_from_200_day_moving_average": 0.012,
    "percent_change_from_50_day_moving_average": -0.0191,
    "shares_owned": "N/A",
    "short_ratio": 7.41,
    "two_hundred_day_moving_average": 47.01,
    "volume": 216659.0,
    "market_cap": 731480000.0,
    "price_to_sales_ttm": 0.37,
    "price_to_book_mrq": 3.25,
    "roa_ttm": 0.038,
    "roe_ttm": 0.06,
    "shares_outstanding": 15370000.0,
    "pcnt_held_by_insiders": 0.0103,
    "pcnt_held_by_institutions": 0.9309999999999999,
    "pcnt_short_of_float": 0.0594,
    "operating_cash_flow_ttm": 46510000.0,
    "levered_cash_flow_ttm": -18350000.0,
    "book_value_per_share_mrq": 14.59,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "Providence Service Corp."
  },
  "PRSN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.724,
    "ebitda": -13040000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.6511,
    "fifty_two_week_high": 7.6,
    "fifty_two_week_low": 0.27,
    "percent_change_from_200_day_moving_average": -0.308218,
    "percent_change_from_50_day_moving_average": 0.09699400000000001,
    "shares_owned": "N/A",
    "short_ratio": 2.15,
    "two_hundred_day_moving_average": 1.0325,
    "volume": 51199.0,
    "market_cap": 6980000.0,
    "price_to_sales_ttm": 3.34,
    "price_to_book_mrq": 2.32,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 9770000.0,
    "pcnt_held_by_insiders": 0.2023,
    "pcnt_held_by_institutions": 0.012,
    "pcnt_short_of_float": 0.1252,
    "operating_cash_flow_ttm": -10140000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.32,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Perseon Corporation"
  },
  "PRTA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.19,
    "earnings_per_share": -2.38,
    "ebitda": -68050000.0,
    "eps_estimate_current_year": -2.68,
    "eps_estimate_next_quarter": -0.8,
    "fifty_day_moving_average": 65.81,
    "fifty_two_week_high": 76.42,
    "fifty_two_week_low": 18.68,
    "percent_change_from_200_day_moving_average": 0.2445,
    "percent_change_from_50_day_moving_average": 0.0793,
    "shares_owned": "N/A",
    "short_ratio": 7.63,
    "two_hundred_day_moving_average": 57.08,
    "volume": 1017264.0,
    "market_cap": 2240000000.0,
    "price_to_sales_ttm": 641.57,
    "price_to_book_mrq": 5.62,
    "roa_ttm": -0.1208,
    "roe_ttm": -0.2048,
    "shares_outstanding": 31520000.0,
    "pcnt_held_by_insiders": 0.20170000000000002,
    "pcnt_held_by_institutions": 0.815,
    "pcnt_short_of_float": 0.1476,
    "operating_cash_flow_ttm": -55300000.0,
    "levered_cash_flow_ttm": -28690000.0,
    "book_value_per_share_mrq": 11.99,
    "next_earnings_announcement_date": [
      "2016-03-03",
      "2016-03-07"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Prothena Corporation plc"
  },
  "PRTK": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.01,
    "earnings_per_share": -4.2,
    "ebitda": -49810000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": -1.5,
    "fifty_day_moving_average": 18.13,
    "fifty_two_week_high": 39.8,
    "fifty_two_week_low": 15.02,
    "percent_change_from_200_day_moving_average": -0.2682,
    "percent_change_from_50_day_moving_average": -0.0678,
    "shares_owned": "N/A",
    "short_ratio": 9.58,
    "two_hundred_day_moving_average": 23.09,
    "volume": 136118.0,
    "market_cap": 297590000.0,
    "price_to_sales_ttm": 71.4,
    "price_to_book_mrq": 2.38,
    "roa_ttm": -0.38780000000000003,
    "roe_ttm": -1.2004000000000001,
    "shares_outstanding": 17610000.0,
    "pcnt_held_by_insiders": 0.1463,
    "pcnt_held_by_institutions": 0.769,
    "pcnt_short_of_float": 0.1151,
    "operating_cash_flow_ttm": -49390000.0,
    "levered_cash_flow_ttm": -30350000.0,
    "book_value_per_share_mrq": 6.83,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Paratek Pharmaceuticals, Inc."
  },
  "PRTO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.56,
    "ebitda": -17910000.0,
    "eps_estimate_current_year": -1.26,
    "eps_estimate_next_quarter": -0.4,
    "fifty_day_moving_average": 14.57,
    "fifty_two_week_high": 20.0,
    "fifty_two_week_low": 9.82,
    "percent_change_from_200_day_moving_average": -0.08410000000000001,
    "percent_change_from_50_day_moving_average": -0.034,
    "shares_owned": "N/A",
    "short_ratio": 35.93,
    "two_hundred_day_moving_average": 15.36,
    "volume": 36878.0,
    "market_cap": 231940000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.34,
    "roa_ttm": -0.2327,
    "roe_ttm": -0.1984,
    "shares_outstanding": 16480000.0,
    "pcnt_held_by_insiders": 0.4138,
    "pcnt_held_by_institutions": 0.5489999999999999,
    "pcnt_short_of_float": 0.050300000000000004,
    "operating_cash_flow_ttm": -14430000.0,
    "levered_cash_flow_ttm": -9760000.0,
    "book_value_per_share_mrq": 4.19,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Proteon Therapeutics Inc"
  },
  "PRXL": {
    "p_e_ratio": 26.56,
    "peg_ratio": 1.16,
    "earnings_per_share": 2.43,
    "ebitda": 301320000.0,
    "eps_estimate_current_year": 3.28,
    "eps_estimate_next_quarter": 0.88,
    "fifty_day_moving_average": 66.61,
    "fifty_two_week_high": 76.17,
    "fifty_two_week_low": 55.22,
    "percent_change_from_200_day_moving_average": -0.0263,
    "percent_change_from_50_day_moving_average": -0.030899999999999997,
    "shares_owned": "N/A",
    "short_ratio": 7.62,
    "two_hundred_day_moving_average": 66.29,
    "volume": 1585212.0,
    "market_cap": 3440000000.0,
    "price_to_sales_ttm": 1.69,
    "price_to_book_mrq": 7.17,
    "roa_ttm": 0.0736,
    "roe_ttm": 0.2569,
    "shares_outstanding": 53240000.0,
    "pcnt_held_by_insiders": 0.0213,
    "pcnt_held_by_institutions": 1.026,
    "pcnt_short_of_float": 0.0605,
    "operating_cash_flow_ttm": 193140000.0,
    "levered_cash_flow_ttm": 92720000.0,
    "book_value_per_share_mrq": 9.02,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "PAREXEL International Corporation"
  },
  "PSDV": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.65,
    "ebitda": -18480000.0,
    "eps_estimate_current_year": -0.65,
    "eps_estimate_next_quarter": -0.18,
    "fifty_day_moving_average": 3.81,
    "fifty_two_week_high": 4.64,
    "fifty_two_week_low": 3.23,
    "percent_change_from_200_day_moving_average": -0.0466,
    "percent_change_from_50_day_moving_average": -0.030600000000000002,
    "shares_owned": "N/A",
    "short_ratio": 17.29,
    "two_hundred_day_moving_average": 3.87,
    "volume": 156228.0,
    "market_cap": 108550000.0,
    "price_to_sales_ttm": 67.4,
    "price_to_book_mrq": 6.17,
    "roa_ttm": -0.3398,
    "roe_ttm": -0.7012,
    "shares_outstanding": 29420000.0,
    "pcnt_held_by_insiders": 0.161,
    "pcnt_held_by_institutions": 0.196,
    "pcnt_short_of_float": 0.030600000000000002,
    "operating_cash_flow_ttm": 9800000.0,
    "levered_cash_flow_ttm": 16570000.0,
    "book_value_per_share_mrq": 0.64,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "pSivida Corp."
  },
  "PSTI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.34,
    "ebitda": -23090000.0,
    "eps_estimate_current_year": -0.35,
    "eps_estimate_next_quarter": -0.1,
    "fifty_day_moving_average": 1.44,
    "fifty_two_week_high": 3.78,
    "fifty_two_week_low": 0.98,
    "percent_change_from_200_day_moving_average": -0.4105,
    "percent_change_from_50_day_moving_average": -0.1793,
    "shares_owned": "N/A",
    "short_ratio": 3.76,
    "two_hundred_day_moving_average": 2.0,
    "volume": 529547.0,
    "market_cap": 93590000.0,
    "price_to_sales_ttm": 234.39,
    "price_to_book_mrq": 1.69,
    "roa_ttm": -0.2534,
    "roe_ttm": -0.4648,
    "shares_outstanding": 79320000.0,
    "pcnt_held_by_insiders": 0.06269999999999999,
    "pcnt_held_by_institutions": 0.064,
    "pcnt_short_of_float": 0.0083,
    "operating_cash_flow_ttm": -20920000.0,
    "levered_cash_flow_ttm": -9050000.0,
    "book_value_per_share_mrq": 0.66,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Pluristem Therapeutics, Inc."
  },
  "PTCT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.71,
    "earnings_per_share": -4.15,
    "ebitda": -148540000.0,
    "eps_estimate_current_year": -4.81,
    "eps_estimate_next_quarter": -1.24,
    "fifty_day_moving_average": 29.19,
    "fifty_two_week_high": 78.72,
    "fifty_two_week_low": 22.67,
    "percent_change_from_200_day_moving_average": -0.1592,
    "percent_change_from_50_day_moving_average": 0.11359999999999999,
    "shares_owned": "N/A",
    "short_ratio": 7.9,
    "two_hundred_day_moving_average": 38.65,
    "volume": 1984486.0,
    "market_cap": 1110000000.0,
    "price_to_sales_ttm": 30.04,
    "price_to_book_mrq": 4.1,
    "roa_ttm": -0.3063,
    "roe_ttm": -0.624,
    "shares_outstanding": 34270000.0,
    "pcnt_held_by_insiders": 0.20879999999999999,
    "pcnt_held_by_institutions": 0.971,
    "pcnt_short_of_float": 0.316,
    "operating_cash_flow_ttm": -102000000.0,
    "levered_cash_flow_ttm": -57600000.0,
    "book_value_per_share_mrq": 7.94,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "PTC Therapeutics, Inc."
  },
  "PTIE": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.06,
    "earnings_per_share": -0.26,
    "ebitda": -11800000.0,
    "eps_estimate_current_year": -0.35,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.9,
    "fifty_two_week_high": 3.65,
    "fifty_two_week_low": 1.53,
    "percent_change_from_200_day_moving_average": -0.005600000000000001,
    "percent_change_from_50_day_moving_average": -0.030299999999999997,
    "shares_owned": "N/A",
    "short_ratio": 9.62,
    "two_hundred_day_moving_average": 1.85,
    "volume": 125520.0,
    "market_cap": 84190000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.59,
    "roa_ttm": -0.1867,
    "roe_ttm": -0.3173,
    "shares_outstanding": 45760000.0,
    "pcnt_held_by_insiders": 0.23379999999999998,
    "pcnt_held_by_institutions": 0.45299999999999996,
    "pcnt_short_of_float": 0.021400000000000002,
    "operating_cash_flow_ttm": -8070000.0,
    "levered_cash_flow_ttm": -3870000.0,
    "book_value_per_share_mrq": 0.72,
    "next_earnings_announcement_date": [
      "2016-02-15",
      "2016-02-19"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Pain Therapeutics Inc."
  },
  "PTLA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.94,
    "ebitda": -198810000.0,
    "eps_estimate_current_year": -4.31,
    "eps_estimate_next_quarter": -1.1,
    "fifty_day_moving_average": 49.54,
    "fifty_two_week_high": 57.96,
    "fifty_two_week_low": 26.26,
    "percent_change_from_200_day_moving_average": 0.039900000000000005,
    "percent_change_from_50_day_moving_average": -0.0005,
    "shares_owned": "N/A",
    "short_ratio": 5.13,
    "two_hundred_day_moving_average": 47.62,
    "volume": 1565742.0,
    "market_cap": 2760000000.0,
    "price_to_sales_ttm": 264.05,
    "price_to_book_mrq": 8.23,
    "roa_ttm": -0.371,
    "roe_ttm": -0.7504000000000001,
    "shares_outstanding": 55830000.0,
    "pcnt_held_by_insiders": 0.0258,
    "pcnt_held_by_institutions": 0.9420000000000001,
    "pcnt_short_of_float": 0.0917,
    "operating_cash_flow_ttm": -194130000.0,
    "levered_cash_flow_ttm": -115440000.0,
    "book_value_per_share_mrq": 6.13,
    "next_earnings_announcement_date": [
      "2016-02-29",
      "2016-03-04"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Portola Pharmaceuticals, Inc."
  },
  "PTN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.454,
    "ebitda": -29880000.0,
    "eps_estimate_current_year": -0.3,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 0.7209,
    "fifty_two_week_high": 1.58,
    "fifty_two_week_low": 0.63,
    "percent_change_from_200_day_moving_average": -0.233732,
    "percent_change_from_50_day_moving_average": -0.082204,
    "shares_owned": "N/A",
    "short_ratio": 12.55,
    "two_hundred_day_moving_average": 0.8634,
    "volume": 413268.0,
    "market_cap": 45010000.0,
    "price_to_sales_ttm": 6.18,
    "price_to_book_mrq": 2.45,
    "roa_ttm": -0.55,
    "roe_ttm": -1.9896,
    "shares_outstanding": 68030000.0,
    "pcnt_held_by_insiders": 0.0187,
    "pcnt_held_by_institutions": 0.22399999999999998,
    "pcnt_short_of_float": 0.0387,
    "operating_cash_flow_ttm": -28480000.0,
    "levered_cash_flow_ttm": -17550000.0,
    "book_value_per_share_mrq": 0.3,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Palatin Technologies Inc."
  },
  "PTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -8.06,
    "earnings_per_share": -1.57,
    "ebitda": 38590000.0,
    "eps_estimate_current_year": -0.08,
    "eps_estimate_next_quarter": 0.05,
    "fifty_day_moving_average": 2.96,
    "fifty_two_week_high": 12.88,
    "fifty_two_week_low": 1.91,
    "percent_change_from_200_day_moving_average": -0.3946,
    "percent_change_from_50_day_moving_average": -0.1288,
    "shares_owned": "N/A",
    "short_ratio": 9.9,
    "two_hundred_day_moving_average": 4.26,
    "volume": 2261011.0,
    "market_cap": 157530000.0,
    "price_to_sales_ttm": 0.85,
    "price_to_book_mrq": 1.37,
    "roa_ttm": -0.0535,
    "roe_ttm": -0.737,
    "shares_outstanding": 61060000.0,
    "pcnt_held_by_insiders": 0.39039999999999997,
    "pcnt_held_by_institutions": 0.5870000000000001,
    "pcnt_short_of_float": 0.1884,
    "operating_cash_flow_ttm": 21250000.0,
    "levered_cash_flow_ttm": 62670000.0,
    "book_value_per_share_mrq": 1.85,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Pernix Therapeutics Holdings, Inc."
  },
  "PULM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.87,
    "ebitda": -13210000.0,
    "eps_estimate_current_year": -4.13,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 4.62,
    "fifty_two_week_high": 14.55,
    "fifty_two_week_low": 3.3,
    "percent_change_from_200_day_moving_average": -0.2444,
    "percent_change_from_50_day_moving_average": 0.022400000000000003,
    "shares_owned": "N/A",
    "short_ratio": 0.01,
    "two_hundred_day_moving_average": 6.25,
    "volume": 12837.0,
    "market_cap": 69370000.0,
    "price_to_sales_ttm": 51.32,
    "price_to_book_mrq": 1.77,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 14700000.0,
    "pcnt_held_by_insiders": 0.2644,
    "pcnt_held_by_institutions": 0.359,
    "pcnt_short_of_float": 0.0001,
    "operating_cash_flow_ttm": -11330000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 2.44,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Pulmatrix, Inc."
  },
  "PVCT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.074,
    "ebitda": -18750000.0,
    "eps_estimate_current_year": -0.12,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.4549,
    "fifty_two_week_high": 0.99,
    "fifty_two_week_low": 0.34,
    "percent_change_from_200_day_moving_average": -0.249146,
    "percent_change_from_50_day_moving_average": -0.117252,
    "shares_owned": "N/A",
    "short_ratio": 9.12,
    "two_hundred_day_moving_average": 0.5349,
    "volume": 543589.0,
    "market_cap": 82180000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.42,
    "roa_ttm": -0.5035000000000001,
    "roe_ttm": -0.6369,
    "shares_outstanding": 204640000.0,
    "pcnt_held_by_insiders": 0.057800000000000004,
    "pcnt_held_by_institutions": 0.062,
    "pcnt_short_of_float": 0.01,
    "operating_cash_flow_ttm": -16620000.000000002,
    "levered_cash_flow_ttm": -10060000.0,
    "book_value_per_share_mrq": 0.12,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Provectus Biopharmaceuticals, Inc."
  },
  "Q": {
    "p_e_ratio": 23.73,
    "peg_ratio": 1.54,
    "earnings_per_share": 2.93,
    "ebitda": 781470000.0,
    "eps_estimate_current_year": 3.31,
    "eps_estimate_next_quarter": 0.85,
    "fifty_day_moving_average": 67.61,
    "fifty_two_week_high": 80.45,
    "fifty_two_week_low": 56.46,
    "percent_change_from_200_day_moving_average": -0.029300000000000003,
    "percent_change_from_50_day_moving_average": 0.028300000000000002,
    "shares_owned": "N/A",
    "short_ratio": 3.97,
    "two_hundred_day_moving_average": 71.62,
    "volume": 1204605.0,
    "market_cap": 8560000000.000001,
    "price_to_sales_ttm": 2.02,
    "price_to_book_mrq": "N/A",
    "roa_ttm": 0.1149,
    "roe_ttm": "N/A",
    "shares_outstanding": 123090000.0,
    "pcnt_held_by_insiders": 0.2402,
    "pcnt_held_by_institutions": 0.784,
    "pcnt_short_of_float": 0.059699999999999996,
    "operating_cash_flow_ttm": 525330000.00000006,
    "levered_cash_flow_ttm": 367790000.0,
    "book_value_per_share_mrq": -3.3,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Quintiles Transnational Holdings Inc."
  },
  "QDEL": {
    "p_e_ratio": 565.83,
    "peg_ratio": -51.45,
    "earnings_per_share": 0.04,
    "ebitda": 37010000.0,
    "eps_estimate_current_year": -0.02,
    "eps_estimate_next_quarter": 0.15,
    "fifty_day_moving_average": 21.21,
    "fifty_two_week_high": 29.38,
    "fifty_two_week_low": 17.16,
    "percent_change_from_200_day_moving_average": -0.0356,
    "percent_change_from_50_day_moving_average": -0.0397,
    "shares_owned": "N/A",
    "short_ratio": 22.78,
    "two_hundred_day_moving_average": 21.12,
    "volume": 313821.0,
    "market_cap": 677400000.0,
    "price_to_sales_ttm": 3.35,
    "price_to_book_mrq": 3.13,
    "roa_ttm": 0.0236,
    "roe_ttm": 0.006500000000000001,
    "shares_outstanding": 33259999.999999996,
    "pcnt_held_by_insiders": 0.172,
    "pcnt_held_by_institutions": 1.033,
    "pcnt_short_of_float": 0.1961,
    "operating_cash_flow_ttm": 38460000.0,
    "levered_cash_flow_ttm": 33030000.0,
    "book_value_per_share_mrq": 6.57,
    "next_earnings_announcement_date": [
      "2016-02-09",
      "2016-02-15"
    ],
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Quidel Corp."
  },
  "QLTI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.3,
    "earnings_per_share": -0.07,
    "ebitda": -26160000.0,
    "eps_estimate_current_year": -0.46,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.76,
    "fifty_two_week_high": 4.86,
    "fifty_two_week_low": 2.49,
    "percent_change_from_200_day_moving_average": -0.2459,
    "percent_change_from_50_day_moving_average": -0.0737,
    "shares_owned": "N/A",
    "short_ratio": 3.14,
    "two_hundred_day_moving_average": 3.39,
    "volume": 2153545.0,
    "market_cap": 135240000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 0.95,
    "roa_ttm": -0.11410000000000001,
    "roe_ttm": -0.0236,
    "shares_outstanding": 52830000.0,
    "pcnt_held_by_insiders": 0.1324,
    "pcnt_held_by_institutions": 0.508,
    "pcnt_short_of_float": 0.0101,
    "operating_cash_flow_ttm": 3890000.0,
    "levered_cash_flow_ttm": -7640000.0,
    "book_value_per_share_mrq": 2.75,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "QLT Inc."
  },
  "QTNT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.58,
    "ebitda": -38950000.0,
    "eps_estimate_current_year": -2.44,
    "eps_estimate_next_quarter": -0.73,
    "fifty_day_moving_average": 13.93,
    "fifty_two_week_high": 19.95,
    "fifty_two_week_low": 11.05,
    "percent_change_from_200_day_moving_average": 0.08789999999999999,
    "percent_change_from_50_day_moving_average": 0.1476,
    "shares_owned": "N/A",
    "short_ratio": 1.8,
    "two_hundred_day_moving_average": 14.7,
    "volume": 11836.0,
    "market_cap": 335170000.0,
    "price_to_sales_ttm": 13.35,
    "price_to_book_mrq": 30.46,
    "roa_ttm": -0.3815,
    "roe_ttm": -6.063,
    "shares_outstanding": 20960000.0,
    "pcnt_held_by_insiders": 0.6485,
    "pcnt_held_by_institutions": 0.35100000000000003,
    "pcnt_short_of_float": 0.0091,
    "operating_cash_flow_ttm": -40030000.0,
    "levered_cash_flow_ttm": -45560000.0,
    "book_value_per_share_mrq": 0.52,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Quotient Limited"
  },
  "QURE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.64,
    "ebitda": -51990000.0,
    "eps_estimate_current_year": -3.03,
    "eps_estimate_next_quarter": -0.63,
    "fifty_day_moving_average": 18.65,
    "fifty_two_week_high": 36.38,
    "fifty_two_week_low": 13.89,
    "percent_change_from_200_day_moving_average": -0.3323,
    "percent_change_from_50_day_moving_average": -0.1422,
    "shares_owned": "N/A",
    "short_ratio": 3.41,
    "two_hundred_day_moving_average": 23.96,
    "volume": 1345078.0,
    "market_cap": 387500000.0,
    "price_to_sales_ttm": 52.92,
    "price_to_book_mrq": 2.98,
    "roa_ttm": -0.1812,
    "roe_ttm": -0.7545000000000001,
    "shares_outstanding": 24220000.0,
    "pcnt_held_by_insiders": 0.1646,
    "pcnt_held_by_institutions": 0.34299999999999997,
    "pcnt_short_of_float": 0.09720000000000001,
    "operating_cash_flow_ttm": 21680000.0,
    "levered_cash_flow_ttm": -32240000.000000004,
    "book_value_per_share_mrq": 5.84,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "uniQure N.V."
  },
  "RARE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.06,
    "ebitda": -107410000.0,
    "eps_estimate_current_year": -3.64,
    "eps_estimate_next_quarter": -1.21,
    "fifty_day_moving_average": 101.12,
    "fifty_two_week_high": 137.05,
    "fifty_two_week_low": 43.13,
    "percent_change_from_200_day_moving_average": 0.0462,
    "percent_change_from_50_day_moving_average": 0.08650000000000001,
    "shares_owned": "N/A",
    "short_ratio": 5.96,
    "two_hundred_day_moving_average": 105.01,
    "volume": 1025863.0,
    "market_cap": 4269999999.9999995,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 7.43,
    "roa_ttm": -0.1668,
    "roe_ttm": -0.2761,
    "shares_outstanding": 38840000.0,
    "pcnt_held_by_insiders": 0.0875,
    "pcnt_held_by_institutions": 0.8490000000000001,
    "pcnt_short_of_float": 0.0875,
    "operating_cash_flow_ttm": -77990000.0,
    "levered_cash_flow_ttm": -45920000.0,
    "book_value_per_share_mrq": 14.86,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ultragenyx Pharmaceutical Inc."
  },
  "RCPI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.143,
    "ebitda": -13450000.0,
    "eps_estimate_current_year": -0.07,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.89,
    "fifty_two_week_high": 7.0,
    "fifty_two_week_low": 0.65,
    "percent_change_from_200_day_moving_average": -0.42436500000000005,
    "percent_change_from_50_day_moving_average": -0.236067,
    "shares_owned": "N/A",
    "short_ratio": 8.88,
    "two_hundred_day_moving_average": 1.1811,
    "volume": 127722.0,
    "market_cap": 7640000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": -2.3291,
    "roe_ttm": "N/A",
    "shares_outstanding": 11240000.0,
    "pcnt_held_by_insiders": 0.0394,
    "pcnt_held_by_institutions": 0.105,
    "pcnt_short_of_float": 0.1199,
    "operating_cash_flow_ttm": -8340000.0,
    "levered_cash_flow_ttm": -6560000.0,
    "book_value_per_share_mrq": -0.87,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Rock Creek Pharmaceuticals, Inc."
  },
  "RDHL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.98,
    "ebitda": -20020000.0,
    "eps_estimate_current_year": -1.8,
    "eps_estimate_next_quarter": -0.51,
    "fifty_day_moving_average": 12.44,
    "fifty_two_week_high": 22.22,
    "fifty_two_week_low": 10.1,
    "percent_change_from_200_day_moving_average": -0.162,
    "percent_change_from_50_day_moving_average": -0.0361,
    "shares_owned": "N/A",
    "short_ratio": 3.53,
    "two_hundred_day_moving_average": 14.31,
    "volume": 17978.0,
    "market_cap": 146940000.0,
    "price_to_sales_ttm": 37316.48,
    "price_to_book_mrq": 2.26,
    "roa_ttm": -0.2364,
    "roe_ttm": -0.4131,
    "shares_outstanding": 12260000.0,
    "pcnt_held_by_insiders": 0.5139,
    "pcnt_held_by_institutions": 0.095,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -17740000.0,
    "levered_cash_flow_ttm": -9990000.0,
    "book_value_per_share_mrq": 5.4,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "RedHill Biopharma Ltd."
  },
  "RDNT": {
    "p_e_ratio": 26.13,
    "peg_ratio": 2.01,
    "earnings_per_share": 0.23,
    "ebitda": 102310000.0,
    "eps_estimate_current_year": 0.31,
    "eps_estimate_next_quarter": 0.1,
    "fifty_day_moving_average": 6.35,
    "fifty_two_week_high": 9.99,
    "fifty_two_week_low": 5.19,
    "percent_change_from_200_day_moving_average": -0.0395,
    "percent_change_from_50_day_moving_average": -0.0332,
    "shares_owned": "N/A",
    "short_ratio": 3.18,
    "two_hundred_day_moving_average": 6.39,
    "volume": 241296.0,
    "market_cap": 283180000.0,
    "price_to_sales_ttm": 0.37,
    "price_to_book_mrq": 12.19,
    "roa_ttm": 0.035699999999999996,
    "roe_ttm": 0.8062999999999999,
    "shares_outstanding": 46120000.0,
    "pcnt_held_by_insiders": 0.3577,
    "pcnt_held_by_institutions": 0.503,
    "pcnt_short_of_float": 0.0322,
    "operating_cash_flow_ttm": 67030000.0,
    "levered_cash_flow_ttm": 787750.0,
    "book_value_per_share_mrq": 0.51,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "RadNet, Inc."
  },
  "RDUS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -8.11,
    "earnings_per_share": -2.32,
    "ebitda": -82330000.0,
    "eps_estimate_current_year": -2.41,
    "eps_estimate_next_quarter": -0.67,
    "fifty_day_moving_average": 63.07,
    "fifty_two_week_high": 84.64,
    "fifty_two_week_low": 30.46,
    "percent_change_from_200_day_moving_average": -0.092,
    "percent_change_from_50_day_moving_average": -0.065,
    "shares_owned": "N/A",
    "short_ratio": 4.0,
    "two_hundred_day_moving_average": 64.94,
    "volume": 1345127.0,
    "market_cap": 2530000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 5.14,
    "roa_ttm": -0.17850000000000002,
    "roe_ttm": -0.337,
    "shares_outstanding": 42920000.0,
    "pcnt_held_by_insiders": 0.26280000000000003,
    "pcnt_held_by_institutions": 0.659,
    "pcnt_short_of_float": 0.1491,
    "operating_cash_flow_ttm": -76440000.0,
    "levered_cash_flow_ttm": -47310000.0,
    "book_value_per_share_mrq": 11.41,
    "next_earnings_announcement_date": [
      "2016-03-08",
      "2016-03-14"
    ],
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Radius Health, Inc."
  },
  "RDY": {
    "p_e_ratio": 20.63,
    "peg_ratio": 1.28,
    "earnings_per_share": 2.15,
    "ebitda": 602700000.0,
    "eps_estimate_current_year": 2.37,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 50.63,
    "fifty_two_week_high": 68.0,
    "fifty_two_week_low": 43.41,
    "percent_change_from_200_day_moving_average": -0.242,
    "percent_change_from_50_day_moving_average": -0.1255,
    "shares_owned": "N/A",
    "short_ratio": 6.31,
    "two_hundred_day_moving_average": 58.42,
    "volume": 359304.0,
    "market_cap": 7550000000.0,
    "price_to_sales_ttm": 3.26,
    "price_to_book_mrq": 4.13,
    "roa_ttm": 0.1025,
    "roe_ttm": 0.2214,
    "shares_outstanding": 170590000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": 541620000.0,
    "levered_cash_flow_ttm": 192500000.0,
    "book_value_per_share_mrq": 10.71,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Dr. Reddy's Laboratories Ltd."
  },
  "REPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.63,
    "ebitda": 1160000.0,
    "eps_estimate_current_year": -1.17,
    "eps_estimate_next_quarter": -0.36,
    "fifty_day_moving_average": 9.2,
    "fifty_two_week_high": 18.3,
    "fifty_two_week_low": 2.71,
    "percent_change_from_200_day_moving_average": -0.285,
    "percent_change_from_50_day_moving_average": -0.062,
    "shares_owned": "N/A",
    "short_ratio": 7.15,
    "two_hundred_day_moving_average": 12.07,
    "volume": 9008.0,
    "market_cap": 79610000.0,
    "price_to_sales_ttm": 2.21,
    "price_to_book_mrq": 2.75,
    "roa_ttm": -0.022099999999999998,
    "roe_ttm": -0.4382,
    "shares_outstanding": 9220000.0,
    "pcnt_held_by_insiders": 0.6577,
    "pcnt_held_by_institutions": 0.125,
    "pcnt_short_of_float": 0.0481,
    "operating_cash_flow_ttm": 3620000.0,
    "levered_cash_flow_ttm": -16469999.999999998,
    "book_value_per_share_mrq": 3.08,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Recro Pharma, Inc."
  },
  "RGEN": {
    "p_e_ratio": 111.84,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.26,
    "ebitda": 20960000.0,
    "eps_estimate_current_year": 0.39,
    "eps_estimate_next_quarter": 0.12,
    "fifty_day_moving_average": 28.8,
    "fifty_two_week_high": 42.48,
    "fifty_two_week_low": 19.02,
    "percent_change_from_200_day_moving_average": -0.13470000000000001,
    "percent_change_from_50_day_moving_average": 0.013500000000000002,
    "shares_owned": "N/A",
    "short_ratio": 5.69,
    "two_hundred_day_moving_average": 33.73,
    "volume": 1292940.0,
    "market_cap": 961640000.0,
    "price_to_sales_ttm": 12.14,
    "price_to_book_mrq": 7.85,
    "roa_ttm": 0.0766,
    "roe_ttm": 0.0736,
    "shares_outstanding": 32939999.999999996,
    "pcnt_held_by_insiders": 0.0149,
    "pcnt_held_by_institutions": 0.972,
    "pcnt_short_of_float": 0.08199999999999999,
    "operating_cash_flow_ttm": 13450000.0,
    "levered_cash_flow_ttm": 12570000.0,
    "book_value_per_share_mrq": 3.69,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Repligen Corporation"
  },
  "RGLS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.2,
    "earnings_per_share": -1.41,
    "ebitda": -50760000.0,
    "eps_estimate_current_year": -1.19,
    "eps_estimate_next_quarter": -0.34,
    "fifty_day_moving_average": 9.11,
    "fifty_two_week_high": 21.22,
    "fifty_two_week_low": 5.85,
    "percent_change_from_200_day_moving_average": 0.0776,
    "percent_change_from_50_day_moving_average": 0.03,
    "shares_owned": "N/A",
    "short_ratio": 11.32,
    "two_hundred_day_moving_average": 8.7,
    "volume": 828525.0,
    "market_cap": 490980000.0,
    "price_to_sales_ttm": 32.63,
    "price_to_book_mrq": 3.66,
    "roa_ttm": -0.2643,
    "roe_ttm": -0.7071,
    "shares_outstanding": 52340000.0,
    "pcnt_held_by_insiders": 0.4292,
    "pcnt_held_by_institutions": 0.655,
    "pcnt_short_of_float": 0.2634,
    "operating_cash_flow_ttm": -44470000.0,
    "levered_cash_flow_ttm": -17780000.0,
    "book_value_per_share_mrq": 2.41,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Regulus Therapeutics Inc."
  },
  "RGNX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -6.6,
    "ebitda": 0.0,
    "eps_estimate_current_year": -1.77,
    "eps_estimate_next_quarter": -0.34,
    "fifty_day_moving_average": 21.21,
    "fifty_two_week_high": 32.0,
    "fifty_two_week_low": 13.77,
    "percent_change_from_200_day_moving_average": -0.1502,
    "percent_change_from_50_day_moving_average": -0.1607,
    "shares_owned": "N/A",
    "short_ratio": 7.95,
    "two_hundred_day_moving_average": 20.95,
    "volume": 1077548.0,
    "market_cap": 468380000.0,
    "price_to_sales_ttm": 114.2,
    "price_to_book_mrq": 2.21,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 26310000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.022799999999999997,
    "operating_cash_flow_ttm": -17930000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 8.43,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Regenxbio Inc."
  },
  "RIGL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.7,
    "ebitda": -59760000.0,
    "eps_estimate_current_year": -0.57,
    "eps_estimate_next_quarter": -0.17,
    "fifty_day_moving_average": 3.16,
    "fifty_two_week_high": 5.2,
    "fifty_two_week_low": 2.02,
    "percent_change_from_200_day_moving_average": 0.1244,
    "percent_change_from_50_day_moving_average": 0.08900000000000001,
    "shares_owned": "N/A",
    "short_ratio": 7.33,
    "two_hundred_day_moving_average": 3.06,
    "volume": 2882701.0,
    "market_cap": 304530000.0,
    "price_to_sales_ttm": 10.99,
    "price_to_book_mrq": 3.26,
    "roa_ttm": -0.25370000000000004,
    "roe_ttm": -0.5019,
    "shares_outstanding": 88530000.0,
    "pcnt_held_by_insiders": 0.004,
    "pcnt_held_by_institutions": 0.898,
    "pcnt_short_of_float": 0.0337,
    "operating_cash_flow_ttm": -24620000.0,
    "levered_cash_flow_ttm": -4290000.0,
    "book_value_per_share_mrq": 1.09,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Rigel Pharmaceuticals, Inc."
  },
  "RLYP": {
    "p_e_ratio": "N/A",
    "peg_ratio": -2.67,
    "earnings_per_share": -3.81,
    "ebitda": -140040000.0,
    "eps_estimate_current_year": -4.32,
    "eps_estimate_next_quarter": -1.34,
    "fifty_day_moving_average": 22.65,
    "fifty_two_week_high": 42.26,
    "fifty_two_week_low": 10.26,
    "percent_change_from_200_day_moving_average": 0.08349999999999999,
    "percent_change_from_50_day_moving_average": 0.23260000000000003,
    "shares_owned": "N/A",
    "short_ratio": 3.11,
    "two_hundred_day_moving_average": 25.77,
    "volume": 2637481.0,
    "market_cap": 1160000000.0,
    "price_to_sales_ttm": 175.05,
    "price_to_book_mrq": 5.06,
    "roa_ttm": -0.3884,
    "roe_ttm": -0.8384,
    "shares_outstanding": 41690000.0,
    "pcnt_held_by_insiders": 0.1101,
    "pcnt_held_by_institutions": 0.8690000000000001,
    "pcnt_short_of_float": 0.19210000000000002,
    "operating_cash_flow_ttm": -80620000.0,
    "levered_cash_flow_ttm": -36180000.0,
    "book_value_per_share_mrq": 5.47,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Relypsa, Inc."
  },
  "RMD": {
    "p_e_ratio": 21.95,
    "peg_ratio": 2.16,
    "earnings_per_share": 2.46,
    "ebitda": 485460000.0,
    "eps_estimate_current_year": 2.67,
    "eps_estimate_next_quarter": 0.68,
    "fifty_day_moving_average": 57.64,
    "fifty_two_week_high": 75.33,
    "fifty_two_week_low": 48.99,
    "percent_change_from_200_day_moving_average": -0.0285,
    "percent_change_from_50_day_moving_average": -0.0632,
    "shares_owned": "N/A",
    "short_ratio": 15.74,
    "two_hundred_day_moving_average": 55.58,
    "volume": 2071872.0,
    "market_cap": 7540000000.0,
    "price_to_sales_ttm": 4.51,
    "price_to_book_mrq": 5.27,
    "roa_ttm": 0.113,
    "roe_ttm": 0.2248,
    "shares_outstanding": 139650000.0,
    "pcnt_held_by_insiders": 0.0134,
    "pcnt_held_by_institutions": 0.609,
    "pcnt_short_of_float": 0.0706,
    "operating_cash_flow_ttm": 418720000.0,
    "levered_cash_flow_ttm": 253600000.0,
    "book_value_per_share_mrq": 10.47,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "ResMed Inc."
  },
  "RMTI": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.21,
    "earnings_per_share": -0.31,
    "ebitda": -13220000.0,
    "eps_estimate_current_year": -0.17,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 10.88,
    "fifty_two_week_high": 18.9,
    "fifty_two_week_low": 7.09,
    "percent_change_from_200_day_moving_average": -0.17489999999999997,
    "percent_change_from_50_day_moving_average": -0.0697,
    "shares_owned": "N/A",
    "short_ratio": 24.85,
    "two_hundred_day_moving_average": 12.27,
    "volume": 437698.0,
    "market_cap": 516909999.99999994,
    "price_to_sales_ttm": 9.18,
    "price_to_book_mrq": 7.79,
    "roa_ttm": -0.1531,
    "roe_ttm": -0.5099,
    "shares_outstanding": 51080000.0,
    "pcnt_held_by_insiders": 0.1448,
    "pcnt_held_by_institutions": 0.303,
    "pcnt_short_of_float": 0.214,
    "operating_cash_flow_ttm": 4019999.9999999995,
    "levered_cash_flow_ttm": -6800000.0,
    "book_value_per_share_mrq": 1.28,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Rockwell Medical, Inc."
  },
  "RNN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.08,
    "ebitda": -17720000.0,
    "eps_estimate_current_year": -0.09,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.44,
    "fifty_two_week_high": 0.96,
    "fifty_two_week_low": 0.37,
    "percent_change_from_200_day_moving_average": -0.3119,
    "percent_change_from_50_day_moving_average": -0.1591,
    "shares_owned": "N/A",
    "short_ratio": 6.37,
    "two_hundred_day_moving_average": 0.54,
    "volume": 1071003.0,
    "market_cap": 73040000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.18,
    "roa_ttm": -0.37270000000000003,
    "roe_ttm": -0.5936,
    "shares_outstanding": 197410000.0,
    "pcnt_held_by_insiders": 0.04190000000000001,
    "pcnt_held_by_institutions": 0.048,
    "pcnt_short_of_float": 0.0172,
    "operating_cash_flow_ttm": -15860000.0,
    "levered_cash_flow_ttm": -9270000.0,
    "book_value_per_share_mrq": 0.1,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Rexahn Pharmaceuticals, Inc."
  },
  "ROKA": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.03,
    "earnings_per_share": -1.7,
    "ebitda": -26920000.0,
    "eps_estimate_current_year": -2.03,
    "eps_estimate_next_quarter": -0.47,
    "fifty_day_moving_average": 1.39,
    "fifty_two_week_high": 4.95,
    "fifty_two_week_low": 1.09,
    "percent_change_from_200_day_moving_average": -0.4385,
    "percent_change_from_50_day_moving_average": -0.0793,
    "shares_owned": "N/A",
    "short_ratio": 2.03,
    "two_hundred_day_moving_average": 2.28,
    "volume": 28037.0,
    "market_cap": 23130000.0,
    "price_to_sales_ttm": 3.99,
    "price_to_book_mrq": 0.43,
    "roa_ttm": -0.22260000000000002,
    "roe_ttm": -0.4843,
    "shares_outstanding": 18070000.0,
    "pcnt_held_by_insiders": 0.17010000000000003,
    "pcnt_held_by_institutions": 0.6859999999999999,
    "pcnt_short_of_float": 0.0127,
    "operating_cash_flow_ttm": -23830000.0,
    "levered_cash_flow_ttm": -13420000.0,
    "book_value_per_share_mrq": 3.0,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Roka Bioscience, Inc."
  },
  "ROSG": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.09,
    "ebitda": -16040000.0,
    "eps_estimate_current_year": -1.37,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.57,
    "fifty_two_week_high": 5.55,
    "fifty_two_week_low": 1.05,
    "percent_change_from_200_day_moving_average": -0.49119999999999997,
    "percent_change_from_50_day_moving_average": -0.172,
    "shares_owned": "N/A",
    "short_ratio": 1.18,
    "two_hundred_day_moving_average": 2.56,
    "volume": 2145690.0,
    "market_cap": 23630000.0,
    "price_to_sales_ttm": 3.53,
    "price_to_book_mrq": 1.07,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 18180000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": 0.032,
    "pcnt_short_of_float": 0.043899999999999995,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 1.16,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Rosetta Genomics, Ltd."
  },
  "RPRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.04,
    "earnings_per_share": -1.25,
    "ebitda": -30340000.0,
    "eps_estimate_current_year": -1.27,
    "eps_estimate_next_quarter": -0.22,
    "fifty_day_moving_average": 1.6,
    "fifty_two_week_high": 10.55,
    "fifty_two_week_low": 1.09,
    "percent_change_from_200_day_moving_average": -0.7863,
    "percent_change_from_50_day_moving_average": -0.2064,
    "shares_owned": "N/A",
    "short_ratio": 0.44,
    "two_hundred_day_moving_average": 5.94,
    "volume": 411791.0,
    "market_cap": 30880000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.34,
    "roa_ttm": -0.456,
    "roe_ttm": -0.7807,
    "shares_outstanding": 24320000.0,
    "pcnt_held_by_insiders": 0.0045000000000000005,
    "pcnt_held_by_institutions": 0.609,
    "pcnt_short_of_float": 0.032799999999999996,
    "operating_cash_flow_ttm": -27000000.0,
    "levered_cash_flow_ttm": -15610000.0,
    "book_value_per_share_mrq": 0.99,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Repros Therapeutics Inc."
  },
  "RPTP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.91,
    "ebitda": -49140000.0,
    "eps_estimate_current_year": -0.78,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 5.95,
    "fifty_two_week_high": 16.28,
    "fifty_two_week_low": 4.27,
    "percent_change_from_200_day_moving_average": -0.4921,
    "percent_change_from_50_day_moving_average": -0.1391,
    "shares_owned": "N/A",
    "short_ratio": 10.05,
    "two_hundred_day_moving_average": 10.08,
    "volume": 2322405.0,
    "market_cap": 435720000.0,
    "price_to_sales_ttm": 5.03,
    "price_to_book_mrq": 3.78,
    "roa_ttm": -0.1536,
    "roe_ttm": -1.0452,
    "shares_outstanding": 85100000.0,
    "pcnt_held_by_insiders": 0.1404,
    "pcnt_held_by_institutions": 0.573,
    "pcnt_short_of_float": 0.1316,
    "operating_cash_flow_ttm": -42710000.0,
    "levered_cash_flow_ttm": -22510000.0,
    "book_value_per_share_mrq": 1.36,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Raptor Pharmaceuticals Corp."
  },
  "RTIX": {
    "p_e_ratio": 27.87,
    "peg_ratio": 1.29,
    "earnings_per_share": 0.14,
    "ebitda": 39910000.0,
    "eps_estimate_current_year": 0.19,
    "eps_estimate_next_quarter": 0.06,
    "fifty_day_moving_average": 3.87,
    "fifty_two_week_high": 7.48,
    "fifty_two_week_low": 3.65,
    "percent_change_from_200_day_moving_average": -0.3249,
    "percent_change_from_50_day_moving_average": -0.020499999999999997,
    "shares_owned": "N/A",
    "short_ratio": 5.16,
    "two_hundred_day_moving_average": 5.61,
    "volume": 365831.0,
    "market_cap": 219020000.0,
    "price_to_sales_ttm": 0.77,
    "price_to_book_mrq": 1.19,
    "roa_ttm": 0.038900000000000004,
    "roe_ttm": 0.050300000000000004,
    "shares_outstanding": 57790000.0,
    "pcnt_held_by_insiders": 0.1155,
    "pcnt_held_by_institutions": 0.754,
    "pcnt_short_of_float": 0.0384,
    "operating_cash_flow_ttm": 7850000.0,
    "levered_cash_flow_ttm": -3100000.0,
    "book_value_per_share_mrq": 3.1,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "RTI Surgical Inc."
  },
  "RTRX": {
    "p_e_ratio": 7.32,
    "peg_ratio": 0.34,
    "earnings_per_share": 2.74,
    "ebitda": -24850000.0,
    "eps_estimate_current_year": 2.95,
    "eps_estimate_next_quarter": -0.19,
    "fifty_day_moving_average": 20.31,
    "fifty_two_week_high": 37.04,
    "fifty_two_week_low": 11.87,
    "percent_change_from_200_day_moving_average": -0.2368,
    "percent_change_from_50_day_moving_average": -0.0134,
    "shares_owned": "N/A",
    "short_ratio": 6.51,
    "two_hundred_day_moving_average": 26.26,
    "volume": 1422546.0,
    "market_cap": 724420000.0,
    "price_to_sales_ttm": 9.06,
    "price_to_book_mrq": 2.59,
    "roa_ttm": -0.0687,
    "roe_ttm": 0.6457999999999999,
    "shares_outstanding": 36150000.0,
    "pcnt_held_by_insiders": 0.162,
    "pcnt_held_by_institutions": 0.858,
    "pcnt_short_of_float": 0.1316,
    "operating_cash_flow_ttm": -7100000.0,
    "levered_cash_flow_ttm": -79710.0,
    "book_value_per_share_mrq": 8.08,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Retrophin, Inc."
  },
  "RTTR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.7,
    "ebitda": -7960000.0,
    "eps_estimate_current_year": -2.18,
    "eps_estimate_next_quarter": -0.38,
    "fifty_day_moving_average": 2.17,
    "fifty_two_week_high": 5.5,
    "fifty_two_week_low": 1.61,
    "percent_change_from_200_day_moving_average": -0.39759999999999995,
    "percent_change_from_50_day_moving_average": -0.1747,
    "shares_owned": "N/A",
    "short_ratio": 0.35,
    "two_hundred_day_moving_average": 2.97,
    "volume": 26828.0,
    "market_cap": 13950000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 0.84,
    "roa_ttm": -0.5949,
    "roe_ttm": -1.1438,
    "shares_outstanding": 7790000.0,
    "pcnt_held_by_insiders": 0.3071,
    "pcnt_held_by_institutions": 0.258,
    "pcnt_short_of_float": 0.0022,
    "operating_cash_flow_ttm": -4570000.0,
    "levered_cash_flow_ttm": -1970000.0,
    "book_value_per_share_mrq": 1.98,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ritter Pharmaceuticals, Inc."
  },
  "RVNC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.78,
    "ebitda": -62300000.0,
    "eps_estimate_current_year": -3.22,
    "eps_estimate_next_quarter": -0.76,
    "fifty_day_moving_average": 37.71,
    "fifty_two_week_high": 42.41,
    "fifty_two_week_low": 14.1,
    "percent_change_from_200_day_moving_average": 0.1127,
    "percent_change_from_50_day_moving_average": -0.0462,
    "shares_owned": "N/A",
    "short_ratio": 3.19,
    "two_hundred_day_moving_average": 32.33,
    "volume": 1225610.0,
    "market_cap": 1010000000.0,
    "price_to_sales_ttm": 3357.15,
    "price_to_book_mrq": 6.13,
    "roa_ttm": -0.21489999999999998,
    "roe_ttm": -0.3972,
    "shares_outstanding": 28060000.0,
    "pcnt_held_by_insiders": 0.0436,
    "pcnt_held_by_institutions": 0.8740000000000001,
    "pcnt_short_of_float": 0.371,
    "operating_cash_flow_ttm": -48340000.0,
    "levered_cash_flow_ttm": -29360000.0,
    "book_value_per_share_mrq": 5.86,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Revance Therapeutics, Inc."
  },
  "RVP": {
    "p_e_ratio": 16.96,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.17,
    "ebitda": -698762.0,
    "eps_estimate_current_year": -0.46,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.47,
    "fifty_two_week_high": 5.7,
    "fifty_two_week_low": 2.5,
    "percent_change_from_200_day_moving_average": -0.22030000000000002,
    "percent_change_from_50_day_moving_average": -0.1636,
    "shares_owned": "N/A",
    "short_ratio": 3.44,
    "two_hundred_day_moving_average": 3.72,
    "volume": 27010.0,
    "market_cap": 80890000.0,
    "price_to_sales_ttm": 2.66,
    "price_to_book_mrq": 2.76,
    "roa_ttm": -0.0222,
    "roe_ttm": 0.2048,
    "shares_outstanding": 27890000.0,
    "pcnt_held_by_insiders": 0.6065,
    "pcnt_held_by_institutions": 0.061,
    "pcnt_short_of_float": 0.002,
    "operating_cash_flow_ttm": -2000000.0,
    "levered_cash_flow_ttm": -9720000.0,
    "book_value_per_share_mrq": 1.11,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Retractable Technologies, Inc."
  },
  "RWLK": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.93,
    "ebitda": -22370000.0,
    "eps_estimate_current_year": -1.96,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 7.69,
    "fifty_two_week_high": 23.5,
    "fifty_two_week_low": 5.55,
    "percent_change_from_200_day_moving_average": 0.4686,
    "percent_change_from_50_day_moving_average": 0.7563,
    "shares_owned": "N/A",
    "short_ratio": 12.23,
    "two_hundred_day_moving_average": 9.19,
    "volume": 9244655.0,
    "market_cap": 164060000.0,
    "price_to_sales_ttm": 34.48,
    "price_to_book_mrq": 4.82,
    "roa_ttm": -0.3262,
    "roe_ttm": -0.6074,
    "shares_outstanding": 12150000.0,
    "pcnt_held_by_insiders": 0.5115999999999999,
    "pcnt_held_by_institutions": 0.052000000000000005,
    "pcnt_short_of_float": 0.0583,
    "operating_cash_flow_ttm": -20730000.0,
    "levered_cash_flow_ttm": -11930000.0,
    "book_value_per_share_mrq": 2.28,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "ReWalk Robotics Ltd."
  },
  "RXDX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.97,
    "ebitda": -67830000.0,
    "eps_estimate_current_year": -2.4,
    "eps_estimate_next_quarter": -0.63,
    "fifty_day_moving_average": 12.76,
    "fifty_two_week_high": 19.4,
    "fifty_two_week_low": 6.34,
    "percent_change_from_200_day_moving_average": 0.0381,
    "percent_change_from_50_day_moving_average": 0.11460000000000001,
    "shares_owned": "N/A",
    "short_ratio": 4.49,
    "two_hundred_day_moving_average": 13.7,
    "volume": 443177.0,
    "market_cap": 421190000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.01,
    "roa_ttm": -0.3156,
    "roe_ttm": -0.6864,
    "shares_outstanding": 29620000.0,
    "pcnt_held_by_insiders": 0.23379999999999998,
    "pcnt_held_by_institutions": 0.6509999999999999,
    "pcnt_short_of_float": 0.054400000000000004,
    "operating_cash_flow_ttm": -47960000.0,
    "levered_cash_flow_ttm": -37850000.0,
    "book_value_per_share_mrq": 4.46,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ignyta, Inc."
  },
  "RXII": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.274,
    "ebitda": -9840000.0,
    "eps_estimate_current_year": -0.22,
    "eps_estimate_next_quarter": -0.05,
    "fifty_day_moving_average": 0.4051,
    "fifty_two_week_high": 1.74,
    "fifty_two_week_low": 0.342,
    "percent_change_from_200_day_moving_average": -0.09032299999999999,
    "percent_change_from_50_day_moving_average": -0.018548,
    "shares_owned": "N/A",
    "short_ratio": 10.82,
    "two_hundred_day_moving_average": 0.4371,
    "volume": 750091.0,
    "market_cap": 25980000.0,
    "price_to_sales_ttm": 544.03,
    "price_to_book_mrq": 2.35,
    "roa_ttm": -0.5255,
    "roe_ttm": -0.9540000000000001,
    "shares_outstanding": 65349999.99999999,
    "pcnt_held_by_insiders": 0.2194,
    "pcnt_held_by_institutions": 0.121,
    "pcnt_short_of_float": 0.15539999999999998,
    "operating_cash_flow_ttm": -7330000.0,
    "levered_cash_flow_ttm": -3870000.0,
    "book_value_per_share_mrq": 0.17,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "RXi Pharmaceuticals Corporation"
  },
  "SAGE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.15,
    "ebitda": -78300000.0,
    "eps_estimate_current_year": -3.35,
    "eps_estimate_next_quarter": -0.98,
    "fifty_day_moving_average": 49.85,
    "fifty_two_week_high": 89.04,
    "fifty_two_week_low": 35.0,
    "percent_change_from_200_day_moving_average": 0.04190000000000001,
    "percent_change_from_50_day_moving_average": 0.2227,
    "shares_owned": "N/A",
    "short_ratio": 6.43,
    "two_hundred_day_moving_average": 58.5,
    "volume": 1085234.0,
    "market_cap": 1760000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 8.61,
    "roa_ttm": -0.2829,
    "roe_ttm": -0.473,
    "shares_outstanding": 28860000.0,
    "pcnt_held_by_insiders": 0.185,
    "pcnt_held_by_institutions": 0.94,
    "pcnt_short_of_float": 0.2757,
    "operating_cash_flow_ttm": -61230000.0,
    "levered_cash_flow_ttm": -32759999.999999996,
    "book_value_per_share_mrq": 6.88,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Sage Therapeutics, Inc."
  },
  "SBBP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.48,
    "ebitda": 0.0,
    "eps_estimate_current_year": -2.63,
    "eps_estimate_next_quarter": -0.73,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 6.32,
    "fifty_two_week_low": 6.0,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 0.0,
    "two_hundred_day_moving_average": 0.0,
    "volume": 18759.0,
    "market_cap": null,
    "price_to_sales_ttm": null,
    "price_to_book_mrq": null,
    "roa_ttm": null,
    "roe_ttm": null,
    "shares_outstanding": null,
    "pcnt_held_by_insiders": null,
    "pcnt_held_by_institutions": null,
    "pcnt_short_of_float": null,
    "operating_cash_flow_ttm": null,
    "levered_cash_flow_ttm": null,
    "book_value_per_share_mrq": null,
    "next_earnings_announcement_date": null,
    "sector": null,
    "industry": null
  },
  "SBOT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.36,
    "ebitda": -4179999.9999999995,
    "eps_estimate_current_year": -0.3,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 7.8,
    "fifty_two_week_low": 7.09,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 2.57,
    "two_hundred_day_moving_average": 0.0,
    "volume": 51905.0,
    "market_cap": 59730000.0,
    "price_to_sales_ttm": 84.05,
    "price_to_book_mrq": 7.55,
    "roa_ttm": -0.2151,
    "roe_ttm": -0.3079,
    "shares_outstanding": 8420000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.009000000000000001,
    "operating_cash_flow_ttm": -4410000.0,
    "levered_cash_flow_ttm": -1540000.0,
    "book_value_per_share_mrq": 1.0,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Stellar Biotechnologies, Inc."
  },
  "SCAI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.52,
    "earnings_per_share": "N/A",
    "ebitda": 0.0,
    "eps_estimate_current_year": 2.01,
    "eps_estimate_next_quarter": 0.34,
    "fifty_day_moving_average": 36.06,
    "fifty_two_week_high": 40.99,
    "fifty_two_week_low": 27.88,
    "percent_change_from_200_day_moving_average": 0.079,
    "percent_change_from_50_day_moving_average": 0.0867,
    "shares_owned": "N/A",
    "short_ratio": 0.0,
    "two_hundred_day_moving_average": 36.32,
    "volume": 375135.0,
    "market_cap": null,
    "price_to_sales_ttm": null,
    "price_to_book_mrq": null,
    "roa_ttm": null,
    "roe_ttm": null,
    "shares_outstanding": null,
    "pcnt_held_by_insiders": null,
    "pcnt_held_by_institutions": null,
    "pcnt_short_of_float": null,
    "operating_cash_flow_ttm": null,
    "levered_cash_flow_ttm": null,
    "book_value_per_share_mrq": null,
    "next_earnings_announcement_date": [
      "2016-03-08",
      "2016-03-14"
    ],
    "sector": null,
    "industry": null
  },
  "SCLN": {
    "p_e_ratio": 22.74,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.39,
    "ebitda": 32630000.000000004,
    "eps_estimate_current_year": 0.33,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 8.85,
    "fifty_two_week_high": 11.71,
    "fifty_two_week_low": 6.47,
    "percent_change_from_200_day_moving_average": 0.037000000000000005,
    "percent_change_from_50_day_moving_average": 0.0021,
    "shares_owned": "N/A",
    "short_ratio": 8.15,
    "two_hundred_day_moving_average": 8.55,
    "volume": 1746518.0,
    "market_cap": 437970000.0,
    "price_to_sales_ttm": 2.8,
    "price_to_book_mrq": 2.63,
    "roa_ttm": 0.1018,
    "roe_ttm": 0.1253,
    "shares_outstanding": 49380000.0,
    "pcnt_held_by_insiders": 0.12480000000000001,
    "pcnt_held_by_institutions": 0.8079999999999999,
    "pcnt_short_of_float": 0.0644,
    "operating_cash_flow_ttm": 31520000.0,
    "levered_cash_flow_ttm": 29030000.0,
    "book_value_per_share_mrq": 3.36,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "SciClone Pharmaceuticals, Inc."
  },
  "SCMP": {
    "p_e_ratio": 25.32,
    "peg_ratio": 2.3,
    "earnings_per_share": 0.7,
    "ebitda": 50480000.0,
    "eps_estimate_current_year": 0.71,
    "eps_estimate_next_quarter": 0.21,
    "fifty_day_moving_average": 17.38,
    "fifty_two_week_high": 29.67,
    "fifty_two_week_low": 12.87,
    "percent_change_from_200_day_moving_average": -0.11109999999999999,
    "percent_change_from_50_day_moving_average": 0.021,
    "shares_owned": "N/A",
    "short_ratio": 5.85,
    "two_hundred_day_moving_average": 19.97,
    "volume": 1440570.0,
    "market_cap": 794970000.0,
    "price_to_sales_ttm": 5.83,
    "price_to_book_mrq": 6.64,
    "roa_ttm": 0.1961,
    "roe_ttm": 0.3431,
    "shares_outstanding": 44790000.0,
    "pcnt_held_by_insiders": 0.5418999999999999,
    "pcnt_held_by_institutions": 0.503,
    "pcnt_short_of_float": 0.26530000000000004,
    "operating_cash_flow_ttm": 47550000.0,
    "levered_cash_flow_ttm": 72870000.0,
    "book_value_per_share_mrq": 2.63,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Sucampo Pharmaceuticals, Inc."
  },
  "SCYX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.52,
    "ebitda": -20460000.0,
    "eps_estimate_current_year": -2.57,
    "eps_estimate_next_quarter": -0.6,
    "fifty_day_moving_average": 6.69,
    "fifty_two_week_high": 15.0,
    "fifty_two_week_low": 6.1,
    "percent_change_from_200_day_moving_average": -0.1693,
    "percent_change_from_50_day_moving_average": -0.075,
    "shares_owned": "N/A",
    "short_ratio": 9.38,
    "two_hundred_day_moving_average": 7.45,
    "volume": 10903.0,
    "market_cap": 86080000.0,
    "price_to_sales_ttm": 4.51,
    "price_to_book_mrq": 1.72,
    "roa_ttm": -0.2706,
    "roe_ttm": -0.51,
    "shares_outstanding": 13910000.0,
    "pcnt_held_by_insiders": 0.258,
    "pcnt_held_by_institutions": 0.589,
    "pcnt_short_of_float": 0.015300000000000001,
    "operating_cash_flow_ttm": -20280000.0,
    "levered_cash_flow_ttm": -7370000.0,
    "book_value_per_share_mrq": 3.59,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "SCYNEXIS, Inc."
  },
  "SEM": {
    "p_e_ratio": 12.41,
    "peg_ratio": 1.16,
    "earnings_per_share": 0.97,
    "ebitda": 363040000.0,
    "eps_estimate_current_year": 0.83,
    "eps_estimate_next_quarter": 0.27,
    "fifty_day_moving_average": 11.93,
    "fifty_two_week_high": 17.2,
    "fifty_two_week_low": 10.07,
    "percent_change_from_200_day_moving_average": -0.09369999999999999,
    "percent_change_from_50_day_moving_average": 0.0064,
    "shares_owned": "N/A",
    "short_ratio": 10.79,
    "two_hundred_day_moving_average": 13.25,
    "volume": 2584532.0,
    "market_cap": 1580000000.0,
    "price_to_sales_ttm": 0.47,
    "price_to_book_mrq": 1.97,
    "roa_ttm": 0.0479,
    "roe_ttm": 0.1445,
    "shares_outstanding": 131190000.0,
    "pcnt_held_by_insiders": 0.2014,
    "pcnt_held_by_institutions": 0.836,
    "pcnt_short_of_float": 0.11109999999999999,
    "operating_cash_flow_ttm": 221830000.0,
    "levered_cash_flow_ttm": 15160000.0,
    "book_value_per_share_mrq": 6.29,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Hospitals",
    "company_name": "Select Medical Holdings Corporation"
  },
  "SGEN": {
    "p_e_ratio": "N/A",
    "peg_ratio": -2.53,
    "earnings_per_share": -0.98,
    "ebitda": -109390000.0,
    "eps_estimate_current_year": -0.94,
    "eps_estimate_next_quarter": -0.18,
    "fifty_day_moving_average": 42.23,
    "fifty_two_week_high": 52.33,
    "fifty_two_week_low": 30.05,
    "percent_change_from_200_day_moving_average": -0.050199999999999995,
    "percent_change_from_50_day_moving_average": -0.013300000000000001,
    "shares_owned": "N/A",
    "short_ratio": 15.06,
    "two_hundred_day_moving_average": 43.87,
    "volume": 2116220.0,
    "market_cap": 5810000000.0,
    "price_to_sales_ttm": 18.19,
    "price_to_book_mrq": 8.3,
    "roa_ttm": -0.1114,
    "roe_ttm": -0.2655,
    "shares_outstanding": 139480000.0,
    "pcnt_held_by_insiders": 0.2716,
    "pcnt_held_by_institutions": 0.72,
    "pcnt_short_of_float": 0.2631,
    "operating_cash_flow_ttm": -135030000.0,
    "levered_cash_flow_ttm": -56720000.0,
    "book_value_per_share_mrq": 4.99,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Seattle Genetics, Inc."
  },
  "SGMO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.45,
    "ebitda": -34590000.0,
    "eps_estimate_current_year": -0.6,
    "eps_estimate_next_quarter": -0.21,
    "fifty_day_moving_average": 8.18,
    "fifty_two_week_high": 19.25,
    "fifty_two_week_low": 5.3,
    "percent_change_from_200_day_moving_average": 0.1406,
    "percent_change_from_50_day_moving_average": 0.1766,
    "shares_owned": "N/A",
    "short_ratio": 15.84,
    "two_hundred_day_moving_average": 8.44,
    "volume": 7393301.0,
    "market_cap": 674550000.0,
    "price_to_sales_ttm": 14.54,
    "price_to_book_mrq": 3.24,
    "roa_ttm": -0.0924,
    "roe_ttm": -0.1499,
    "shares_outstanding": 70050000.0,
    "pcnt_held_by_insiders": 0.0418,
    "pcnt_held_by_institutions": 0.71,
    "pcnt_short_of_float": 0.1893,
    "operating_cash_flow_ttm": -27330000.0,
    "levered_cash_flow_ttm": -6950000.0,
    "book_value_per_share_mrq": 2.91,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Sangamo Biosciences Inc."
  },
  "SGNL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.646,
    "ebitda": -10510000.0,
    "eps_estimate_current_year": -1.48,
    "eps_estimate_next_quarter": -0.18,
    "fifty_day_moving_average": 0.8298,
    "fifty_two_week_high": 5.799,
    "fifty_two_week_low": 0.663,
    "percent_change_from_200_day_moving_average": -0.471249,
    "percent_change_from_50_day_moving_average": -0.176279,
    "shares_owned": "N/A",
    "short_ratio": 2.16,
    "two_hundred_day_moving_average": 1.2927,
    "volume": 73099.0,
    "market_cap": 7270000.0,
    "price_to_sales_ttm": 2.94,
    "price_to_book_mrq": 0.59,
    "roa_ttm": -0.5492,
    "roe_ttm": -1.052,
    "shares_outstanding": 10640000.0,
    "pcnt_held_by_insiders": 0.4836,
    "pcnt_held_by_institutions": 0.07200000000000001,
    "pcnt_short_of_float": 0.09609999999999999,
    "operating_cash_flow_ttm": -6600000.0,
    "levered_cash_flow_ttm": -3110000.0,
    "book_value_per_share_mrq": 1.19,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Signal Genetics, Inc."
  },
  "SGNT": {
    "p_e_ratio": 19.67,
    "peg_ratio": -3.13,
    "earnings_per_share": 0.8,
    "ebitda": 28680000.0,
    "eps_estimate_current_year": -0.17,
    "eps_estimate_next_quarter": 0.09,
    "fifty_day_moving_average": 15.35,
    "fifty_two_week_high": 30.75,
    "fifty_two_week_low": 13.66,
    "percent_change_from_200_day_moving_average": -0.1993,
    "percent_change_from_50_day_moving_average": 0.0239,
    "shares_owned": "N/A",
    "short_ratio": 5.83,
    "two_hundred_day_moving_average": 19.63,
    "volume": 1744128.0,
    "market_cap": 515419999.99999994,
    "price_to_sales_ttm": 1.66,
    "price_to_book_mrq": 1.94,
    "roa_ttm": 0.031200000000000002,
    "roe_ttm": 0.09880000000000001,
    "shares_outstanding": 32790000.0,
    "pcnt_held_by_insiders": 0.2774,
    "pcnt_held_by_institutions": 0.768,
    "pcnt_short_of_float": 0.1469,
    "operating_cash_flow_ttm": -9180000.0,
    "levered_cash_flow_ttm": -35590000.0,
    "book_value_per_share_mrq": 8.32,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Sagent Pharmaceuticals, Inc."
  },
  "SGRY": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.05,
    "ebitda": 205230000.0,
    "eps_estimate_current_year": 0.13,
    "eps_estimate_next_quarter": 0.12,
    "fifty_day_moving_average": 19.12,
    "fifty_two_week_high": 22.32,
    "fifty_two_week_low": 16.26,
    "percent_change_from_200_day_moving_average": 0.019799999999999998,
    "percent_change_from_50_day_moving_average": 0.008,
    "shares_owned": "N/A",
    "short_ratio": 6.1,
    "two_hundred_day_moving_average": 18.9,
    "volume": 3144842.0,
    "market_cap": 927990000.0,
    "price_to_sales_ttm": 1.17,
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 48160000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0649,
    "operating_cash_flow_ttm": 53010000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -8.19,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Surgery Partners, Inc."
  },
  "SGYP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.16,
    "ebitda": -100330000.0,
    "eps_estimate_current_year": -1.11,
    "eps_estimate_next_quarter": -0.26,
    "fifty_day_moving_average": 6.16,
    "fifty_two_week_high": 10.15,
    "fifty_two_week_low": 2.75,
    "percent_change_from_200_day_moving_average": -0.1335,
    "percent_change_from_50_day_moving_average": -0.0252,
    "shares_owned": "N/A",
    "short_ratio": 19.74,
    "two_hundred_day_moving_average": 6.92,
    "volume": 6749629.0,
    "market_cap": 682040000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.6915,
    "roe_ttm": "N/A",
    "shares_outstanding": 113670000.0,
    "pcnt_held_by_insiders": 0.0701,
    "pcnt_held_by_institutions": 0.467,
    "pcnt_short_of_float": 0.2893,
    "operating_cash_flow_ttm": -99110000.0,
    "levered_cash_flow_ttm": -55460000.0,
    "book_value_per_share_mrq": -0.24,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Synergy Pharmaceuticals, Inc."
  },
  "SIEN": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.23,
    "earnings_per_share": -1.18,
    "ebitda": -12360000.0,
    "eps_estimate_current_year": -1.17,
    "eps_estimate_next_quarter": -0.31,
    "fifty_day_moving_average": 4.4,
    "fifty_two_week_high": 26.67,
    "fifty_two_week_low": 2.78,
    "percent_change_from_200_day_moving_average": -0.65,
    "percent_change_from_50_day_moving_average": 0.26899999999999996,
    "shares_owned": "N/A",
    "short_ratio": 1.55,
    "two_hundred_day_moving_average": 15.94,
    "volume": 367336.0,
    "market_cap": 100400000.0,
    "price_to_sales_ttm": 2.03,
    "price_to_book_mrq": 0.67,
    "roa_ttm": -0.0626,
    "roe_ttm": -0.1925,
    "shares_outstanding": 17990000.0,
    "pcnt_held_by_insiders": 0.0712,
    "pcnt_held_by_institutions": 0.49,
    "pcnt_short_of_float": 0.1303,
    "operating_cash_flow_ttm": -9120000.0,
    "levered_cash_flow_ttm": -4340000.0,
    "book_value_per_share_mrq": 8.14,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Sientra, Inc."
  },
  "SIRO": {
    "p_e_ratio": 32.23,
    "peg_ratio": 2.04,
    "earnings_per_share": 3.3,
    "ebitda": 312200000.0,
    "eps_estimate_current_year": 4.35,
    "eps_estimate_next_quarter": 0.94,
    "fifty_day_moving_average": 108.83,
    "fifty_two_week_high": 113.58,
    "fifty_two_week_low": 86.29,
    "percent_change_from_200_day_moving_average": 0.039599999999999996,
    "percent_change_from_50_day_moving_average": -0.022799999999999997,
    "shares_owned": "N/A",
    "short_ratio": 6.77,
    "two_hundred_day_moving_average": 102.3,
    "volume": 396567.0,
    "market_cap": 5950000000.0,
    "price_to_sales_ttm": 5.18,
    "price_to_book_mrq": 4.49,
    "roa_ttm": 0.08539999999999999,
    "roe_ttm": 0.1446,
    "shares_outstanding": 55940000.0,
    "pcnt_held_by_insiders": 0.0621,
    "pcnt_held_by_institutions": 1.002,
    "pcnt_short_of_float": 0.0438,
    "operating_cash_flow_ttm": 239200000.0,
    "levered_cash_flow_ttm": 167340000.0,
    "book_value_per_share_mrq": 23.94,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Sirona Dental Systems Inc."
  },
  "SKBI": {
    "p_e_ratio": 0.77,
    "peg_ratio": 0.0,
    "earnings_per_share": 1.37,
    "ebitda": 14480000.0,
    "eps_estimate_current_year": 2.25,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.24,
    "fifty_two_week_high": 4.81,
    "fifty_two_week_low": 0.85,
    "percent_change_from_200_day_moving_average": -0.375,
    "percent_change_from_50_day_moving_average": -0.1426,
    "shares_owned": "N/A",
    "short_ratio": 4.45,
    "two_hundred_day_moving_average": 1.7,
    "volume": 30270.0,
    "market_cap": 9220000.0,
    "price_to_sales_ttm": 0.21,
    "price_to_book_mrq": 0.08,
    "roa_ttm": 0.051100000000000007,
    "roe_ttm": 0.09609999999999999,
    "shares_outstanding": 8700000.0,
    "pcnt_held_by_insiders": 0.3642,
    "pcnt_held_by_institutions": 0.061,
    "pcnt_short_of_float": 0.0046,
    "operating_cash_flow_ttm": 18910000.0,
    "levered_cash_flow_ttm": -1920000.0,
    "book_value_per_share_mrq": 14.41,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Skystar Bio Pharmaceutical Company"
  },
  "SKLN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.47,
    "ebitda": -4210000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.67,
    "fifty_two_week_high": 7.15,
    "fifty_two_week_low": 2.0,
    "percent_change_from_200_day_moving_average": -0.11199999999999999,
    "percent_change_from_50_day_moving_average": -0.1471,
    "shares_owned": "N/A",
    "short_ratio": 2.3,
    "two_hundred_day_moving_average": 3.52,
    "volume": 39982.0,
    "market_cap": 16290000.0,
    "price_to_sales_ttm": 31.04,
    "price_to_book_mrq": 3.41,
    "roa_ttm": -0.5549000000000001,
    "roe_ttm": -4.9437,
    "shares_outstanding": 5200000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0369,
    "operating_cash_flow_ttm": -4870000.0,
    "levered_cash_flow_ttm": -2860000.0,
    "book_value_per_share_mrq": 1.11,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Skyline Medical Inc."
  },
  "SMLR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.13,
    "ebitda": -5120000.0,
    "eps_estimate_current_year": -1.19,
    "eps_estimate_next_quarter": -0.13,
    "fifty_day_moving_average": 2.624,
    "fifty_two_week_high": 6.9,
    "fifty_two_week_low": 1.65,
    "percent_change_from_200_day_moving_average": -0.13730399999999998,
    "percent_change_from_50_day_moving_average": -0.002428,
    "shares_owned": "N/A",
    "short_ratio": 2.02,
    "two_hundred_day_moving_average": 3.0342,
    "volume": 3698.0,
    "market_cap": 13050000.0,
    "price_to_sales_ttm": 2.53,
    "price_to_book_mrq": 24.3,
    "roa_ttm": -0.6269,
    "roe_ttm": -2.1328,
    "shares_outstanding": 4980000.0,
    "pcnt_held_by_insiders": 0.5581,
    "pcnt_held_by_institutions": 0.073,
    "pcnt_short_of_float": 0.004,
    "operating_cash_flow_ttm": -4050000.0,
    "levered_cash_flow_ttm": -2860000.0,
    "book_value_per_share_mrq": 0.11,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Semler Scientific Inc"
  },
  "SMMT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.13,
    "ebitda": 0.0,
    "eps_estimate_current_year": -0.42,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 10.14,
    "fifty_two_week_high": 14.78,
    "fifty_two_week_low": 8.84,
    "percent_change_from_200_day_moving_average": -0.0183,
    "percent_change_from_50_day_moving_average": 0.0794,
    "shares_owned": "N/A",
    "short_ratio": 10.04,
    "two_hundred_day_moving_average": 11.15,
    "volume": 8247.0,
    "market_cap": "N/A",
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": "NaN",
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.0,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Summit Therapeutics plc"
  },
  "SNSS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.02,
    "earnings_per_share": -0.436,
    "ebitda": -39080000.0,
    "eps_estimate_current_year": -0.49,
    "eps_estimate_next_quarter": -0.16,
    "fifty_day_moving_average": 0.869,
    "fifty_two_week_high": 3.72,
    "fifty_two_week_low": 0.74,
    "percent_change_from_200_day_moving_average": -0.42640999999999996,
    "percent_change_from_50_day_moving_average": 0.00986,
    "shares_owned": "N/A",
    "short_ratio": 2.6,
    "two_hundred_day_moving_average": 1.531,
    "volume": 216541.0,
    "market_cap": 74660000.0,
    "price_to_sales_ttm": 20.01,
    "price_to_book_mrq": 5.45,
    "roa_ttm": -0.632,
    "roe_ttm": -3.3714999999999997,
    "shares_outstanding": 85030000.0,
    "pcnt_held_by_insiders": 0.0729,
    "pcnt_held_by_institutions": 0.5920000000000001,
    "pcnt_short_of_float": 0.019299999999999998,
    "operating_cash_flow_ttm": -38470000.0,
    "levered_cash_flow_ttm": -35110000.0,
    "book_value_per_share_mrq": 0.16,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Sunesis Pharmaceuticals, Inc."
  },
  "SNTA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.647,
    "ebitda": -76450000.0,
    "eps_estimate_current_year": -0.61,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 0.4566,
    "fifty_two_week_high": 3.17,
    "fifty_two_week_low": 0.29,
    "percent_change_from_200_day_moving_average": -0.8116639999999999,
    "percent_change_from_50_day_moving_average": -0.328472,
    "shares_owned": "N/A",
    "short_ratio": 2.94,
    "two_hundred_day_moving_average": 1.6279,
    "volume": 5370690.0,
    "market_cap": 42250000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 0.73,
    "roa_ttm": -0.44909999999999994,
    "roe_ttm": -1.0894,
    "shares_outstanding": 137790000.0,
    "pcnt_held_by_insiders": 0.3311,
    "pcnt_held_by_institutions": 0.21600000000000003,
    "pcnt_short_of_float": 0.06509999999999999,
    "operating_cash_flow_ttm": -71320000.0,
    "levered_cash_flow_ttm": -42090000.0,
    "book_value_per_share_mrq": 0.44,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Synta Pharmaceuticals Corp."
  },
  "SPAN": {
    "p_e_ratio": 14.68,
    "peg_ratio": 0.0,
    "earnings_per_share": 1.33,
    "ebitda": 6480000.0,
    "eps_estimate_current_year": 0.86,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 19.02,
    "fifty_two_week_high": 21.62,
    "fifty_two_week_low": 16.44,
    "percent_change_from_200_day_moving_average": 0.0691,
    "percent_change_from_50_day_moving_average": 0.027000000000000003,
    "shares_owned": "N/A",
    "short_ratio": 1.5,
    "two_hundred_day_moving_average": 18.27,
    "volume": 26979.0,
    "market_cap": 53460000.0,
    "price_to_sales_ttm": 0.81,
    "price_to_book_mrq": 2.14,
    "roa_ttm": 0.0966,
    "roe_ttm": 0.1452,
    "shares_outstanding": 2740000.0,
    "pcnt_held_by_insiders": 0.1959,
    "pcnt_held_by_institutions": 0.35700000000000004,
    "pcnt_short_of_float": 0.0021,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 8.88,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Span-America Medical Systems Inc."
  },
  "SPHS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.01,
    "ebitda": -16230000.0,
    "eps_estimate_current_year": -0.95,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.81,
    "fifty_two_week_high": 3.85,
    "fifty_two_week_low": 0.42,
    "percent_change_from_200_day_moving_average": 0.5504,
    "percent_change_from_50_day_moving_average": -0.04190000000000001,
    "shares_owned": "N/A",
    "short_ratio": 0.04,
    "two_hundred_day_moving_average": 1.12,
    "volume": 245077.0,
    "market_cap": 29140000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 8.13,
    "roa_ttm": -0.4644,
    "roe_ttm": -1.4691999999999998,
    "shares_outstanding": 16840000.0,
    "pcnt_held_by_insiders": 0.0785,
    "pcnt_held_by_institutions": 0.055,
    "pcnt_short_of_float": 0.009399999999999999,
    "operating_cash_flow_ttm": -18960000.0,
    "levered_cash_flow_ttm": -12620000.0,
    "book_value_per_share_mrq": 0.21,
    "next_earnings_announcement_date": [
      "2016-03-08",
      "2016-03-14"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Sophiris Bio, Inc."
  },
  "SPNC": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.96,
    "earnings_per_share": -1.54,
    "ebitda": -12040000.0,
    "eps_estimate_current_year": -0.97,
    "eps_estimate_next_quarter": -0.23,
    "fifty_day_moving_average": 13.63,
    "fifty_two_week_high": 37.04,
    "fifty_two_week_low": 10.65,
    "percent_change_from_200_day_moving_average": -0.1531,
    "percent_change_from_50_day_moving_average": 0.066,
    "shares_owned": "N/A",
    "short_ratio": 13.9,
    "two_hundred_day_moving_average": 17.16,
    "volume": 624952.0,
    "market_cap": 619520000.0,
    "price_to_sales_ttm": 2.49,
    "price_to_book_mrq": 4.74,
    "roa_ttm": -0.0506,
    "roe_ttm": -0.4349,
    "shares_outstanding": 42640000.0,
    "pcnt_held_by_insiders": 0.0677,
    "pcnt_held_by_institutions": 1.004,
    "pcnt_short_of_float": 0.1616,
    "operating_cash_flow_ttm": -50340000.0,
    "levered_cash_flow_ttm": 11580000.0,
    "book_value_per_share_mrq": 2.96,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "The Spectranetics Corporation"
  },
  "SPNE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -4.51,
    "ebitda": -10450000.0,
    "eps_estimate_current_year": -4.74,
    "eps_estimate_next_quarter": -0.39,
    "fifty_day_moving_average": 15.59,
    "fifty_two_week_high": 26.0,
    "fifty_two_week_low": 13.56,
    "percent_change_from_200_day_moving_average": -0.021099999999999997,
    "percent_change_from_50_day_moving_average": 0.0334,
    "shares_owned": "N/A",
    "short_ratio": 6.83,
    "two_hundred_day_moving_average": 16.46,
    "volume": 81380.0,
    "market_cap": 178870000.0,
    "price_to_sales_ttm": 1.36,
    "price_to_book_mrq": 1.14,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 11100000.0,
    "pcnt_held_by_insiders": 0.42340000000000005,
    "pcnt_held_by_institutions": 0.17,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -33580000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 14.34,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "SeaSpine Holdings Corporation"
  },
  "SPPI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.76,
    "ebitda": -6450000.0,
    "eps_estimate_current_year": -0.88,
    "eps_estimate_next_quarter": -0.22,
    "fifty_day_moving_average": 5.47,
    "fifty_two_week_high": 7.74,
    "fifty_two_week_low": 4.89,
    "percent_change_from_200_day_moving_average": -0.059500000000000004,
    "percent_change_from_50_day_moving_average": 0.1041,
    "shares_owned": "N/A",
    "short_ratio": 16.77,
    "two_hundred_day_moving_average": 6.42,
    "volume": 6557846.0,
    "market_cap": 406730000.0,
    "price_to_sales_ttm": 2.35,
    "price_to_book_mrq": 1.8,
    "roa_ttm": -0.044800000000000006,
    "roe_ttm": -0.21050000000000002,
    "shares_outstanding": 67340000.0,
    "pcnt_held_by_insiders": 0.1306,
    "pcnt_held_by_institutions": 0.768,
    "pcnt_short_of_float": 0.2934,
    "operating_cash_flow_ttm": 14660000.0,
    "levered_cash_flow_ttm": -6320000.0,
    "book_value_per_share_mrq": 3.26,
    "next_earnings_announcement_date": [
      "2016-03-11",
      "2016-03-15"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Spectrum Pharmaceuticals, Inc."
  },
  "SQNM": {
    "p_e_ratio": 12.25,
    "peg_ratio": -0.19,
    "earnings_per_share": 0.12,
    "ebitda": 3880000.0,
    "eps_estimate_current_year": -0.3,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 1.59,
    "fifty_two_week_high": 4.8,
    "fifty_two_week_low": 1.1,
    "percent_change_from_200_day_moving_average": -0.3549,
    "percent_change_from_50_day_moving_average": -0.0755,
    "shares_owned": "N/A",
    "short_ratio": 19.2,
    "two_hundred_day_moving_average": 2.28,
    "volume": 3628171.0,
    "market_cap": 174300000.0,
    "price_to_sales_ttm": 1.21,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.034,
    "roe_ttm": "N/A",
    "shares_outstanding": 118570000.0,
    "pcnt_held_by_insiders": 0.0092,
    "pcnt_held_by_institutions": 0.518,
    "pcnt_short_of_float": 0.128,
    "operating_cash_flow_ttm": -21770000.0,
    "levered_cash_flow_ttm": 15050000.0,
    "book_value_per_share_mrq": -0.23,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Sequenom Inc."
  },
  "SRDX": {
    "p_e_ratio": 22.42,
    "peg_ratio": 1.85,
    "earnings_per_share": 0.9,
    "ebitda": 24390000.0,
    "eps_estimate_current_year": 0.73,
    "eps_estimate_next_quarter": 0.16,
    "fifty_day_moving_average": 21.19,
    "fifty_two_week_high": 27.68,
    "fifty_two_week_low": 19.64,
    "percent_change_from_200_day_moving_average": -0.11,
    "percent_change_from_50_day_moving_average": -0.0475,
    "shares_owned": "N/A",
    "short_ratio": 23.39,
    "two_hundred_day_moving_average": 22.68,
    "volume": 267417.0,
    "market_cap": 261220000.00000003,
    "price_to_sales_ttm": 4.23,
    "price_to_book_mrq": 2.85,
    "roa_ttm": 0.1326,
    "roe_ttm": 0.12539999999999998,
    "shares_outstanding": 12940000.0,
    "pcnt_held_by_insiders": 0.016200000000000003,
    "pcnt_held_by_institutions": 0.934,
    "pcnt_short_of_float": 0.1025,
    "operating_cash_flow_ttm": 15020000.0,
    "levered_cash_flow_ttm": 13960000.0,
    "book_value_per_share_mrq": 7.1,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "SurModics, Inc."
  },
  "SRNE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.88,
    "ebitda": -39370000.0,
    "eps_estimate_current_year": -1.87,
    "eps_estimate_next_quarter": -0.25,
    "fifty_day_moving_average": 8.37,
    "fifty_two_week_high": 26.8,
    "fifty_two_week_low": 7.18,
    "percent_change_from_200_day_moving_average": -0.3906,
    "percent_change_from_50_day_moving_average": -0.067,
    "shares_owned": "N/A",
    "short_ratio": 8.03,
    "two_hundred_day_moving_average": 12.82,
    "volume": 532754.0,
    "market_cap": 294960000.0,
    "price_to_sales_ttm": 75.61,
    "price_to_book_mrq": 2.1,
    "roa_ttm": -0.1223,
    "roe_ttm": -0.2937,
    "shares_outstanding": 37770000.0,
    "pcnt_held_by_insiders": 0.33759999999999996,
    "pcnt_held_by_institutions": 0.405,
    "pcnt_short_of_float": 0.129,
    "operating_cash_flow_ttm": -33560000.0,
    "levered_cash_flow_ttm": -4030000.0000000005,
    "book_value_per_share_mrq": 3.87,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Sorrento Therapeutics, Inc."
  },
  "SRPT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 36.7,
    "earnings_per_share": -4.83,
    "ebitda": -186120000.0,
    "eps_estimate_current_year": -4.88,
    "eps_estimate_next_quarter": -1.19,
    "fifty_day_moving_average": 31.88,
    "fifty_two_week_high": 41.97,
    "fifty_two_week_low": 11.33,
    "percent_change_from_200_day_moving_average": 0.1646,
    "percent_change_from_50_day_moving_average": 0.1775,
    "shares_owned": "N/A",
    "short_ratio": 4.54,
    "two_hundred_day_moving_average": 32.23,
    "volume": 2346480.0,
    "market_cap": 1700000000.0,
    "price_to_sales_ttm": 60076.3,
    "price_to_book_mrq": 12.2,
    "roa_ttm": -0.4743,
    "roe_ttm": -0.9758,
    "shares_outstanding": 45270000.0,
    "pcnt_held_by_insiders": 0.0779,
    "pcnt_held_by_institutions": 0.612,
    "pcnt_short_of_float": 0.24600000000000002,
    "operating_cash_flow_ttm": -143640000.0,
    "levered_cash_flow_ttm": -66800000.0,
    "book_value_per_share_mrq": 2.94,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Sarepta Therapeutics, Inc."
  },
  "SSH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.5,
    "ebitda": -25940000.0,
    "eps_estimate_current_year": -1.47,
    "eps_estimate_next_quarter": -0.37,
    "fifty_day_moving_average": 1.84,
    "fifty_two_week_high": 6.9,
    "fifty_two_week_low": 1.06,
    "percent_change_from_200_day_moving_average": -0.5371,
    "percent_change_from_50_day_moving_average": -0.3059,
    "shares_owned": "N/A",
    "short_ratio": 11.96,
    "two_hundred_day_moving_average": 2.77,
    "volume": 130963.0,
    "market_cap": 23480000.0,
    "price_to_sales_ttm": 99.47,
    "price_to_book_mrq": 1.27,
    "roa_ttm": -0.4888,
    "roe_ttm": -0.9990000000000001,
    "shares_outstanding": 18340000.0,
    "pcnt_held_by_insiders": 0.1686,
    "pcnt_held_by_institutions": 0.115,
    "pcnt_short_of_float": 0.055999999999999994,
    "operating_cash_flow_ttm": -23520000.0,
    "levered_cash_flow_ttm": -13010000.0,
    "book_value_per_share_mrq": 1.0,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Sunshine Heart Inc."
  },
  "SSRG": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.94,
    "ebitda": 7800000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 8.95,
    "fifty_two_week_high": 9.74,
    "fifty_two_week_low": 6.83,
    "percent_change_from_200_day_moving_average": 0.08779999999999999,
    "percent_change_from_50_day_moving_average": 0.0613,
    "shares_owned": "N/A",
    "short_ratio": 1.28,
    "two_hundred_day_moving_average": 8.73,
    "volume": 33518.0,
    "market_cap": 98230000.0,
    "price_to_sales_ttm": 1.19,
    "price_to_book_mrq": 0.7,
    "roa_ttm": 0.005,
    "roe_ttm": -0.18539999999999998,
    "shares_outstanding": 10340000.0,
    "pcnt_held_by_insiders": 0.15960000000000002,
    "pcnt_held_by_institutions": 0.736,
    "pcnt_short_of_float": 0.0055000000000000005,
    "operating_cash_flow_ttm": 6760000.0,
    "levered_cash_flow_ttm": 6340000.0,
    "book_value_per_share_mrq": 13.56,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Symmetry Surgical Inc."
  },
  "SSY": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.11,
    "ebitda": 2080000.0,
    "eps_estimate_current_year": "nan",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.27,
    "fifty_two_week_high": 2.01,
    "fifty_two_week_low": 0.89,
    "percent_change_from_200_day_moving_average": -0.395,
    "percent_change_from_50_day_moving_average": -0.2585,
    "shares_owned": "N/A",
    "short_ratio": 0.59,
    "two_hundred_day_moving_average": 1.55,
    "volume": 32192.0,
    "market_cap": 8880000.0,
    "price_to_sales_ttm": 0.11,
    "price_to_book_mrq": 0.3,
    "roa_ttm": -0.005600000000000001,
    "roe_ttm": -0.0227,
    "shares_outstanding": 9440000.0,
    "pcnt_held_by_insiders": 0.5195000000000001,
    "pcnt_held_by_institutions": 0.09699999999999999,
    "pcnt_short_of_float": 0.0018,
    "operating_cash_flow_ttm": 3060000.0,
    "levered_cash_flow_ttm": 4230000.0,
    "book_value_per_share_mrq": 3.38,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Hospitals",
    "company_name": "SunLink Health Systems Inc."
  },
  "STAA": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.9,
    "earnings_per_share": -0.21,
    "ebitda": -6690000.0,
    "eps_estimate_current_year": -0.16,
    "eps_estimate_next_quarter": 0.03,
    "fifty_day_moving_average": 8.21,
    "fifty_two_week_high": 10.76,
    "fifty_two_week_low": 4.84,
    "percent_change_from_200_day_moving_average": -0.129,
    "percent_change_from_50_day_moving_average": -0.0975,
    "shares_owned": "N/A",
    "short_ratio": 29.61,
    "two_hundred_day_moving_average": 8.51,
    "volume": 176448.0,
    "market_cap": 295580000.0,
    "price_to_sales_ttm": 4.17,
    "price_to_book_mrq": 7.68,
    "roa_ttm": -0.09050000000000001,
    "roe_ttm": -0.2052,
    "shares_outstanding": 39890000.0,
    "pcnt_held_by_insiders": 0.2546,
    "pcnt_held_by_institutions": 0.611,
    "pcnt_short_of_float": 0.1105,
    "operating_cash_flow_ttm": -3840000.0,
    "levered_cash_flow_ttm": -4110000.0000000005,
    "book_value_per_share_mrq": 0.99,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "STAAR Surgical Company"
  },
  "STDY": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.03,
    "earnings_per_share": -1.69,
    "ebitda": -22370000.0,
    "eps_estimate_current_year": -2.36,
    "eps_estimate_next_quarter": -2.4,
    "fifty_day_moving_average": 3.14,
    "fifty_two_week_high": 11.14,
    "fifty_two_week_low": 2.62,
    "percent_change_from_200_day_moving_average": -0.3543,
    "percent_change_from_50_day_moving_average": -0.13720000000000002,
    "shares_owned": "N/A",
    "short_ratio": 4.76,
    "two_hundred_day_moving_average": 4.2,
    "volume": 23987.0,
    "market_cap": 36810000.0,
    "price_to_sales_ttm": 82.6,
    "price_to_book_mrq": 1.04,
    "roa_ttm": -0.49829999999999997,
    "roe_ttm": -1.0744,
    "shares_outstanding": 13580000.0,
    "pcnt_held_by_insiders": 0.45520000000000005,
    "pcnt_held_by_institutions": 0.298,
    "pcnt_short_of_float": 0.0095,
    "operating_cash_flow_ttm": -18690000.0,
    "levered_cash_flow_ttm": -12630000.0,
    "book_value_per_share_mrq": 2.57,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "SteadyMed Ltd."
  },
  "STE": {
    "p_e_ratio": 38.02,
    "peg_ratio": 2.2,
    "earnings_per_share": 1.87,
    "ebitda": 341900000.0,
    "eps_estimate_current_year": 3.35,
    "eps_estimate_next_quarter": 1.02,
    "fifty_day_moving_average": 74.48,
    "fifty_two_week_high": 77.47,
    "fifty_two_week_low": 60.75,
    "percent_change_from_200_day_moving_average": 0.042699999999999995,
    "percent_change_from_50_day_moving_average": -0.0463,
    "shares_owned": "N/A",
    "short_ratio": 6.31,
    "two_hundred_day_moving_average": 68.12,
    "volume": 2494135.0,
    "market_cap": 6100000000.0,
    "price_to_sales_ttm": 2.33,
    "price_to_book_mrq": 4.04,
    "roa_ttm": 0.07429999999999999,
    "roe_ttm": 0.1042,
    "shares_outstanding": 85840000.0,
    "pcnt_held_by_insiders": 0.0037,
    "pcnt_held_by_institutions": 0.512,
    "pcnt_short_of_float": 0.1094,
    "operating_cash_flow_ttm": 220600000.0,
    "levered_cash_flow_ttm": 145220000.0,
    "book_value_per_share_mrq": 18.21,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Steris Plc"
  },
  "STEM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.44,
    "ebitda": -36790000.0,
    "eps_estimate_current_year": -0.39,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 0.48,
    "fifty_two_week_high": 1.39,
    "fifty_two_week_low": 0.31,
    "percent_change_from_200_day_moving_average": -0.0712,
    "percent_change_from_50_day_moving_average": -0.0405,
    "shares_owned": "N/A",
    "short_ratio": 2.27,
    "two_hundred_day_moving_average": 0.5,
    "volume": 235003.0,
    "market_cap": 50050000.0,
    "price_to_sales_ttm": 49.64,
    "price_to_book_mrq": 6.82,
    "roa_ttm": -0.6667000000000001,
    "roe_ttm": -3.2870999999999997,
    "shares_outstanding": 108810000.0,
    "pcnt_held_by_insiders": 0.029300000000000003,
    "pcnt_held_by_institutions": 0.08900000000000001,
    "pcnt_short_of_float": 0.045599999999999995,
    "operating_cash_flow_ttm": -30140000.0,
    "levered_cash_flow_ttm": -16090000.0,
    "book_value_per_share_mrq": 0.07,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "StemCells Inc."
  },
  "STML": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.11,
    "ebitda": -34130000.0,
    "eps_estimate_current_year": -2.14,
    "eps_estimate_next_quarter": -0.56,
    "fifty_day_moving_average": 7.92,
    "fifty_two_week_high": 18.94,
    "fifty_two_week_low": 5.92,
    "percent_change_from_200_day_moving_average": -0.3714,
    "percent_change_from_50_day_moving_average": -0.20829999999999999,
    "shares_owned": "N/A",
    "short_ratio": 7.56,
    "two_hundred_day_moving_average": 9.97,
    "volume": 292549.0,
    "market_cap": 112850000.0,
    "price_to_sales_ttm": 194.57,
    "price_to_book_mrq": 1.14,
    "roa_ttm": -0.2507,
    "roe_ttm": -0.4289,
    "shares_outstanding": 18000000.0,
    "pcnt_held_by_insiders": 0.132,
    "pcnt_held_by_institutions": 0.625,
    "pcnt_short_of_float": 0.031,
    "operating_cash_flow_ttm": -25330000.0,
    "levered_cash_flow_ttm": -13400000.0,
    "book_value_per_share_mrq": 5.56,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Stemline Therapeutics, Inc."
  },
  "STXS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.231,
    "ebitda": -3130000.0,
    "eps_estimate_current_year": -2.03,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.9737,
    "fifty_two_week_high": 2.97,
    "fifty_two_week_low": 0.65,
    "percent_change_from_200_day_moving_average": -0.298634,
    "percent_change_from_50_day_moving_average": -0.15776099999999998,
    "shares_owned": "N/A",
    "short_ratio": 8.04,
    "two_hundred_day_moving_average": 1.1693,
    "volume": 45625.0,
    "market_cap": 17670000.0,
    "price_to_sales_ttm": 0.48,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.1041,
    "roe_ttm": "N/A",
    "shares_outstanding": 21540000.0,
    "pcnt_held_by_insiders": 0.1552,
    "pcnt_held_by_institutions": 0.168,
    "pcnt_short_of_float": 0.0441,
    "operating_cash_flow_ttm": -5540000.0,
    "levered_cash_flow_ttm": -4680000.0,
    "book_value_per_share_mrq": -0.78,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Stereotaxis Inc."
  },
  "SUPN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.99,
    "earnings_per_share": 0.25,
    "ebitda": 0.0,
    "eps_estimate_current_year": 0.2,
    "eps_estimate_next_quarter": 0.09,
    "fifty_day_moving_average": 15.9,
    "fifty_two_week_high": 23.3,
    "fifty_two_week_low": 7.97,
    "percent_change_from_200_day_moving_average": -0.174,
    "percent_change_from_50_day_moving_average": -0.111,
    "shares_owned": "N/A",
    "short_ratio": 6.06,
    "two_hundred_day_moving_average": 17.11,
    "volume": 1823030.0,
    "market_cap": 691290000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 48920000.0,
    "pcnt_held_by_insiders": 0.0368,
    "pcnt_held_by_institutions": 0.914,
    "pcnt_short_of_float": 0.142,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.0,
    "next_earnings_announcement_date": [
      "2016-03-08",
      "2016-03-14"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Supernus Pharmaceuticals, Inc."
  },
  "SVA": {
    "p_e_ratio": "N/A",
    "peg_ratio": -8.9,
    "earnings_per_share": -0.01,
    "ebitda": 0.0,
    "eps_estimate_current_year": -0.05,
    "eps_estimate_next_quarter": 0.03,
    "fifty_day_moving_average": 5.41,
    "fifty_two_week_high": 6.18,
    "fifty_two_week_low": 4.56,
    "percent_change_from_200_day_moving_average": 0.016399999999999998,
    "percent_change_from_50_day_moving_average": 0.0032,
    "shares_owned": "N/A",
    "short_ratio": 17.34,
    "two_hundred_day_moving_average": 5.34,
    "volume": 1601444.0,
    "market_cap": 303050000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 55810000.0,
    "pcnt_held_by_insiders": 0.0379,
    "pcnt_held_by_institutions": 0.23199999999999998,
    "pcnt_short_of_float": 0.0236,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.0,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Sinovac Biotech Ltd."
  },
  "SYN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.51,
    "ebitda": -36640000.0,
    "eps_estimate_current_year": -0.55,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 2.5,
    "fifty_two_week_high": 4.32,
    "fifty_two_week_low": 1.41,
    "percent_change_from_200_day_moving_average": -0.0579,
    "percent_change_from_50_day_moving_average": -0.0060999999999999995,
    "shares_owned": "N/A",
    "short_ratio": 6.15,
    "two_hundred_day_moving_average": 2.63,
    "volume": 668341.0,
    "market_cap": 225210000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 8.53,
    "roa_ttm": -0.968,
    "roe_ttm": -2.7667,
    "shares_outstanding": 90810000.0,
    "pcnt_held_by_insiders": 0.0673,
    "pcnt_held_by_institutions": 0.255,
    "pcnt_short_of_float": 0.1263,
    "operating_cash_flow_ttm": -32700000.000000004,
    "levered_cash_flow_ttm": -13270000.0,
    "book_value_per_share_mrq": 0.28,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Synthetic Biologics Inc."
  },
  "TARO": {
    "p_e_ratio": 13.8,
    "peg_ratio": 0.83,
    "earnings_per_share": 12.41,
    "ebitda": 0.0,
    "eps_estimate_current_year": 11.92,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 143.57,
    "fifty_two_week_high": 173.0,
    "fifty_two_week_low": 124.35,
    "percent_change_from_200_day_moving_average": 0.0969,
    "percent_change_from_50_day_moving_average": 0.0863,
    "shares_owned": "N/A",
    "short_ratio": 1.21,
    "two_hundred_day_moving_average": 142.18,
    "volume": 85103.0,
    "market_cap": 6680000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.66,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 42830000.0,
    "pcnt_held_by_insiders": 0.6887000000000001,
    "pcnt_held_by_institutions": 0.126,
    "pcnt_short_of_float": 0.012199999999999999,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 32.96,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Taro Pharmaceutical Industries Ltd."
  },
  "TBPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.36,
    "earnings_per_share": -6.12,
    "ebitda": 0.0,
    "eps_estimate_current_year": -5.65,
    "eps_estimate_next_quarter": -1.29,
    "fifty_day_moving_average": 17.2,
    "fifty_two_week_high": 22.0,
    "fifty_two_week_low": 10.56,
    "percent_change_from_200_day_moving_average": 0.1035,
    "percent_change_from_50_day_moving_average": -0.0949,
    "shares_owned": "N/A",
    "short_ratio": 14.08,
    "two_hundred_day_moving_average": 14.11,
    "volume": 1000392.0,
    "market_cap": 589160000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 37840000.0,
    "pcnt_held_by_insiders": 0.28059999999999996,
    "pcnt_held_by_institutions": 0.6579999999999999,
    "pcnt_short_of_float": 0.1598,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.0,
    "next_earnings_announcement_date": [
      "2016-03-08",
      "2016-03-14"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Theravance Biopharma, Inc."
  },
  "TBRA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.08,
    "earnings_per_share": -6.82,
    "ebitda": 0.0,
    "eps_estimate_current_year": -2.59,
    "eps_estimate_next_quarter": -0.55,
    "fifty_day_moving_average": 10.66,
    "fifty_two_week_high": 24.31,
    "fifty_two_week_low": 7.38,
    "percent_change_from_200_day_moving_average": -0.3114,
    "percent_change_from_50_day_moving_average": -0.13699999999999998,
    "shares_owned": "N/A",
    "short_ratio": 1.86,
    "two_hundred_day_moving_average": 13.36,
    "volume": 111900.0,
    "market_cap": 173050000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.5,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 18810000.0,
    "pcnt_held_by_insiders": 0.0661,
    "pcnt_held_by_institutions": 0.385,
    "pcnt_short_of_float": 0.016399999999999998,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 2.73,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Tobira Therapeutics, Inc."
  },
  "TCON": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.89,
    "ebitda": 0.0,
    "eps_estimate_current_year": -1.87,
    "eps_estimate_next_quarter": -0.6,
    "fifty_day_moving_average": 10.07,
    "fifty_two_week_high": 21.0,
    "fifty_two_week_low": 8.35,
    "percent_change_from_200_day_moving_average": -0.098,
    "percent_change_from_50_day_moving_average": -0.0161,
    "shares_owned": "N/A",
    "short_ratio": 5.01,
    "two_hundred_day_moving_average": 10.99,
    "volume": 33910.0,
    "market_cap": 120660000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 12180000.0,
    "pcnt_held_by_insiders": 0.37689999999999996,
    "pcnt_held_by_institutions": 0.361,
    "pcnt_short_of_float": 0.04190000000000001,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.0,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "TRACON Pharmaceuticals, Inc."
  },
  "TEAR": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.05,
    "earnings_per_share": -0.93,
    "ebitda": 0.0,
    "eps_estimate_current_year": -0.95,
    "eps_estimate_next_quarter": -0.23,
    "fifty_day_moving_average": 1.6,
    "fifty_two_week_high": 3.15,
    "fifty_two_week_low": 1.15,
    "percent_change_from_200_day_moving_average": -0.3383,
    "percent_change_from_50_day_moving_average": -0.1333,
    "shares_owned": "N/A",
    "short_ratio": 31.67,
    "two_hundred_day_moving_average": 2.1,
    "volume": 200166.0,
    "market_cap": 46930000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.72,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 33760000.0,
    "pcnt_held_by_insiders": 0.2032,
    "pcnt_held_by_institutions": 0.27399999999999997,
    "pcnt_short_of_float": 0.1075,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.73,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "TearLab Corporation"
  },
  "TECH": {
    "p_e_ratio": 30.82,
    "peg_ratio": 2.09,
    "earnings_per_share": 2.86,
    "ebitda": 180040000.0,
    "eps_estimate_current_year": 3.43,
    "eps_estimate_next_quarter": 0.9,
    "fifty_day_moving_average": 89.98,
    "fifty_two_week_high": 114.56,
    "fifty_two_week_low": 83.9,
    "percent_change_from_200_day_moving_average": -0.0877,
    "percent_change_from_50_day_moving_average": -0.0204,
    "shares_owned": "N/A",
    "short_ratio": 10.5,
    "two_hundred_day_moving_average": 96.61,
    "volume": 523623.0,
    "market_cap": 3280000000.0,
    "price_to_sales_ttm": 7.32,
    "price_to_book_mrq": 3.98,
    "roa_ttm": 0.0875,
    "roe_ttm": 0.1306,
    "shares_outstanding": 37190000.0,
    "pcnt_held_by_insiders": 0.0049,
    "pcnt_held_by_institutions": 1.0090000000000001,
    "pcnt_short_of_float": 0.057800000000000004,
    "operating_cash_flow_ttm": 135470000.0,
    "levered_cash_flow_ttm": 107750000.0,
    "book_value_per_share_mrq": 22.54,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Bio-Techne Corp."
  },
  "TENX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.51,
    "ebitda": -13750000.0,
    "eps_estimate_current_year": -0.53,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 3.21,
    "fifty_two_week_high": 3.98,
    "fifty_two_week_low": 2.88,
    "percent_change_from_200_day_moving_average": -0.09050000000000001,
    "percent_change_from_50_day_moving_average": -0.0202,
    "shares_owned": "N/A",
    "short_ratio": 18.69,
    "two_hundred_day_moving_average": 3.46,
    "volume": 92842.0,
    "market_cap": 88580000.0,
    "price_to_sales_ttm": 1814.28,
    "price_to_book_mrq": 1.4,
    "roa_ttm": -0.1051,
    "roe_ttm": -0.20370000000000002,
    "shares_outstanding": 28120000.0,
    "pcnt_held_by_insiders": 0.1563,
    "pcnt_held_by_institutions": 0.397,
    "pcnt_short_of_float": 0.038,
    "operating_cash_flow_ttm": -11400000.0,
    "levered_cash_flow_ttm": -7630000.0,
    "book_value_per_share_mrq": 2.27,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Tenax Therapeutics, Inc."
  },
  "TFX": {
    "p_e_ratio": 32.33,
    "peg_ratio": 1.86,
    "earnings_per_share": 4.07,
    "ebitda": 0.0,
    "eps_estimate_current_year": 6.25,
    "eps_estimate_next_quarter": 1.6,
    "fifty_day_moving_average": 131.48,
    "fifty_two_week_high": 140.5,
    "fifty_two_week_low": 107.45,
    "percent_change_from_200_day_moving_average": -0.0095,
    "percent_change_from_50_day_moving_average": -0.0060999999999999995,
    "shares_owned": "N/A",
    "short_ratio": 13.6,
    "two_hundred_day_moving_average": 131.93,
    "volume": 363412.0,
    "market_cap": 5440000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.86,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 41600000.0,
    "pcnt_held_by_insiders": 0.0032,
    "pcnt_held_by_institutions": 1.025,
    "pcnt_short_of_float": 0.0679,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 46.17,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Teleflex Incorporated"
  },
  "TGTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.48,
    "ebitda": 0.0,
    "eps_estimate_current_year": -1.32,
    "eps_estimate_next_quarter": -0.32,
    "fifty_day_moving_average": 12.8,
    "fifty_two_week_high": 20.0,
    "fifty_two_week_low": 9.54,
    "percent_change_from_200_day_moving_average": -0.2002,
    "percent_change_from_50_day_moving_average": -0.1105,
    "shares_owned": "N/A",
    "short_ratio": 19.85,
    "two_hundred_day_moving_average": 14.24,
    "volume": 4078966.0,
    "market_cap": 598200000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 52520000.0,
    "pcnt_held_by_insiders": 0.4975,
    "pcnt_held_by_institutions": 0.35100000000000003,
    "pcnt_short_of_float": 0.2526,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.0,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "TG Therapeutics, Inc."
  },
  "THC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.73,
    "earnings_per_share": 0.18,
    "ebitda": 0.0,
    "eps_estimate_current_year": 2.04,
    "eps_estimate_next_quarter": 0.54,
    "fifty_day_moving_average": 32.04,
    "fifty_two_week_high": 60.93,
    "fifty_two_week_low": 26.6,
    "percent_change_from_200_day_moving_average": -0.3833,
    "percent_change_from_50_day_moving_average": -0.1445,
    "shares_owned": "N/A",
    "short_ratio": 4.97,
    "two_hundred_day_moving_average": 44.44,
    "volume": 3866351.0,
    "market_cap": 2730000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 99670000.0,
    "pcnt_held_by_insiders": 0.0129,
    "pcnt_held_by_institutions": 1.004,
    "pcnt_short_of_float": 0.1586,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.0,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Hospitals",
    "company_name": "Tenet Healthcare Corp."
  },
  "THLD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.49,
    "ebitda": -31850000.0,
    "eps_estimate_current_year": -0.52,
    "eps_estimate_next_quarter": -0.03,
    "fifty_day_moving_average": 2.9737,
    "fifty_two_week_high": 5.28,
    "fifty_two_week_low": 0.45,
    "percent_change_from_200_day_moving_average": -0.867624,
    "percent_change_from_50_day_moving_average": -0.827118,
    "shares_owned": "N/A",
    "short_ratio": 10.65,
    "two_hundred_day_moving_average": 3.8836,
    "volume": 1778967.0,
    "market_cap": 36740000.0,
    "price_to_sales_ttm": 2.62,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.2923,
    "roe_ttm": "N/A",
    "shares_outstanding": 71460000.0,
    "pcnt_held_by_insiders": 0.1038,
    "pcnt_held_by_institutions": 0.524,
    "pcnt_short_of_float": 0.1206,
    "operating_cash_flow_ttm": -40550000.0,
    "levered_cash_flow_ttm": -13440000.0,
    "book_value_per_share_mrq": -0.43,
    "next_earnings_announcement_date": [
      "2016-03-01",
      "2016-03-07"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Threshold Pharmaceuticals Inc."
  },
  "THRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.32,
    "earnings_per_share": -0.34,
    "ebitda": 14500000.0,
    "eps_estimate_current_year": -0.19,
    "eps_estimate_next_quarter": 0.04,
    "fifty_day_moving_average": 9.23,
    "fifty_two_week_high": 21.16,
    "fifty_two_week_low": 6.36,
    "percent_change_from_200_day_moving_average": -0.1791,
    "percent_change_from_50_day_moving_average": 0.1099,
    "shares_owned": "N/A",
    "short_ratio": 25.57,
    "two_hundred_day_moving_average": 12.47,
    "volume": 3293654.0,
    "market_cap": 1200000000.0,
    "price_to_sales_ttm": 30.83,
    "price_to_book_mrq": "N/A",
    "roa_ttm": 0.0182,
    "roe_ttm": "N/A",
    "shares_outstanding": 117440000.0,
    "pcnt_held_by_insiders": 0.3095,
    "pcnt_held_by_institutions": 0.86,
    "pcnt_short_of_float": 0.7354,
    "operating_cash_flow_ttm": -1400000.0,
    "levered_cash_flow_ttm": -41570000.0,
    "book_value_per_share_mrq": -2.75,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Theravance Inc."
  },
  "TKAI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.79,
    "ebitda": 0.0,
    "eps_estimate_current_year": -1.99,
    "eps_estimate_next_quarter": -0.22,
    "fifty_day_moving_average": 11.0,
    "fifty_two_week_high": 16.09,
    "fifty_two_week_low": 9.38,
    "percent_change_from_200_day_moving_average": -0.22329999999999997,
    "percent_change_from_50_day_moving_average": -0.1447,
    "shares_owned": "N/A",
    "short_ratio": 15.96,
    "two_hundred_day_moving_average": 12.11,
    "volume": 711339.0,
    "market_cap": 212520000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.1,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 22580000.0,
    "pcnt_held_by_insiders": 0.8382999999999999,
    "pcnt_held_by_institutions": 0.29,
    "pcnt_short_of_float": 0.30519999999999997,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 4.62,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Tokai Pharmaceuticals, Inc."
  },
  "TLOG": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.06,
    "ebitda": -37330000.0,
    "eps_estimate_current_year": -1.82,
    "eps_estimate_next_quarter": -0.43,
    "fifty_day_moving_average": 1.71,
    "fifty_two_week_high": 6.25,
    "fifty_two_week_low": 0.72,
    "percent_change_from_200_day_moving_average": -0.35609999999999997,
    "percent_change_from_50_day_moving_average": -0.1906,
    "shares_owned": "N/A",
    "short_ratio": 6.83,
    "two_hundred_day_moving_average": 2.14,
    "volume": 193309.0,
    "market_cap": 34180000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.83,
    "roa_ttm": -0.22,
    "roe_ttm": -1.8455000000000001,
    "shares_outstanding": 24770000.0,
    "pcnt_held_by_insiders": 0.35719999999999996,
    "pcnt_held_by_institutions": 0.271,
    "pcnt_short_of_float": 0.044199999999999996,
    "operating_cash_flow_ttm": -37010000.0,
    "levered_cash_flow_ttm": -20460000.0,
    "book_value_per_share_mrq": 0.29,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "TetraLogic Pharmaceuticals Corporation"
  },
  "TNDM": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.27,
    "earnings_per_share": -2.89,
    "ebitda": -70370000.0,
    "eps_estimate_current_year": -2.66,
    "eps_estimate_next_quarter": -0.7,
    "fifty_day_moving_average": 10.59,
    "fifty_two_week_high": 14.27,
    "fifty_two_week_low": 7.26,
    "percent_change_from_200_day_moving_average": 0.0518,
    "percent_change_from_50_day_moving_average": 0.0754,
    "shares_owned": "N/A",
    "short_ratio": 11.74,
    "two_hundred_day_moving_average": 10.83,
    "volume": 359756.0,
    "market_cap": 342550000.0,
    "price_to_sales_ttm": 5.42,
    "price_to_book_mrq": 4.69,
    "roa_ttm": -0.384,
    "roe_ttm": -1.136,
    "shares_outstanding": 30080000.0,
    "pcnt_held_by_insiders": 0.32030000000000003,
    "pcnt_held_by_institutions": 0.6709999999999999,
    "pcnt_short_of_float": 0.1967,
    "operating_cash_flow_ttm": -62060000.0,
    "levered_cash_flow_ttm": -36600000.0,
    "book_value_per_share_mrq": 2.37,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Tandem Diabetes Care, Inc."
  },
  "TNXP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.96,
    "ebitda": -43650000.0,
    "eps_estimate_current_year": -2.83,
    "eps_estimate_next_quarter": -0.64,
    "fifty_day_moving_average": 6.8,
    "fifty_two_week_high": 10.72,
    "fifty_two_week_low": 5.05,
    "percent_change_from_200_day_moving_average": -0.12390000000000001,
    "percent_change_from_50_day_moving_average": -0.0432,
    "shares_owned": "N/A",
    "short_ratio": 10.82,
    "two_hundred_day_moving_average": 7.43,
    "volume": 170892.0,
    "market_cap": 122390000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.94,
    "roa_ttm": -0.5202,
    "roe_ttm": -0.9059999999999999,
    "shares_outstanding": 18800000.0,
    "pcnt_held_by_insiders": 0.0924,
    "pcnt_held_by_institutions": 0.409,
    "pcnt_short_of_float": 0.058600000000000006,
    "operating_cash_flow_ttm": -38830000.0,
    "levered_cash_flow_ttm": -22930000.0,
    "book_value_per_share_mrq": 3.34,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Tonix Pharmaceuticals Holding Corp"
  },
  "TPI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.14,
    "ebitda": 3120000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.22,
    "fifty_two_week_high": 0.78,
    "fifty_two_week_low": 0.19,
    "percent_change_from_200_day_moving_average": -0.3177,
    "percent_change_from_50_day_moving_average": -0.0814,
    "shares_owned": "N/A",
    "short_ratio": 0.33,
    "two_hundred_day_moving_average": 0.29,
    "volume": 15017.0,
    "market_cap": 5890000.0,
    "price_to_sales_ttm": 0.21,
    "price_to_book_mrq": 0.06,
    "roa_ttm": -0.0124,
    "roe_ttm": -0.041100000000000005,
    "shares_outstanding": 29430000.0,
    "pcnt_held_by_insiders": 0.2644,
    "pcnt_held_by_institutions": 0.064,
    "pcnt_short_of_float": 0.0002,
    "operating_cash_flow_ttm": -1250000.0,
    "levered_cash_flow_ttm": -10240000.0,
    "book_value_per_share_mrq": 3.25,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Tianyin Pharmaceutical Co., Inc."
  },
  "TRIB": {
    "p_e_ratio": 13.92,
    "peg_ratio": 1.15,
    "earnings_per_share": 0.88,
    "ebitda": 17180000.0,
    "eps_estimate_current_year": 0.51,
    "eps_estimate_next_quarter": 0.09,
    "fifty_day_moving_average": 11.79,
    "fifty_two_week_high": 20.24,
    "fifty_two_week_low": 10.74,
    "percent_change_from_200_day_moving_average": -0.1698,
    "percent_change_from_50_day_moving_average": 0.0332,
    "shares_owned": "N/A",
    "short_ratio": 11.04,
    "two_hundred_day_moving_average": 14.67,
    "volume": 143529.0,
    "market_cap": 282600000.0,
    "price_to_sales_ttm": 2.69,
    "price_to_book_mrq": 1.29,
    "roa_ttm": 0.026699999999999998,
    "roe_ttm": 0.11380000000000001,
    "shares_outstanding": 23200000.0,
    "pcnt_held_by_insiders": 0.050300000000000004,
    "pcnt_held_by_institutions": 0.755,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": 14960000.0,
    "levered_cash_flow_ttm": -15100000.0,
    "book_value_per_share_mrq": 9.09,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Trinity Biotech plc"
  },
  "TRIL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.97,
    "ebitda": -14220000.0,
    "eps_estimate_current_year": -3.96,
    "eps_estimate_next_quarter": -1.47,
    "fifty_day_moving_average": 14.2,
    "fifty_two_week_high": 29.92,
    "fifty_two_week_low": 7.01,
    "percent_change_from_200_day_moving_average": -0.2569,
    "percent_change_from_50_day_moving_average": -0.09140000000000001,
    "shares_owned": "N/A",
    "short_ratio": 5.13,
    "two_hundred_day_moving_average": 17.36,
    "volume": 36594.0,
    "market_cap": 94780000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.38,
    "roa_ttm": -0.20809999999999998,
    "roe_ttm": -0.276,
    "shares_outstanding": 7350000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0321,
    "operating_cash_flow_ttm": -11300000.0,
    "levered_cash_flow_ttm": -6460000.0,
    "book_value_per_share_mrq": 5.24,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Trillium Therapeutics Inc."
  },
  "TRIV": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.11,
    "earnings_per_share": -2.88,
    "ebitda": -49820000.0,
    "eps_estimate_current_year": -2.85,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 7.11,
    "fifty_two_week_high": 13.9,
    "fifty_two_week_low": 3.98,
    "percent_change_from_200_day_moving_average": 0.15869999999999998,
    "percent_change_from_50_day_moving_average": -0.0223,
    "shares_owned": "N/A",
    "short_ratio": 8.58,
    "two_hundred_day_moving_average": 6.0,
    "volume": 11577.0,
    "market_cap": 142970000.0,
    "price_to_sales_ttm": 3.96,
    "price_to_book_mrq": 93.07,
    "roa_ttm": -0.3319,
    "roe_ttm": -2.1691,
    "shares_outstanding": 20570000.0,
    "pcnt_held_by_insiders": 0.2843,
    "pcnt_held_by_institutions": 0.643,
    "pcnt_short_of_float": 0.022000000000000002,
    "operating_cash_flow_ttm": -53620000.0,
    "levered_cash_flow_ttm": -33210000.0,
    "book_value_per_share_mrq": 0.08,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "TriVascular Technologies, Inc."
  },
  "TROV": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.24,
    "ebitda": 0.0,
    "eps_estimate_current_year": -1.05,
    "eps_estimate_next_quarter": -0.29,
    "fifty_day_moving_average": 5.55,
    "fifty_two_week_high": 13.58,
    "fifty_two_week_low": 4.12,
    "percent_change_from_200_day_moving_average": -0.21960000000000002,
    "percent_change_from_50_day_moving_average": 0.0040999999999999995,
    "shares_owned": "N/A",
    "short_ratio": 9.54,
    "two_hundred_day_moving_average": 7.14,
    "volume": 460341.0,
    "market_cap": 165560000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 12.47,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 29720000.0,
    "pcnt_held_by_insiders": 0.09480000000000001,
    "pcnt_held_by_institutions": 0.294,
    "pcnt_short_of_float": 0.14859999999999998,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.44,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "TrovaGene, Inc."
  },
  "TRVN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.26,
    "ebitda": -48160000.0,
    "eps_estimate_current_year": -1.11,
    "eps_estimate_next_quarter": -0.25,
    "fifty_day_moving_average": 11.22,
    "fifty_two_week_high": 13.57,
    "fifty_two_week_low": 4.71,
    "percent_change_from_200_day_moving_average": 0.1313,
    "percent_change_from_50_day_moving_average": -0.106,
    "shares_owned": "N/A",
    "short_ratio": 5.06,
    "two_hundred_day_moving_average": 8.87,
    "volume": 1579544.0,
    "market_cap": 509470000.0,
    "price_to_sales_ttm": 119.75,
    "price_to_book_mrq": 3.32,
    "roa_ttm": -0.24719999999999998,
    "roe_ttm": -0.4357,
    "shares_outstanding": 50800000.0,
    "pcnt_held_by_insiders": 0.35609999999999997,
    "pcnt_held_by_institutions": 0.409,
    "pcnt_short_of_float": 0.11259999999999999,
    "operating_cash_flow_ttm": -41270000.0,
    "levered_cash_flow_ttm": -24350000.0,
    "book_value_per_share_mrq": 3.11,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Trevena, Inc."
  },
  "TRXC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.59,
    "ebitda": -34500000.0,
    "eps_estimate_current_year": -0.52,
    "eps_estimate_next_quarter": -0.13,
    "fifty_day_moving_average": 2.55,
    "fifty_two_week_high": 4.87,
    "fifty_two_week_low": 2.07,
    "percent_change_from_200_day_moving_average": -0.1591,
    "percent_change_from_50_day_moving_average": -0.08560000000000001,
    "shares_owned": "N/A",
    "short_ratio": 10.0,
    "two_hundred_day_moving_average": 2.77,
    "volume": 480681.0,
    "market_cap": 233330000.0,
    "price_to_sales_ttm": 1733.8,
    "price_to_book_mrq": 1.21,
    "roa_ttm": -0.1097,
    "roe_ttm": -0.2569,
    "shares_outstanding": 100140000.0,
    "pcnt_held_by_insiders": 0.42590000000000006,
    "pcnt_held_by_institutions": 0.53,
    "pcnt_short_of_float": 0.1419,
    "operating_cash_flow_ttm": -33590000.0,
    "levered_cash_flow_ttm": -22950000.0,
    "book_value_per_share_mrq": 1.93,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "TransEnterix, Inc."
  },
  "TSRO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 2.56,
    "earnings_per_share": -5.83,
    "ebitda": -199920000.0,
    "eps_estimate_current_year": -5.99,
    "eps_estimate_next_quarter": -1.17,
    "fifty_day_moving_average": 49.45,
    "fifty_two_week_high": 66.95,
    "fifty_two_week_low": 36.02,
    "percent_change_from_200_day_moving_average": -0.0436,
    "percent_change_from_50_day_moving_average": 0.0096,
    "shares_owned": "N/A",
    "short_ratio": 14.32,
    "two_hundred_day_moving_average": 52.19,
    "volume": 1598949.0,
    "market_cap": 2000000000.0,
    "price_to_sales_ttm": 23384.18,
    "price_to_book_mrq": 13.57,
    "roa_ttm": -0.4053,
    "roe_ttm": -1.4059,
    "shares_outstanding": 40090000.0,
    "pcnt_held_by_insiders": 0.1334,
    "pcnt_held_by_institutions": 1.052,
    "pcnt_short_of_float": 0.3538,
    "operating_cash_flow_ttm": -167810000.0,
    "levered_cash_flow_ttm": -106880000.0,
    "book_value_per_share_mrq": 3.75,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Tesaro, Inc."
  },
  "TTHI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.778,
    "ebitda": -30750000.0,
    "eps_estimate_current_year": -1.47,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.8774,
    "fifty_two_week_high": 9.3,
    "fifty_two_week_low": 1.7,
    "percent_change_from_200_day_moving_average": -0.31083700000000003,
    "percent_change_from_50_day_moving_average": 0.001316,
    "shares_owned": "N/A",
    "short_ratio": 7.97,
    "two_hundred_day_moving_average": 2.7278,
    "volume": 110343.0,
    "market_cap": 72940000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.05,
    "roa_ttm": -0.5681,
    "roe_ttm": -1.0429000000000002,
    "shares_outstanding": 38800000.0,
    "pcnt_held_by_insiders": 0.1108,
    "pcnt_held_by_institutions": 0.405,
    "pcnt_short_of_float": 0.0217,
    "operating_cash_flow_ttm": -30250000.0,
    "levered_cash_flow_ttm": -19150000.0,
    "book_value_per_share_mrq": 0.6,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Transition Therapeutics Inc."
  },
  "TTNP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.51,
    "ebitda": -5410000.0,
    "eps_estimate_current_year": -0.54,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 4.58,
    "fifty_two_week_high": 10.0,
    "fifty_two_week_low": 2.49,
    "percent_change_from_200_day_moving_average": 0.0313,
    "percent_change_from_50_day_moving_average": -0.0346,
    "shares_owned": "N/A",
    "short_ratio": 16.65,
    "two_hundred_day_moving_average": 4.29,
    "volume": 321980.0,
    "market_cap": 88660000.0,
    "price_to_sales_ttm": 37.28,
    "price_to_book_mrq": 10.79,
    "roa_ttm": -0.2561,
    "roe_ttm": -1.4365,
    "shares_outstanding": 20060000.0,
    "pcnt_held_by_insiders": 0.22510000000000002,
    "pcnt_held_by_institutions": 0.003,
    "pcnt_short_of_float": 0.0319,
    "operating_cash_flow_ttm": -7280000.0,
    "levered_cash_flow_ttm": -5180000.0,
    "book_value_per_share_mrq": 0.45,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Titan Pharmaceuticals Inc."
  },
  "TTOO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.12,
    "ebitda": 0.0,
    "eps_estimate_current_year": -2.26,
    "eps_estimate_next_quarter": -0.56,
    "fifty_day_moving_average": 10.56,
    "fifty_two_week_high": 24.04,
    "fifty_two_week_low": 8.45,
    "percent_change_from_200_day_moving_average": -0.1723,
    "percent_change_from_50_day_moving_average": 0.0183,
    "shares_owned": "N/A",
    "short_ratio": 7.97,
    "two_hundred_day_moving_average": 12.99,
    "volume": 448866.0,
    "market_cap": 256269999.99999997,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.94,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 23840000.0,
    "pcnt_held_by_insiders": 0.20489999999999997,
    "pcnt_held_by_institutions": 0.687,
    "pcnt_short_of_float": 0.07400000000000001,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 2.65,
    "next_earnings_announcement_date": [
      "2016-02-15",
      "2016-02-19"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "T2 Biosystems, Inc."
  },
  "TTPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.03,
    "earnings_per_share": -2.55,
    "ebitda": -85090000.0,
    "eps_estimate_current_year": -2.34,
    "eps_estimate_next_quarter": -0.54,
    "fifty_day_moving_average": 10.64,
    "fifty_two_week_high": 52.9,
    "fifty_two_week_low": 7.2,
    "percent_change_from_200_day_moving_average": -0.6322,
    "percent_change_from_50_day_moving_average": -0.0625,
    "shares_owned": "N/A",
    "short_ratio": 5.46,
    "two_hundred_day_moving_average": 27.13,
    "volume": 4190119.0,
    "market_cap": 364690000.0,
    "price_to_sales_ttm": 28.7,
    "price_to_book_mrq": 1.61,
    "roa_ttm": -0.3671,
    "roe_ttm": -0.649,
    "shares_outstanding": 36540000.0,
    "pcnt_held_by_insiders": 0.3215,
    "pcnt_held_by_institutions": 0.674,
    "pcnt_short_of_float": 0.2192,
    "operating_cash_flow_ttm": -75480000.0,
    "levered_cash_flow_ttm": -44270000.0,
    "book_value_per_share_mrq": 5.98,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Tetraphase Pharmaceuticals, Inc."
  },
  "TXMD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.5,
    "ebitda": -83940000.0,
    "eps_estimate_current_year": -0.47,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 7.48,
    "fifty_two_week_high": 9.81,
    "fifty_two_week_low": 4.0,
    "percent_change_from_200_day_moving_average": 0.282,
    "percent_change_from_50_day_moving_average": 0.22760000000000002,
    "shares_owned": "N/A",
    "short_ratio": 27.89,
    "two_hundred_day_moving_average": 7.16,
    "volume": 5353508.0,
    "market_cap": 1630000000.0,
    "price_to_sales_ttm": 84.51,
    "price_to_book_mrq": 20.46,
    "roa_ttm": -0.6361,
    "roe_ttm": -1.1887,
    "shares_outstanding": 177800000.0,
    "pcnt_held_by_insiders": 0.248,
    "pcnt_held_by_institutions": 0.647,
    "pcnt_short_of_float": 0.24780000000000002,
    "operating_cash_flow_ttm": -77720000.0,
    "levered_cash_flow_ttm": -47990000.0,
    "book_value_per_share_mrq": 0.44,
    "next_earnings_announcement_date": [
      "2016-03-08",
      "2016-03-14"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "TherapeuticsMD, Inc."
  },
  "UAM": {
    "p_e_ratio": "N/A",
    "peg_ratio": -3.19,
    "earnings_per_share": -0.19,
    "ebitda": 18190000.0,
    "eps_estimate_current_year": -0.05,
    "eps_estimate_next_quarter": 0.05,
    "fifty_day_moving_average": 7.06,
    "fifty_two_week_high": 11.16,
    "fifty_two_week_low": 6.38,
    "percent_change_from_200_day_moving_average": -0.155,
    "percent_change_from_50_day_moving_average": -0.034300000000000004,
    "shares_owned": "N/A",
    "short_ratio": 12.1,
    "two_hundred_day_moving_average": 8.07,
    "volume": 336297.0,
    "market_cap": 550550000.0,
    "price_to_sales_ttm": 0.28,
    "price_to_book_mrq": 0.89,
    "roa_ttm": 0.0025,
    "roe_ttm": -0.0116,
    "shares_outstanding": 80730000.0,
    "pcnt_held_by_insiders": 0.28850000000000003,
    "pcnt_held_by_institutions": 0.698,
    "pcnt_short_of_float": 0.030600000000000002,
    "operating_cash_flow_ttm": -35210000.0,
    "levered_cash_flow_ttm": 61410000.0,
    "book_value_per_share_mrq": 7.56,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Health Care Plans",
    "company_name": "Universal American Corp"
  },
  "UNIS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.8084,
    "ebitda": -79750000.0,
    "eps_estimate_current_year": -0.4,
    "eps_estimate_next_quarter": -0.11,
    "fifty_day_moving_average": 0.7666,
    "fifty_two_week_high": 4.9,
    "fifty_two_week_low": 0.48,
    "percent_change_from_200_day_moving_average": -0.625797,
    "percent_change_from_50_day_moving_average": -0.33535200000000004,
    "shares_owned": "N/A",
    "short_ratio": 27.5,
    "two_hundred_day_moving_average": 1.3616,
    "volume": 894578.0,
    "market_cap": 65790000.00000001,
    "price_to_sales_ttm": 4.19,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.5893,
    "roe_ttm": "N/A",
    "shares_outstanding": 129120000.0,
    "pcnt_held_by_insiders": 0.1106,
    "pcnt_held_by_institutions": 0.379,
    "pcnt_short_of_float": 0.1974,
    "operating_cash_flow_ttm": -55720000.0,
    "levered_cash_flow_ttm": -30450000.0,
    "book_value_per_share_mrq": -0.25,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Unilife Corporation"
  },
  "USMD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.07,
    "ebitda": -3780000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 8.3,
    "fifty_two_week_high": 18.0,
    "fifty_two_week_low": 6.51,
    "percent_change_from_200_day_moving_average": -0.059699999999999996,
    "percent_change_from_50_day_moving_average": -0.0721,
    "shares_owned": "N/A",
    "short_ratio": 0.28,
    "two_hundred_day_moving_average": 8.19,
    "volume": 2137.0,
    "market_cap": 84810000.0,
    "price_to_sales_ttm": 0.28,
    "price_to_book_mrq": 0.62,
    "roa_ttm": -0.0282,
    "roe_ttm": -0.14279999999999998,
    "shares_outstanding": 11010000.0,
    "pcnt_held_by_insiders": 0.87,
    "pcnt_held_by_institutions": 0.005,
    "pcnt_short_of_float": 0.0005,
    "operating_cash_flow_ttm": 3290000.0,
    "levered_cash_flow_ttm": -6930000.0,
    "book_value_per_share_mrq": 12.94,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Hospitals",
    "company_name": "USMD Holdings, Inc."
  },
  "USNA": {
    "p_e_ratio": 18.43,
    "peg_ratio": 1.76,
    "earnings_per_share": 7.01,
    "ebitda": 148570000.0,
    "eps_estimate_current_year": 7.36,
    "eps_estimate_next_quarter": 2.0,
    "fifty_day_moving_average": 130.47,
    "fifty_two_week_high": 176.88,
    "fifty_two_week_low": 96.04,
    "percent_change_from_200_day_moving_average": -0.0479,
    "percent_change_from_50_day_moving_average": -0.0095,
    "shares_owned": "N/A",
    "short_ratio": 5.5,
    "two_hundred_day_moving_average": 135.75,
    "volume": 136380.0,
    "market_cap": 1650000000.0,
    "price_to_sales_ttm": 1.83,
    "price_to_book_mrq": 5.4,
    "roa_ttm": 0.23010000000000003,
    "roe_ttm": 0.3588,
    "shares_outstanding": 12770000.0,
    "pcnt_held_by_insiders": 0.5442,
    "pcnt_held_by_institutions": 0.46299999999999997,
    "pcnt_short_of_float": 0.1671,
    "operating_cash_flow_ttm": 112310000.0,
    "levered_cash_flow_ttm": 81660000.0,
    "book_value_per_share_mrq": 24.32,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Related Products",
    "company_name": "USANA Health Sciences Inc."
  },
  "USPH": {
    "p_e_ratio": 30.58,
    "peg_ratio": 2.1,
    "earnings_per_share": 1.69,
    "ebitda": 53700000.0,
    "eps_estimate_current_year": 1.79,
    "eps_estimate_next_quarter": 0.4,
    "fifty_day_moving_average": 51.28,
    "fifty_two_week_high": 56.37,
    "fifty_two_week_low": 38.17,
    "percent_change_from_200_day_moving_average": 0.0332,
    "percent_change_from_50_day_moving_average": 0.0083,
    "shares_owned": "N/A",
    "short_ratio": 8.99,
    "two_hundred_day_moving_average": 50.05,
    "volume": 278872.0,
    "market_cap": 642300000.0,
    "price_to_sales_ttm": 2.0,
    "price_to_book_mrq": 4.03,
    "roa_ttm": 0.1097,
    "roe_ttm": 0.1673,
    "shares_outstanding": 12420000.0,
    "pcnt_held_by_insiders": 0.0444,
    "pcnt_held_by_institutions": 0.9420000000000001,
    "pcnt_short_of_float": 0.0662,
    "operating_cash_flow_ttm": 45230000.0,
    "levered_cash_flow_ttm": 30800000.0,
    "book_value_per_share_mrq": 12.8,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "US Physical Therapy Inc."
  },
  "UTHR": {
    "p_e_ratio": 12.21,
    "peg_ratio": 0.61,
    "earnings_per_share": 12.71,
    "ebitda": 756430000.0,
    "eps_estimate_current_year": 13.27,
    "eps_estimate_next_quarter": 2.8,
    "fifty_day_moving_average": 153.52,
    "fifty_two_week_high": 190.29,
    "fifty_two_week_low": 117.88,
    "percent_change_from_200_day_moving_average": -0.011399999999999999,
    "percent_change_from_50_day_moving_average": 0.0108,
    "shares_owned": "N/A",
    "short_ratio": 11.68,
    "two_hundred_day_moving_average": 156.97,
    "volume": 840009.0,
    "market_cap": 7080000000.0,
    "price_to_sales_ttm": 5.13,
    "price_to_book_mrq": 4.91,
    "roa_ttm": 0.21350000000000002,
    "roe_ttm": 0.5008,
    "shares_outstanding": 45630000.0,
    "pcnt_held_by_insiders": 0.014499999999999999,
    "pcnt_held_by_institutions": 1.137,
    "pcnt_short_of_float": 0.1789,
    "operating_cash_flow_ttm": 447850000.0,
    "levered_cash_flow_ttm": 1080000000.0,
    "book_value_per_share_mrq": 32.18,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "United Therapeutics Corporation"
  },
  "UTMD": {
    "p_e_ratio": 18.86,
    "peg_ratio": 0.0,
    "earnings_per_share": 3.08,
    "ebitda": 19400000.0,
    "eps_estimate_current_year": 2.81,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 57.36,
    "fifty_two_week_high": 63.98,
    "fifty_two_week_low": 50.0,
    "percent_change_from_200_day_moving_average": 0.0447,
    "percent_change_from_50_day_moving_average": 0.0138,
    "shares_owned": "N/A",
    "short_ratio": 4.34,
    "two_hundred_day_moving_average": 55.66,
    "volume": 26425.0,
    "market_cap": 218080000.0,
    "price_to_sales_ttm": 5.27,
    "price_to_book_mrq": 3.12,
    "roa_ttm": 0.12480000000000001,
    "roe_ttm": 0.17550000000000002,
    "shares_outstanding": 3750000.0,
    "pcnt_held_by_insiders": 0.0955,
    "pcnt_held_by_institutions": 0.654,
    "pcnt_short_of_float": 0.0233,
    "operating_cash_flow_ttm": 14420000.0,
    "levered_cash_flow_ttm": 13170000.0,
    "book_value_per_share_mrq": 18.23,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Utah Medical Products Inc."
  },
  "VAR": {
    "p_e_ratio": 19.29,
    "peg_ratio": 2.33,
    "earnings_per_share": 4.09,
    "ebitda": 634090000.0,
    "eps_estimate_current_year": 4.45,
    "eps_estimate_next_quarter": 1.11,
    "fifty_day_moving_average": 79.67,
    "fifty_two_week_high": 96.67,
    "fifty_two_week_low": 71.07,
    "percent_change_from_200_day_moving_average": -0.0352,
    "percent_change_from_50_day_moving_average": -0.0097,
    "shares_owned": "N/A",
    "short_ratio": 8.27,
    "two_hundred_day_moving_average": 81.77,
    "volume": 1779219.0,
    "market_cap": 7640000000.0,
    "price_to_sales_ttm": 2.45,
    "price_to_book_mrq": 4.49,
    "roa_ttm": 0.1016,
    "roe_ttm": 0.2465,
    "shares_outstanding": 96880000.0,
    "pcnt_held_by_insiders": 0.0024,
    "pcnt_held_by_institutions": 0.988,
    "pcnt_short_of_float": 0.0632,
    "operating_cash_flow_ttm": 469560000.0,
    "levered_cash_flow_ttm": 343900000.0,
    "book_value_per_share_mrq": 17.45,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Varian Medical Systems, Inc."
  },
  "VASC": {
    "p_e_ratio": 47.58,
    "peg_ratio": 1.65,
    "earnings_per_share": 0.72,
    "ebitda": 31980000.0,
    "eps_estimate_current_year": 1.04,
    "eps_estimate_next_quarter": 0.26,
    "fifty_day_moving_average": 34.13,
    "fifty_two_week_high": 40.33,
    "fifty_two_week_low": 25.41,
    "percent_change_from_200_day_moving_average": -0.0137,
    "percent_change_from_50_day_moving_average": 0.0024,
    "shares_owned": "N/A",
    "short_ratio": 7.26,
    "two_hundred_day_moving_average": 34.68,
    "volume": 265402.0,
    "market_cap": 593330000.0,
    "price_to_sales_ttm": 4.22,
    "price_to_book_mrq": 4.78,
    "roa_ttm": 0.1231,
    "roe_ttm": 0.1124,
    "shares_outstanding": 17340000.0,
    "pcnt_held_by_insiders": 0.0398,
    "pcnt_held_by_institutions": 0.7340000000000001,
    "pcnt_short_of_float": 0.0393,
    "operating_cash_flow_ttm": 18400000.0,
    "levered_cash_flow_ttm": 4040000.0,
    "book_value_per_share_mrq": 7.19,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Vascular Solutions Inc."
  },
  "VBIV": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.65,
    "ebitda": -15570000.0,
    "eps_estimate_current_year": -0.58,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.61,
    "fifty_two_week_high": 3.46,
    "fifty_two_week_low": 1.94,
    "percent_change_from_200_day_moving_average": 0.046799999999999994,
    "percent_change_from_50_day_moving_average": 0.0533,
    "shares_owned": "N/A",
    "short_ratio": 0.05,
    "two_hundred_day_moving_average": 2.63,
    "volume": 67657.0,
    "market_cap": 64709999.99999999,
    "price_to_sales_ttm": 155.06,
    "price_to_book_mrq": 7.21,
    "roa_ttm": -0.6794,
    "roe_ttm": -1.224,
    "shares_outstanding": 23530000.0,
    "pcnt_held_by_insiders": 0.3786,
    "pcnt_held_by_institutions": 0.42100000000000004,
    "pcnt_short_of_float": 0.0012,
    "operating_cash_flow_ttm": -9760000.0,
    "levered_cash_flow_ttm": -7100000.0,
    "book_value_per_share_mrq": 0.36,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "VBI Vaccines Inc"
  },
  "VBLT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.86,
    "ebitda": -16579999.999999998,
    "eps_estimate_current_year": -0.87,
    "eps_estimate_next_quarter": -0.2,
    "fifty_day_moving_average": 5.48,
    "fifty_two_week_high": 17.02,
    "fifty_two_week_low": 3.09,
    "percent_change_from_200_day_moving_average": -0.2289,
    "percent_change_from_50_day_moving_average": -0.1244,
    "shares_owned": "N/A",
    "short_ratio": 1.39,
    "two_hundred_day_moving_average": 6.22,
    "volume": 123467.0,
    "market_cap": 107800000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.05,
    "roa_ttm": -0.5518,
    "roe_ttm": -1.2497,
    "shares_outstanding": 22460000.0,
    "pcnt_held_by_insiders": 0.04019999999999999,
    "pcnt_held_by_institutions": 0.004,
    "pcnt_short_of_float": 0.0373,
    "operating_cash_flow_ttm": -11520000.0,
    "levered_cash_flow_ttm": -5270000.0,
    "book_value_per_share_mrq": 1.2,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Vascular Biogenics Ltd."
  },
  "VCEL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.86,
    "ebitda": -12720000.0,
    "eps_estimate_current_year": -0.83,
    "eps_estimate_next_quarter": -0.2,
    "fifty_day_moving_average": 2.07,
    "fifty_two_week_high": 4.35,
    "fifty_two_week_low": 1.69,
    "percent_change_from_200_day_moving_average": -0.20129999999999998,
    "percent_change_from_50_day_moving_average": 0.1094,
    "shares_owned": "N/A",
    "short_ratio": 1.2,
    "two_hundred_day_moving_average": 2.88,
    "volume": 176148.0,
    "market_cap": 54720000.0,
    "price_to_sales_ttm": 0.91,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.2053,
    "roe_ttm": -0.43,
    "shares_outstanding": 23790000.0,
    "pcnt_held_by_insiders": 0.1106,
    "pcnt_held_by_institutions": 0.455,
    "pcnt_short_of_float": 0.0034000000000000002,
    "operating_cash_flow_ttm": -15550000.0,
    "levered_cash_flow_ttm": -13960000.0,
    "book_value_per_share_mrq": -0.5,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Vericel Corporation"
  },
  "VCYT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.37,
    "ebitda": -32320000.0,
    "eps_estimate_current_year": -1.3,
    "eps_estimate_next_quarter": -0.32,
    "fifty_day_moving_average": 6.9,
    "fifty_two_week_high": 12.47,
    "fifty_two_week_low": 4.59,
    "percent_change_from_200_day_moving_average": -0.1867,
    "percent_change_from_50_day_moving_average": 0.0204,
    "shares_owned": "N/A",
    "short_ratio": 8.22,
    "two_hundred_day_moving_average": 8.66,
    "volume": 263312.0,
    "market_cap": 194760000.0,
    "price_to_sales_ttm": 4.12,
    "price_to_book_mrq": 3.4,
    "roa_ttm": -0.2749,
    "roe_ttm": -0.6378,
    "shares_outstanding": 27660000.0,
    "pcnt_held_by_insiders": 0.3779,
    "pcnt_held_by_institutions": 0.561,
    "pcnt_short_of_float": 0.1298,
    "operating_cash_flow_ttm": -32570000.0,
    "levered_cash_flow_ttm": -22060000.0,
    "book_value_per_share_mrq": 2.09,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Veracyte, Inc."
  },
  "VICL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.13,
    "ebitda": -10100000.0,
    "eps_estimate_current_year": -0.1,
    "eps_estimate_next_quarter": -0.03,
    "fifty_day_moving_average": 0.42,
    "fifty_two_week_high": 1.55,
    "fifty_two_week_low": 0.35,
    "percent_change_from_200_day_moving_average": -0.3943,
    "percent_change_from_50_day_moving_average": -0.1291,
    "shares_owned": "N/A",
    "short_ratio": 0.62,
    "two_hundred_day_moving_average": 0.61,
    "volume": 501511.0,
    "market_cap": 33860000.0,
    "price_to_sales_ttm": 1.74,
    "price_to_book_mrq": 0.69,
    "roa_ttm": -0.1233,
    "roe_ttm": -0.2234,
    "shares_outstanding": 91520000.0,
    "pcnt_held_by_insiders": 0.2014,
    "pcnt_held_by_institutions": 0.264,
    "pcnt_short_of_float": 0.0024,
    "operating_cash_flow_ttm": -7760000.0,
    "levered_cash_flow_ttm": -4099999.9999999995,
    "book_value_per_share_mrq": 0.52,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Vical Incorporated"
  },
  "VIVO": {
    "p_e_ratio": 23.35,
    "peg_ratio": 1.42,
    "earnings_per_share": 0.85,
    "ebitda": 61280000.0,
    "eps_estimate_current_year": 0.88,
    "eps_estimate_next_quarter": 0.24,
    "fifty_day_moving_average": 19.61,
    "fifty_two_week_high": 20.62,
    "fifty_two_week_low": 15.56,
    "percent_change_from_200_day_moving_average": 0.0676,
    "percent_change_from_50_day_moving_average": 0.012,
    "shares_owned": "N/A",
    "short_ratio": 17.68,
    "two_hundred_day_moving_average": 18.59,
    "volume": 721115.0,
    "market_cap": 834420000.0,
    "price_to_sales_ttm": 4.34,
    "price_to_book_mrq": 5.04,
    "roa_ttm": 0.1945,
    "roe_ttm": 0.21739999999999998,
    "shares_outstanding": 42040000.0,
    "pcnt_held_by_insiders": 0.0116,
    "pcnt_held_by_institutions": 0.9109999999999999,
    "pcnt_short_of_float": 0.1051,
    "operating_cash_flow_ttm": 42810000.0,
    "levered_cash_flow_ttm": 38540000.0,
    "book_value_per_share_mrq": 3.97,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Meridian Bioscience, Inc."
  },
  "VKTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.02,
    "earnings_per_share": -2.63,
    "ebitda": 0.0,
    "eps_estimate_current_year": -2.95,
    "eps_estimate_next_quarter": -0.41,
    "fifty_day_moving_average": 3.84,
    "fifty_two_week_high": 10.23,
    "fifty_two_week_low": 1.89,
    "percent_change_from_200_day_moving_average": -0.6576000000000001,
    "percent_change_from_50_day_moving_average": -0.4738,
    "shares_owned": "N/A",
    "short_ratio": 0.91,
    "two_hundred_day_moving_average": 5.9,
    "volume": 53465.0,
    "market_cap": 19550000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.54,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 9680000.0,
    "pcnt_held_by_insiders": 0.7190000000000001,
    "pcnt_held_by_institutions": 0.006,
    "pcnt_short_of_float": 0.0032,
    "operating_cash_flow_ttm": -5870000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 1.36,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Viking Therapeutics, Inc."
  },
  "VNDA": {
    "p_e_ratio": 8.99,
    "peg_ratio": -0.9,
    "earnings_per_share": 1.04,
    "ebitda": -21500000.0,
    "eps_estimate_current_year": -0.66,
    "eps_estimate_next_quarter": -0.19,
    "fifty_day_moving_average": 9.5,
    "fifty_two_week_high": 15.51,
    "fifty_two_week_low": 8.0,
    "percent_change_from_200_day_moving_average": -0.1818,
    "percent_change_from_50_day_moving_average": -0.0147,
    "shares_owned": "N/A",
    "short_ratio": 14.01,
    "two_hundred_day_moving_average": 11.44,
    "volume": 3083426.0,
    "market_cap": 400750000.0,
    "price_to_sales_ttm": 4.3,
    "price_to_book_mrq": 2.75,
    "roa_ttm": -0.136,
    "roe_ttm": 0.6075,
    "shares_outstanding": 42820000.0,
    "pcnt_held_by_insiders": 0.07629999999999999,
    "pcnt_held_by_institutions": 1.021,
    "pcnt_short_of_float": 0.20670000000000002,
    "operating_cash_flow_ttm": -581000.0,
    "levered_cash_flow_ttm": -17480000.0,
    "book_value_per_share_mrq": 3.41,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Vanda Pharmaceuticals, Inc."
  },
  "VNRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.46,
    "ebitda": -9010000.0,
    "eps_estimate_current_year": -0.52,
    "eps_estimate_next_quarter": -0.11,
    "fifty_day_moving_average": 4.1,
    "fifty_two_week_high": 5.3,
    "fifty_two_week_low": 2.81,
    "percent_change_from_200_day_moving_average": 0.0601,
    "percent_change_from_50_day_moving_average": 0.0362,
    "shares_owned": "N/A",
    "short_ratio": 0.17,
    "two_hundred_day_moving_average": 4.01,
    "volume": 22160.0,
    "market_cap": 78510000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 11.32,
    "roa_ttm": -0.9067000000000001,
    "roe_ttm": -5.1175999999999995,
    "shares_outstanding": 18470000.0,
    "pcnt_held_by_insiders": 0.3507,
    "pcnt_held_by_institutions": 0.048,
    "pcnt_short_of_float": 0.0003,
    "operating_cash_flow_ttm": -7680000.0,
    "levered_cash_flow_ttm": -10860000.0,
    "book_value_per_share_mrq": 0.4,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "VolitionRX Ltd"
  },
  "VRML": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.42,
    "ebitda": -17250000.0,
    "eps_estimate_current_year": -0.43,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 1.87,
    "fifty_two_week_high": 2.5,
    "fifty_two_week_low": 1.47,
    "percent_change_from_200_day_moving_average": -0.1175,
    "percent_change_from_50_day_moving_average": -0.0513,
    "shares_owned": "N/A",
    "short_ratio": 57.77,
    "two_hundred_day_moving_average": 2.01,
    "volume": 69598.0,
    "market_cap": 92060000.0,
    "price_to_sales_ttm": 26.58,
    "price_to_book_mrq": 4.07,
    "roa_ttm": -0.49939999999999996,
    "roe_ttm": -1.0497,
    "shares_outstanding": 52010000.0,
    "pcnt_held_by_insiders": 0.6461,
    "pcnt_held_by_institutions": 0.036000000000000004,
    "pcnt_short_of_float": 0.051500000000000004,
    "operating_cash_flow_ttm": -17990000.0,
    "levered_cash_flow_ttm": -10680000.0,
    "book_value_per_share_mrq": 0.43,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Vermillion, Inc."
  },
  "VSAR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.81,
    "ebitda": -75620000.0,
    "eps_estimate_current_year": -3.05,
    "eps_estimate_next_quarter": -0.98,
    "fifty_day_moving_average": 11.19,
    "fifty_two_week_high": 23.99,
    "fifty_two_week_low": 9.69,
    "percent_change_from_200_day_moving_average": -0.23670000000000002,
    "percent_change_from_50_day_moving_average": -0.0478,
    "shares_owned": "N/A",
    "short_ratio": 14.72,
    "two_hundred_day_moving_average": 13.97,
    "volume": 220772.0,
    "market_cap": 312980000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.6,
    "roa_ttm": -0.24489999999999998,
    "roe_ttm": -0.414,
    "shares_outstanding": 29360000.0,
    "pcnt_held_by_insiders": 0.23989999999999997,
    "pcnt_held_by_institutions": 0.7120000000000001,
    "pcnt_short_of_float": 0.1103,
    "operating_cash_flow_ttm": -63960000.0,
    "levered_cash_flow_ttm": -33760000.0,
    "book_value_per_share_mrq": 6.61,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Versartis, Inc."
  },
  "VSCP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.8,
    "ebitda": -1810000.0,
    "eps_estimate_current_year": -0.85,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.19,
    "fifty_two_week_high": 6.65,
    "fifty_two_week_low": 1.73,
    "percent_change_from_200_day_moving_average": 0.19149999999999998,
    "percent_change_from_50_day_moving_average": -0.053,
    "shares_owned": "N/A",
    "short_ratio": 0.02,
    "two_hundred_day_moving_average": 2.53,
    "volume": 44701.0,
    "market_cap": 9070000.0,
    "price_to_sales_ttm": 0.87,
    "price_to_book_mrq": 2.6,
    "roa_ttm": -0.1777,
    "roe_ttm": -0.45890000000000003,
    "shares_outstanding": 3000000.0,
    "pcnt_held_by_insiders": 0.2727,
    "pcnt_held_by_institutions": 0.073,
    "pcnt_short_of_float": 0.0105,
    "operating_cash_flow_ttm": -3080000.0,
    "levered_cash_flow_ttm": -2590000.0,
    "book_value_per_share_mrq": 1.24,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "VirtualScopics Inc."
  },
  "VSTM": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.63,
    "earnings_per_share": -1.8,
    "ebitda": -59490000.0,
    "eps_estimate_current_year": -1.64,
    "eps_estimate_next_quarter": -0.3,
    "fifty_day_moving_average": 2.03,
    "fifty_two_week_high": 12.35,
    "fifty_two_week_low": 1.5,
    "percent_change_from_200_day_moving_average": -0.6489,
    "percent_change_from_50_day_moving_average": -0.1366,
    "shares_owned": "N/A",
    "short_ratio": 2.39,
    "two_hundred_day_moving_average": 4.98,
    "volume": 1553665.0,
    "market_cap": 64640000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 0.59,
    "roa_ttm": -0.33990000000000004,
    "roe_ttm": -0.5964,
    "shares_outstanding": 36930000.0,
    "pcnt_held_by_insiders": 0.20379999999999998,
    "pcnt_held_by_institutions": 0.581,
    "pcnt_short_of_float": 0.0351,
    "operating_cash_flow_ttm": -45010000.0,
    "levered_cash_flow_ttm": -24710000.0,
    "book_value_per_share_mrq": 3.04,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Verastem, Inc."
  },
  "VTAE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.93,
    "ebitda": -39390000.0,
    "eps_estimate_current_year": -2.13,
    "eps_estimate_next_quarter": -0.59,
    "fifty_day_moving_average": 13.91,
    "fifty_two_week_high": 21.83,
    "fifty_two_week_low": 6.39,
    "percent_change_from_200_day_moving_average": 0.3357,
    "percent_change_from_50_day_moving_average": 0.165,
    "shares_owned": "N/A",
    "short_ratio": 8.94,
    "two_hundred_day_moving_average": 12.13,
    "volume": 1048060.0,
    "market_cap": 354300000.0,
    "price_to_sales_ttm": 510.32,
    "price_to_book_mrq": 5.15,
    "roa_ttm": -0.3488,
    "roe_ttm": -0.6498,
    "shares_outstanding": 21870000.0,
    "pcnt_held_by_insiders": 0.6062,
    "pcnt_held_by_institutions": 0.406,
    "pcnt_short_of_float": 0.1377,
    "operating_cash_flow_ttm": -34400000.0,
    "levered_cash_flow_ttm": -21170000.0,
    "book_value_per_share_mrq": 2.94,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Vitae Pharmaceuticals, Inc."
  },
  "VTL": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.46,
    "earnings_per_share": -2.34,
    "ebitda": -54450000.0,
    "eps_estimate_current_year": -2.15,
    "eps_estimate_next_quarter": -0.32,
    "fifty_day_moving_average": 9.01,
    "fifty_two_week_high": 29.67,
    "fifty_two_week_low": 2.81,
    "percent_change_from_200_day_moving_average": -0.16519999999999999,
    "percent_change_from_50_day_moving_average": 0.1175,
    "shares_owned": "N/A",
    "short_ratio": 6.95,
    "two_hundred_day_moving_average": 12.06,
    "volume": 1620909.0,
    "market_cap": 306390000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.21,
    "roa_ttm": -0.45520000000000005,
    "roe_ttm": -0.8269,
    "shares_outstanding": 30430000.0,
    "pcnt_held_by_insiders": 0.3078,
    "pcnt_held_by_institutions": 0.293,
    "pcnt_short_of_float": 0.17629999999999998,
    "operating_cash_flow_ttm": -51050000.0,
    "levered_cash_flow_ttm": -31980000.0,
    "book_value_per_share_mrq": 2.43,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Vital Therapies, Inc."
  },
  "VTVT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.5,
    "ebitda": -33180000.0,
    "eps_estimate_current_year": -3.85,
    "eps_estimate_next_quarter": -1.35,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 6.69,
    "fifty_two_week_low": 6.07,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 8.5,
    "two_hundred_day_moving_average": 0.0,
    "volume": 116923.0,
    "market_cap": 213610000.0,
    "price_to_sales_ttm": 47.68,
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 9160000.0,
    "pcnt_held_by_insiders": 0.3127,
    "pcnt_held_by_institutions": 0.162,
    "pcnt_short_of_float": 0.0451,
    "operating_cash_flow_ttm": -34960000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -10.29,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "vTv Therapeutics Inc."
  },
  "VVUS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.36,
    "earnings_per_share": -1.02,
    "ebitda": -40060000.0,
    "eps_estimate_current_year": -0.95,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 1.26,
    "fifty_two_week_high": 3.4,
    "fifty_two_week_low": 0.94,
    "percent_change_from_200_day_moving_average": -0.39149999999999996,
    "percent_change_from_50_day_moving_average": -0.2072,
    "shares_owned": "N/A",
    "short_ratio": 20.7,
    "two_hundred_day_moving_average": 1.64,
    "volume": 4299963.0,
    "market_cap": 104040000.0,
    "price_to_sales_ttm": 1.06,
    "price_to_book_mrq": 22.13,
    "roa_ttm": -0.0761,
    "roe_ttm": -1.9196,
    "shares_outstanding": 104040000.0,
    "pcnt_held_by_insiders": 0.079,
    "pcnt_held_by_institutions": 0.645,
    "pcnt_short_of_float": 0.363,
    "operating_cash_flow_ttm": -47220000.0,
    "levered_cash_flow_ttm": 11520000.0,
    "book_value_per_share_mrq": 0.05,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "VIVUS Inc."
  },
  "VWR": {
    "p_e_ratio": 22.99,
    "peg_ratio": 1.5,
    "earnings_per_share": 1.14,
    "ebitda": 448400000.0,
    "eps_estimate_current_year": 1.46,
    "eps_estimate_next_quarter": 0.38,
    "fifty_day_moving_average": 26.53,
    "fifty_two_week_high": 28.83,
    "fifty_two_week_low": 23.18,
    "percent_change_from_200_day_moving_average": -0.0064,
    "percent_change_from_50_day_moving_average": -0.015300000000000001,
    "shares_owned": "N/A",
    "short_ratio": 4.3,
    "two_hundred_day_moving_average": 26.29,
    "volume": 1100819.0,
    "market_cap": 3430000000.0,
    "price_to_sales_ttm": 0.81,
    "price_to_book_mrq": 2.69,
    "roa_ttm": 0.0409,
    "roe_ttm": 0.13019999999999998,
    "shares_outstanding": 131360000.00000001,
    "pcnt_held_by_insiders": 0.0,
    "pcnt_held_by_institutions": 0.386,
    "pcnt_short_of_float": 0.1246,
    "operating_cash_flow_ttm": 261200000.0,
    "levered_cash_flow_ttm": 297450000.0,
    "book_value_per_share_mrq": 9.88,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "VWR Corporation"
  },
  "VYGR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -8.31,
    "ebitda": -16760000.000000002,
    "eps_estimate_current_year": -8.89,
    "eps_estimate_next_quarter": -0.44,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 21.8,
    "fifty_two_week_low": 19.28,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 0.03,
    "two_hundred_day_moving_average": 0.0,
    "volume": 805545.0,
    "market_cap": 558180000.0,
    "price_to_sales_ttm": 44.64,
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 26030000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0002,
    "operating_cash_flow_ttm": 46060000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -34.42,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Voyager Therapeutics, Inc."
  },
  "WCG": {
    "p_e_ratio": 32.07,
    "peg_ratio": 0.97,
    "earnings_per_share": 2.55,
    "ebitda": 447800000.0,
    "eps_estimate_current_year": 3.43,
    "eps_estimate_next_quarter": 0.74,
    "fifty_day_moving_average": 81.38,
    "fifty_two_week_high": 98.79,
    "fifty_two_week_low": 71.4,
    "percent_change_from_200_day_moving_average": -0.0437,
    "percent_change_from_50_day_moving_average": 0.0058,
    "shares_owned": "N/A",
    "short_ratio": 4.04,
    "two_hundred_day_moving_average": 85.59,
    "volume": 766091.0,
    "market_cap": 3610000000.0,
    "price_to_sales_ttm": 0.26,
    "price_to_book_mrq": 2.08,
    "roa_ttm": 0.054400000000000004,
    "roe_ttm": 0.0689,
    "shares_outstanding": 44110000.0,
    "pcnt_held_by_insiders": 0.005699999999999999,
    "pcnt_held_by_institutions": 1.0270000000000001,
    "pcnt_short_of_float": 0.0644,
    "operating_cash_flow_ttm": 357800000.0,
    "levered_cash_flow_ttm": -331950000.0,
    "book_value_per_share_mrq": 38.75,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Health Care Plans",
    "company_name": "WellCare Health Plans, Inc."
  },
  "WGBS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.704,
    "ebitda": -14420000.0,
    "eps_estimate_current_year": -2.42,
    "eps_estimate_next_quarter": -0.28,
    "fifty_day_moving_average": 0.8437,
    "fifty_two_week_high": 5.89,
    "fifty_two_week_low": 0.7,
    "percent_change_from_200_day_moving_average": -0.599392,
    "percent_change_from_50_day_moving_average": -0.140586,
    "shares_owned": "N/A",
    "short_ratio": 0.57,
    "two_hundred_day_moving_average": 1.81,
    "volume": 313366.0,
    "market_cap": 10480000.0,
    "price_to_sales_ttm": 1.67,
    "price_to_book_mrq": 1.51,
    "roa_ttm": -0.5583,
    "roe_ttm": -1.5308000000000002,
    "shares_outstanding": 14460000.0,
    "pcnt_held_by_insiders": 0.195,
    "pcnt_held_by_institutions": 0.057999999999999996,
    "pcnt_short_of_float": 0.1607,
    "operating_cash_flow_ttm": -13180000.0,
    "levered_cash_flow_ttm": -7260000.0,
    "book_value_per_share_mrq": 0.49,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "WaferGen Bio-systems, Inc."
  },
  "WMGI": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.12,
    "earnings_per_share": -5.97,
    "ebitda": -76910000.0,
    "eps_estimate_current_year": -1.35,
    "eps_estimate_next_quarter": -0.32,
    "fifty_day_moving_average": 21.91,
    "fifty_two_week_high": 27.06,
    "fifty_two_week_low": 18.03,
    "percent_change_from_200_day_moving_average": -0.0288,
    "percent_change_from_50_day_moving_average": 0.0331,
    "shares_owned": "N/A",
    "short_ratio": 7.74,
    "two_hundred_day_moving_average": 23.31,
    "volume": 666243.0,
    "market_cap": 2320000000.0,
    "price_to_sales_ttm": 3.65,
    "price_to_book_mrq": 10.19,
    "roa_ttm": -0.0708,
    "roe_ttm": -1.0191,
    "shares_outstanding": 102660000.0,
    "pcnt_held_by_insiders": 0.0217,
    "pcnt_held_by_institutions": 0.46,
    "pcnt_short_of_float": 0.2922,
    "operating_cash_flow_ttm": -171690000.0,
    "levered_cash_flow_ttm": -105770000.0,
    "book_value_per_share_mrq": 2.23,
    "next_earnings_announcement_date": [
      "2016-02-22",
      "2016-02-26"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Wright Medical Group N.V."
  },
  "WST": {
    "p_e_ratio": 47.36,
    "peg_ratio": 2.28,
    "earnings_per_share": 1.28,
    "ebitda": 216600000.0,
    "eps_estimate_current_year": 1.83,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 62.49,
    "fifty_two_week_high": 64.59,
    "fifty_two_week_low": 48.66,
    "percent_change_from_200_day_moving_average": 0.0315,
    "percent_change_from_50_day_moving_average": -0.029900000000000003,
    "shares_owned": "N/A",
    "short_ratio": 10.44,
    "two_hundred_day_moving_average": 58.77,
    "volume": 717829.0,
    "market_cap": 4370000000.0,
    "price_to_sales_ttm": 3.22,
    "price_to_book_mrq": 4.49,
    "roa_ttm": 0.0479,
    "roe_ttm": 0.0953,
    "shares_outstanding": 72090000.0,
    "pcnt_held_by_insiders": 0.1225,
    "pcnt_held_by_institutions": 0.862,
    "pcnt_short_of_float": 0.0387,
    "operating_cash_flow_ttm": 190400000.0,
    "levered_cash_flow_ttm": 97820000.0,
    "book_value_per_share_mrq": 13.81,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "West Pharmaceutical Services, Inc."
  },
  "WVE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -6.39,
    "ebitda": -13320000.0,
    "eps_estimate_current_year": -1.56,
    "eps_estimate_next_quarter": -0.26,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 16.8,
    "fifty_two_week_low": 14.6,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 0.32,
    "two_hundred_day_moving_average": 0.0,
    "volume": 193807.0,
    "market_cap": 330170000.0,
    "price_to_sales_ttm": 2275.63,
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 21550000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0045000000000000005,
    "operating_cash_flow_ttm": -7090000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -0.34,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "WAVE Life Sciences Pte. Ltd."
  },
  "XBIT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.1,
    "ebitda": -31090000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 11.97,
    "fifty_two_week_high": 32.5,
    "fifty_two_week_low": 7.17,
    "percent_change_from_200_day_moving_average": -0.3589,
    "percent_change_from_50_day_moving_average": -0.13470000000000001,
    "shares_owned": "N/A",
    "short_ratio": 10.05,
    "two_hundred_day_moving_average": 16.16,
    "volume": 934957.0,
    "market_cap": 333430000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.1,
    "roa_ttm": -0.2868,
    "roe_ttm": -0.4866,
    "shares_outstanding": 32180000.0,
    "pcnt_held_by_insiders": 0.0723,
    "pcnt_held_by_institutions": 0.02,
    "pcnt_short_of_float": 0.0582,
    "operating_cash_flow_ttm": -26060000.0,
    "levered_cash_flow_ttm": -19960000.0,
    "book_value_per_share_mrq": 3.56,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "XBiotech, Inc."
  },
  "XENE": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.81,
    "earnings_per_share": -0.19,
    "ebitda": -5760000.0,
    "eps_estimate_current_year": -0.99,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 8.45,
    "fifty_two_week_high": 23.5,
    "fifty_two_week_low": 7.6,
    "percent_change_from_200_day_moving_average": -0.2151,
    "percent_change_from_50_day_moving_average": -0.09029999999999999,
    "shares_owned": "N/A",
    "short_ratio": 1.0,
    "two_hundred_day_moving_average": 9.8,
    "volume": 23221.0,
    "market_cap": 110550000.0,
    "price_to_sales_ttm": 6.72,
    "price_to_book_mrq": 1.79,
    "roa_ttm": -0.0677,
    "roe_ttm": -0.213,
    "shares_outstanding": 14380000.0,
    "pcnt_held_by_insiders": 0.4476,
    "pcnt_held_by_institutions": 0.289,
    "pcnt_short_of_float": 0.0013,
    "operating_cash_flow_ttm": -15810000.0,
    "levered_cash_flow_ttm": -12290000.0,
    "book_value_per_share_mrq": 4.49,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Xenon Pharmaceuticals Inc."
  },
  "XENT": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.99,
    "earnings_per_share": -0.98,
    "ebitda": -24060000.0,
    "eps_estimate_current_year": -1.07,
    "eps_estimate_next_quarter": -0.29,
    "fifty_day_moving_average": 19.45,
    "fifty_two_week_high": 32.85,
    "fifty_two_week_low": 15.74,
    "percent_change_from_200_day_moving_average": -0.13570000000000002,
    "percent_change_from_50_day_moving_average": 0.0877,
    "shares_owned": "N/A",
    "short_ratio": 4.76,
    "two_hundred_day_moving_average": 24.47,
    "volume": 1362591.0,
    "market_cap": 592470000.0,
    "price_to_sales_ttm": 10.03,
    "price_to_book_mrq": 4.11,
    "roa_ttm": -0.1456,
    "roe_ttm": -0.258,
    "shares_outstanding": 28010000.0,
    "pcnt_held_by_insiders": 0.0827,
    "pcnt_held_by_institutions": 0.6629999999999999,
    "pcnt_short_of_float": 0.21780000000000002,
    "operating_cash_flow_ttm": -17850000.0,
    "levered_cash_flow_ttm": -10980000.0,
    "book_value_per_share_mrq": 4.77,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Intersect ENT, Inc."
  },
  "XLRN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.57,
    "ebitda": -56160000.0,
    "eps_estimate_current_year": -1.12,
    "eps_estimate_next_quarter": -0.48,
    "fifty_day_moving_average": 39.64,
    "fifty_two_week_high": 45.6,
    "fifty_two_week_low": 20.0,
    "percent_change_from_200_day_moving_average": 0.3931,
    "percent_change_from_50_day_moving_average": 0.1226,
    "shares_owned": "N/A",
    "short_ratio": 6.94,
    "two_hundred_day_moving_average": 31.94,
    "volume": 829024.0,
    "market_cap": 1480000000.0,
    "price_to_sales_ttm": 80.97,
    "price_to_book_mrq": 11.06,
    "roa_ttm": -0.19949999999999998,
    "roe_ttm": -0.3636,
    "shares_outstanding": 33250000.0,
    "pcnt_held_by_insiders": 0.2899,
    "pcnt_held_by_institutions": 0.715,
    "pcnt_short_of_float": 0.1115,
    "operating_cash_flow_ttm": -45370000.0,
    "levered_cash_flow_ttm": -23150000.0,
    "book_value_per_share_mrq": 3.97,
    "next_earnings_announcement_date": [
      "2016-02-29",
      "2016-03-04"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Acceleron Pharma, Inc."
  },
  "XNCR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.73,
    "ebitda": -25590000.0,
    "eps_estimate_current_year": -0.95,
    "eps_estimate_next_quarter": -0.28,
    "fifty_day_moving_average": 13.98,
    "fifty_two_week_high": 24.82,
    "fifty_two_week_low": 10.68,
    "percent_change_from_200_day_moving_average": -0.1233,
    "percent_change_from_50_day_moving_average": 0.0771,
    "shares_owned": "N/A",
    "short_ratio": 12.94,
    "two_hundred_day_moving_average": 17.18,
    "volume": 4047915.0,
    "market_cap": 609580000.0,
    "price_to_sales_ttm": 51.32,
    "price_to_book_mrq": 3.91,
    "roa_ttm": -0.11779999999999999,
    "roe_ttm": -0.2507,
    "shares_outstanding": 40480000.0,
    "pcnt_held_by_insiders": 0.2534,
    "pcnt_held_by_institutions": 0.624,
    "pcnt_short_of_float": 0.15,
    "operating_cash_flow_ttm": 24650000.0,
    "levered_cash_flow_ttm": 29890000.0,
    "book_value_per_share_mrq": 3.79,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Xencor, Inc."
  },
  "XNPT": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.82,
    "earnings_per_share": -1.39,
    "ebitda": -81940000.0,
    "eps_estimate_current_year": -1.4,
    "eps_estimate_next_quarter": -0.25,
    "fifty_day_moving_average": 6.06,
    "fifty_two_week_high": 9.6,
    "fifty_two_week_low": 3.35,
    "percent_change_from_200_day_moving_average": -0.0754,
    "percent_change_from_50_day_moving_average": -0.07780000000000001,
    "shares_owned": "N/A",
    "short_ratio": 6.98,
    "two_hundred_day_moving_average": 6.05,
    "volume": 2258734.0,
    "market_cap": 353330000.0,
    "price_to_sales_ttm": 10.67,
    "price_to_book_mrq": 11.9,
    "roa_ttm": -0.3321,
    "roe_ttm": -1.2699,
    "shares_outstanding": 63210000.0,
    "pcnt_held_by_insiders": 0.23190000000000002,
    "pcnt_held_by_institutions": 0.904,
    "pcnt_short_of_float": 0.2189,
    "operating_cash_flow_ttm": -72350000.0,
    "levered_cash_flow_ttm": -41580000.0,
    "book_value_per_share_mrq": 0.49,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Xenoport, Inc."
  },
  "XOMA": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.13,
    "earnings_per_share": -0.52,
    "ebitda": -83750000.0,
    "eps_estimate_current_year": -0.54,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 1.4,
    "fifty_two_week_high": 4.93,
    "fifty_two_week_low": 0.69,
    "percent_change_from_200_day_moving_average": -0.2357,
    "percent_change_from_50_day_moving_average": -0.027000000000000003,
    "shares_owned": "N/A",
    "short_ratio": 2.85,
    "two_hundred_day_moving_average": 1.78,
    "volume": 5144615.0,
    "market_cap": 161590000.0,
    "price_to_sales_ttm": 14.12,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.7129000000000001,
    "roe_ttm": "N/A",
    "shares_outstanding": 118820000.0,
    "pcnt_held_by_insiders": 0.0786,
    "pcnt_held_by_institutions": 0.5579999999999999,
    "pcnt_short_of_float": 0.2384,
    "operating_cash_flow_ttm": -77040000.0,
    "levered_cash_flow_ttm": -40740000.0,
    "book_value_per_share_mrq": -0.25,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "XOMA Corporation"
  },
  "XON": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.63,
    "earnings_per_share": -0.31,
    "ebitda": -113360000.0,
    "eps_estimate_current_year": -0.63,
    "eps_estimate_next_quarter": -0.19,
    "fifty_day_moving_average": 35.18,
    "fifty_two_week_high": 69.45,
    "fifty_two_week_low": 24.41,
    "percent_change_from_200_day_moving_average": -0.2726,
    "percent_change_from_50_day_moving_average": -0.1109,
    "shares_owned": "N/A",
    "short_ratio": 7.56,
    "two_hundred_day_moving_average": 43.0,
    "volume": 2448059.0,
    "market_cap": 3640000000.0,
    "price_to_sales_ttm": 22.69,
    "price_to_book_mrq": 5.15,
    "roa_ttm": -0.1056,
    "roe_ttm": -0.0663,
    "shares_outstanding": 116400000.0,
    "pcnt_held_by_insiders": 0.0058,
    "pcnt_held_by_institutions": 0.8290000000000001,
    "pcnt_short_of_float": 0.3125,
    "operating_cash_flow_ttm": 14290000.0,
    "levered_cash_flow_ttm": -32159999.999999996,
    "book_value_per_share_mrq": 6.17,
    "next_earnings_announcement_date": [
      "2016-02-29",
      "2016-03-04"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Intrexon Corporation"
  },
  "XRAY": {
    "p_e_ratio": 30.72,
    "peg_ratio": 2.74,
    "earnings_per_share": 1.94,
    "ebitda": 566980000.0,
    "eps_estimate_current_year": 2.62,
    "eps_estimate_next_quarter": 0.62,
    "fifty_day_moving_average": 61.09,
    "fifty_two_week_high": 63.45,
    "fifty_two_week_low": 49.42,
    "percent_change_from_200_day_moving_average": 0.0742,
    "percent_change_from_50_day_moving_average": -0.0239,
    "shares_owned": "N/A",
    "short_ratio": 8.31,
    "two_hundred_day_moving_average": 55.51,
    "volume": 1265871.0,
    "market_cap": 8350000000.0,
    "price_to_sales_ttm": 3.1,
    "price_to_book_mrq": 3.69,
    "roa_ttm": 0.0596,
    "roe_ttm": 0.11599999999999999,
    "shares_outstanding": 140040000.0,
    "pcnt_held_by_insiders": 0.0034999999999999996,
    "pcnt_held_by_institutions": 0.9259999999999999,
    "pcnt_short_of_float": 0.0677,
    "operating_cash_flow_ttm": 563700000.0,
    "levered_cash_flow_ttm": 450530000.0,
    "book_value_per_share_mrq": 16.31,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "DENTSPLY International Inc."
  },
  "XTLB": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.22,
    "ebitda": -1900000.0,
    "eps_estimate_current_year": -0.01,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.6614,
    "fifty_two_week_high": 2.87,
    "fifty_two_week_low": 1.37,
    "percent_change_from_200_day_moving_average": -0.098208,
    "percent_change_from_50_day_moving_average": -0.018376,
    "shares_owned": "N/A",
    "short_ratio": 0.45,
    "two_hundred_day_moving_average": 1.8085,
    "volume": 320.0,
    "market_cap": 18060000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.67,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 11080000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": 0.10800000000000001,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.6,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "XTL Biopharmaceuticals Ltd."
  },
  "XXII": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.21,
    "ebitda": -14170000.0,
    "eps_estimate_current_year": -0.14,
    "eps_estimate_next_quarter": -0.03,
    "fifty_day_moving_average": 1.36,
    "fifty_two_week_high": 1.78,
    "fifty_two_week_low": 0.56,
    "percent_change_from_200_day_moving_average": 0.3741,
    "percent_change_from_50_day_moving_average": 0.0342,
    "shares_owned": "N/A",
    "short_ratio": 5.3,
    "two_hundred_day_moving_average": 1.03,
    "volume": 1490563.0,
    "market_cap": 99580000.0,
    "price_to_sales_ttm": 18.36,
    "price_to_book_mrq": 7.21,
    "roa_ttm": -0.39039999999999997,
    "roe_ttm": -0.8012,
    "shares_outstanding": 70620000.0,
    "pcnt_held_by_insiders": 0.3951,
    "pcnt_held_by_institutions": 0.049,
    "pcnt_short_of_float": 0.0352,
    "operating_cash_flow_ttm": -7650000.0,
    "levered_cash_flow_ttm": -653530.0,
    "book_value_per_share_mrq": 0.2,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "22nd Century Group, Inc."
  },
  "ZFGN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.42,
    "ebitda": -61200000.0,
    "eps_estimate_current_year": -2.71,
    "eps_estimate_next_quarter": -0.7,
    "fifty_day_moving_average": 10.98,
    "fifty_two_week_high": 55.36,
    "fifty_two_week_low": 5.43,
    "percent_change_from_200_day_moving_average": -0.7451000000000001,
    "percent_change_from_50_day_moving_average": -0.349,
    "shares_owned": "N/A",
    "short_ratio": 4.57,
    "two_hundred_day_moving_average": 28.05,
    "volume": 2683924.0,
    "market_cap": 194730000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.03,
    "roa_ttm": -0.2271,
    "roe_ttm": -0.41240000000000004,
    "shares_outstanding": 27240000.0,
    "pcnt_held_by_insiders": 0.2697,
    "pcnt_held_by_institutions": 0.836,
    "pcnt_short_of_float": 0.2217,
    "operating_cash_flow_ttm": -53320000.0,
    "levered_cash_flow_ttm": -32479999.999999996,
    "book_value_per_share_mrq": 6.97,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Zafgen, Inc."
  },
  "ZGNX": {
    "p_e_ratio": 18.84,
    "peg_ratio": 0.9,
    "earnings_per_share": 0.73,
    "ebitda": -102890000.0,
    "eps_estimate_current_year": 0.61,
    "eps_estimate_next_quarter": -0.76,
    "fifty_day_moving_average": 13.8,
    "fifty_two_week_high": 21.65,
    "fifty_two_week_low": 9.2,
    "percent_change_from_200_day_moving_average": -0.1143,
    "percent_change_from_50_day_moving_average": -0.009899999999999999,
    "shares_owned": "N/A",
    "short_ratio": 9.69,
    "two_hundred_day_moving_average": 15.42,
    "volume": 1274675.0,
    "market_cap": 261860000.0,
    "price_to_sales_ttm": 7.98,
    "price_to_book_mrq": 1.79,
    "roa_ttm": -0.3049,
    "roe_ttm": -0.7464,
    "shares_outstanding": 24760000.0,
    "pcnt_held_by_insiders": 0.35100000000000003,
    "pcnt_held_by_institutions": 0.632,
    "pcnt_short_of_float": 0.20170000000000002,
    "operating_cash_flow_ttm": -60420000.0,
    "levered_cash_flow_ttm": -57830000.0,
    "book_value_per_share_mrq": 7.67,
    "next_earnings_announcement_date": [
      "2016-03-08",
      "2016-03-14"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Zogenix, Inc."
  },
  "ZIOP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.02,
    "ebitda": -120800000.0,
    "eps_estimate_current_year": -0.81,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 11.82,
    "fifty_two_week_high": 14.93,
    "fifty_two_week_low": 4.52,
    "percent_change_from_200_day_moving_average": -0.2771,
    "percent_change_from_50_day_moving_average": -0.3173,
    "shares_owned": "N/A",
    "short_ratio": 11.85,
    "two_hundred_day_moving_average": 11.16,
    "volume": 8083153.0,
    "market_cap": 1060000000.0,
    "price_to_sales_ttm": 389.33,
    "price_to_book_mrq": 11.42,
    "roa_ttm": -0.6811,
    "roe_ttm": -1.8572,
    "shares_outstanding": 130889999.99999999,
    "pcnt_held_by_insiders": 0.0212,
    "pcnt_held_by_institutions": 0.509,
    "pcnt_short_of_float": 0.327,
    "operating_cash_flow_ttm": 13920000.0,
    "levered_cash_flow_ttm": -57170000.0,
    "book_value_per_share_mrq": 0.72,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ZIOPHARM Oncology, Inc."
  },
  "ZLTQ": {
    "p_e_ratio": 493.83,
    "peg_ratio": 7.66,
    "earnings_per_share": 0.06,
    "ebitda": 5690000.0,
    "eps_estimate_current_year": 0.13,
    "eps_estimate_next_quarter": 0.01,
    "fifty_day_moving_average": 31.27,
    "fifty_two_week_high": 38.49,
    "fifty_two_week_low": 25.79,
    "percent_change_from_200_day_moving_average": -0.0768,
    "percent_change_from_50_day_moving_average": -0.0525,
    "shares_owned": "N/A",
    "short_ratio": 11.34,
    "two_hundred_day_moving_average": 32.09,
    "volume": 1122295.0,
    "market_cap": 1160000000.0,
    "price_to_sales_ttm": 5.11,
    "price_to_book_mrq": 14.72,
    "roa_ttm": 0.019299999999999998,
    "roe_ttm": 0.0341,
    "shares_outstanding": 39030000.0,
    "pcnt_held_by_insiders": 0.09380000000000001,
    "pcnt_held_by_institutions": 0.9279999999999999,
    "pcnt_short_of_float": 0.2334,
    "operating_cash_flow_ttm": 10200000.0,
    "levered_cash_flow_ttm": 5800000.0,
    "book_value_per_share_mrq": 2.03,
    "next_earnings_announcement_date": [
      "2016-03-01",
      "2016-03-07"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "ZELTIQ Aesthetics, Inc."
  },
  "ZSAN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.58,
    "ebitda": -20140000.0,
    "eps_estimate_current_year": -2.5,
    "eps_estimate_next_quarter": -0.73,
    "fifty_day_moving_average": 2.78,
    "fifty_two_week_high": 12.4,
    "fifty_two_week_low": 2.25,
    "percent_change_from_200_day_moving_average": -0.5671,
    "percent_change_from_50_day_moving_average": -0.0837,
    "shares_owned": "N/A",
    "short_ratio": 0.97,
    "two_hundred_day_moving_average": 5.89,
    "volume": 8483.0,
    "market_cap": 30520000.0,
    "price_to_sales_ttm": 40.58,
    "price_to_book_mrq": 0.83,
    "roa_ttm": -0.4169,
    "roe_ttm": -1.6387,
    "shares_outstanding": 11970000.0,
    "pcnt_held_by_insiders": 0.5744,
    "pcnt_held_by_institutions": 0.35100000000000003,
    "pcnt_short_of_float": 0.0113,
    "operating_cash_flow_ttm": -19440000.0,
    "levered_cash_flow_ttm": -12800000.0,
    "book_value_per_share_mrq": 2.83,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Zosano Pharma Corporation"
  },
  "ZSPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -4.78,
    "ebitda": 0.0,
    "eps_estimate_current_year": -5.07,
    "eps_estimate_next_quarter": -1.6,
    "fifty_day_moving_average": 85.57,
    "fifty_two_week_high": 91.24,
    "fifty_two_week_low": 37.52,
    "percent_change_from_200_day_moving_average": 0.35340000000000005,
    "percent_change_from_50_day_moving_average": 0.0516,
    "shares_owned": "N/A",
    "short_ratio": 0.0,
    "two_hundred_day_moving_average": 66.48,
    "volume": 0.0,
    "market_cap": null,
    "price_to_sales_ttm": null,
    "price_to_book_mrq": null,
    "roa_ttm": null,
    "roe_ttm": null,
    "shares_outstanding": null,
    "pcnt_held_by_insiders": null,
    "pcnt_held_by_institutions": null,
    "pcnt_short_of_float": null,
    "operating_cash_flow_ttm": null,
    "levered_cash_flow_ttm": null,
    "book_value_per_share_mrq": null,
    "next_earnings_announcement_date": null,
    "sector": null,
    "industry": null
  },
  "ZYNE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.14,
    "ebitda": -8510000.0,
    "eps_estimate_current_year": -2.39,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 13.26,
    "fifty_two_week_high": 43.0,
    "fifty_two_week_low": 12.0,
    "percent_change_from_200_day_moving_average": -0.3268,
    "percent_change_from_50_day_moving_average": -0.0788,
    "shares_owned": "N/A",
    "short_ratio": 5.53,
    "two_hundred_day_moving_average": 18.15,
    "volume": 124523.0,
    "market_cap": 112420000.0,
    "price_to_sales_ttm": 394.57,
    "price_to_book_mrq": 2.7,
    "roa_ttm": -0.2006,
    "roe_ttm": -0.3546,
    "shares_outstanding": 9200000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0584,
    "operating_cash_flow_ttm": -8060000.000000001,
    "levered_cash_flow_ttm": -4730000.0,
    "book_value_per_share_mrq": 4.82,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Zynerba Pharmaceuticals, Inc."
  }
}